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Objective: To examine the association between patient- and provider-level 
characteristics and utilization of five low-value health care services and to estimate the 
prevalence and costs of those services.  
Methods: This study uses 2012 administrative claims data from an Upper Midwest 
health plan on enrollees who were at risk of receiving five commonly overused services, 
including: (1) Pap tests performed on females younger than 21 years old. (2) HPV tests 
performed on females younger than 30 years old. (3) PSA tests performed on male 
patients 75 years and older. (4) Colorectal cancer screening tests performed on patients 
older than 75 years old. (5) Imaging tests for non-specific low back pain within four 
weeks of diagnosis. I used a two-level mixed-effects probit model to estimate the 
association between patient and provider characteristics and occurrence of selected 
services. 
Results: The prevalence varied across services from 2.3 percent to 17.4 percent, and 
generated $1.38 million in allowed charges in one year. Probabilities of cervical cancer 
screening overuse increased with age for girls, and the probabilities for prostate and 
colorectal cancer screening declined with age for the elderly. Individuals with moderate 
and high health risks were more likely to receive low-value services, but the probability 
decreased for the highest risk category. Medicare enrollment was associated with 
increased utilization of low-value preventive cancer screenings. Some neighborhood 
socio-economic determinants were associated with overuse; these included a greater 
proportion of White residents, less well-educated residents, and neighborhoods with low 
iv 
 
poverty rate. After controlling for both patient and provider characteristics, overuse was 
positively associated with older providers, specialists, and physicians, as opposed to other 
non-physician clinicians.  
Conclusions: Overall, this study expanded on prior literature by examining additional 
provider characteristics associated with overuse. The patient- and provider level 
correlates and their relative contribution varied for the five selected services.  
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CHAPTER 1. INTRODUCTION 
This thesis is organized as follows. The first section provides an introduction and 
background information on the overuse of health care services, as well as a literature 
review. The second section is devoted to discussion of the analytic methods used in this 
study. The third section presents the results and findings from the quantitative analyses, 
including prevalence and associated costs of the selected low-value health care services, 
and the impact of patient and provider characteristics. The last section discusses 
implication of this study for practice and policy, and directions for future research.  
Background and Significance 
Rising Health Care Costs 
U.S. national health care expenditures are growing at an unsustainable rate - $2.8 
trillion in 2012, or $8,915 per capita, accounting for 17.2 percent of the nation’s gross 
domestic product (GDP). This is more than twice as much as the average of developed 
countries measured per capita and as percentage of GDP [1-3]. Expenditure reached $3.3 
trillion in 2016 and the share of GDP devote to health care spending was 17.9 percent, 
more than any other country [4]. By 2022, an estimated one-fifth of U.S. GDP will be 
spent on health care or $5 trillion. This increase translates into an average growth rate of 
5.8 percent annually between 2012 and 2022, bringing annual per capita health 
expenditures to $14,664 [5, 6]. Despite a reputation of efficient delivery of care in 
Minnesota, health care spending reached $39.8 billion in 2012, accounting for 13.5 
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percent of the state’s economy, or $7,403 per capita. State projections indicate that health 
care expenditure may almost double by 2022 [7].  
U.S. national health expenditures on personal health care are increasing largely 
due to the growth in physician and clinical services among all types of personal health 
care services [1]. Private health insurance spending on these services is growing fast with 
an acceleration in the out-of-pocket spending, while Medicare spending decelerated  
slightly in 2012 [2]. Non-price factors including the volume and intensity of services are 
growing at a faster pace than unit prices in fees, leading to the increase in private health 
insurance payments for physician and clinical services [2, 6]. It becomes not only a 
policy imperative but it is also important for all health stakeholders including patients, 
providers, and payers to work together to reducing ever-escalating health care costs. 
Overuse in Health Care 
In addition to rising health care costs, there is growing evidence that the current 
way health care is delivered include too much waste. Though analytic approaches varied, 
several studies arrived at similar approximations on the amount of waste, estimated at 
least 30 percent to one-third of national health expenditures were spent on unnecessary 
health care services, accounting for approximately $700 billion in waste annually [8-10]  
The Institute of Medicine (IOM) convened a series of meetings and defined six 
major areas of excess health costs: unnecessary services, services inefficiently delivered, 
prices that are too high, excessive administrative costs, missed prevention opportunities, 
and medical fraud. The IOM reported more than $750 billion were wasted in 2009 and 
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the biggest contributor, unnecessary services, was more than $200 billion [8]. The 
Centers for Medicare and Medicaid Services (CMS) estimated that 15 to 30 percent of 
health care expenditures are wasteful. Medicare spending exceeded $500 billion in 2010, 
suggesting that $75 billion to $150 billion could be cut without reducing necessary 
services [9, 11]. The Congressional Budget Office reported that 10 to 30 percent of $2.7 
trillion spending on health care in U.S. in 2011 is unnecessary, a midpoint estimate of 
$910 billion, or 34 percent of national health expenditures were wasted in a year. The 
spending on overtreatment is estimated to be between $158 and $226 billion, representing 
the largest category of waste. Upon this trend, overall excess expenditures would be 
translated to over a trillion in 2014 [12]. 
Physician and Patients’ Concern on Overuse 
While the concept still is evolving, there is broad agreement among physicians 
that the negative consequences of some procedures for some patients outweigh the 
expected benefits. In a survey of primary care providers conducted by the American 
Medical Association (AMA) in 2009, 42 percent of primary care providers reported that 
their patients received too many unnecessary medical services [13].  According to a 
nationwide survey for physicians in 2013, over sixty percent of providers reported 
patients request tests or procedures that the clinician considered unnecessary at least 
several times per week. More than seventy percent of physicians said that average 
medical doctor prescribes an unnecessary service at least once a week. Eighty percent of 
them said they would order tests or procedures when a patient insisted [14]. In 2013, a 
local survey conducted by the Minnesota Medical Association (MMA) reported 35 
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percent of local practicing physicians said that patients ask for unnecessary tests or 
procedures several times a week, and only 44 percent of patients would follow the 
physician’s advice to avoid it. Specifically, a national survey found that more than one-
third of physicians would order lumbar magnetic resonance imaging for uncomplicated 
acute low back pain if a patient insisted on it even after the physician explained that it 
was unnecessary [15]. 
From the patient’s perspective, according to a survey conducted by the 
Commonwealth Fund, one-third of U.S. adults reported they experienced duplicative or 
unnecessary care [16]. In another recent national survey, less than 10 percent of the 
patients reported that their physician had informed them about the risk of overdiagnosis 
and overtreatment when discussing cancer screening [17].  
Literature Review 
Defining Overuse 
Overuse of health services increasingly is recognized as a problem that affects 
both the quality and cost of health care. In addition to physicians’ and patients’ concerns, 
policy and advocacy groups and researchers have a longstanding interest in overuse. An 
“Inappropriate service” was defined in 1980s by the RAND Corporation as a service 
when the expected negative consequences (e.g., mortality, morbidity, anxiety, pain, time 
loss) outweighed the expected benefits of a procedure [18]. In 1998, the Institute of 
Medicine Roundtable on Health Care Quality defined the term “overuse” as provision of 
care in circumstances where potential for harm exceeds the possible benefit [19]. Their 
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report in 2010 categorized “unnecessary service” as (1) overuse of services beyond 
evidence-established levels, (2) discretionary use of services beyond benchmarks, and (3) 
unnecessary choice of higher-cost services [8]. 
In 2008, the National Quality Forum (NQF) convened the National Priorities 
Partnership (NPP) and declared a priority of curbing overuse while ensuring the delivery 
of appropriate care. Nine domains of “overuse” or “inappropriate care” were identified: 
(1) inappropriate medication use, (2) unnecessary laboratory tests, (3) unwarranted 
maternity care interventions, (4) unwarranted diagnostic procedures, (5) inappropriate 
non-palliative services at the end of life, (6) unwarranted surgical procedures, (7) 
unnecessary consultations, (8) preventable emergency department visits and 
hospitalizations, and (9) potentially harmful preventive services with no benefits [20]. In 
2009, three types of overuse were identified at Agency for Healthcare Research and 
Quality (AHRQ) Appropriateness Small Conference: (1) clinically harmful overuse, (2) 
overuse that is not cost-effective, and (3) overuse of appropriate care.  
While definitions differ in the literatures, more recent studies used the term “low-
value” to indicate care for which risk of harm outweighs potential clinical benefit, given 
the cost, available alternatives, and preferences of the patient [21]. For example, an 
imaging test is considered as low-value is if it is unlikely to provide information that will 
change the course of treatment. For clarification, the terms “overutilization”, “overuse”, 
“inappropriate”, “unnecessary”, and “low-value”, all refer to this pattern of resource use 
in this study. 
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Developing Guidelines Identifying Overuse 
The overuse of health care services is prevalent, inefficient, and costly to both 
individuals and the U.S. health system [22]. Low-value services do not only result in 
unsustainable expenditures, but also pose significant risks to the health of individual 
patients and the overall population. They are less cost-effective compared to alternatives 
and other appropriate treatments, and often trigger unnecessary follow-up tests and 
treatments with additional risks and costs.  
According to the Institute of Medicine report, one-third of the health care 
expenditures could be considered wasteful and one-third of this waste is due to the 
provision of low-value services, which provide us a sense of the scope of overuse [8]. 
However, while there is long-standing agreement about the need to reduce overuse and 
deliver high-value care, there is limited guidance and consensus on which services are 
low-value, why they are provided, how to measure them and what to do to reduce it.  
Over the past several years, scholars, professional societies, provider 
organizations, and expert panels have conducted evidence-based reviews of specific 
health care services and identified low-value services that contribute to waste in health 
care. In 2008, the Centers for Medicare & Medicaid Services (CMS) released a list of 
health services that may be low-value or provide minimal benefit as potential candidates 
for national coverage determination (NCD). A NCD is a nationwide determination of 
whether Medicare will consider the service as reasonable and necessary and pay for it. 
The CMS is keeping this list updated by synthesizing public’s concern and internal 
consideration. Some NCD topics sparked discussion but most services like PSA tests and 
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colonoscopies are still covered for all Medicare beneficiaries. The United States 
Preventive Services Task Force (USPSTF), an independent panel of experts in primary 
care and prevention, has conducted evidence-based guidelines to review clinical 
preventive health care services by age, gender and medical history. Their 
recommendation statements suggested that those who receive health services outside of 
these guidelines incur potentially unnecessary and costly services of low-value [23]. 
In recent years, physician specialty societies are taking the lead in developing 
guidelines to identify low-value services across different specialties. A working group of 
the American College of Physicians (ACP) devoted early effort to identify high-value, 
cost-conscious screening or diagnostic tests. They convened a workgroup of physicians to 
identify 37 common clinical situations in which screening and diagnostic tests are used in 
ways that do not reflect high-value care. Examples include screening for colorectal 
cancer or in adults older than 75 years or in adults with a life expectancy of less than 10 
years; screening for prostate cancer in men older than 75 years or with a life expectancy 
of less than 10 years; and performing imaging studies in patients with nonspecific low-
back pain [24]. The concept of “Top Five List” proposed by Brody provided the 
groundwork of developing lists of top five unnecessary tests or procedures commonly 
ordered by clinicians [25]. In 2009, inspired by the “Physician Charter on 
Professionalism” [26], the Promoting Good Stewardship in Clinical Practice project 
funded by the American Board of Internal Medicine (ABIM) foundation put the 
framework of Brody into practice. The project engaged National Physicians Alliance 
(NPA) members from three primary care specialties: Family Medicine, Internal Medicine, 
and Pediatrics. In 2011, each group released an evidence-based list of “5 Things You Can 
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Do in Your Practice” identified common clinical activities where the quality of care and 
efficiency of resource use could be improved [27]. Twelve unique low-value services 
from NPA’s “top 5 lists” generated $6.76 billion in health expenditures in 2009 [28, 29].  
Originally piloted by NPA’s Good Stewardship project, the Choosing Wisely 
campaign was launched in April 2012 for patients and physicians to question about 
overuse of health care resources and encourage them to share decision-making on 
treatment choices [30]. Nine leading medical specialty societies representing 375,000 
physicians each released a list of "Five Things Physicians and Patients Should Question" 
and identified five tests or procedures commonly used in their field, whose necessity 
should be questioned and discussed [27, 30]. The Choosing Wisely Campaign is a 
collaborative multi-year effort by the ABIM Foundation to improve health care outcomes 
and reduce costs. By the end of 2017, their original “Top-five” lists now have grown to 
over 500 tests and procedures identified by over one hundred medical specialty societies 
as low-value, and more organizations are joining. Their recommendations were shared 
with their collective membership of more than 700,000 physicians. Consumer Reports, 
the world’s largest independent consumer organization, has also participated to provide 
patient-education resources and promote dissemination. 
Measures and Magnitude of Overuse 
While many public and private sector initiatives, including the Choosing Wisely 
campaign, are gaining momentum in developing guidelines to identify low-value services 
and to improve quality of care, there has been limited empirical work on the extent to 
which patients actually are receiving the low-value services and the magnitude of overuse. 
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According to a systematic review of 22 years (1978-2009) of studies on overuse in the 
U.S., 172 articles examined rates of procedures, tests and medications [31]. Within each 
service studied, rates of overuse varied widely in different studies. 
Previous studies estimating the magnitude of overuse are limited, due in part to 
the lack of a comprehensive set of overuse measures. Most overuse concepts in medical 
standards and clinical guidelines are missing specific definitions of the selection criteria 
for valid measure development. In a critical review of existing overuse measures, Chan 
and colleagues identified 160 measures of overused health services, but only 37 were 
specified measures that provided definitions of denominators, numerators and exclusions.  
Only 15 of the specified measures could be computed using only administrative claims 
data. Most measures require medical records or patient-reported data. In addition, the 
specified measures were limited to only a few clinical topics [32].  
The RAND Appropriateness Method (RAM) is the first and most widely accepted 
method for defining appropriate care. It provided guideline to measure the 
appropriateness of medical interventions in a large number of clinical situations [33, 34]. 
More organizations started developing measures of overuse in recent years. The National 
Quality Forum (NQF) and the National Committee for Quality Assurance (NCQA) have 
identified curbing overuse as one of their priority areas and are developing measures to 
identify inappropriate care [35]. The NQF endorsed specialty performance standards for 
physician-focused ambulatory care through their Quality Positioning System [36]. The 
NCQA developed the Healthcare Effectiveness Data and Information Set (HEDIS) 
provided specifically defined performance measures of care and service. The CMS 
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collaborated with the Lewin Group and developed a set of outpatient imaging efficiency 
measures disseminated through QualityNet. The AHRQ established National Guideline 
Clearinghouse (NGC) to provide quality measures and evidence-based clinical practice 
guidelines. 
While most previous studies focused on the overall waste of overuse, not many 
studies have looked at the magnitude of overuse of specific services, particularly 
preventive screening and imaging tests. Screening tests have been used for the early 
detection and treatment of chronic diseases, such as cancers. Diagnostic imaging tests 
have been used to warrant further treatment if a disease condition exists. These tests 
could increase individual’s life expectancy and reduce costs. However, cancer screening 
and diagnostic imaging tests are associated with complications and risks, leading to 
overdiagnosis and overtreatment [37]. As reported in a national survey, Americans have 
been enthusiastic about preventive screening for years. Eighty-seven percent adults 
believe that routine cancer screening is always good [38]. Among the medical guidelines 
identifying unnecessary services, NPA, ACP, USPSTF, and Choosing Wisely lists largely 
are populated by overuse of screening and imaging studies. However, previous studies 
are focused principally on the assessment of antibiotics use or over-prescription. In 
Korenstein’s 2012 systematic review, 18 unique therapeutic procedures, 24 diagnostic 
tests, and 13 medications were evaluated among the 172 studies, 59 of them focused on 
antibiotics for upper respiratory tract infections, only 8 publications addressed preventive 
and diagnostic services [31]. Furthermore, the published interventions to reduce overuse 
by primary care providers are outdated. In a total of 35 interventions between 1996 and 
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2011, 24 interventions to reduce overuse were attributed to the clinical domain of 
antibiotics, prescribing or polypharmacy [39]. 
Low-value preventive service use of low-risk or asymptomatic patients may lead 
to unnecessary follow-up treatment which result in substantial harms and costs. Overuse 
of screening and imaging studies is prevalent, although the rate of specific health care 
services varied. Methodologically, specifying appropriateness for preventive cancer 
screening and diagnostic services relies on fewer prognostic factors than most services, 
and often do not require clinical records [22]. Imaging services represented the largest 
category of low-value services with specified measures and measurement opportunities 
[32]. The current dearth of research allowed further investigation on the overuse of 
preventive cancer screening and diagnostic imaging studies. 
Since the launch of the Choosing Wisely campaign, several recent studies have 
published prevalence of a limited set of low-value service measures primarily using a 
national population. A study examined costs of 12 commonly overused services 
identified by the Good Stewardship Working Group using data from federal medical 
surveys. Tests included Pap tests to screen for cervical cancer in teenagers and low back 
pain imaging studies. The 12 health care services accounted for $6.8 billion in medical 
costs in 2009. The largest waste category in dollars was physicians ordering brand-name 
statins before trying patients on a generic drug first, which accounted for $5.8 billion [27].  
In recent years, researchers started translating Choosing Wisely recommendations 
into claims-based algorithms for measurement purposes. Both the prevalence of these 
services and the associated spending has been estimated at the population level. One of 
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the first data-driven efforts to quantify the magnitude of low-value care using 
administrative data was published in 2014. This study developed a list of 26 overuse 
measures using 2008-2009 Medicare claims data. Depending on the level of sensitivity 
used, their measures found that 25 to 42 percent of beneficiaries received at least one 
low-value service in a year, comprised between 0.6 and 2.7 percent of Medicare spending. 
Among them, 4 to 9 percent of patients with a diagnosis of low back pain received non-
indicated imaging, corresponding to 1.1 to 2.5 million beneficiaries for the entire 
Medicare population. Estimates of annual Medicare spending on imaging for 
uncomplicated low back pain ranged from $82 million to $226 million, while the cost of 
all 26 services totaled 1.9 to 8.5 billion for the entire Medicare population, or $189 
to$227 per beneficiary [40].  
Taking low-value low back pain imaging test as an example, the rates of overuse 
varied widely. Another retrospective analysis using Medicare claims data between 2006 
and 2011 to compare rates of low-value services estimated that among 2 million 
beneficiaries with uncomplicated low back pain, 22.5 percent received an X-ray, CT scan, 
or MRI within six-weeks of initial diagnosis [41]. A study examined the use of seven 
Choosing Wisely low-value services in commercially insured adults. The percentage of 
receiving low back pain imaging remained high (53.7 percent) from 2010 to 2013 [42]. 
Another study examined the use of 28 Choosing Wisely low-value services in 1.5 million 
commercially insured adults in 2013 and found the rate of imaging for nonspecific low 
back pain was only 1.3 percent [43]. 
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Factors Contributing to Overuse 
While previous studies have examined potential effects of individual or provider-
level variations on the health services utilization, results have focused largely on 
underuse of services [44]. Factors associated with underuse of preventive care and 
disparities in access to care have received a great deal of attention in the health services 
research literature; the interest in overuse is more recent and there are fewer empirical 
studies on factors contributing to overuse. 
In 1990, the RAND Corporation assessed the use of carotid endarterectomy, 
upper gastrointestinal endoscopy, and coronary angiography and they concluded that 
appropriateness of care cannot be adequately explained from easily observable 
characteristics of patients, physicians, or hospitals [45, 46]. Other studies showed that 
overuse rates could not be explained by different health care systems or different 
coverage types, or geographic locations. A 2013 systematic review by Keyhani compared 
rates of overused health care services in different health care systems and among 
different coverage types. The review provided no consistent evidence that any specific 
type of delivery system or insurer had lower rates of overuse of health care services [47]. 
A comparison study on low-value care in Medicaid vs. commercially insured populations 
using regional claims data found no consistent association between insurance types. They 
summarized low-value care may be more closely related to local practice patterns than to 
insurance benefit structures [48]. Another systematic review by Keyhani and colleagues 
on geographic variation found limited literature that explored the relationship between 
inappropriate use of procedures and geographic variations in cost or intensity of services 
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[49]. However, the influence of regional variation on health care utilization has been 
controversial. When explaining cost-outcomes disparities, studies reported geographic 
variation across the U.S. [50, 51]. According to other studies, geographic variation is not 
associated with overuse, underuse or misuse [49, 52]. 
In recent years, some studies have shown that overuse varies by patient 
characteristics. For example, patient’s socioeconomic status, race, and ethnicity are 
known to impact prevalence and cost of health services use [53]. There are substantial 
disparities in utilization of low-value screenings across socio-economic groups, but there 
is a lack of agreement about their relative contribution. For example, overuse of 
colorectal cancer screening and cervical cancer screening are associated with more 
frequent outpatient visits. Overuse did not vary by patient demographic characteristics or 
health status for colorectal cancer screening, but younger women are more likely to 
receive the Pap test [54-56]. Some studies have reported that patients who were male, 
white, and with a higher income level were more likely to receive unnecessary colorectal 
cancer screening [43].  Other studies concluded that patients who were female, African-
American, or had more comorbidity were more likely to experience colonoscopy overuse 
[57-60]. 
Relatively few studies have identified the potential provider characteristics 
associated with overuse, and the findings vary from one study to another. Previous 
studies have examined physician factors affecting utilization of services and referrals to 
specialists, and medical group determinants of the volume of resource used [61, 62]. 
Controlling for patient factors and disease severity, larger-size medical groups with a 
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higher percentage of primary care providers, and multispecialty group practices, were 
associated with higher resource utilization and more inappropriate emergency department 
(ED) visits [62, 63]. Bridges and colleagues used 2008 Medicare claims data to examine 
healthcare infrastructure measures associated with 20 overused services, and found that 
overuse was associated with higher hospital bed count, hospital-based physicians count, 
and primary care physician count [64]. Moreover, physicians who were female or were 
gynecologist were more likely to overuse cervical cancer screening [56, 65]. Another 
study concluded that physicians who were male, older, or urologists were more likely to 
order inappropriate prostate cancer screening. Nurse practitioners and physician assistants 
had a lower level of inappropriate prostate-specific antigen (PSA) screening than 
physicians [66]. However, family physicians had a lower rate of inappropriate MRI 
ordering for the low back than neurologists, neurosurgeons, or orthopedic surgeons [67]. 
Rural providers were reported more likely to overuse imaging studies [68]. 
While some studies reported that overuse varies by patient or provider 
characteristics, most studies are limited since they did not systematically look at different 
levels of factors, such as the patient and provider level characteristics. Colla and 
colleagues incorporated a set of both patient and provider characteristics in their model 
and found areas with higher proportions of minority groups (Hispanic, black), worse 
health, higher overall Medicare spending, and a greater concentration of specialists used 
more low-value care. Rural areas, areas with a greater proportion of population in poverty, 
and a greater density of primary care providers were less likely to use low-value tests and 
services [41].  
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In sum, to date in the literature, a large proportion of previous research used data 
collected prior to 2010. Most claim-based studies used administrative data from Medicare, 
and only assessed a limited set of measures. Although previous studies found statistically 
significant differences across health plans in utilization rates of six preventive care 
services [69], results based on older adults in fee-for–service Medicare may not be 
generalizable to younger populations or those in managed care [40].  
This analysis expands on prior studies by incorporating both government and 
commercial health plans. Its unique contribution is the examination of overuse of 
imaging and screening studies as a function of both patient- and physician-level 
characteristics in a hierarchical model. A hierarchical model could ascertain the precision 
of their relative contribution by accounting for the within-provider correlation due to 




CHAPTER 2. METHODS  
Specifying the Low-value Services 
Previous studies have shown that administrative data provide an important source 
of information that can be used to identify patients receiving potentially overused 
procedures but the identification process is not straightforward [70]. Identification of 
low-value services can be an essential first step in improving quality and reducing 
overuse. 
I considered services that have been identified as low-value by professional norms, 
clinical practice guidelines, and panel recommendations (e.g., Choosing Wisely 
campaign, USPSTF, NPA, ICSI) and existing consensus overuse measures from major 
measure developers and measure clearinghouses (e.g., QualityNet, NCQA, AHRQ’s 
NGC, NQF), or peer-reviewed medical literature [71]. Because many procedures require 
judgment based on symptoms, testing or clinical results, the health plan administrative 
data may lack the clinical information and level of specificity to determine the 
appropriateness of the procedure. Many risk factors could not be captured in claims (e.g., 
smoking status, family history). I reviewed the list of low-value health care services and 
selected the low-value services reliably measurable through claims and applicable to the 
general population. 
I chose procedures with the least ambiguous conditions that did not require 
information on patient symptoms, risk factors, or disease severity for their identification; 
as such information cannot be directly gathered from claims (e.g. cardiac imaging in the 
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evaluation of patients without risk factors or symptoms). I also excluded procedures that 
did not require multiple (>2) years of claims for their identification (e.g. Dual-energy X-
ray absorptiometry bone scan in an interval shorter than two years). Moreover, services 
that required prescription drug claims were also excluded (e.g. routine antibiotic 
prescription for acute sinusitis).  
After applying the exclusion criteria, I developed five low-value scenarios that 
could be evaluated using health plan claims data. Selected health care services are based 
on both the “Five Things Physician and Patients Should Question” lists from the 
Choosing Wisely Initiative and the USPSTF “D” recommendations.  They come from the 
original 45 non-recommended services in the initial nine specialty societies’ lists released 
in 2012, representing 15 Choosing Wisely recommendations. They also represented a 
compilation of services listed by multiple agencies, and associated with high levels of 
overuse based on previous literature.  
Cervical cancer screening for young women 
Cervical cancer is a disease in which cells in the cervix, the lower, narrow end of the 
uterus, grow out of control. Each year, approximately 12,000 women are diagnosed with 
cervical cancer in the U.S., resulting in an estimated 4,000 deaths annually[72]. Cervical 
cancer can be detected early by Cytology (Pap test) or Cytology/HPV co-testing. A Pap 
test looks for cells that are not normal and can cause cervical cancer.  Pap tests scrape 
cells from the cervix that are viewed under a microscope to look for pre-cancerous 
lesions and cellular changes. Pap tests can detect pre-cancerous lesions before developing 
into cervical cancer and identify cervical cancer in its earliest states when treatment is 
19 
 
most effective. An HPV test looks for high-risk HPV genotypes, which are known to 
cause precancerous cell changes and cervical cancer.  
All women with a cervix are at risk for cervical cancer, but it occurs most often in 
women over the age of 30. Cervical cancer is rare in women younger than 21 years old, 
even if they are sexually active. According to Surveillance, Epidemiology, and End 
Results statistics, cervical cancer occurs in approximately 1 in 1,000,000 girls aged 15 to 
19 years. Cervical cancer screening in adolescents has not changed the incidence of 
cervical cancer [73]. Adolescent females tend to have high rates of transient HPV 
infection and regressive cervical abnormalities [72, 74]. Abnormal cervical cytology 
findings due to HPV infections are common, leading to a higher incidence of false-
positive results in younger women [75]. Most suspected abnormalities for cervical cancer 
disappear spontaneously in adolescents. 
A Pap test could cause temporary bleeding and infection. Abnormal screening test 
results may lead to psychological harms including anxiety, distress and depression for 
adolescents [74], and also may result in more frequent unnecessary possibly harmful 
follow-up tests and treatments [72]. A HPV testing, alone or in combination with 
cytology, could result in more harm than benefits in women younger than 30 years of age. 
The harms include additional testing and invasive diagnostic procedures such as 
colposcopy and cervical biopsy that might cause bleeding, cramping, discharge, and 
infection. Follow-up tests, lab fees and treatments resulting in significant costs [76][77]. 
Approximately 4.7 million women under 21 receive a Pap test annually, equating to a 
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cost of about $500 million per year in the United States. This estimated cost does not 
include downstream costs for monitoring and/or treating irregular screening results [75]. 
Before 2012, cervical cancer screening guidelines differed by age to start and how 
often to get screened for cervical cancer [78]. This made it difficult for providers to 
follow the guidelines and provide preventive services. Fewer than 25 percent of clinicians 
provide care consistent with current cervical cancer screening guidelines, even though 
many medical societies and evidence-based guidelines recommend against cervical 
cancer screening in females less than 21 years of age[79, 80]. The USPSTF determined 
that screening of women younger than 21, regardless of sexual history, does not reduce 
the incidence and mortality of cervical cancer compared with beginning screening at 21. 
In 2012, a symposium cosponsored by the American Cancer Society (ACS), the 
American Society for Colposcopy and Cervical Pathology (ASCCP) , and the American 
Society for Clinical Pathology (ASCP), which was attended by 25 organizations, 
recommended that cervical cancer screening by Pap test should not be used for women 
aged <21 years, regardless of initiation of sexual activity [81]. The guidelines are based 
on a systematic evidence review, contributions from six working groups and have 
become the consistent standard for cervical cancer screening. The agencies in Table 1 
recommend against screening for women younger than 21 years, and recommend against 
screening with HPV testing (alone or with cytology) prior to age 30.  
Prostate cancer screening for men 75 years and older 
Prostate cancer is cancer of the male prostate gland, which is the most common 
cancer affecting men. Approximately one out of six men in the United States will develop 
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prostate cancer in their lifetime. However, it grows slowly and does not have symptoms 
until it has spread, and the mortality rate is relatively low [82].  
The early detection of prostate cancer is difficult due to lack of symptoms at early 
stages. Screening for prostate cancer is carried out primarily by prostate-speciﬁc antigen 
(PSA) tests. PSA is a protein produced by cells in the prostate gland and released into the 
blood. The screening test measures the level of PSA in human blood. Individuals with 
higher PSA levels have a greater risk of prostate cancer. It also serves as a tumor marker 
to follow the progress of diagnosed prostate cancer.  
Medicare provides coverage of preventive prostate cancer screening tests for the 
early detection of prostate cancer. PSA has been a common screening test among older 
men, including those with severe comorbidity[83]. The introduction of prostate cancer 
screening reduced the incidence and mortality of advanced stage prostate cancer. 
However, there is convincing evidence that PSA-based screening leads to substantial 
over-diagnosis of prostate tumors, up to two-thirds of prostate cancer detected by PSA 
test are over-diagnosed [84].  Because PSA tests have a high rate of both false positive 
and false negative results, the risks of follow-up treatment are significant [85]. Higher 
than normal PSA levels may be due to other reasons including natural variation over time, 
prostatic infections and benign prostate hyperplasia [86]. In addition, the imperfect nature 
of PSA test could lead to stress and anxiety, unnecessary follow-up tests and subsequent 
invasive procedures, associated costs and quality of life decrements. Since all-cause 
mortality rate increases with age and prostate cancer grows slowly, the screening 
procedure loses its efficiency in older patients. From 1986 to 2005, one million men 
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received surgery, radiation therapy or both who would not have been treated without a 
PSA test. At least 5,000 among them died soon after surgery and 10,000 to 70,000 
suffered serious complications [87, 88]. The U.S. Prostate, Lung, Colorectal, and Ovarian 
(PLCO) Cancer Screening Trial on prostate-cancer mortality concluded that PSA 
screening does not significantly reduce the rate of death from prostate cancer [89]. For 
patients with limited life expectancy, screening exposes them to immediate harms with 
little benefit. In addition, it imposes substantial psychological and financial costs[87]. 
Furthermore, agreement on prostate cancer screening guidelines is not unanimous 
in the U.S. The optimal screening policy for prostate cancer is highly debated among 
health care professionals and researchers. According to the USPSTF recommendation 
released in 2008, there is sufficient evidence that the associated harms of routine 
screening and treatment outweigh the overall benefits of PSA-based screening for 
prostate cancer in men 75 years or older. The USPSTF updated its recommendations in 
2012 discouraging the use of PSA-based prostate cancer screening in asymptomatic men 
in all age groups. In 2017, the USPSTF are back to recommendations against PSA-based 
screening for prostate cancer in men age 70 years and older. It concluded that there is no 
reduction in prostate cancer-specific and all-cause mortality from PSA-based screening, 
and there are harms related to potentially unnecessary subsequent evaluation and 
treatments [88].  
Similarly, the American Urological Association (AUA) recommended no routine 
screening of men after age 70 years in their 2013 guideline for early detection of prostate 
cancer. ACP also recommended against screening for prostate cancer in men older than 
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75 years or in adults with a life expectancy of less than 10 years through the Choosing 
Wisely. The ACS, American Society of Clinical Oncology (ASCO), American Academy 
of Family Physicians (AAFP), and American Geriatrics Society (AGS) all recommend 
against routine PSA-based screening for prostate cancer without considering life 
expectancy and the risks of testing [90]. Though CMS considered PSA-based screening 
as a potentially overused procedure for national coverage determination, it is covered for 
all Medicare beneficiaries [91].  
The agencies shown in Table 2 developed major clinical practice guidelines that 
recommend against PSA screening in asymptomatic men older than 75 years, or with less 
than a 10-year life expectancy.  
Colorectal cancer screening for adults older than 75 years 
Colorectal cancer is the third most common cancer and the second leading cause 
of cancer-related deaths in the U.S. for both men and women [92]. The lifetime risk of 
colorectal cancer is 5 percent among all Americans [93]. However, the incidence and 
mortality of colorectal cancer has been declining in the U.S. due to the routine preventive 
screening [92].  
The most common symptom of colorectal cancer is blood in the stool. Screening 
for colorectal cancer could identify pre-cancerous adenomas that can be removed before 
they develop into cancer [92]. There are several different screening services to test for 
adenomas or colorectal cancer, each screening procedure can be used alone or in 
combination. Fecal occult blood test (FOBT) checks for hidden blood or DNA in the 
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stool. The flexible sigmoidoscopy uses a short tube to examine polyps in the rectum and 
lower colon. The barium enema is an X-ray examination of the large intestine to check 
for polyps or other abnormalities. CT colonography inserts a tube into the rectum and an 
X-ray scanner creates pictures. The colonoscopy uses a colonoscope to provide a direct 
visual inspection of the colon and rectum for adenomas or early cancer. The colonoscopy 
is considered to be a reference standard among all colorectal cancer screening tests. A 
positive result or abnormalities from alternative tests requires a follow-up colonoscopy to 
confirm diagnosis and remove lesions [94]. 
Medicare provides coverage of colorectal cancer screening for all beneficiaries 
aged 50 and older. Routine screening colonoscopies in patients over 75 is common. 
Medicare spent over $100 million for screening colonoscopies in 2009, 40 percent of 
which was for patients over 75 [95]. 
The test provides the opportunity to detect precancerous polyps and reduce the 
incidence of cancer, but it takes a long time to show benefits from the procedure through 
a reduced incidence of cancer. Moreover, colonoscopy is associated with serious 
complications such as perforation, major bleeding, diverticulitis, severe abdominal pain 
and cardiovascular events [60]. Complications can lead to potential harmful subsequent 
procedures, surgery, and hospitalization. The risk of harm associated with screening 
begins to outweigh the benefit of early detection of colorectal cancer after the age of 75 
[96]. 
The agencies shown in Table 3 summarized the evidence on colorectal cancer 
screening. In 2008, the USPSTF recommends against routine screening for colorectal 
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cancer using a fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy in adults 
older than 75 years, (and against any screening for patients over 85, routine or not) [97]. 
In the Choosing Wisely Campaign, ACP also recommended against screening for 
colorectal cancer in adults older than 75 years or in adults with a life expectancy of less 
than 10 years.  
Imaging studies for non-specific low back pain 
Low back pain is the fifth most common reason for physician visits in the United 
States [27]. It is also among the most common causes of disability and lost productivity 
in the United States. Half of the U.S. adults have an episode of acute low back pain in a 
year and more than 80 percent of the population will experience low back pain in their 
lifetime, which is the most common cause of job-related disability and a leading 
contributor to missed work [98] [99]. According to the 2002 National Ambulatory 
Medical Care Survey, low back pain was the most frequent cause of pain reported by 
patients seeking outpatient medical care. Approximately 26 percent of patients surveyed 
reported experiencing low back pain within the last 3 months [99], and 2 percent of 
primary diagnoses for office visits during that year were for low back pain[100]. Total 
costs of low-back pain exceed $100 billion per year [101]. Individuals with back pain 
incurred 60 percent higher health care costs per capita than those without back pain[102].  
Physicians perform imaging tests such as plain radiography (X-ray), computed 
tomography (CT) scans, and magnetic resonance imaging (MRI) for low back pain to 
determine the presence of serious underlying conditions, such as cancer or spinal 
infection [103]. Imaging tests are commonly used, but ordering routine spine imaging 
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within the first six weeks has not been shown to improve clinical outcomes [104] [105]. 
Low back pain usually subsides in about a month; over 90 percent of patients with low 
back pain recover spontaneously within four weeks with no obvious improvements from 
imaging, while only 5 percent remain disabled for more than 3 months [106, 107]. The 
likelihood of identifying a serious underlying condition of lower back pain with imaging 
is rare [108]. Over 85 percent of patients seen at primary care practices have low back 
pain that cannot be attributed to a specific disease or an anatomic abnormality [109]. One 
study estimates that only 0.01 percent of patients with low back pain in primary care 
settings have spinal infection, and 0.7 percent of them have metastatic cancer [99] [110].  
There is substantial evidence demonstrating little benefit for the potential harmful 
effects involved in imaging of the spine in patients with acute low back pain during the 
early phase of symptom onset. Lumbar radiography is responsible for the greatest 
proportion of total radiation exposure from medical imaging in the U.S. given its 
frequency of use [111]. Finding abnormalities that are not clinically relevant to the pain 
could divert attention and expose patients to unnecessary risks and harms that complicate 
recovery. X-ray is unhelpful for the initial routine management of low back pain unless 
red flags or more complicating factors are present [105] [112][113]. Red flags include 
severe progressive neurologic deficit, history of cancer, trauma, fracture, or infection, or 
when symptoms are present to indicate a serious underlying condition. Even when red 
flags are suspected, it should not be mandatory to order an X-ray in all cases [114][115]. 
X-rays and CT-scans result in potentially cancer-causing radiation exposure, which could 
increase cancer risks, and lead to further follow-up tests, spinal injections, and surgery 
with additional risks [116]. Over forty percent of patients with back pain receive imaging 
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within 1 year. Of these, 60 percent had imaging on the same day as the index diagnosis of 
back pain and 80 percent within 1 month of the diagnosis [117]. Medicare data indicate 
that almost one-third of patients identified with lumbar pain had diagnostic radiography 
within 28 days [67]. Studies reported that patients who had imaging also were more 
likely to seek follow-up care, non-specific back-pain sufferers who had an MRI within 
the first month after diagnosis didn’t recover any faster, but they were eight times more 
likely to have surgery, and had a five-fold increase in medical costs compared with those 
who did not have early MRI [118] [31]. Patients who underwent lumbar radiography 
within 6 weeks’ duration reported more pain and worse overall health status after 3 
months than those who did not undergo radiography [109]. One study projected 1,200 
new cancers based on the 2.2 million CT scans of the lower back performed in the U.S. in 
2007 [119] [120].  
Imaging is an important driver of low back pain costs and the costs can be 
substantial, not only because of the direct costs of the procedures, but also the 
downstream effects [121]. The inappropriate use of imaging is a large contributing factor 
to the high costs associated with low back pain. Reducing inappropriate imaging is 
critical for reducing the number of ineffective treatments and unnecessary costs [122]. 
CT scans and MRI for the lower back are typically over $1000, while X-rays are 
approximately $300. A study estimated the cost associated with unnecessary imaging for 
low back pain at $300 million in 2013 [109] [123]. The total costs related to back pain, 




The agencies shown in Table 4 recommend against obtaining imaging studies in 
patents with non-specific low back pain within the first six weeks after diagnosis, unless 
red flags are present.  
Data 
This section describes the source and data entities used in this study. 
Accurate estimation of overuse requires appropriate data. In this cross-sectional 
study, I used administrative data from a non-profit upper Midwest health plan providing 
coverage to 1.5 million members whose network includes 27,000 providers in Minnesota, 
Wisconsin, North Dakota and South Dakota in 2012. The health plan offers both 
commercial and government insurance products with varying deductible and co-
insurance provision, including managed Medicare and managed Medicaid coverage. 
Table 5 summarizes the government plan types with descriptions of each type. 
I used health plan member year information to get basic demographics including 
member’s age. Age was defined on the beginning or the end as of year 2012 depending 
on how the age range is defined for each low-value service. Enrollment information 
provides coverage history and product information. No more than a single month gap in 
continuous enrollment during each year of continuous enrollment is allowed. 
I collected de-identified claims data from 1/1/2011 to 12/31/2012 for health plan 
enrollees at risk of receiving the five common low-value services in 2012 as specified in 
the previous section. Physician/professional claims were sent from the physician practice, 
while facility/hospital claims were sent from hospitals for the use of equipment and 
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hospital services. Claims in 2011 also were included if member is enrolled in that year. 
The detailed claim records contain all information needed to process an insurance claim 
including identification of provider. For each record, de-identified member ID, provider 
ID, claim ID, claim type, claim detail line number, claim reason code, diagnosis codes, 
and procedure codes are included in the data entities with description.  Moreover, charges 
claimed and allowed after provider discounts are applied, amounts allowed by the plan, 
and amounts paid by the member (deductible, coinsurance, and copay) are included. 
I used Johns Hopkins Adjusted Clinical Groups (ACG) data to measure member’s 
health status in 2011 and 2012. The ACG system measures the morbidity burden of 
patient populations based on disease patterns, age and gender found on insurance claims 
or other computerized medical records. I used the expected health care utilization band 
based on a cluster of diagnosis codes from ACG data to identify the health risk level of 
each enrollee. I also used U.S. Census data and American Community Survey data to 
capture enrollees’ neighborhood socioeconomic status (e.g. race, education, and poverty 
level) at block, block group or Census tract levels. The Census and American Community 
Survey information provide broad social, economic, housing, and demographic profiles. I 
used the merged data to measure these neighborhood characteristics.  
In addition, each member at risk of receiving selected low-value health care 
services was attributed to a servicing provider or a primary care provider as discussed in 
a later section. Information regarding the attributed provider characteristics was available 




The aim of this section is to describe the measure construction for low-value 
services, developing claim-based algorithms, operational definitions, and inclusion/ 
exclusion criteria of the study sample.  
Since there are no publicly tested and widely accepted claim-based measure to 
identify low-value services based on Choosing Wisely recommendations, USPSTF and 
other sources, I conducted a review on the identified low-value scenarios from major 
repositories of quality of care measures (e.g., AHRQ National Quality Measures 
Clearinghouse, National Quality Forum, CMS Physician Quality Reporting System) and 
major measure developers (AMA Physician Consortium for Performance Improvement, 
National Committee for Quality Assurance). I drew measure definitions from established 
claims algorithms in the literature, a Washington State report that measured low-value 
care in state-based all payer claims database, and the National Committee for Quality 
Assurance’s Healthcare Effectiveness Data and Information Set (HEDIS) [35]. These 
sources will be referred as “professional agencies” in this study. 
Specifically, I adapted 2015 HEDIS-defined claims-based measures with small 
changes to optimize the measures and constructed the five cohorts at risk of receiving 
specified low-value services. I conservatively excluded enrollees for whom the select 
services might be appropriate (e.g., not clearly low-value). For all five cohorts, the 
denominators are patients at risk of overuse who meet age and gender-specific criteria, 
which mean any services would be low-value for them. For example, I use all men 75 
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years or over who should not receive a PSA test as the denominator for low-value 
prostate cancer screening.  
I applied these measures to medical and hospital claims data with a sufficiently 
long temporal window of claims preceding a target service. In order to ensure I excluded 
individuals with a prior diagnosis or history indicating appropriate use of selected 
services, I included only members who were continuously enrolled in the prior year in 
addition to the study year. I used a combination of International Classification of 
Diseases, Ninth Revision (ICD-9) codes, Current Procedural Terminology (CPT) codes 
and HCPCS codes to exclude enrollees with a history of related disease in the one year 
baseline period prior to the service occurrence in a given study year. For example, when 
assessing whether the use of cervical cancer screening met the operational definition of 
low-value cervical cancer screening measure, I used claims data from 2011 to check for 
relevant diagnoses for women were at risk of receiving low-value screening in 2012.  
The definition, diagnoses codes, procedure codes, inclusion and exclusion criteria 
for computing the numerator and denominator populations for the five services are 
summarized in Table 6. All codes used for measures construction are listed for each 
service in Appendix Tables 14-17.  
Cervical cancer screening for young women 
Professional agencies agreed that cervical cancer screening could result in more 
harm than benefits for adolescent females. They all recommend against any screening for 
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women younger than 21 years, and recommend against screening with HPV testing 
(alone or with cytology) prior to age 30. 
Accordingly, I split the study population to two denominators, all eligible female 
enrollees age 13 years as of January 1 to 29 years as of December 31 of the measurement 
year, and a subset population, female enrollees age 13 years as of January 1 to 20 years as 
of December 31 of the measurement year. Enrollees must have been continuously 
enrolled during the measurement year and the year prior to the measurement year. No 
more than a single month gap in continuous enrollment during each year of continuous 
enrollment is allowed. To determine continuous enrollment for whom enrollment is 
verified monthly, the member must have greater than or equal to 11 months in coverage 
during the measurement year. 
In order to distinguish between tests used to screen for cancer in asymptomatic 
women, I excluded women with any diagnosis of cervical cancer, HIV or 
immunodeficiency any time on or between January 1 of the year prior to the 
measurement year and December 31 of the measurement year.  
First, I will calculate the percentage of females 13 to 29 years of age who were 
screened unnecessarily for cervical cancer. The numerator population includes all 
denominator patients receiving HPV tests during the measurement year. Secondly, I will 
use adolescent females 13 to 20 years of age as the denominator and calculate of the 
percentage of denominator patients using Pap tests during the measurement year. All 
codes used for measures construction are listed in the codebook (Appendix Table 14). 
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Prostate cancer screening for men 75 years and older 
Although the most updated USPSTF in 2012 recommends against PSA-based 
screening in men of all ages, this recommendation is debated for men younger than 75. 
This study specifies an age range of 75 and older because all professional agencies agree 
with the clear lack of benefits of screening and treatment in men of this age group. 
The denominator of this study sample are all eligible male enrollees 75 years or 
older as of January 1 of the measurement year. Enrollees must have been continuously 
enrolled during the measurement year and the year prior to the measurement year. No 
more than a single month gap in continuous enrollment during each year of continuous 
enrollment is allowed. 
In order to distinguish between PSA tests used to screen for cancer in 
asymptomatic men and men who had a diagnosis for which PSA-based testing is 
clinically appropriate, I excluded men with prostate cancer diagnosis, dysplasia of the 
prostate, or prostatectomy on or between January 1 of the year prior to the measurement 
year and December 31 of the measurement year. I also excluded all denominator patients 
with any diagnosis of elevated PSA result (>4.0ng/mL) during the year prior to the 
measurement year.  
I will calculate the percentage of men 75 years and older who were screened 
unnecessarily for prostate cancer using PSA-based screening. The numerator population 
includes all denominator patients receiving a PSA test during the measurement year. All 
codes used for measures construction are listed in the codebook (Appendix Table 15). 
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Colorectal cancer screening for adults older than 75 years 
All professional agencies recommended against screening for colorectal cancer in 
adults older than 75 years or in adults with a life expectancy of less than 10 years. 
The denominator of this study sample is restricted to all enrollees who were 76 
years or older as of January 1 of the measurement year. Enrollees must have been 
continuously enrolled during the measurement year and the year prior to the measurement 
year. No more than a single month gap in continuous enrollment during each year of 
continuous enrollment is allowed.  
In order to distinguish between preventive screening tests used to screen for 
cancer in asymptomatic men and diagnostic tests, I excluded men with colorectal cancer 
diagnosis, iron deficiency anemia, lower gastrointestinal bleeding, Crohn’s Disease (i.e., 
regional enteritis), familial adenomatous polyposis, Lynch syndrome (i.e., hereditary non-
polyposis colorectal cancer), inflammatory bowel disease, ulcerative colitis, abnormal 
imaging findings of gastrointestinal tract, changes in bowel habits, total colectomy or a 
personal or family history of colorectal cancer on or between January 1 of the year prior 
to the measurement year and December 31 of the measurement year.  
I will calculate the percentage of members 76 years and older who were screened 
unnecessarily for colorectal cancer. The numerator population includes all denominator 
enrollees receiving one or more screenings for colorectal cancer during the measurement 
year, identified as any of the following:  colonoscopy, flexible sigmoidoscopy, fecal 
occult blood test (guaiac or immunochemical), barium enema, CT colonography, fecal 
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DNA test. All codes used for measures construction are listed in the codebook (Appendix 
Table 16). 
Imaging studies for non-specific low back pain 
In contrast to preventive cancer screening measures, the study population for 
diagnostic imaging tests includes patients with the diagnosis. I used the nationally vetted 
HEDIS specification to measure low-value imaging studies for low back pain. The 
HEDIS specification captures the essence of the guidelines developed by major 
professional agencies. Conservatively, I used screening within four weeks instead of six 
weeks.  
The denominator of this study sample are all enrollees age 18 years or older as of 
January 1 of the measurement year to 50 years as of December 31 of the measurement 
year, who had an outpatient visit, an observation visit, an emergency department visit, or 
osteopathic manipulative treatment with any primary diagnosis of low back pain. 
Enrollees must have been continuously enrolled during the measurement year and the 
year prior to the measurement year without any gap allowed. 
The index date was defined as the earliest encounter during the measurement year 
with a primary diagnosis of low back pain. If the patient had more than one encounter, I 
included only the first encounter. In order to exclude patients with red flags who had a 
diagnosis for which imaging studies are clinically appropriate, I excluded patients with 
any low back pain diagnosis within six months prior to their index date. In addition, I 
excluded patients with any diagnosis of cancer, trauma, intravenous drug abuse, 
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neurologic impairment, HIV, or intraspinal abscess from January 1 of the year prior to the 
measurement year to 28 days after the index date. 
I calculated the percentage of members with a diagnosis of low back pain who 
had an imaging study test within 28 days of the diagnosis. The numerator population is 
all denominator patients receiving imaging studies (plain X-ray, CT scan, and MRI) on 
the index date or within 28 days following the date. All codes used for measures 
construction are listed in the codebook (Appendix Table 17). 
Conceptual Model 
There are numerous factors that affect patients’ use of health care services. A 
model developed by Zapka assessed factors at the patient level, the provider level, and 
the organization and practice setting levels interacting in a synergistic manner to impact 
provider’s delivery and patients’ utilization of preventive services [124, 125]. Taplin and 
colleagues used an ecological framework to consider the multilayered influences on the 
delivery of care and a variety of environmental factors influencing productive 
interactions between providers and patients [126]. A conceptual model of patient-
centered care consists of multiple domains, including patient demographics and clinical 
characteristics, hospital, nurse and physician attributes influencing treatment choices and 
outcomes [127].  
Conceptual model in this study is based on the theoretical frameworks of Zapka 
and Taplin to illustrate the multilevel environment in which patients and providers 
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collaboratively make decisions that affecting the use of low-value health services. Figure 
1 provides lists of example measurable factors within each level.  
The individual enrollee’s characteristics such as age, gender, health status, and 
insurance plan design will have a significant impact on enrollee’s decisions to seek 
medical care and treatment. The enrollee’s demographics represent their life experiences, 
providing social and cultural context for their decision-making. For example, Hispanic or 
Black enrollees may have faced historical prejudice or other cultural barriers in accessing 
care. Example health-related characteristics include health status, diagnosis history, 
comorbidities, and health utilization level.  
In addition, individuals make their decisions in their local community 
environment; their population socio-demographics such as education and income of 
neighborhood will affect the enrollee’s willingness to use and use patterns of health 
services. For example, financial resources, such as higher income or more health 
insurance benefits, help the enrollee overcome financial barriers to accessing the health 
care system. However, higher income individuals may have greater expectation to get 
more frequent preventive cancer screening.  
Moreover, providers’ demographics, specialty and clinic’s location, 
organizational structure may also impact demand of health services. Specifically, I expect 
local providers to behave differently, due to the longstanding differences in efficiency of 
care delivery pattern. In addition, provider characteristics may interact with patient 
characteristics to influence utilization (e.g., specialty or gender of physician).  
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Finally, national and state environment including macroeconomic trends, evolving 
best practices of care, professional standards and norms, evidence-based guidelines, and 
their local implementation affect patient’s choices and provider’s treatment patterns. It is 
important to integrate the multilevel environment in order to capture the heterogeneity in 
patient and provider characteristics collaboratively affecting the treatment decisions.  
Variables 
The objective of this analysis is to understand how the variation in use of each 
service in the specified study population could be attributed to observed patient and 
physician characteristics. This section briefly summarized variables that could be 
collected from data (Table 7) and the imputation algorithm for missing values. The list of 
variables of interest with description is documented in Appendix Table 18. 
On patient level, first I included member’s age, gender and location as factors 
influencing overuse. Members age 85 or older were coded as 85 to reduce the re-
identification risk. Since member’s socioeconomic status is not available  at the 
individual level, I created neighborhood-level characteristics for race/ethnicity, education 
level, and income/poverty rate from member address merged with U.S. Census data and 
American Community Survey data. Census data (race) were joined to geocoded address 
at block level. Other data from the American Community Survey were joined to 
geocoded address at block group and Census tract level, depending on the availability of 
the statistic. Addresses were stripped from the data prior to delivery of the research 
dataset. I classified neighborhoods as high poverty or low education based on the 
proportion of residents below the federal poverty level or with less than a high school 
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education. In addition, I used member’s current year and prior year health status 
measured by the Johns Hopkins ACG resource utilization band. The banded indicator of 
aggregations of ACGs is based upon estimates of concurrent resource use. This variable 
is used to classify enrollees by health risk level (very healthy, healthy users, low health 
risk, moderate health risk, high health risk, very high health risk). Lastly, I included 
member’s insurance type (managed Medicare, managed Medicaid, or commercial plan) 
to analyze product with various benefit design as a factor in health care utilization.  
For provider level characteristics, I included physician demographics (age and 
gender), specialty, and credentialing level (physician or physician extender). I also 
controlled for urbanicity based on Primary and Secondary Rural Urban Commuting Area 
(RUCA) score of provider’s servicing location as described in Appendix Table 19. 
I found that not all providers had valid gender, age and urbanicity data. About 10 
percent of gender and 20 percent of age were missing in provider demographics data. I 
used multiple imputation by chained equations (MICE) to impute missing provider 
demographics. MICE is a major method of addressing missing data. Multiple imputation 
fills in the missing values multiple times and creates multiple predictions for each 
missing value. It takes into account the uncertainty in the imputations to yield accurate 
standard errors. The chained equation approach assumes that the probability that a value 
is missing depends only on observed values and not on unobserved values. This method 
runs a series of regression models for each variable with missing data conditional upon 
the other variables in the data. Also, each variable can be modeled according to its 
distribution [128, 129]. In this study, first I imputed missing gender based on provider’s 
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specialty and credentialing level. Because gender is a binary variable, I predicted gender 
using logistic regression. Because provider age is categorical, I modeled provider’s 
missing age using an ordered logistic regression based on specialty, credentialing and 
imputed gender.  
In addition, 34.9 percent RUCA of provider’s Primary RUCA codes are missing. 
Because patient’s location is a more relevant predictor for provider’s location than other 
control variables, I filled in missing provider urbanicity based on the patterns of 
urbanicity among their patients. For each provider with a missing RUCA value, I looked 
at the urban/rural distribution of patients associated with the provider and imputed using 
their largest share of patient urbanicity. 
Attribution of Patients to Providers 
This study aims to examine the influence of provider’s characteristics on the 
probability of receiving low-value health care services. Modeling provider characteristics 
requires patients to be linked to individual providers who managed their health care. This 
section describes the method for attributing health plan enrollees to providers using 
administrative claims data.  
Attribution is the assignment of responsibility of each patient to a provider. In the 
study population using data from an Upper Midwest health plan, we presume that each 
health plan enrollee had a single primary care provider from the four states service area 
(MN, WI, ND, SD) who served as the coordinator of their care. Then creating attribution 
algorithms that assign responsibilities between patients and the coordinating providers. In 
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this study, I used one attribution rule for the three preventive cancer screenings and a 
different attribution rule for low back pain imaging studies.  
Attribution for Cancer Screening 
Most enrollees who seek preventive services visit their primary care providers 
(PCP). A previous study examined that stability of attribution rules [130]. For preventive 
services including cervical cancer screening, prostate cancer screening, colorectal cancer 
screening, I attributed enrollees to an in-network PCP based on their pattern of outpatient 
primary care service visits that occurred in a home or clinic setting. Primary care services 
visits were identified by evaluation and management (E&M) CPT codes (Appendix 
Table 20) in the measurement year. I ruled out out-of-network providers by participation 
status on claims. I identified outpatient visits based on the outpatient location of 
professional claims detailed in Appendix Table 21. I did not attribute enrollees with 
preventive cancer screenings provided in nursing facilities or other settings. 
Only PCPs with certain credentialing and specialty codes were considered for 
attribution (Appendix Table 22, Appendix Table 23). As shown in Table 23, providers 
with a specialty in general practice, family practice, internal medicine, pediatrics or 
obstetrics-gynecology were categorized as PCPs. Visits to other specialties were 
excluded from the PCP attribution method. Visits to physician extenders (physician 
assistants, nurse practitioners) with primary care specialties were retained in the 
attribution rule.  
The attribution algorithm for preventive cancer screenings retrospectively 
assigned health plan enrollees to an eligible servicing provider who provided the plurality 
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of their primary care visits as detailed below. For professional claims, the servicing 
provider is the individual who performed the service. The plurality algorithm consists of 
five steps. First, I identified primary care E&M visits for each patient in the measurement 
year based upon criteria I described above. Second, I added up the total counts and costs 
of primary care E&M visits for each eligible provider and in total. Cost is defined as total 
allowed charges, including the amounts allowed by both the health plan and the member. 
Third, I calculated the percentage of counts and costs of each provider. Fourth, I selected 
the provider with the highest concentration of counts of visits. Attributed patients are 
health plan enrollees who had the most primary care E&M visits to one unique provider 
in the measurement year if the percentage of number of visits is 35 percent or greater. 
Enrollees who obtained less than 35 percent of their primary care E&M visits from a 
provider were dropped from the study. Fifth, any ties in comparing percentage of visit 
counts go to the provider with the largest total allowed costs share. 
In Figure 2, I focused on enrollees who were attributed to an eligible provider 
after applied above attribution rules (approximately 60 percent, section a of the figure). 
To ensure the precision and stability of attribution, enrollees who were spread thinly 
across many providers and obtained less than 35 percent of their primary care E&M visits 
from one unique provider were not attributed for the study (section b). Enrollees without 
any qualifying E&M visits to primary care in the measurement year were excluded from 
the preventive screening analyses (section c). 
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Attribution for Low Back Pain Imaging 
Responsibility of care is more straightforward for patients with low back pain 
diagnosis. I attributed patients to the servicing provider for the encounter with the first 
observed primary low back pain diagnosis in the measurement year. As shown in Table 
19, this attributed provider could be one of a wide range of specialties (e.g., orthopedist, 
chiropractor, or other specialists). There are less than 10 percent of the low back pain 
patients not attributed to a provider; these patients were excluded from the analysis. 
Statistical Approach 
The purpose of this study was to estimate patient- and provider-level influence on 
the utilization of five specified health care services, measured by variables capturing 
patient and provider characteristics. Specifically, the outcome of interest is a binary 
dependent variable, defined as occurrence of a low-value health care service. In this 
section, I described the econometric models used to investigate whether patient- and 
provider-level factors result in variation in utilization of each service. 
Multilevel mixed-effects models have been widely used in health services 
research to analyze data with a hierarchical or clustered structure. While fixed effects are 
estimated directly in the standard regression model, random effects are not directly 
estimated because of the nesting structure and intra-cluster correlation of the data. In this 
study, outcomes for enrollees attributed to the same provider may be correlated because 
they share the common provider. Accordingly, I applied a mixed-effects probit model 
with a provider-specific random intercept to account for this within-provider correlation. 
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Multilevel models also are known as hierarchical models. There are two 
hierarchical levels in my model. The lower level is patient characteristics, with enrollees 
nested within the higher level: their attributed providers. I allowed patient-level outcomes 
for each enrollee to depend on both patient-level and provider-level effects, and to be 
predicted by the provider-specific intercept. I also took into account the same 
heterogeneity and clustered standard errors at the provider-level to produce robust 
standard errors.  
For each study sample, I estimated a model corresponding to the probability that 
the enrollee received that low-value service. The general format of the probit model with 
a random intercept is shown as follows:  
𝑃𝑟(𝑌𝑖𝑗 = 1) = Pr(𝑋𝑖𝑗𝛽1 + 𝑍𝑗𝛽2 + 𝑢𝑗 + 𝜖𝑖𝑗 > 0) 
In this formula, 𝑌𝑖𝑗 indicates whether the ith enrollee, attributed to the jth provider 
had the service in the measurement year. The outcome variable was coded as 1 for 
enrollee i who received selected low-value service in 2012, and 0 for otherwise in this 
sample. The conditional distribution of the outcome given the random effects is assumed 
to be Bernoulli.  𝑋𝑖𝑗 is a vector of associated characteristics of the enrollees and their 
neighborhood effects. The vector 𝑍𝑗 contains covariates that control for observed 
characteristics of enrollee’s attributed provider. Both 𝛽1 and 𝛽2 are vectors of parameters 
to be estimated. The 𝑢𝑗  are provider-specific random intercepts, are assumed to be 
uncorrelated with X and Z. The error terms 𝜖𝑖𝑗 are assumed to be distributed standard 
normal with mean 0 and variable 1 and assumed to be independent of 𝑋𝑖𝑗, 𝑍𝑗 and 𝑢𝑗 .  
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I used the two-level random-intercept model to estimate the association between 
the patient and provider characteristics and utilization of low-value health care services. 
However, enrollee’s health risk measures from the aggregated Johns Hopkins ACG data 
may be correlated with the outcome variable, which would create biased parameter 
estimates in regression results. I used health risk measures are based on prior-year 
experience to predict utilization in current year and to avoid issues of endogeneity. 
Alternative regression results are shown in the robustness checks section. 
Claims Analysis 
Prevalence Analysis 
The prevalence analysis proceeded as shown in Figure 3. First, I identified the 
size of population at risk of overuse by applying the claim-based algorithms I developed 
in a previous section. The denominator was all enrollees at risk of receiving  the specified 
low-value health care services during 2012, which means the service would be low-value 
for them after applying the appropriateness selection criteria. Second, I excluded 
duplicate claims that have already been processed by the health plan and claims with 
missing or incorrect information to obtain the number of services performed in each 
cohort during 2012. Third, I excluded disallowed claims. Some claims were disallowed 
due to enrollees, providers, or time periods that were not covered, and other services were 
rejected or sent back for more information after health plan adjudication. Fourth, I broke 
down allowed claims to “health plan allowed in full” and “coordination of benefits 
(COB).” COB indicates the claim was allowed partially or fully with another payer, 
including Medicare, secondary health plan, auto insurance, worker’s compensation 
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liability, etc. Fifth, I categorized COB claims to obtain number of services allowed in full 
by Medicare, allowed in part by Medicare, allowed in full elsewhere, and allowed in part 
elsewhere.  
Cost Analysis 
The cost analysis proceeded in three steps as shown in Figure 4. First, I 
calculated the total and averaged claimed amount for each identified service during 2012. 
Second, I calculated the total amounts allowed by the health plan. Third, I broke down 
amount allowed by the health plan into “health plan allowed in full” and “COB”. I 
calculated the allowed amount per test and per capita of each service for denominator 
population.  
A few observations have zero claimed amounts and some claims have positive 
claimed amounts but their allowed amounts are zero due to some particular billing reason 
codes. I categorized the zero allowed claims as duplicated claims, disallowed claims and 
“paid elsewhere” based on specific denial reason codes identified at the detail level which 
are necessary to evaluate inclusion of claims. Most zero allowed claims were due to 
duplicative, missing or incorrect information. They were denied because of original 
billing errors and were corrected and resubmitted under different claim IDs. Other zero 
allowed claims were fully adjudicated but denied because of eligibility. I first excluded 
all duplicate claims then included other zero-allowed claims when calculating service 




In addition, a few claims have positive claim amounts but their allowed amounts 
are zero because the health plan did not fully cover all claims. Only the amounts allowed 
by the health plan can be captured in the database. For example, according to claims 
operations, when a patient has a Medicare Cost plan, the provider bills Medicare first. 
Medicare then sends all claims to the health plan when there is a member responsibility, 
regardless of whether the health plan has a liability for payment. Consequently, if 
Medicare paid in full, no additional payments by the health plans is required and thus the 
allowed amount is zero in the data. If Medicare denies the claim, the plan covers state 
mandated services and preventive health services, includes routine screening procedures. 
If Medicare pays on a primary basis and the health plan supplements Medicare benefits, 
this study observe only the part allowed by the health plan. When a member has other 
insurance with respective payment responsibilities and partially paid by the health plan, 
allowed amounts will be understated without accounting for this coordination of benefit. 





CHAPTER 3. RESULTS 
Prevalence 
This section provides estimates of the number of enrollees at risk of receiving 
each specified health care service and the number of services performed during 2012. I 
refer to enrollees who underwent the services as Adverse Event Patients (AEPs), defined 
as recipients of any untoward medical occurrence in a patient which does not necessarily 
have a causal relationship with the service [131].  
The results are shown in Table 8, 10,466 potentially low-value health care 
services were performed and claimed for studied services during 2012, the prevalence 
varied across services from 3.0 percent of at risk enrollees receiving colorectal cancer 
screening in adults older than 75 years old to 17.4 percent for non-specific low back pain 
imaging within four weeks of first diagnosis. Among the 10,466 performed low-value 
services, 93.2 percent of the services were allowed.  
About 5.2 percent of females who were younger than 21 years old received a Pap 
test for cervical cancer screening during 2012. The allowed rate (86.4 percent) is 
comparatively low compared to females younger than 30 years who received a HPV test 
(94.6 percent). In sum, cervical cancer screening using Pap test or HPV test resulted in 
the largest number of services performed (N=3,515) and allowed (N=3,071) among the 
low-value services, but not representing the highest percentage (4.8 percent). 
Another comparatively high overuse area is prostate cancer screening, which is 
the most commonly overused cancer screening. There were 2,935 low-value PSA tests 
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performed during 2012 on 2,522 Adverse Event Patients (AEPs) who were 75 years or 
older, representing 13.9 percent of the population at risk, and 94.6 percent of them were 
allowed. The upper limit of claim denials is 5.4 percent. 
Prevalence of colorectal cancer screening overuse is low. Among 40,944 adults 
older than 75 years, only 3.0 percent had a low-value colorectal cancer screening. These 
claims largely used colonoscopy (1.5 percent) and fecal occult blood test (1.5 percent), 
and 94.3 percent were allowed.  
There were 9,383 patients who had a new diagnosis of non-specific low back pain 
in 2012, 17.4 percent of them received an imaging test within four weeks of diagnosis, 
and 2,477 of the 2,612 tests (94.8 percent) were allowed. I reported imaging tests for low 
back pain with radiography, CT scan and MRI separately. Plain radiography accounted 
for 13.9 percent of the patients receiving low-value imaging, while 6.7 percent of patients 
received a low-value MRI. Less than 1 percent received a low-value CT scan. Some 
patients received more than one diagnostic imaging tests. 
Costs 
This section shows the total dollar amount allowed for the five low-value health 
care services and estimates the magnitude of the potential savings that could be achieved 
by eliminating overuse of those services. I did not attempt to assess ancillary costs such 
as the cost of follow-up treatments on false positive tests due to data limitation. 
Summarized in Table 9, selected low-value services resulted in an excess claimed 
amount of $4.15 million in a year, and $1.38 million were allowed by the health plan. 
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Claimed and allowed costs varied widely among services. Though Pap test for cervical 
cancer screening is used more frequently than HPV test, the claimed and allowed cost per 
test is lower. These two low-value cervical cancer screening tests resulted in a total 
allowed costs of $169,330. PSA-based screening in older men has been performed 
frequently but the test itself is comparatively less expensive than other services. The 
health plan’s unit cost for PSA test was only $27. The total costs allowed by the health 
plan was $75,648.  
In a similar elderly population, colorectal cancer screening triggered higher 
claimed and allowed costs. Although the service is used infrequently, colonoscopy is the 
most expensive procedure among all studied services, with an average claimed amount of 
$2,442, and an average allowed amount of $489. The total costs allowed by the health 
plan for colorectal cancer screening was $395,165 in a year.  
Among the low-value imaging tests for low back pain, MRI is the most expensive 
test, with an average claimed amount of $1,870, and an average allowed cost of $830. 
Additional imaging tests included X-Ray cost $64 and CT scan cost $327. From health 
plan’s perspective, the total low-value expenditure for low back pain imaging tests 
totaled $743,312. MRI tests totaled $620,691, which accounts for the largest portion of 
costs among selected low-value services. 
In 2012, the total count of health plan enrollees eligible for this study with 
continuous enrollment and full-service coverage is 941,975. The total allowed amount for 
potentially low-value utilization is $1.38 million, resulting in a per member per year out-
of-pocket premium cost of $1.5 for all enrollees in the health plan. Some low cost but 
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highly overused services could still result in large overall cost, such as plain radiography 
for low back pain and PSA test for elderlies. X-ray within four weeks of low back pain 
diagnosis was the most prevalent procedure and it accounted for $100,802 in one year. 
Multivariate Analysis 
Descriptive Statistics 
The descriptive statistics of explanatory variables included in the analysis are 
shown in Table 10 and Table 11. Sample characteristics with percentage distribution of 
the five cohorts are shown in Appendix Tables 24-27.  
In all five cohorts, although the means are similar in most variables between 
patient-level model and the full patient- and provider-level model, the population differs 
slightly because the full model excludes patients that were not attributed to a servicing 
provider. The percentage of AEPs among all enrollees is higher in the full model than 
patient-level model and the prevalence analysis reported in previous section. Because the 
attribution approach used to select study sample relied on primary care or diagnosis 
seeking patterns, these attributed enrollees were more likely to have those services than 
the full population, which includes enrollees that never sought care.  
Among the conditions for which both males and females are at risk, 62 percent of 
the older adults at risk of receiving low-value colorectal cancer screening and 58 percent 
of patients with low back pain are female. On average, all enrollees’ neighborhoods are 
primarily White and non-Hispanic (85 percent), have residents with at least a high 
school degree (90 percent), and have few households below the federal poverty level 
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(approximately 10 percent). In non-elderly cohorts at risk of receiving low-value cervical 
cancer screening and low back pain imaging, most (85 percent) of the population is 
assigned to a moderate health risk or better based on their prior-year utilization history. 
Over 80 percent of them live in urban areas, and enrolled in a commercial health plan. On 
the contrary, more than half of the elderly population (average age 80 years old) are 
assigned to a high or very high health risk category, over 30 percent of them live in rural 
areas, and over 80 percent enrolled in a managed Medicare plan. Medicaid enrollees over 
75 years old are mainly beneficiaries who are eligible for both Medicare and Medicaid. 
Regarding provider characteristics, the average age of provider does not vary 
much across cohorts (45 to 51 years old). However, older population were more likely to 
be attributed to an older provider, more than 50 percent of the providers for cohorts 75 
years and over are over 50 years old. On the other hand, over 60 percent of young women 
and adults 18 to 50 years old with low back pain were attributed to provider younger than 
50 years old. Over 70 percent of the providers for young women are female and adults 
are more likely to have a male provider. Provider’s rural or urban location follows similar 
patterns as patient’s urbanicity, except rural rate decreased in elderly population due to 
the lower attribution rate in rural area. The four study cohorts for cancer screening tests 
and procedure share similar provider credentialing (physician vs. physician extenders) 
and specialty characteristics. Services were managed primarily by primary care provider 
credentialed as a physician.  Patients with low back pain have a higher proportion of 
diagnosis provided by a chiropractor or a physician extender.  
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Impact of Patient Characteristics 
In addition to showing descriptive statistics measuring the explanatory variables 
in the study population, I estimated the association between the enrollee characteristics 
and utilization of low-value health care services to compare to the literature that uses only 
patient-level characteristics. The sample size for this analysis is not the same as 
population at risk in the prevalence analysis because some enrollees (14 to 23 percent) do 
not have Johns Hopkins ACG or Census and American Community Survey information. 
I first estimated a probit model including only enrollee characteristics and without 
provider characteristics and the provider random intercept. From the probit coefficients I 
calculated marginal effects as the effect of an increase in the covariate to provide more 
intuitive measures of the influence, defined as the average percentage-point change in the 
predicted probability of the service would occur, based on a one-unit change in the 
explanatory variable. The partial effects of patient-level characteristics on the probability 
of receiving each service are shown in Table 12 and include both marginal effects for 
continuous variables and incremental effects for discrete variables. The following 
discussion focuses on statistically significant (p<0.05) and marginally significant (p<0.10) 
effects.  
The statistically significant partial effects vary across cohorts and services. For 
young women at risk of receiving low-value cervical cancer screening, a one-year 
increase in age increases the probability of getting a Pap test by 3.45 percentage points. 
The effect of age on the probability of receiving an HPV test is less, indicates a 0.39 
percentage-point increase for a one-year increase in age. In contrast, for adults over 75 
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years and at risk of receiving low-value prostate cancer or colorectal cancer screening, a 
one-year increase in age decreases the probability of getting a PSA test by 1.29 
percentage points and decreases the probability of colorectal cancer screening by 0.39 
percentage points.  
For patients with low back pain, female’s probability of receiving a low-value 
imaging test within four weeks of diagnosis is marginally significantly higher than for 
males. Males 75 years and older living in rural areas have 2.86 percentage points lower 
probability of using low-value PSA tests than those living in urban areas.  
Block, block group or census tract level neighborhood impacts have 
comparatively small marginal effects in percentage-point changes. Enrollees living in 
areas with a greater proportion in poverty are less likely to have an imaging test within 
four weeks of low back pain diagnosis. A one-percent increase in proportion of 
household with income below federal poverty limit decreases the probability of getting a 
low-value imaging test for low back pain by 0.24 percentage points. In addition, enrollees 
in higher education neighborhoods are less likely to receive low-value Pap test and 
colorectal cancer screening. Enrollees in White/non-Hispanic neighborhoods are more 
likely to receive Pap tests and less likely to receive low-value colorectal cancer screening, 
but the percentage-point change is very small. 
Also, the probability of cancer screening varied by insurance plan types. Young 
women in commercial plans have significantly lower probability of getting Pap tests 
compare to Medicaid enrollees. For the elderly population at risk of receiving prostate 
cancer or colorectal cancer screening, there was a significantly higher probability of 
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receiving low-value screenings among Medicare enrollees, and a lower probability 
among commercial enrollees. 
In addition to enrollee’s socio-demographics, patient’s health status is 
significantly associated with the probability of receiving low-value health care services. I 
found an inverted U-shaped correlation between prior year health status and probability 
of utilization in cancer screening cohorts. As shown in Figure 5, I used very healthy 
people as the referent value, defined as enrollees without expected health care utilization 
based on a cluster of diagnosis codes in prior year. Enrollee’s probability of receiving the 
low-value service peaked in either moderate or high health risk category in all five 
cohorts, which are significantly different from very healthy enrollees. Enrollees in these 
two categories were significantly more likely to receive low-value cancer screening 
procedures than enrollees in the healthy, low or very high health risk category. When the 
member moves from high health risk to very health risk category in the prior year, their 
probability of receiving low-value Pap tests, PSA tests, and colorectal cancer screening 
decreased. 
Full Model with Patient and Provider Characteristic 
Patient Characteristics 
The full model controls for both patient characteristics and provider-level 
characteristics. Table 13 shows the marginal effects and standard errors for the 
explanatory variables on the probability of using each procedure. Some enrollees (11 to 
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37 percent) were excluded from the full model because they were not attributed to a 
provider. 
I compared patient-level marginal effects in the full model with the patient only 
model. First, enrollee’s age remains significant for the cancer screening cohorts and 
marginal effects increased after controlling for provider-level characteristics and random 
intercept. A one-year age increase in young women increase the probability of getting a 
Pap test by 4.03 percentage points and an HPV test by 0.44 percentage points. A one-year 
age increase in adults over 75 years old decrease the probability of getting a PSA test by 
1.65 percentage points and a colorectal cancer screening procedure by 0.46 percentage 
points. Gender effect is not significant anymore in the full model.  
Secondly, neighborhood effects are consistent with patient-level estimates with 
small marginal value. The probability of low-value cervical cancer screening using Pap 
test increased in neighborhoods with a higher proportion of White and non-Hispanic, and 
decreased in more highly educated neighborhoods. Low-value colorectal cancer 
screening utilization declined in higher education neighborhoods and use of low back 
pain imaging declined for residents of lower-income neighborhoods.  
Third, impact of insurance plan type on utilization is significant in elderly 
population. As expected, men 75 years or older enrolled in a Medicare plan were 6.76 
percentage point more likely to undergo a low-value PSA test, relative to Medicaid 
enrollees. Those enrolled in a commercial plan were 4.75 percentage points less likely to 
receive the screening. Consistently, adults over 75 years in Medicare plan were slightly 
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more likely to use colorectal cancer screening (1.05 percentage points), while commercial 
plan enrollees were 0.59 percentage point less likely to use the low-value service.  
Fourth, after adjustment for provider-level characteristics, some of enrollee’s 
health status lost significance and the curve slightly changed, but the inverted U-shape 
pattern remains in Figure 6. The peak of prostate cancer screening utilization changed 
from moderate health risk enrollees to those in low health risk category, indicating low 
health risk enrollees’ probability of receiving a PSA test is 12.99 percentage points higher 
than very healthy users. The peak of Pap test and low back pain imaging use remain the 
same in the high health risk enrollees, respectively represents a 3.27 percentage point 
increase in younger women, and a 4.81 percentage point increase in patients with a low 
back pain diagnosis. Women younger than 30 years old with moderate health risk in prior 
year have 1.10 percentage point higher probability of receiving a HPV test than those 
with no diagnosis in prior year, which is consistent with the patient characteristics-only 
model results. Health status factors in colorectal cancer screening cohort become not 
statistically significant anymore. 
Provider characteristics 
The results show the association between provider characteristics and health care 
services utilization. First, I found older providers have a higher probability of performing 
low-value cancer screening. Providers 50 to 59 years old and over 60 years old have, 
respectively, 2.75 and 3.04 percentage point higher probability performing PSA tests than 
providers under 40 years old. Providers over 60 years old have 0.91 percentage point 
higher probability of performing colorectal cancer screening than providers under 40 
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years old. Providers 40 to 49 years old have 0.89 percentage point higher probability 
performing Pap tests than those younger than 40.  
Second, female providers’ probability of performing cervical cancer and 
colorectal cancer screening is higher. Female providers have 1.39 higher percentage point 
of probability performing Pap tests, 0.77 higher percentage point of probability 
performing HPV tests, and 0.55 higher percentage point of probability performing 
colorectal cancer screening procedures than male providers. In contrast, male providers’ 
probability of performing early low back imaging studies is 2.53 percentage points higher 
than female providers.  
Third, I excluded patient urbanicity from the full model due to high correlation 
with provider urbanicity. I found rural providers have 1.41 percentage point higher 
probability of performing low-value Pap tests than urban providers, and 1.13 percentage 
point higher probability of performing low-value colorectal cancer screening procedures.  
Fourth, physicians were more likely to order tests for older adults. Physicians 
have respectively 4.61 percentage points and 0.89 percentage point higher probability of 
performing prostate and colorectal cancer screening, respectively, than physician 
extenders. When I take into consideration physician’s specific specialties for cervical 
cancer screening and low back pain imaging, I found that obstetricians and gynecologists 
have 3.10 percentage point higher probability of performing Pap tests than primary care 
providers. Specialty effects are especially significant in low back pain imaging 
management. A patient has a 35.42 percentage point higher probability of undergoing 
early imaging tests if the first provider who saw the low back pain patients is an 
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orthopedist rather than a primary care provider, while a chiropractor’s probability of 
referring imaging tests is 14.21 percentage points lower than primary care providers.  
Robustness Checks 
In this section, I conducted robustness checks to strengthen the association 
reported in previous section. For parsimony, regression results of alternative models are 
summarized in the Appendix Tables 28-32. 
Imputed missing provider demographics reduced models’ precision. I restricted 
the study sample to the subset of enrollees whose providers’ age, gender, and urbanicity 
are known and re-estimated models for all cohorts. The sample size reduced by 6 to 30 
percent and the results were consistent with results from imputed models. However, 
provider age is sensitive to imputation. The marginally significant effects in providers 40 
to 49 years old for Pap test and providers 60 years or older for colorectal cancer screening 
become not significant in the smaller sample without imputation. In addition, higher 
marginal effects of performing prostate cancer screening by 50 to 59 years old and 60+ 
years old providers become marginally significant. In addition, I found providers 50 to 59 
years old and over 60 years old respectively have 3.17 and 3.74 percentage point lower 
probability recommending imaging tests for non-specific low back pain within four 
weeks of diagnosis than those younger than 40. In sum, though some marginally 
significant effects in provider age disappeared in the robustness check, findings in the 
study remained robust. 
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In addition, I compared the full model containing all variables of interest with 
sub-models containing various combinations of parameters. I estimated several different 
specifications including enrollee’s current year health status vs. prior year health status, 
enrollee’s urbanicity vs. provider’s urbanicity, percentage of households with income 
below federal poverty level vs. median household income in the neighborhood, and 
remove provider’s specialty to account for the high correlation with provider’s 
credentialing.  
First, I re-estimated the model with patient current year health risks and found that 
patient current year health status is highly correlated with prostate cancer screening, 
colorectal cancer screening, and low back pain imaging utilization, which did not 
converge in the patient-level model. In the younger and healthier population, the marginal 
effects become higher in Pap tests and the curve remains unchanged. Women in high and 
very high risk categories have higher marginal effects in the probability of receiving HPV 
tests in the current year. In the full model controlled for provider characteristics, none of 
the cohorts was estimable except men 75 years or older. The main model suggested men 
in low health risk category in prior year have the highest probability receiving PSA tests 
and this model suggested men in high health risk category in current year have the 
highest probability receiving the screening.  
Second, the marginal effects were unchanged when I used patient urbanicity 
instead of provider urbanicity. Enrollees in rural areas have statistically significant higher 
probability receiving low-value Pap tests and colorectal cancer screening procedures.  
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Third, a robust check using median household income in the neighborhood 
yielded the same results as poverty rate. Residents of lower income neighborhoods are 
less likely to have an imaging test within four weeks of low back pain diagnosis.  
Fourth, results were extremely close to those presented in full model when I 
excluded provider’s specialty from the model, except provider’s credentialing become 
significant and physicians have 14.99 percentage point higher probability recommending 
early imaging tests for non-specific low back pain than physician extenders. These 
different parameterizations confirmed the statistically significant results presenting in 
previous section. 
Lastly, I estimated several alternate models to test the robustness of the results 
found in the main model. I ran fixed effects standard probit model and fixed effects probit 
model with clustered standard errors at the provider-level for each cohort of interest. In 




CHAPTER 4. DISCUSSION 
Conclusion 
Identify measures and data source 
The Choosing Wisely Campaign, along with the USPSTF and other efforts have 
drawn more attention from academia and public in recent years. Their recommendations 
endorsed by professional agencies provide an opportunity to identify low-value health 
care services. An essential first step in reducing overuse is to identify these services from 
appropriate datasets and document the analytic algorithms. 
The prevalence of low-value services and potential correlates of overuse have 
been examined previously has been estimated using electronic health records (EHR) and 
Medicare claims data. However, a large proportion of previous studies are outdated using 
the data collected in 1990’s and early 2000’s. Results from this study indicate that private 
health insurance administrative data provide an important alternative perspective to 
measure the use of low-value health care services. 
In all scenarios, this study used services reliably measurable through 
administrative claims and applicable to private health plan enrollees and conservatively 
excluded enrollees for whom the select services which are not clearly low-value. These 
measures represent important areas for quality improvement by assessing the use of 
services identified as low-value for specific populations.  
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Prevalence and Cost 
This study examined prevalence and costs related to the selected services in the 
U.S. using administrative claims data. The rates of overuse varied widely by services, 
which is consistent with previous literature. Korenstein et al. reported the overuse rates 
ranged from 1 to 89 percent among 22 years’ publications on different services. Rates 
ranged from 5 to 28 percent for imaging in low back pain, 8 to 61 percent for 
colonoscopy, and from 16 to 80 percent for PSA test [31]. As reported by the Good 
Stewardship Working Group, 2.9 percent of girls aged 10-21 were performed Pap tests 
and 16.7 percent of adults aged 18-55 were ordered unnecessary imaging studies for 
acute low back pain [29]. The results show the prevalence range from 3.0 percent for 
colorectal cancer screening to 17.8 percent for low back pain imaging. However, the rates 
estimated in this study were lower compared to national estimates reported by other 
studies [13, 16]. With exception of low back pain imaging and PSA test, some services 
were not frequently performed, although experts questioned them frequently. Only five 
percent of women under 21 are receiving Pap tests. Possibly because this 
recommendation already became a part of most providers’ and organizations’ standards 
of care. Even for low back pain, tests were largely performed by plain radiography. 
Because this study used claims data from a health plan located in a geographic area with 
a reputation for efficient delivery and coordinated care, estimated use of selected services 
maybe more conservative compared to national rates reported by other studies using 
comparative selection criteria. For example, Minnesota’s state-wide initiative for 
ordering appropriate high-tech diagnostic imaging reduces overall prevalence of imaging 
tests use by prompting health plans to ensure that only appropriate imaging scans are 
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ordered [132]. In addition, there may be some scenarios where providing the service was 
the appropriate clinical choice given the patient’s specific situation that administrative 
claims data could not completely capture. However, these cases should be rare. 
Prevalence rate reported in this study could be interpreted as a lower bound estimate.  
Additionally, this study reported the dollar amounts that the health plan allowed, a 
total of $1.38 million could have been saved by eliminating studied low-value services. 
Savings on enrollee’s per-member, per year premium that this health plan could achieve 
is relatively small. However, there are some low-cost but frequently delivered services 
such as plain radiography in low back pain and the PSA test for older adults. These two 
tests still accounted for substantial overall costs in 2012. For instance, X-ray for low back 
pain within six weeks of diagnosis was the most prevalent performed low-value service – 
the payer allowed about $100,000 in one year. This study reported conservative estimates 
of the direct cost of the low-value services. These estimates did not account for the costs 
of additional testing or follow-up procedures that resulted from ambiguous or false 
positive initial results. For example, if a patient requires a biopsy as the follow-up test, 
physicians may charge a significant amount of dollars for anesthesia, and there would be 
an additional pathology fee.  
This study provided a baseline assessment of prevalence and associated potential 
cost savings that could be achieved by eliminating the selected commonly used low-value 
health care services. The results suggest that prevalence and costs of selected services 
may be lower than previously estimated, and that private health insurance claims data 
could provide an important alternative perspective on health care resources utilization. 
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Patient and Provider Characteristics 
This study demonstrated that health claims could monitor the utilization of low-
value health care services. These data include enrollees in all age groups with health 
insurance coverage type information. These data could capture claims for services linked 
to specific patient and provider characteristics, regardless of where the patients obtain the 
services.  
Previous studies found statistically significant differences across health plans in 
utilization rates of six preventive care services [69]. Patients’ demographics and 
socioeconomic status are also known to impact prevalence and cost of health services use 
[62]. This study incorporated both government and commercial plan products using 
health plan administrative data. Results from this study examined variation in the use of 
selected low-value services at individual level and identified significant correlates of 
overuse across the levels of patient and provider with their relative contribution. 
Results indicate that, in general, increased probabilities of overuse are associated 
with government health plans, worse health status in the prior year, lower-education 
neighborhoods, and areas with a smaller proportion of population under federal poverty 
line. Probabilities of low-value cervical cancer screening increased with age for women 
under 30, but probabilities for prostate and colorectal cancer screening declined with age 
for those over 75.  
These results are consistent with medical guidelines. In addition, Colla at al. used 
self-reported health status and found that overuse of 11 low-value services was correlated 
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with worse health status [41]. This study used more refined algorithms in Johns Hopkins 
ACG system to capture enrollee’s prior year health status, specified the enrollee’s health 
risk by their expected resource utilization categories. Enrollees under moderate and high 
health risk were more likely to receive low-value care, but the probability decreased for 
very high risk category. In addition, coverage type has significant influence on enrollees 
using low-value preventive services, government plan enrollees were more likely to get 
low-value prostate and colorectal cancer screenings. Among them, Medicare 
beneficiaries have higher probability of obtaining a low-value screening than Medicaid 
enrollees. Colla reported areas with higher proportions of minority groups (Hispanic, 
black) and population under federal poverty limit are less likely to use low-value services. 
This study found patients from lower-income neighborhoods had fewer low-value low 
back pain imaging tests, which could be due to difficulty accessing care and less 
exposure to the health care system.  
Because there is limited research controlling for provider-level factors, this study 
expands on prior literature by using health plan claims data to capture additional provider 
characteristics associated with overuse. Results show overuse of preventive screening to 
be positively associated with females, older providers, specialists, and providers with 
physician credentialing, possibly because females and older providers were more 
conservative and more likely to stick to performance conventions in cancer screening 
[133].  In contrary, older providers were less likely to order diagnostic imaging tests for 
low back pain patients. A possible explanation could be younger providers rely more on 
imaging tests to make a diagnosis. Another significant indicator of low-value services use 
is specialist. Comparing to primary care providers, OB/gynecologists were more likely to 
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order low-value cervical cancer screening, and orthopedists were more likely to order 
low-value low back pain imaging. Colla and colleagues reported primary care providers 
were more aware of the Choosing Wisely campaign than specialists [134]. However, 
primary care provider may refer low back pain patients to an orthopedist, which 
generated increased specialist costs. According to a 2013 study, family physicians had a 
lower rate of appropriate low back MRI ordering than other specialties. Among the 
subspecialties, neurosurgeons were most likely to order appropriately (76 percent), 
whereas less than half of referrals by neurologists and orthopedic surgeons were 
appropriate [67]. In this study, chiropractors had a much lower probability of ordering 
low-value imaging tests, presumably they were more likely to disapprove low-value 
imaging tests. 
Conclusions from this study provide a great insight into what specific attributes 
most influence the delivery of low-value services. It would provide implication of when 
services are inappropriately delivered and why certain physicians or clinics 
inappropriately and more frequently use than other providers.   
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Implication for practice and policy 
Identifying and measuring low-value health services are prerequisites for reducing 
overuse and controlling excess health care expenditures. This study provided a starting 
point for further evaluation of the predictors of low-value care utilization. The studied 
services represent tests or procedures with longstanding agreement on their low value. 
Findings from this study highlighted the inherent challenges in defining and assessing 
low-value care as well as in implementing effective policies and payment mechanisms to 
promote high-value care use. It would be a collaborative, multi-faceted endeavor, 
engaging all stakeholders, including providers, patients, payers, policymakers, and the 
media to bring about a culture change and to inform action on greater value in health care. 
The goal of this study is to lay the groundwork for practice and policy agenda to reduce 
future utilization of low-value services and to improve the quality of health care delivered.  
Provider-based efforts 
As measuring and reducing low-value services is a goal shared by providers, 
patients and payers, overuse is also driven by multiple factors. Major drivers that promote 
overuse reported in prior studies include financial and payment incentives, malpractice 
concerns, time constraints, clinical performance measures and quality standards of care, 
patient preferences and demand [13, 67]. Studies found that some providers insist using 
more tests regardless of clinical scenario or patient risk status [135]. Also, nearly half 
primary care providers reported that they still order unnecessary tests or procedures on 
patients, while they know they were overusing [13]. Provider-based effort is a key 
component to combat overuse. 
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The Choosing Wisely campaign represents a physician-driven effort in identifying 
and reducing low-value care. It has the weight of physician societies behind the 
identification of low-value services. Based on a survey, approximately two-thirds of 
providers were aware of this national campaign; nearly all of them agreed it’s a legitimate 
source of information on unnecessary tests and procedures [14]. The recommendations 
should be translated into measurable quality indicators and adopted in actual practice. 
This study made a critical step to translate a list of low-value services into claim-based 
quality measures. Work is ongoing to incorporate these lists and guidelines into CMS, 
PQRS and NCQA quality-measurement efforts, reimbursement standards, and specialty 
recognition programs [136]. The priority could be de-adopting services when clinical 
nuance is not needed to identify as low-value. For example, age-delimited screening 
guidelines provide a clear, easy-to-implement standard of care. The USPSTF 
recommended against prostate cancer screening for men ages 75 and older in 2008. The 
recommendation led to 8 percent decline in annual PSA testing rates among men ages 75 
and older in 2009 and 2010, which highlighted the potential of guidelines to reduce the 
use of low-value health services [87]. I encourage providers to develop and validate more 
quality measures and interventions for wider implementation of Choosing Wisely 
recommendations.  
Some physicians with limited experience or insufficient time to spend with 
patients also reported to over-testing and treatment. They worry about malpractice 
liability and order too many tests for fear of overlooking diagnostic information [137]. It 
is likely due to inadequate education and awareness of guidelines at the point of care. The 
Choosing Wisely campaign could help providers to review relevant scientific evidence 
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and comply with clinical guidelines and performance standards. Evidence-based 
appropriateness guidelines and clinical decision-support tools could be embedded into 
electronic health records, to aid providers in their decision-making.  
The EHR-based technology-driven tools created a shared decision-making 
environment through targeting clinical situations in which services are low-value. For 
example, Computerized Physician Order Entry (CPOE) has been proven to reduce low-
value tests at Cleveland Clinic. Evidence-based decision rules were pre-established into 
the existing workflow of providers at the point of ordering an advanced imaging test. If 
the provider cannot specify an appropriate evidence-based decision rule, the test cannot 
be ordered [138]. A private health plan in Minnesota developed a decision support tool 
for medical group practices to use in their electronic medical record systems. The tool 
could provide feedback and make recommendations on diagnostic procedures. The tool 
helped the health plan to avoid 7,000 inappropriate imaging tests [139]. Eight practices 
incorporated the U.S. Oncology Network’s recommendation for lung cancer into an EHR 
decision-support system, after which patients had lower drug costs and similar one-year 
survival as patients without the decision-support system [140].  At the point of order, it 
assists physicians in performing a comprehensive medical history review and determining 
if further services are necessary. It could also help busy physicians to adhere to the 
professional standards and avoid ordering unnecessary testing through real-time clinical 
decision supports.  
Some of overuse appears to be driven by financial incentives that reward the 
provision of costly procedures.  Providers historically have been financially incentivized 
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to deliver more rather than less care. In the fee-for-service system, providers receive 
payment for volume, regardless of appropriateness. In the Medicare Physician Fee 
Schedule, payment for imaging tests and minor procedures often far exceed the resource 
costs, making them highly profitable [22]. This economic incentive influences provider’s 
decision depends on whether or not the service is covered by a payer and how profitable 
to deliver it. 
It is expected to reduce overuse through value-based physician payment 
mechanisms. Global or bundled payment models could reduce incentives of overuse and 
allow great provider discretion in providing services within the most clinically 
appropriate levels. Pay-for-performance, in which providers receive financial rewards or 
penalties based on their performance on a set of quality measures could reduce patients’ 
out-of-pocket costs of preventive care but has limited potential to reduce the provision of 
low-value services, due to the small number of quality measures available to identify 
low-value services. While translating more recommendations into measurable 
specification of low-value services, reducing overuse could play a more important role in 
provider payment reform and value-based purchasing. 
Patient-based efforts 
Longstanding social cultural perspective leading to patient demand is another 
important driver for overuse. There is a cultural assumption that more services equal to 
better care. Professional and cultural biases favor delivering a health care service even if 
there is doubt about its potential benefits. Patients have lack of knowledge on the risks 
and harms involved with low-value services. On the other hand, providers fear of patients’ 
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dissatisfaction or unmet expectations. For example, patients with low back pain have 
higher levels of satisfaction when they received routine imaging tests, although clinical 
outcomes were not different from those patients who did not receive imaging [109].  
Consumer education efforts are critical. The Choosing Wisely campaign is an 
important step to promote conversations between providers and patients on the overuse of 
low-value health services. Whereas professional agencies long have promoted practice 
guidelines, guidelines generally were disseminated within the confines of teaching 
hospitals, peer-reviewed journals, and academic conferences. The Choosing Wisely 
campaign involved a more public process, collaborating with Consumer Reports to create 
educational materials on low-value care specifically directed toward patients, presenting 
accessible information on websites and magazines to amplify the campaign’s key 
messages. It would help patients to understand the risks and benefits of certain services 
and to switch from the perception that more care is always better. It also would encourage 
patients to ask more questions and discuss with health care providers. As a patient 
becomes an active part of the care system, providers could make more informed decision 
regarding choosing care. It allows physicians to say no and still maintain a high level of 
patient satisfaction. Finally, it helps to promote more efficient use of health care 
resources. 
Payer-based efforts 
This study demonstrated how a private sector health insurance plan could monitor 
the use of services that have been designated as low-value. About seven percent of claims 
were rejected for studied services. The payer incorporated both government and 
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commercial plan products. Medicare did not deny many claims and government plan 
enrollees were more likely to get overuse. There are significant gaps between guidelines 
and actual clinical practice. The results could provide guidance for payers and 
policymakers to facilitate effective payment policies. 
At the payer level, simply stopping the provision of coverage for low-value 
services could have a dramatic effect on overuse. For example, payers can restrict the 
frequency with which a service is prescribed or remove the service from their coverage 
criteria. Most insurers pay for a colonoscopy only every four years, unless there is a 
medical reason for more frequent screenings. However, Medicare’s coverage and 
reimbursement rules make it hard to track the appropriateness of services provided. 
While Medicare is obligated to follow the medical guidelines to cover new preventive 
services, it has no mandate to deny coverage for newly non-recommended services. Only 
four of the 39 quality measures in the 2011 HEDIS that commonly are used by 
government and commercial payers to assess care quality and overuse [22]. This 
highlights the importance of translating evidence of low-value care into payment policy 
by developing quality measures.  
The patient’s type of health plan influences provider's advice to patients. 
Commercial payers, who bear the majority of low-value services costs analyzed in this 
study, could use estimates of low-value services utilization as an external benchmark for 
their own quality improvement work. Payment models reward volume of services, 
commercial payers could use these data to aid in developing incentive structures and 
reforming payment mechanisms for providers and patients to discourage use of low-value 
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services. For example, there are ongoing efforts to provide fair compensation without 
excessive incentives for advance imaging to address financial incentives [106]. Some 
health plans require pre-authorization for outpatient imaging services, including MRI and 
CT scans. However, the denial of claims for low-value services or a pre-authorization 
requirement might risk a return to the managed care backlash of the 1990s. 
Value-based insurance benefit designs are gaining prominence as an efficient way 
to facilitate effective care and lower out-of-pocket costs. It increases patient’s out-of-
pocket costs for services with uncertain benefits (low-value) and reduce cost-sharing for 
services which clinical benefits exceed the cost (high-value). The goal of value-based 
insurance design is encouraging patients to consider the value of care by shifting costs to 
the patient for low-value services. However, assigning deductible or copayments rates is 
challenging because the discretion needed on individual level. Research shown increasing 
patient cost-sharing could reduce use of both low-value and high-value care [141]. 
Patient cost-sharing in commercial insurance could only reduce use of low-value care if 
they have enough information and support to make good decisions. In addition, 
preventive services must be covered in full under Affordable Care Act since 2010. 
Revising reimbursement schedules may prompt resistance from consumers and 
providers. Partnership between payers and the Choosing Wisely campaign provides 
another way to increase patient accountability for those demanding low-value services by 
encouraging enrollees to talk to their providers about the type and value of care they are 
receiving. Third-party payers are collaborating in creating high-impact lists of low-value 
services, and estimate the volume and cost of services.  
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In conclusion, this analysis suggests that Choosing Wisely recommendations 
combined with provider and patient education might be insufficient to reduce overuse. 
Nevertheless, results from this study have the potential to begin conversations leading to 
attitudes and behavioral changes among providers and patients about resource use and 
support shared decision-making. The findings provide solid scientific evidence to foster 
researcher’s further academic inquiry, but do not automatically suggest a readily 
intervention on regulatory policies or payment reforms.  
By examining patient and provider-level correlates of use of selected low-value 
services, this study provides implications of what specific attributes most influence the 
overuse; when services were inappropriately delivered; which providers inappropriately 
and more frequently use than other providers. Health plans could identify clinics and 
physicians with high levels of overuse, and target their quality and costs efforts on those 
providers. Informed clinical and policy interventions could be developed, together with 
benefit designs and reimbursement changes.  
In general, this issue of overuse involves stakeholders at all levels, including 
federal, state, and local governments; public and private insurers; health care delivery 
organizations; employers; patients and consumers, etc. If guidance on low-value care 
were adopted broadly, many elements could work together with the shared objectives of 
controlling health care costs and improving health care quality, to achieve a continuously 




Limitation of Data 
This study has several limitations. The main limitation is the reliance on 
administrative claims to measure use of low-value services. Administrative claims have 
some inherent limitations common to all analyses using this type of data. As claims data 
are collected for the purpose of payment, not research, there are limits to the degree to 
which claims data can accurately capture an individual's medical and pharmacy history. 
While they are excellent for understanding “real world” patterns of health outcomes, 
these data may not provide the clinical nuance needed to identify certain scenarios of 
low-value care. This retrospective study looked back for only one year’s medical history. 
Any medical diagnoses or use of health services that occurred prior to the study period 
could not be observed. The patient’s entire past medical history and all laboratory results 
are not available in claims data. It is difficult to determine clinically low-value care and 
measure utilization without clinical information that accurately captures the decision 
making of providers. For example, because the patient’s first outpatient or emergency 
visit occurs after the onset of low back pain, it is likely that some patients with long-term, 
untreated chronic back pain were marked as receiving low-value imaging tests may in 
fact have received care appropriately. Even after restricting the analysis to relatively 
unambiguous measures, data demands are substantial. 
Medical record data capture the clinical circumstances that led to ordering a 
service and provide detailed information on the clinical context to determine whether the 
service was low-value. However, challenges are not unique to claims-based analyses 
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alone, and in fact, it is hard to assess appropriateness of health services even from 
medical records. Appropriateness under certain circumstances has to be reviewed and 
determined on an individual basis according to disease history, clinical symptoms, 
previous screening results, predicted intervention risks, family history, life expectancy, 
and patient preference. A service that is low-value in some clinical circumstances might 
be high-value in others. The clinical heterogeneity makes it challenging to develop 
measures for identifying low-value services. Negative diagnosis history is not sufficient 
to make the exclusion criteria. Guidelines developed by professional agencies generally 
do not precisely define the overuse measures and applicable population. For example, 
they differ as to how they define “non-specific” low back pain and low back pain with 
“red flags”. There are also ambiguous definitions indicated by terms “low-risk”, 
“average-risk”, “asymptomatic” or “routine” describing the population or intensities. 
Consequently, these nuances in specification or exclusion criteria (e.g. starting/ending 
age and interval for screening, red flag symptoms in diagnostic imaging) would produce 
conflicting results and impede researchers from further investigation. 
These data deficiencies present fundamental obstacles for identifying and 
measuring all low-value services specified by professional agencies. This study made a 
diligent effort to mitigate the impact by providing justification in identification criteria. I 
focused on services that were most likely to be clinically low-value and believe they are 
highly conservative starting points to estimate prevalence of each service, associated 
spending, and correlates of utilization.  
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Limitation on Costs 
While estimates of prevalence could be an upper bound on how many low-value 
services had taken place, the actual costs are larger than reported in this study. As noted, 
this study was not able to capture full extent of how much money was unnecessarily paid 
for these low-value services, because claims spending estimates did not include 
downstream services that result from initial services.  
Another limitation on costs to this study is the lack of information on Medicare 
payments in private health plan claims data. Among the estimated $4.2 million of 
claimed unnecessary annual expenditure, only one-third of them were allowed. The 
understated allowed amounts were due to the limitation of commercial claims data on 
aging populations. For services performed on Medicare Cost enrollees, the costs were 
zero if Medicare paid in full. For enrollees covered by more than one plan, only the 
portion of costs allowed by the health plan from which the data was obtained are 
presented in this study. 
Limitation on Model 
Although this study controlled for known patient and provider characteristics, a 
limitation exists in this study is that not all potential factors affecting overuse in the 
conceptual model were adjusted in the analytic model. In real clinical practice, provider 
and patient engage in a more complicated circumstance of decision-making. Previous 
studies reported that physician characteristics associated with overuse include doctor’s 
perception and desire to satisfy patient’s expectation [142, 143]. Other studies focused on 
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system-level interventions to reduce overuse. Decision support systems and shared 
decision-making with patients has been shown to reduce unnecessary tests, improve 
physician-patient’s communication, and their knowledge and adherence to clinical 
guidelines [144-146]. In addition, organization and practice-level variables were not 
incorporated due to the inability to capture the information through claims data. Another 
important variable not included in the model due to lack of data is the enrollment in high 
deductible health plan (HDHP). Nonetheless, the association of health plan product and 
use of low-value care are statistically significant.  
Limitation on Generalizability 
This study is also subject to a set of limitations associated with generalizability. I 
found patient- and provider level correlates and their relative contribution widely varied 
for the five selected cohorts. The results cannot be generalized to all services designated 
as overuse. Given the clinical nuance, not all of the recommendations can be readily 
measured using administrative data. The studied low-value services may not be sufficient 
but would be a step to call for including more measures. 
The results from Minnesota may not be nationally generalizable. Previous studies 
suggest substantial regional variations in low-value care [147]. Commercial data are not 
distributed evenly across regions, prevalence rates could vary more than threefold 
between different Hospital Referral Regions [135]. For example, colonoscopy is the most 
expensive preventive cancer screening test. According to the Healthcare Blue Book from 
Consumer Reports, colonoscopy pricing frequently varies by over 300 percent nationally 
depending on where to receive care [148]. In addition, some low-risk patients may have 
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been treated as high-risk in areas with more intense health care delivery. This could due 
to regional provider practice patterns, capacity to adapt to change, practice organization 
characteristics, or other unmeasured provider and patient factors. 
Data in this study were collected from a region with a high reputation for efficient 
care delivery, so the use of low-value services may not be representative of the overall 
use in the U.S. The rates of low-value services may be higher in other geographic 
locations where there are fewer large multispecialty group practices with extensive 
quality assurance programs in place. In addition, the estimated associated costs could be 
more conservative than nationally due to state-level efforts. Further research is needed to 




Directions for Future Research 
This study identified five measurable low-value services from administrative 
claims data. A critical next step in reducing overuse is to perform separate analyses of 
more low-value services. Prior studies are limited because they consolidated a list of 
different low-value services in one model and did not specifically identify individual 
services. As reported in this study, different services could have different attributes 
contributing to the variation of overuse. Correlates and their relative contribution are not 
generalizable to all low-value services. This study builds on and improves the literature 
by modeling individual services separately. However, I analyzed only five measures of 
low-value services. The volume of low-value services and associated health care 
spending may appear small in one health plan. Selected services account for just a small 
subset of hundreds of low-value services identified by professional agencies. A study 
using Medicare data reported 3 to 12 percent of Medicare beneficiaries older than 75 
underwent PSA screening in 2008 to 2009, if this test were eliminated, it would have 
reduced overall Medicare spending by only 0.01 to 0.03 percent [40]. However, there are 
many more low-value services that need to be evaluated, including those major, 
substantial, revenue-generating services for providers. There are a limited number of low-
value services that could be readily measured easily using administrative claims data. A 
large clinical database from electronic medical records would support a more extensive 
assessment with an additional set of indicators. It could also expand the current set of five 
measures to look at down-stream costs of additional testing and procedures. I hope this 
study will inspire follow-up research to include a broader set of low-value services with 
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expanded data. The potential impact of reduction in low-value services could be even 
larger. 
Additionally, I am interested in what clinic-level and organizational factors are 
associated with low-value care. Potential measurable clinic characteristics include: (1) 
clinic size (number of FTE physicians, e.g. MD or DO, number of FTE physician 
extenders, e.g. physician assistants, registered nurses, licensed practical nurses, and MD 
trainees). (2) Ownership of practice (hospital-owned, physician-owned, other-owned). (3) 
Type of practice (primary care only, single specialty, e.g. gynecology only, multi-
specialty, e.g. primary care and gynecology, neither). (4) Specialties in the practice (e.g. 
gynecology, urology, gastroenterology). (5) Volume of services (e.g. how many PSA 
tests ordered per month per clinic). (6) EHR capabilities (e.g. number of years since 
adoption of EHR, computerized physician order entry). Ultimately, this will allow further 
study to examine the practice patterns determinants of overuse and develop interventions 
at the practice level. 
This study used data from 2012 and prior. Choosing Wisely campaign and other 
initiatives become influential since 2012. Another direction for future research is to 
examine the effects of the Choosing Wisely initiatives and related programs on use of the 
specified services with longitudinal data. It would be interesting to assess impacts of the 
local implementation on these recommendations. Allowing time for adequate 
dissemination, I will be glad to see the initiatives make a difference for the benefit of 




Table 1 Agencies Recommend against Low-value Cervical Cancer Screening 
Source Guideline Year 
American Cancer Society (ACS) 
American Society for Colposcopy and Cervical Pathology 
(ASCCP) 
American Society for Clinical Pathology (ASCP) 
Cervical cancer screening should begin at age 21 years. Women aged 
younger than 21 years should not be screened regardless of the age of 
sexual initiation or other risk factors. HPV testing should not be used to 
screen women aged 21 to 29 years, either as a stand-alone test or as a co-
test with cytology. 
2012 
United States Preventive Services Task Force (USPSTF) 
The USPSTF recommends against screening for cervical cancer in women 
younger than age 21 years. 
The USPSTF recommends against screening for cervical cancer with HPV 
testing, alone or in combination with cytology, in women younger than age 
30 years. 
2012 
American Congress of Obstetricians and Gynecologists 
(ACOG) 
Women aged <21 years should not be screened regardless of age at 
sexual initiation and other behavior-related risk factors. 
HPV co-testing should not be performed in women aged <30 years.  
2012 
National Physicians Alliance (NPA) Don't perform Pap tests on patients younger than 21 years 2011 
American Academy of Family Physicians (AAFP) Don’t perform Pap tests on women younger than 21 2012 
American Academy of Family Physicians (AAFP) 
Do not screen women younger than 30 years of age for cervical cancer with 
HPV testing, alone or in combination with cytology. 
2013 
National Committee for Quality Assurance (NCQA) 
Adolescent females 16-20 years of age should not be screened for cervical 
cancer 
2014 
Institute for Clinical Systems Improvement (ICSI) 
Recommend against cervical cancer screening regardless of age of onset 





Table 2 Agencies Recommend against Low-value Prostate Cancer Screening 
Source Guideline Year 
USPSTF 




Do not routinely screen for prostate cancer using a prostate-specific antigen 
(PSA) test or digital rectal exam. 2012 
American College of Physicians (ACP) 
Do not screen for prostate cancer in men older than 75 years or with a life 
expectancy of less than 10 years. 2012 
American Urological Association (AUA) 
Not recommend routine PSA screening in men age 70+ years or any men 
with less than a 10-15 year life expectancy 2013 
National Committee for Quality Assurance (NCQA) Recommends against prostate cancer screening using prostate-specific 





Table 3 Agencies Recommend against Low-value Colorectal Cancer Screening 
Source Guideline Year 
USPSTF 
Recommends against routine screening for colorectal cancer in adults ages 
76 to 85 years.  2008 
USPSTF 
Recommends against screening for colorectal cancer in adults older than 
age 85 years.           2008 
American College of Physicians (ACP) 
Do not screen for colorectal cancer in adults older than 75 years or in adults 
with a life expectancy of less than 10 years. 2012 
National Committee for Quality Assurance (NCQA) Recommend against colorectal cancer screening in adults 86 years and 





Table 4 Agencies Recommend against Low-value Low Back Pain Imaging 
Source Guideline Year 
American Association of Neurological Surgeons (AANS) 
Congress of Neurological Surgeons (CNS) 
Do not obtain imaging (plain radiographs, magnetic resonance imaging, 
computed tomography [CT], or other advanced imaging) of the spine in 
patients with non-specific acute low back pain and without red flags. 
2014 
American College of Physicians (ACP) Do not obtain imaging studies in patients with non-specific low back pain.  2012 
American College of Physicians (ACP) American Pain 
Society (APS) 
Clinicians should not routinely obtain imaging or other diagnostic tests in 
patients with nonspecific low back pain. 
2007 
American Society of Anesthesiologists (ASA) 
Avoid imaging studies (MRI, CT or X-rays) for acute low back pain without 
specific indications. 
2014 
North American Spine Society (NASS) 
Do not recommend advanced imaging (e.g., MRI) of the spine within the first 
six weeks in patients with non-specific acute low back pain in the absence of 
red flags.  
2013 
American Academy of Physical Medicine and 
Rehabilitation (AAPMR) 
Do not order an imaging study for back pain without performing a thorough 
physical examination. 
2014 
National Institute for Health and Care Excellence (NICE) 
Do not offer X-ray of the lumbar spine for the management of non-specific 




National Physicians Alliance (NPA) Don’t do imaging for low back pain within the first 6 weeks unless red flags 
are present 2011 
National Committee for Quality Assurance (NCQA) Use of imaging studies (plain x-ray, CT scan, MRI) within 28 days of the 
primary diagnosis of low back pain 2013 
Institute for Clinical Systems Improvement (ICSI) 
Clinicians should not recommend imaging (including computed tomography, 
magnetic resonance imaging and x-ray) for patients with non-specific low 
back pain 
Clinicians should not recommend imaging (including computed tomography, 
magnetic resonance imaging and x-ray) for patients in the first six weeks of 




Table 5 Government Plan Types and Description 
Plan Type Product Description 
Medicare 
Medicare Advantage (Part C) 
A type of Medicare health plan offered by a private company that contracts with 
Medicare to provide Part A and Part B benefits.  
Medicare Cost 
A plan provides options to use in-network providers with lower costs or use out-of-
network providers covered under original Medicare Part A and Part B benefits.  
Medicare Special Needs Plan (SNP) A Medicare Advantage plan for people with specific conditions 
Medicaid 
Prepaid Medical Assistance Plan (PMAP) 
Federal-funded plan for low-income families, children, pregnant women, and people 
with disabilities. 
MinnesotaCare (MNcare) 
A state-funded plan for residents who do not have access to affordable health care 
coverage. 
Special Needs Basic Care (SNBC) A plan for people with disabilities ages 18-64.  
Minnesota Senior Health Options (MSHO) 
A state program for people over age 65 who are dual-eligible for Medical Assistance 
and Medicare Parts A and B. 





Table 6 Definitions for Overuse Measures with Study Sample Inclusion and Exclusion Criteria 





Females 13 to 29 




All female enrollees age 13 years 
as 1/1/2012 to 20 years as of 
12/31/2012 
• All denominator patients with any 
gap of more than one month in 
enrollment during 2012 
• All denominator patients with any 
diagnosis from 1/1/2011 to 
12/31/2012, identified as: 
  • Cervical Cancer (Cervical Cancer 
Codes) 
  • HIV (HIV Codes) 
  • Immunodeficiency (Disorders of 
the Immune System Codes) 
All denominator patients 
receiving Pap tests (Cervical 
Cytology Codes) during 
2012. 
All female enrollees age 13 years 
as 1/1/2012 to 29 years as of 
12/31/2012 
All denominator patients 
receiving HPV Tests (HPV 




men 75 years 
and older 
Men 75 years and 








All male enrollees 75 years or 
older as of 1/1/2012. 
• All denominator patients with any 
gap of more than one month in 
enrollment during 2012 
• All denominator patients with any 
diagnosis from 1/1/2011 to 
12/31/2012, identified as: 
  • Prostate Cancer (Prostate 
Cancer Codes) 
  • Prostate Dysplasia (Prostate 
Dysplasia Codes) 
  • Prostatectomy (Prostatectomy 
Codes) 
• All denominator patients with any 
diagnosis from 1/1/2011 to 
12/31/2011, identified as: 
  • Elevated PSA (Elevated PSA 
Codes) 
All denominator patients 
receiving PSA tests (PSA 







than 75 years 
Members 76 years 




All enrollees age 76 years or older 
as of 1/1/2012. 
• All denominator patients with any 
gap of more than one month in 
enrollment during 2012 
• All denominator patients with any 
diagnosis from 1/1/2011 to 
12/31/2012, identified as: 
  • Colorectal Cancer (Colorectal 
Cancer Codes) 
  • Iron deficiency anemia, lower 
gastrointestinal bleeding, Crohn’s 
Disease, familial adenomatous 
polyposis, Lynch syndrome, 
inflammatory bowel disease, 
ulcerative colitis, abnormal findings 
of gastrointestinal tract, changes in 
bowel habits, or a personal or family 
history of colorectal cancer (CRC 
Exclusions Codes) 
All denominator enrollees 
receiving colorectal cancer 
screening during 2012, 
identified as: 
  • Colonoscopy 
(Colonoscopy Codes) 
  • Flexible sigmoidoscopy 
(Flexible Sigmoidoscopy 
Codes) 
  • Fecal occult blood test 
(FOBT Codes) 
  • Barium enema (Barium 
Enema Codes) 
  • CT colonography (CT 
Colonography Codes) 





low back pain 
Patients with a 
primary diagnosis of 
low back pain 
receiving an 
imaging study (plain 
x-ray, MRI, CT 
scan) within four 
weeks of the 
diagnosis. 
All enrollees age 18 years as 
1/1/2012 to 50 years as of 
12/31/2012 with any primary 
diagnosis of low back pain in 2012, 
identified as: 
• Outpatient visit (Outpatient 
Codes), with a primary diagnosis 
of low back pain (Low Back Pain 
Codes) 
• Observation visit (Observation 
Codes), with a primary diagnosis 
of low back pain (Low Back Pain 
Codes) 
• ED visit (ED Codes), with a 
primary diagnosis of low back pain 
(Low Back Pain Codes) 
• Osteopathic Manipulative 
Treatment (Osteopathic 
Manipulative Treatment Codes), 
• All denominator patients with any 
gap in enrollment during 2012 
• All denominator patients with any 
diagnosis of low back pain (Low 
Back Pain Codes) during the 180 
days prior to the first primary 
diagnosis of low back pain in 2012.  
• All denominator patients with any 
diagnosis from 1/1/2011 to 28 days 
after the first primary diagnosis of 
low back pain in 2012, identified as: 
  • Cancer (Malignant Neoplasms 
Codes, Other Neoplasms Codes, 
History of Malignant Neoplasm 
Codes) 
  • Trauma (Trauma Codes) 
  • Intravenous drug abuse (IV Drug 
Abuse Codes) 
  • Neurologic Impairment 
All denominator patients 
receiving imaging studies for 
low back pain (Imaging 
Study Codes) on the date of 
the first primary diagnosis of 
low back pain or within 28 




with a primary diagnosis of low 
back pain (Low Back Pain Codes) 
• Physical Therapy (Physical 
Therapy Codes), with a primary 
diagnosis of low back pain (Low 
Back Pain Codes) 
(Neurologic Impairment Codes) 
  • HIV (HIV Codes) 
  • Intraspinal Abscess (Intraspinal 
Abscess Codes) 
Abbreviations: AAFP, American Academy of Family Physicians; AANS, American Association of Neurological Surgeons;  AAP, American 
Academy of Pediatrics; ACOG, American Congress of Obstetricians and Gynecologists; ACP, American College of Physicians; ACR, American 
College of Radiology;  ACS, American College of Surgeons; ACS/ASCCP/ASCP, American Cancer society, American Society for Colposcopy and 
Cervical Pathology, American Society of Clinical Pathology; AGS, American Geriatrics Society; ASA, American Society of Anesthesiologists; 
ASCO, American Society of Clinical Oncology; CT, Computerized Tomography; ICSI, Institute for Clinical Systems Improvement; NASS, North 
American Spine Society; NCQA, National Committee for Quality Assurance; NPA, National Physicians Alliance; USPSTF, U.S. Preventive 




Table 7 Summary of Variables and Data Sources 
Level Category Variable Data Source 
Patient Characteristics 
Demographic factors Age, gender, race/ethnicity, location, etc. Member 
Socioeconomic status Income, education, occupation, etc. Census 
Health-related factors Utilization level, comorbid conditions, etc. ACG 




Demographic factors Age, gender, etc.  Provider 
Specialty and training Specialty, sub-specialty, degree, etc. Provider 
Regional factors Location, state, etc. Provider 
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Table 8 Prevalence of Low-value Health Care Services 


























Cervical cancer screening for young women 54,146 2,587 3,515 3,153 3,071 4.78% 89.70% 
Pap test for women under age 21 28,761 1,493 2,080 1,796 1,747 5.19% 86.35% 
HPV test for women under age 30 54,146 1,254 1,435 1,357 1,324 2.32% 94.56% 
Prostate cancer screening for men 75 years and older 18,168 2,522 2,935 2,795 2,747 13.88% 95.23% 
Colorectal cancer screening for adults older than 75 years 40,944 1,237 1,404 1,324 1,265 3.02% 94.30% 
Colonoscopy 40,944 593 670 637 596 1.45% 95.07% 
Fecal occult blood test 40,944 604 640 599 590 1.48% 93.59% 
Barium enema 40,944 46 51 51 47 0.11% 100.00% 
CT colonography 40,944 2 2 2 2 0.00% 100.00% 
Flexible sigmoidoscopy 40,944 35 41 35 30 0.09% 85.37% 
Low back pain imaging within four weeks of diagnosis 9,383 1,629 2,612 2,477 2,304 17.36% 94.83% 
X-ray 9,383 1,303 1,722 1,627 1,530 13.89% 94.48% 
CT Scan 9,383 63 72 69 61 0.67% 95.83% 
MRI 9,383 626 818 781 713 6.67% 95.48% 
Total  941,975 
  






Table 9 Costs of Low-value Health Care Services 






















Cervical cancer screening for young women 332,145 169,330 1,872 167,458 94.49 54.53 0.18 
Pap test for women under age 21 147,750 74,318 591 73,727 71.03 42.20 0.08 
HPV test for women under age 30 184,395 95,012 1,281 93,731 128.50 70.79 0.10 
Prostate cancer screening for men 75 years and older 246,588 75,648 281 75,367 84.02 27.44 0.08 
Colorectal cancer screening for adults older than 75 years 1,714,475 395,165 81,540 313,625 1,221.14 247.93 0.42 
Colonoscopy 1,636,107 370,553 79,336 291,217 2,441.95 488.62 0.39 
Fecal occult blood test 30,338 10,731 8 10,723 47.40 18.17 0.01 
Barium enema 21,524 5,405 1,509 3,896 422.04 82.89 0.01 
CT colonography 1,183 953 0 953 591.50 476.56 0.00 
Flexible sigmoidoscopy 25,323 7,523 687 6,837 617.63 227.88 0.01 
Low back pain imaging within four weeks of diagnosis 1,856,849 743,312 33,399 709,913 710.89 308.12 0.79 
X-ray 241,684 100,802 2,991 97,811 140.35 63.93 0.11 
CT Scan 85,135 21,818 1,838 19,980 1,182.42 327.55 0.02 
MRI 1,530,030 620,691 28,569 592,122 1,870.45 830.47 0.66 





Table 10 Patient-level Model Summary Statistics 
Health care services 
Pap test for 
women 
under age 21 




screening for men 
75 years and older 
Colorectal cancer 
screening for adults 
older than 75 years 
Low back pain 
imaging within four 
weeks of diagnosis 
Patient characteristics           
Age 16.39 20.19 80.25 82.12 36.71 
Female 100.00% 100.00% 0.00% 61.12% 57.68% 
Neighborhood effects           
Rural 15.44% 15.24% 32.70% 30.12% 18.73% 
% White, non-Hispanic 84.97% 84.15% 90.77% 90.07% 86.21% 
% High School Degree 59.43% 59.37% 62.60% 61.86% 60.73% 
% Bachelor's degree or greater 32.71% 32.56% 28.60% 29.29% 31.26% 
% households with income below FPL 9.63% 10.27% 10.52% 10.86% 9.64% 
Plan type           
Medicaid 17.32% 16.73% 8.49% 13.74% 9.18% 
Commercial  82.68% 83.24% 4.88% 4.51% 90.35% 
Medicare 0.00% 0.02% 86.64% 81.74% 0.47% 
Prior year health status      
Very healthy users 12.06% 11.64% 3.09% 2.14% 9.97% 
Healthy users 18.75% 17.89% 2.84% 2.82% 12.11% 
Low health risk 29.40% 23.82% 3.42% 3.22% 16.09% 
Moderate health risk 32.82% 35.77% 42.57% 45.01% 48.67% 
High health risk 6.28% 10.13% 26.99% 27.30% 11.54% 
Very high health risk 0.69% 0.74% 21.08% 19.50% 1.63% 
Observations 22,826 42,793 15,505 35,100 7,193 
AEP 1,147 959 2,103 1,081 1,250 
Prevalence 5.02% 2.24% 13.56% 3.08% 17.38% 
96 
 
Table 11 Full-model Summary Statistics 
Health care services 
Pap test for 
women under 
age 21 




screening for men 
75 years and older 
Colorectal cancer 
screening for 
adults older than 
75 years 
Low back pain 
imaging within four 
weeks of diagnosis 
Patient characteristics           
Age 16.37 20.29 80.25 82.10 36.74 
Female 100.00% 100.00% 0.00% 62.08% 57.95% 
Neighborhood effects           
% White, non-Hispanic 86.06% 84.97% 90.08% 89.26% 86.08% 
% High School Degree 59.33% 59.39% 61.24% 60.69% 60.65% 
% Bachelor's degree or greater 33.13% 32.76% 30.45% 30.92% 31.34% 
% households with income below FPL 9.33% 10.06% 10.10% 10.42% 9.59% 
Plan type           
Medicaid 17.82% 17.20% 8.27% 12.45% 9.15% 
Commercial  82.18% 82.80% 3.28% 2.54% 90.35% 
Medicare 0.00% 0.00% 88.45% 85.01% 0.50% 
Prior year health status           
Very healthy users 8.30% 8.23% 1.18% 0.93% 9.80% 
Healthy users 16.99% 16.68% 1.48% 1.50% 12.45% 
Low health risk 30.50% 24.49% 2.60% 2.49% 16.05% 
Moderate health risk 36.29% 39.07% 42.28% 44.77% 48.55% 
High health risk 7.10% 10.70% 29.14% 29.29% 11.53% 
Very high health risk 0.82% 0.84% 23.33% 21.03% 1.62% 
Provider characteristics           
Age 45.45 45.11 51.06 50.23 45.42 
40- years old 33.22% 35.31% 17.00% 18.80% 33.29% 
40 to 49 years old 29.68% 28.81% 24.08% 26.03% 29.05% 
50 to 59 years old 27.24% 26.04% 35.83% 34.54% 28.31% 
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60+ years old 9.86% 9.84% 23.09% 20.64% 9.35% 
Female 71.56% 72.37% 19.68% 35.29% 29.21% 
Rural 14.50% 14.07% 24.34% 22.97% 20.80% 
Credentialing           
Physician extenders 28.11% 29.60% 11.71% 12.79% 59.25% 
Physician 71.89% 70.40% 88.29% 87.21% 40.75% 
Specialty           
Primary care provider 92.43% 83.60% 100.00% 99.16% 35.33% 
Ob-gynecologist 7.57% 16.40% 0.00% 0.84% 0.00% 
Orthopedist 0.00% 0.00% 0.00% 0.00% 2.23% 
Chiropractor 0.00% 0.00% 0.00% 0.00% 49.11% 
Other Specialist 0.00% 0.00% 0.00% 0.00% 13.33% 
Observations 14,418 27,330 10,091 23,129 6,375 
AEP 872 747 1,834 880 1,122 




Table 12 Marginal Effects (percentage-point change) of Patient Characteristics Associated with Probability of Overuse 
Variables 
Pap test for 
women 
under age 21 
HPV test for 
women 
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 Plan Type (Ref=Medicaid) 
          Commercial  -1.08 ** -0.03 
 
















7.05 *** 1.37 *** -1.86 
 











Prior-year Health Status (Ref=Very healthy users) 

















































 Very high health risk 3.31 * 0.93 
 












 Observations 22,826 42,793 15,505 35,100 7,193 
Percentage Points Change, (Standard Errors) 
*** p<0.01, ** p<0.05, * p<0.1 
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Table 13 Marginal Effects (percentage-point change) of Provider Characteristics Associated with Probability of Overuse 
Variables 
Pap test for 
women under 
age 21 
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6.76 *** 1.05 *** 1.69 
 






 Prior-year Health Status (Ref=Very healthy users) 




















































 High health risk 3.27 *** 0.59 
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          Age (Ref=40- years old) 




















































 Female (Ref=Male) 1.39 *** 0.77 *** 0.27 
 



























 Credentialing (Ref=Physician extenders) 
















 Specialty (Ref=PCP) 
          Ob/gynecologist 3.10 *** 1.43 *** 
  
-0.56 





   
(1.36) 
   Orthopedist 
        
35.42 *** 
         
(4.65) 
 Chiropractor 
        
-14.21 *** 
         
(1.72) 
 Other Specialist 
        
2.75 
 
         
(1.79) 
 Observations 14,418 27,330 10,091 23,129 6,375 
Number of groups 6,148 8,773 3,408 5,635 4,080 
Percentage Points Change, (Standard Errors) 
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Appendices 
Table 14 Codebook - Cervical cancer screening for young women 
Value Set Name Code Code System Definition 
HPV Tests 
87620 CPT 
Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human, 
direct probe technique 
HPV Tests 
87621 CPT 
Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human, 
amplified probe technique 
HPV Tests 
87622 CPT 




Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus 
(HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) 
HPV Tests 
87625 CPT 
Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus 
(HPV), types 16 and 18 only, includes type 45, if performed 
Cervical Cytology 
88141 CPT 




Cytopathology, cervical or vaginal (any reporting system), collected in preservative 




Cytopathology, cervical or vaginal (any reporting system), collected in preservative 
fluid, automated thin layer preparation; with manual screening and rescreening 
under physician supervision 
Cervical Cytology 
88147 CPT 






Cytopathology smears, cervical or vaginal; screening by automated system with 
manual rescreening under physician supervision 
Cervical Cytology 
88150 CPT 




Cytopathology, slides, cervical or vaginal; with manual screening and computer-
assisted rescreening under physician supervision 
Cervical Cytology 
88153 CPT 
Cytopathology, slides, cervical or vaginal; with manual screening and rescreening 
under physician supervision 
Cervical Cytology 
88154 CPT 
Cytopathology, slides, cervical or vaginal; with manual screening and computer-
assisted rescreening using cell selection and review under physician supervision 
Cervical Cytology 
88164 CPT 
Cytopathology, slides, cervical or vaginal (the Bethesda System); manual 
screening under physician supervision 
Cervical Cytology 
88165 CPT 
Cytopathology, slides, cervical or vaginal (the Bethesda System); with manual 
screening and rescreening under physician supervision 
Cervical Cytology 
88166 CPT 
Cytopathology, slides, cervical or vaginal (the Bethesda System); with manual 
screening and computer-assisted rescreening under physician supervision 
Cervical Cytology 
88167 CPT 
Cytopathology, slides, cervical or vaginal (the Bethesda System); with manual 
screening and computer-assisted rescreening using cell selection and review 
under physician supervision 
Cervical Cytology 
88174 CPT 
Cytopathology, cervical or vaginal (any reporting system), collected in preservative 




Cytopathology, cervical or vaginal (any reporting system), collected in preservative 
fluid, automated thin layer preparation; with screening by automated system and 
manual rescreening or review, under physician supervision 
Cervical Cytology 
G0123 HCPCS 
Screening cytopathology, cervical or vaginal (any reporting system), collected in 
preservative fluid, automated thin layer preparation, screening by cytotechnologist 





Screening cytopathology, cervical or vaginal (any reporting system), collected in 




Screening cytopathology smears, cervical or vaginal, performed by automated 
system, with manual rescreening, requiring interpretation by physician 
Cervical Cytology 
G0143 HCPCS 
Screening cytopathology, cervical or vaginal (any reporting system), collected in 
preservative fluid, automated thin layer preparation, with manual screening and 
rescreening by cytotechnologist under physician supervision 
Cervical Cytology 
G0144 HCPCS 
Screening cytopathology, cervical or vaginal (any reporting system), collected in 
preservative fluid, automated thin layer preparation, with screening by automated 
system, under physician supervision 
Cervical Cytology 
G0145 HCPCS 
Screening cytopathology, cervical or vaginal (any reporting system), collected in 
preservative fluid, automated thin layer preparation, with screening by automated 
system and manual rescreening under physician supervision 
Cervical Cytology 
G0147 HCPCS 
Screening cytopathology smears, cervical or vaginal, performed by automated 
system under physician supervision 
Cervical Cytology 
G0148 HCPCS 
Screening cytopathology smears, cervical or vaginal, performed by automated 
system with manual rescreening 
Cervical Cytology 
P3000 HCPCS 
Screening Papanicolaou smear, cervical or vaginal, up to 3 smears, by technician 
under physician supervision 
Cervical Cytology 
P3001 HCPCS 
Screening Papanicolaou smear, cervical or vaginal, up to 3 smears, requiring 
interpretation by physician 
Cervical Cytology 
Q0091 HCPCS 
Screening Papanicolaou smear; obtaining, preparing and conveyance of cervical 
or vaginal smear to laboratory 
Cervical Cancer 180.0 ICD9CM Malignant neoplasm of cervix uteri, endocervix 
Cervical Cancer 180.1 ICD9CM Malignant neoplasm of cervix uteri, exocervix 
Cervical Cancer 180.8 ICD9CM Malignant neoplasm of other specified sites of cervix 
Cervical Cancer 180.9 ICD9CM Malignant neoplasm of cervix uteri, unspecified site 
Cervical Cancer 233.1 ICD9CM Carcinoma in situ of cervix uteri 
Cervical Cancer V10.41 ICD9CM Personal history of malignant neoplasm, cervix uteri 
HIV 042 ICD9CM Human immunodeficiency virus [HIV] disease 
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HIV V08 ICD9CM Asymptomatic human immunodeficiency virus [HIV] infection status 
Disorders of the Immune 
System 279.00 ICD9CM Hypogammaglobulinemia, unspecified  
Disorders of the Immune 
System 279.01 ICD9CM Selective IgA immunodeficiency  
Disorders of the Immune 
System 279.02 ICD9CM Selective IgM immunodeficiency  
Disorders of the Immune 
System 279.03 ICD9CM Other selective immunoglobulin deficiencies  
Disorders of the Immune 
System 279.04 ICD9CM Congenital hypogammaglobulinemia  
Disorders of the Immune 
System 279.05 ICD9CM Immunodeficiency with increased IgM  
Disorders of the Immune 
System 279.06 ICD9CM Common variable immunodeficiency  
Disorders of the Immune 
System 279.09 ICD9CM Other deficiency of humoral immunity  
Disorders of the Immune 
System 279.10 ICD9CM Immunodeficiency with predominant T-cell defect, unspecified  
Disorders of the Immune 
System 279.11 ICD9CM DiGeorge's syndrome  
Disorders of the Immune 
System 279.12 ICD9CM Wiskott-Aldrich syndrome 
Disorders of the Immune 
System 279.13 ICD9CM Nezelof's syndrome  
Disorders of the Immune 
System 279.19 ICD9CM Other deficiency of cell-mediated immunity  
Disorders of the Immune 
System 279.2 ICD9CM Combined immunity deficiency 
Disorders of the Immune 
System 279.3 ICD9CM Unspecified immunity deficiency 
Disorders of the Immune 
System 279.41 ICD9CM Autoimmune lymphoproliferative syndrome 
Disorders of the Immune 
System 279.49 ICD9CM Autoimmune disease, not elsewhere classified 




Disorders of the Immune 
System 279.51 ICD9CM Acute graft-versus-host disease  
Disorders of the Immune 
System 279.52 ICD9CM Chronic graft-versus-host disease  
Disorders of the Immune 
System 279.53 ICD9CM 
Acute on chronic graft-versus-host disease 
Disorders of the Immune 
System 279.8 ICD9CM Other specified disorders involving the immune mechanism 
Disorders of the Immune 





Table 15 Codebook - Prostate cancer screening for men 75 years and older 
Value Set Name Code Code System Definition 
PSA Tests 84152 CPT Prostate specific antigen (PSA); complexed (direct measurement) 
PSA Tests 84153 CPT Prostate specific antigen (PSA); total 
PSA Tests 84154 CPT Prostate specific antigen (PSA); free 
PSA Tests G0103 HCPCS Prostate cancer screening; prostate specific antigen test (PSA) 
Elevated PSA 790.93 ICD9CM Elevated prostate specific antigen, (PSA)  
Prostate Cancer 185 ICD9CM Malignant neoplasm of prostate  
Prostate Cancer 233.4 ICD9CM Carcinoma in situ of  prostate 
Prostate Cancer 236.5 ICD9CM Neoplasm of uncertain behavior of prostate 
Prostate Cancer 
V10.46 ICD9CM Personal history of malignant neoplasm, prostate   
   
Prostate Cancer V16.42 ICD9CM Family history of malignant neoplasm, prostate 
Prostate Cancer V84.03 ICD9CM Genetic susceptibility to malignant neoplasm of prostate  





Table 16 Codebook - Colorectal cancer screening for adults older than 75 years 
Value Set Name Code Code System Definition 
Colorectal Cancer 153.0 ICD9CM Malignant neoplasm of colon,Hepatic flexure   
Colorectal Cancer 153.1 ICD9CM Malignant neoplasm of colon, Transverse colon 
Colorectal Cancer 153.2 ICD9CM Malignant neoplasm of colon, Descending colon  
Colorectal Cancer 153.3 ICD9CM Malignant neoplasm of colon, Sigmoid colon  
Colorectal Cancer 153.4 ICD9CM Malignant neoplasm of colon, Cecum  
Colorectal Cancer 153.5 ICD9CM Malignant neoplasm of colon, Appendix  
Colorectal Cancer 153.6 ICD9CM Malignant neoplasm of colon, Ascending colon  
Colorectal Cancer 153.7 ICD9CM Malignant neoplasm of colon, Splenic flexure  
Colorectal Cancer 153.8 ICD9CM Malignant neoplasm of colon, Other specified sites of large intestine  
Colorectal Cancer 153.9 ICD9CM Malignant neoplasm of colon, unspecified   
Colorectal Cancer 154.0 
ICD9CM Malignant neoplasm of rectosigmoid junction  
  
Colorectal Cancer 154.1 
ICD9CM Malignant neoplasm of rectum, rectosigmoid junction  
  
Colorectal Cancer 197.5 
ICD9CM Secondary malignant neoplasm of respiratory and digestive systems, Large intestine and 
rectum 
Colorectal Cancer V10.05 ICD9CM Personal history of malignant neoplasm, Large intestine   
Colorectal Cancer V10.06 ICD9CM Personal history of malignant neoplasm, Rectum, rectosigmoid junction, and anus 
Colorectal Cancer G0213 HCPCS PET imaging whole body; diagnosis; colorectal 
Colorectal Cancer G0214 HCPCS PET imaging whole body; initial staging; colorectal 
Colorectal Cancer G0215 HCPCS PET imaging whole body; restaging; colorectal cancer 
Colorectal Cancer G0231 
HCPCS 
PET, whole body, for recurrence of colorectal or colorectal metastatic cancer; gamma 
cameras only 
CRC Exclusions 





154.3 ICD9CM Malignant neoplasm of Anus, unspecified 
  
CRC Exclusions 209.10 ICD9CM Malignant carcinoid tumor of the large intestine, unspecified portion 
CRC Exclusions 209.11 ICD9CM Malignant carcinoid tumor of the appendix  
CRC Exclusions 209.12 ICD9CM Malignant carcinoid tumor of the cecum  
CRC Exclusions 209.13 ICD9CM Malignant carcinoid tumor of the ascending colon  
CRC Exclusions 209.14 ICD9CM Malignant carcinoid tumor of the transverse colon  
CRC Exclusions 209.15 ICD9CM Malignant carcinoid tumor of the descending colon  
CRC Exclusions 209.16 ICD9CM Malignant carcinoid tumor of the sigmoid colon  
CRC Exclusions 209.17 ICD9CM Malignant carcinoid tumor of the rectum  
CRC Exclusions 280 ICD9CM Iron deficiency anemias 
CRC Exclusions 280.0 ICD9CM Secondary to blood loss (chronic)  
CRC Exclusions 280.1 ICD9CM Secondary to inadequate dietary iron intake  
CRC Exclusions 280.8 ICD9CM Other specified iron deficiency anemias  
CRC Exclusions 280.9 ICD9CM Iron deficiency anemia, unspecified  
CRC Exclusions 555 ICD9CM Regional enteritis  
CRC Exclusions 555.0 ICD9CM Small intestine  
CRC Exclusions 555.1 ICD9CM Large intestine  
CRC Exclusions 555.2 ICD9CM Small intestine with large intestine  
CRC Exclusions 555.9 ICD9CM Unspecified site  
CRC Exclusions 556 ICD9CM Ulcerative colitis  
CRC Exclusions 556.0 ICD9CM Ulcerative (chronic) enterocolitis  
CRC Exclusions 556.1 ICD9CM Ulcerative (chronic) ileocolitis  
CRC Exclusions 556.2 ICD9CM Ulcerative (chronic) proctitis  
CRC Exclusions 556.3 ICD9CM Ulcerative (chronic) proctosigmoiditis  
CRC Exclusions 556.4 ICD9CM Pseudopolyposis of colon  
CRC Exclusions 556.5 ICD9CM Left-sided ulcerative (chronic) colitis  
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CRC Exclusions 556.6 ICD9CM Universal ulcerative (chronic) colitis  
CRC Exclusions 556.8 ICD9CM Other ulcerative colitis  
CRC Exclusions 556.9 ICD9CM Ulcerative colitis, unspecified  
CRC Exclusions 558.4 ICD9CM Eosinophilic gastroenteritis and colitis  
CRC Exclusions 558.41 ICD9CM Eosinophilic gastroenteritis  
CRC Exclusions 558.42 ICD9CM Eosinophilic colitis  
CRC Exclusions 558.9 ICD9CM Other and unspecified noninfectious gastroenteritis and colitis 
CRC Exclusions 562.02 ICD9CM Diverticulosis of small intestine with hemorrhage  
CRC Exclusions 562.03 ICD9CM Diverticulitis of small intestine with hemorrhage 
CRC Exclusions 562.12 ICD9CM Diverticulosis of colon with hemorrhage  
CRC Exclusions 562.13 ICD9CM Diverticulitis of colon with hemorrhage 
CRC Exclusions 578.1 ICD9CM Blood in stool 
CRC Exclusions 578.9 ICD9CM Hemorrhage of gastrointestinal tract, unspecified 
CRC Exclusions 787.99 ICD9CM Other symptoms involving digestive system em 
CRC Exclusions 
793.4 ICD9CM Nonspecific (abnormal) findings on radiological and other examination of body structure, 
Gastrointestinal tract  
CRC Exclusions 
793.6 ICD9CM Nonspecific (abnormal) findings on radiological and other examination of body structure, 
Abdominal area, including retroperitoneum  
CRC Exclusions V12.72 ICD9CM Diseases of digestive system, Colonic polyps  
CRC Exclusions V16.0 ICD9CM Gastrointestinal tract 
CRC Exclusions V18.51 ICD9CM Family history of Colonic polyps conditions 
CRC Exclusions V84.09 ICD9CM Genetic susceptibility to other malignant neoplasm  
Colonoscopy 
44388 CPT 
Colonoscopy through stoma; diagnostic, including collection of specimen(s) by brushing or 
washing, when performed (separate procedure) 
Colonoscopy 44389 CPT Colonoscopy through stoma; with biopsy, single or multiple 
Colonoscopy 44390 CPT Colonoscopy through stoma; with removal of foreign body(s) 









Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not 
amenable to removal by hot biopsy forceps, bipolar cautery or snare technique 
Colonoscopy 
44394 CPT 
Colonoscopy through stoma; with removal of tumor(s), polyp(s), or other lesion(s) by snare 
technique 
Colonoscopy 
44397 CPT Colonoscopy through stoma; with transendoscopic stent placement (includes predilation) 
Colonoscopy 
44401 CPT 
Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) (includes 
pre-and post-dilation and guide wire passage, when performed) 
Colonoscopy 
44402 CPT 
Colonoscopy through stoma; with endoscopic stent placement (including pre- and post-
dilation and guide wire passage, when performed) 
Colonoscopy 44403 CPT Colonoscopy through stoma; with endoscopic mucosal resection 
Colonoscopy 44404 CPT Colonoscopy through stoma; with directed submucosal injection(s), any substance 
Colonoscopy 44405 CPT Colonoscopy through stoma; with transendoscopic balloon dilation 
Colonoscopy 
44406 CPT 
Colonoscopy through stoma; with endoscopic ultrasound examination, limited to the sigmoid, 
descending, transverse, or ascending colon and cecum and adjacent structures 
Colonoscopy 
44407 CPT 
Colonoscopy through stoma; with transendoscopic ultrasound guided intramural or 
transmural fine needle aspiration/biopsy(s), includes endoscopic ultrasound examination 




Colonoscopy through stoma; with decompression (for pathologic distention) (eg, volvulus, 
megacolon), including placement of decompression tube, when performed 
Colonoscopy 45355 CPT Colonoscopy, rigid or flexible, transabdominal via colotomy, single or multiple 
Colonoscopy 
45378 CPT 
Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or 
washing, when performed (separate procedure) 
Colonoscopy 45379 CPT Colonoscopy, flexible; with removal of foreign body(s) 
Colonoscopy 45380 CPT Colonoscopy, flexible; with biopsy, single or multiple 
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Colonoscopy 45381 CPT Colonoscopy, flexible; with directed submucosal injection(s), any substance 
Colonoscopy 45382 CPT Colonoscopy, flexible; with control of bleeding, any method 
Colonoscopy 
45383 CPT 
Colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other 
lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique 
Colonoscopy 
45384 CPT 




Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare 
technique 
Colonoscopy 45386 CPT Colonoscopy, flexible; with transendoscopic balloon dilation 
Colonoscopy 
45387 CPT 




Colonoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- 
and post-dilation and guide wire passage, when performed) 
Colonoscopy 
45389 CPT 
Colonoscopy, flexible; with endoscopic stent placement (includes pre- and post-dilation and 
guide wire passage, when performed) 
Colonoscopy 45390 CPT Colonoscopy, flexible; with endoscopic mucosal resection 
Colonoscopy 
45391 CPT 
Colonoscopy, flexible; with endoscopic ultrasound examination limited to the rectum, 
sigmoid, descending, transverse, or ascending colon and cecum, and adjacent structures 
Colonoscopy 
45392 CPT 
Colonoscopy, flexible; with transendoscopic ultrasound guided intramural or transmural fine 
needle aspiration/biopsy(s), includes endoscopic ultrasound examination limited to the 




Colonoscopy, flexible; with decompression (for pathologic distention) (eg, volvulus, 
megacolon), including placement of decompression tube, when performed 
Colonoscopy 45398 CPT Colonoscopy, flexible; with band ligation(s) (eg, hemorrhoids) 
Colonoscopy G0105 HCPCS Colorectal cancer screening; colonoscopy on individual at high risk 





Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected 
specimens with single determination, for colorectal neoplasm screening (ie, patient was 
provided 3 cards or single triple card for consecutive collection) 
FOBT 
82274 CPT 




Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 
determinations 
Flexible sigmoidoscopy 45330 CPT 
Sigmoidoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or 
washing, when performed (separate procedure) 
Flexible sigmoidoscopy 45331 CPT Sigmoidoscopy, flexible; with biopsy, single or multiple 
Flexible sigmoidoscopy 45332 CPT Sigmoidoscopy, flexible; with removal of foreign body(s) 
Flexible sigmoidoscopy 45333 CPT 
Sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy 
forceps 
Flexible sigmoidoscopy 45334 CPT Sigmoidoscopy, flexible; with control of bleeding, any method 
Flexible sigmoidoscopy 45335 CPT Sigmoidoscopy, flexible; with directed submucosal injection(s), any substance 
Flexible sigmoidoscopy 45337 CPT 
Sigmoidoscopy, flexible; with decompression (for pathologic distention) (eg, volvulus, 
megacolon), including placement of decompression tube, when performed 
Flexible sigmoidoscopy 45338 CPT 
Sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare 
technique 
Flexible sigmoidoscopy 45339 CPT 
Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable 
to removal by hot biopsy forceps, bipolar cautery or snare technique 
Flexible sigmoidoscopy 45340 CPT Sigmoidoscopy, flexible; with transendoscopic balloon dilation 
Flexible sigmoidoscopy 45341 CPT Sigmoidoscopy, flexible; with endoscopic ultrasound examination 
Flexible sigmoidoscopy 45342 CPT 
Sigmoidoscopy, flexible; with transendoscopic ultrasound guided intramural or transmural 
fine needle aspiration/biopsy(s) 
Flexible sigmoidoscopy 45345 CPT Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) 
Flexible sigmoidoscopy 45346 CPT 
Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- 
and post-dilation and guide wire passage, when performed) 
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Flexible sigmoidoscopy 45347 CPT 
Sigmoidoscopy, flexible; with placement of endoscopic stent (includes pre- and post-dilation 
and guide wire passage, when performed) 
Flexible sigmoidoscopy 45349 CPT Sigmoidoscopy, flexible; with endoscopic mucosal resection 
Flexible sigmoidoscopy 45350 CPT Sigmoidoscopy, flexible; with band ligation(s) (eg, hemorrhoids) 
Flexible sigmoidoscopy G0104 HCPCS Colorectal cancer screening; flexible sigmoidoscopy 
Barium enema 74270 CPT Radiologic examination, colon; contrast (eg, barium) enema, with or without KUB 
Barium enema 74280 CPT 
Radiologic examination, colon; air contrast with specific high density barium, with or without 
glucagon 
Barium enema G0106 HCPCS Colorectal cancer screening; alternative to G0104, screening sigmoidoscopy, barium enema 
Barium enema G0120 HCPCS Colorectal cancer screening; alternative to G0105, screening colonoscopy, barium enema 
Barium enema G0122 HCPCS Colorectal cancer screening; barium enema 
Fecal DNA S3890 HCPCS DNA analysis, fecal, for colorectal cancer screening 





Table 17 Codebook - Imaging studies for non-specific low back pain 
Value Set Name Code Code System Definition 
Physical Therapy 97110 CPT 
Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises 
to develop strength and endurance, range of motion and flexibility 
Physical Therapy 97112 CPT 
Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular 
reeducation of movement, balance, coordination, kinesthetic sense, posture, 
and/or proprioception for sitting and/or standing activities 
Physical Therapy 97113 CPT 
Therapeutic procedure, 1 or more areas, each 15 minutes; aquatic therapy with 
therapeutic exercises 
Physical Therapy 97124 CPT 
Therapeutic procedure, 1 or more areas, each 15 minutes; massage, including 
effleurage, petrissage and/or tapotement (stroking, compression, percussion) 
Physical Therapy 97140 CPT 
Manual therapy techniques (eg, mobilization/ manipulation, manual lymphatic 
drainage, manual traction), 1 or more regions, each 15 minutes 
Outpatient 
99201 CPT 
Office or other outpatient visit for the evaluation and management of a new 
patient, which requires these 3 key components: A problem focused history; A 
problem focused examination; Straightforward medical decision making. 
Counseling and/or coordination of care with other physicians, other qualified 
health care professionals, or agencies are provided consistent with the nature of 
the problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face 





Office or other outpatient visit for the evaluation and management of a new 
patient, which requires these 3 key components: An expanded problem focused 
history; An expanded problem focused examination; Straightforward medical 
decision making. Counseling and/or coordination of care with other physicians, 
other qualified health care professionals, or agencies are provided consistent 
with the nature of the problem(s) and the patient's and/or family's needs. Usually, 
the presenting problem(s) are of low to moderate severity. Typically, 20 minutes 
are spent face-to-face with the patient and/or family. 
Outpatient 
99203 CPT 
Office or other outpatient visit for the evaluation and management of a new 
patient, which requires these 3 key components: A detailed history; A detailed 
examination; Medical decision making of low complexity. Counseling and/or 
coordination of care with other physicians, other qualified health care 
professionals, or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face 
with the patient and/or family. 
Outpatient 
99204 CPT 
Office or other outpatient visit for the evaluation and management of a new 
patient, which requires these 3 key components: A comprehensive history; A 
comprehensive examination; Medical decision making of moderate complexity. 
Counseling and/or coordination of care with other physicians, other qualified 
health care professionals, or agencies are provided consistent with the nature of 
the problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-





Office or other outpatient visit for the evaluation and management of a new 
patient, which requires these 3 key components: A comprehensive history; A 
comprehensive examination; Medical decision making of high complexity. 
Counseling and/or coordination of care with other physicians, other qualified 
health care professionals, or agencies are provided consistent with the nature of 
the problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-
to-face with the patient and/or family. 
Outpatient 
99211 CPT 
Office or other outpatient visit for the evaluation and management of an 
established patient, that may not require the presence of a physician or other 
qualified health care professional. Usually, the presenting problem(s) are 
minimal. Typically, 5 minutes are spent performing or supervising these services. 
Outpatient 
99212 CPT 
Office or other outpatient visit for the evaluation and management of an 
established patient, which requires at least 2 of these 3 key components: A 
problem focused history; A problem focused examination; Straightforward 
medical decision making. Counseling and/or coordination of care with other 
physicians, other qualified health care professionals, or agencies are provided 
consistent with the nature of the problem(s) and the patient's and/or family's 
needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 
minutes are spent face-to-face with the patient and/or family. 
Outpatient 
99213 CPT 
Office or other outpatient visit for the evaluation and management of an 
established patient, which requires at least 2 of these 3 key components: An 
expanded problem focused history; An expanded problem focused examination; 
Medical decision making of low complexity. Counseling and coordination of care 
with other physicians, other qualified health care professionals, or agencies are 
provided consistent with the nature of the problem(s) and the patient's and/or 
family's needs. Usually, the presenting problem(s) are of low to moderate 






Office or other outpatient visit for the evaluation and management of an 
established patient, which requires at least 2 of these 3 key components: A 
detailed history; A detailed examination; Medical decision making of moderate 
complexity. Counseling and/or coordination of care with other physicians, other 
qualified health care professionals, or agencies are provided consistent with the 
nature of the problem(s) and the patient's and/or family's needs. Usually, the 
presenting problem(s) are of moderate to high severity. Typically, 25 minutes are 
spent face-to-face with the patient and/or family 
Outpatient 
99215 CPT 
Office or other outpatient visit for the evaluation and management of an 
established patient, which requires at least 2 of these 3 key components: A 
comprehensive history; A comprehensive examination; Medical decision making 
of high complexity. Counseling and/or coordination of care with other physicians, 
other qualified health care professionals, or agencies are provided consistent 
with the nature of the problem(s) and the patient's and/or family's needs. Usually, 
the presenting problem(s) are of moderate to high severity. Typically, 40 minutes 
are spent face-to-face with the patient and/or family. 
Outpatient 
99241 CPT 
Office consultation for a new or established patient, which requires these 3 key 
components: A problem focused history; A problem focused examination; and 
Straightforward medical decision making. Counseling and/or coordination of care 
with other physicians, other qualified health care professionals, or agencies are 
provided consistent with the nature of the problem(s) and the patient's and/or 
family's needs. Usually, the presenting problem(s) are self limited or minor. 





Office consultation for a new or established patient, which requires these 3 key 
components: An expanded problem focused history; An expanded problem 
focused examination; and Straightforward medical decision making. Counseling 
and/or coordination of care with other physicians, other qualified health care 
professionals, or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of low severity. Typically, 30 minutes are spent face-to-face with 
the patient and/or family. 
Outpatient 
99243 CPT 
Office consultation for a new or established patient, which requires these 3 key 
components: A detailed history; A detailed examination; and Medical decision 
making of low complexity. Counseling and/or coordination of care with other 
physicians, other qualified health care professionals, or agencies are provided 
consistent with the nature of the problem(s) and the patient's and/or family's 
needs. Usually, the presenting problem(s) are of moderate severity. Typically, 40 
minutes are spent face-to-face with the patient and/or family. 
Outpatient 
99244 CPT 
Office consultation for a new or established patient, which requires these 3 key 
components: A comprehensive history; A comprehensive examination; and 
Medical decision making of moderate complexity. Counseling and/or coordination 
of care with other physicians, other qualified health care professionals, or 
agencies are provided consistent with the nature of the problem(s) and the 
patient's and/or family's needs. Usually, the presenting problem(s) are of 
moderate to high severity. Typically, 60 minutes are spent face-to-face with the 
patient and/or family. 
Outpatient 
99245 CPT 
Office consultation for a new or established patient, which requires these 3 key 
components: A comprehensive history; A comprehensive examination; and 
Medical decision making of high complexity. Counseling and/or coordination of 
care with other physicians, other qualified health care professionals, or agencies 
are provided consistent with the nature of the problem(s) and the patient's and/or 
family's needs. Usually, the presenting problem(s) are of moderate to high 






Home visit for the evaluation and management of a new patient, which requires 
these 3 key components: A problem focused history; A problem focused 
examination; and Straightforward medical decision making. Counseling and/or 
coordination of care with other physicians, other qualified health care 
professionals, or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of low severity. Typically, 20 minutes are spent face-to-face with 
the patient and/or family. 
Outpatient 
99342 CPT 
Home visit for the evaluation and management of a new patient, which requires 
these 3 key components: An expanded problem focused history; An expanded 
problem focused examination; and Medical decision making of low complexity. 
Counseling and/or coordination of care with other physicians, other qualified 
health care professionals, or agencies are provided consistent with the nature of 
the problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face 
with the patient and/or family. 
Outpatient 
99343 CPT 
Home visit for the evaluation and management of a new patient, which requires 
these 3 key components: A detailed history; A detailed examination; and Medical 
decision making of moderate complexity. Counseling and/or coordination of care 
with other physicians, other qualified health care professionals, or agencies are 
provided consistent with the nature of the problem(s) and the patient's and/or 
family's needs. Usually, the presenting problem(s) are of moderate to high 






Home visit for the evaluation and management of a new patient, which requires 
these 3 key components: A comprehensive history; A comprehensive 
examination; and Medical decision making of moderate complexity. Counseling 
and/or coordination of care with other physicians, other qualified health care 
professionals, or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of high severity. Typically, 60 minutes are spent face-to-face with 
the patient and/or family. 
Outpatient 
99345 CPT 
Home visit for the evaluation and management of a new patient, which requires 
these 3 key components: A comprehensive history; A comprehensive 
examination; and Medical decision making of high complexity. Counseling and/or 
coordination of care with other physicians, other qualified health care 
professionals, or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the patient is 
unstable or has developed a significant new problem requiring immediate 




Home visit for the evaluation and management of an established patient, which 
requires at least 2 of these 3 key components: A problem focused interval 
history; A problem focused examination; Straightforward medical decision 
making. Counseling and/or coordination of care with other physicians, other 
qualified health care professionals, or agencies are provided consistent with the 
nature of the problem(s) and the patient's and/or family's needs. Usually, the 
presenting problem(s) are self limited or minor. Typically, 15 minutes are spent 





Home visit for the evaluation and management of an established patient, which 
requires at least 2 of these 3 key components: An expanded problem focused 
interval history; An expanded problem focused examination; Medical decision 
making of low complexity. Counseling and/or coordination of care with other 
physicians, other qualified health care professionals, or agencies are provided 
consistent with the nature of the problem(s) and the patient's and/or family's 
needs. Usually, the presenting problem(s) are of low to moderate severity. 
Typically, 25 minutes are spent face-to-face with the patient and/or family. 
Outpatient 
99349 CPT 
Home visit for the evaluation and management of an established patient, which 
requires at least 2 of these 3 key components: A detailed interval history; A 
detailed examination; Medical decision making of moderate complexity. 
Counseling and/or coordination of care with other physicians, other qualified 
health care professionals, or agencies are provided consistent with the nature of 
the problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are moderate to high severity. Typically, 40 minutes are spent face-
to-face with the patient and/or family. 
Outpatient 
99350 CPT 
Home visit for the evaluation and management of an established patient, which 
requires at least 2 of these 3 key components: A comprehensive interval history; 
A comprehensive examination; Medical decision making of moderate to high 
complexity. Counseling and/or coordination of care with other physicians, other 
qualified health care professionals, or agencies are provided consistent with the 
nature of the problem(s) and the patient's and/or family's needs. Usually, the 
presenting problem(s) are of moderate to high severity. The patient may be 
unstable or may have developed a significant new problem requiring immediate 




Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, new patient; infant (age younger 





Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, new patient; early childhood (age 1 
through 4 years) 
Outpatient 
99383 CPT 
Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, new patient; late childhood (age 5 
through 11 years) 
Outpatient 
99384 CPT 
Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 
through 17 years) 
Outpatient 
99385 CPT 
Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, new patient; 18-39 years 
Outpatient 
99386 CPT 
Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, new patient; 40-64 years 
Outpatient 
99387 CPT 
Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 





Periodic comprehensive preventive medicine reevaluation and management of 
an individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, established patient; infant (age 
younger than 1 year) 
Outpatient 
99392 CPT 
Periodic comprehensive preventive medicine reevaluation and management of 
an individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, established patient; early childhood 
(age 1 through 4 years) 
Outpatient 
99393 CPT 
Periodic comprehensive preventive medicine reevaluation and management of 
an individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, established patient; late childhood 
(age 5 through 11 years) 
Outpatient 
99394 CPT 
Periodic comprehensive preventive medicine reevaluation and management of 
an individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, established patient; adolescent 
(age 12 through 17 years) 
Outpatient 
99395 CPT 
Periodic comprehensive preventive medicine reevaluation and management of 
an individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 
ordering of laboratory/diagnostic procedures, established patient; 18-39 years 
Outpatient 
99396 CPT 
Periodic comprehensive preventive medicine reevaluation and management of 
an individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 





Periodic comprehensive preventive medicine reevaluation and management of 
an individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the 




Preventive medicine counseling and/or risk factor reduction intervention(s) 
provided to an individual (separate procedure); approximately 15 minutes 
Outpatient 
99402 CPT 
Preventive medicine counseling and/or risk factor reduction intervention(s) 
provided to an individual (separate procedure); approximately 30 minutes 
Outpatient 
99403 CPT 
Preventive medicine counseling and/or risk factor reduction intervention(s) 
provided to an individual (separate procedure); approximately 45 minutes 
Outpatient 
99404 CPT 
Preventive medicine counseling and/or risk factor reduction intervention(s) 
provided to an individual (separate procedure); approximately 60 minutes 
Outpatient 
99411 CPT 
Preventive medicine counseling and/or risk factor reduction intervention(s) 




Preventive medicine counseling and/or risk factor reduction intervention(s) 




Administration and interpretation of health risk assessment instrument (eg, health 
hazard appraisal) 
Outpatient 99429 CPT Unlisted preventive medicine service 
Outpatient 
99455 CPT 
Work related or medical disability examination by the treating physician that 
includes: Completion of a medical history commensurate with the patient's 
condition; Performance of an examination commensurate with the patient's 
condition; Formulation of a diagnosis, assessment of capabilities and stability, 
and calculation of impairment; Development of future medical treatment plan; 





Work related or medical disability examination by other than the treating 
physician that includes: Completion of a medical history commensurate with the 
patient's condition; Performance of an examination commensurate with the 
patient's condition; Formulation of a diagnosis, assessment of capabilities and 
stability, and calculation of impairment; Development of future medical treatment 
plan; and Completion of necessary documentation/certificates and report. 
Outpatient 
G0402 HCPCS 
Initial preventive physical examination; face-to-face visit, services limited to new 
beneficiary during the first 12 months of Medicare enrollment 
Outpatient 
G0438 HCPCS 




Annual wellness visit, includes a personalized prevention plan of service (PPS), 
subsequent visit 
Outpatient G0463 HCPCS Hospital outpatient clinic visit for assessment and management of a patient 
Outpatient T1015 HCPCS Clinic visit/encounter, all-inclusive 
ED 
99281 CPT 
Emergency department visit for the evaluation and management of a patient, 
which requires these 3 key components: A problem focused history; A problem 
focused examination; and Straightforward medical decision making. Counseling 
and/or coordination of care with other physicians, other qualified health care 
professionals, or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are self limited or minor. 
ED 
99282 CPT 
Emergency department visit for the evaluation and management of a patient, 
which requires these 3 key components: An expanded problem focused history; 
An expanded problem focused examination; and Medical decision making of low 
complexity. Counseling and/or coordination of care with other physicians, other 
qualified health care professionals, or agencies are provided consistent with the 
nature of the problem(s) and the patient's and/or family's needs. Usually, the 





Emergency department visit for the evaluation and management of a patient, 
which requires these 3 key components: An expanded problem focused history; 
An expanded problem focused examination; and Medical decision making of 
moderate complexity. Counseling and/or coordination of care with other 
physicians, other qualified health care professionals, or agencies are provided 
consistent with the nature of the problem(s) and the patient's and/or family's 
needs. Usually, the presenting problem(s) are of moderate severity. 
ED 
99284 CPT 
Emergency department visit for the evaluation and management of a patient, 
which requires these 3 key components: A detailed history; A detailed 
examination; and Medical decision making of moderate complexity. Counseling 
and/or coordination of care with other physicians, other qualified health care 
professionals or agencies are provided consistent with the nature of the 
problem(s) and the patient's and/or family's needs. Usually, the presenting 
problem(s) are of high severity, and require urgent evaluation by the physician or 
other qualified health care professionals but do not pose an immediate significant 
threat to life or physiologic function. 
ED 
99285 CPT 
Emergency department visit for the evaluation and management of a patient, 
which requires these 3 key components within the constraints imposed by the 
urgency of the patient's clinical condition and/or mental status: A comprehensive 
history; A comprehensive examination; and Medical decision making of high 
complexity. Counseling and/or coordination of care with other physicians, other 
qualified health care professionals, or agencies are provided consistent with the 
nature of the problem(s) and the patient's and/or family's needs. Usually, the 
presenting problem(s) are of high severity and pose an immediate significant 





Observation care discharge day management (This code is to be utilized to 
report all services provided to a patient on discharge from "observation status" if 
the discharge is on other than the initial date of "observation status." To report 
services to a patient designated as "observation status" or "inpatient status" and 
discharged on the same date, use the codes for Observation or Inpatient Care 




Initial observation care, per day, for the evaluation and management of a patient 
which requires these 3 key components: A detailed or comprehensive history; A 
detailed or comprehensive examination; and Medical decision making that is 
straightforward or of low complexity. Counseling and/or coordination of care with 
other physicians, other qualified health care professionals, or agencies are 
provided consistent with the nature of the problem(s) and the patient's and/or 
family's needs. Usually, the problem(s) requiring admission to "observation 
status" are of low severity. Typically, 30 minutes are spent at the bedside and on 
the patient's hospital floor or unit. 
Observation 
99219 CPT 
Initial observation care, per day, for the evaluation and management of a patient, 
which requires these 3 key components: A comprehensive history; A 
comprehensive examination; and Medical decision making of moderate 
complexity. Counseling and/or coordination of care with other physicians, other 
qualified health care professionals, or agencies are provided consistent with the 
nature of the problem(s) and the patient's and/or family's needs. Usually, the 
problem(s) requiring admission to "observation status" are of moderate severity. 






Initial observation care, per day, for the evaluation and management of a patient, 
which requires these 3 key components: A comprehensive history; A 
comprehensive examination; and Medical decision making of high complexity. 
Counseling and/or coordination of care with other physicians, other qualified 
health care professionals, or agencies are provided consistent with the nature of 
the problem(s) and the patient's and/or family's needs. Usually, the problem(s) 
requiring admission to "observation status" are of high severity. Typically, 70 
minutes are spent at the bedside and on the patient's hospital floor or unit. 
Osteopathic Manipulative Treatment 98925 CPT Osteopathic manipulative treatment (OMT); 1-2 body regions involved 
Osteopathic Manipulative Treatment 98926 CPT Osteopathic manipulative treatment (OMT); 3-4 body regions involved 
Osteopathic Manipulative Treatment 98927 CPT Osteopathic manipulative treatment (OMT); 5-6 body regions involved 
Osteopathic Manipulative Treatment 98928 CPT Osteopathic manipulative treatment (OMT); 7-8 body regions involved 
Osteopathic Manipulative Treatment 98929 CPT Osteopathic manipulative treatment (OMT); 9-10 body regions involved 
Osteopathic Manipulative Treatment 98940 CPT Chiropractic manipulative treatment (CMT); spinal, 1-2 regions 
Osteopathic Manipulative Treatment 98941 CPT Chiropractic manipulative treatment (CMT); spinal, 3-4 regions 
Osteopathic Manipulative Treatment 98942 CPT Chiropractic manipulative treatment (CMT); spinal, 5 regions 
Low Back Pain 721.3 ICD9CM Lumbosacral spondylosis without myelopathy 
Low Back Pain 722.10 ICD9CM Displacement of lumbar intervertebral disc without myelopathy 
Low Back Pain 722.32 ICD9CM Schmorl's nodes, lumbar region 
Low Back Pain 722.52 ICD9CM Degeneration of lumbar or lumbosacral intervertebral disc 
Low Back Pain 722.93 ICD9CM Other and unspecified disc disorder, lumbar region 
Low Back Pain 724.02 ICD9CM Spinal stenosis, lumbar region, without neurogenic claudication 
Low Back Pain 724.03 ICD9CM Spinal stenosis, lumbar region, with neurogenic claudication 
Low Back Pain 724.2 ICD9CM Lumbago 
Low Back Pain 724.3 ICD9CM Sciatica 
Low Back Pain 724.5 ICD9CM Backache, unspecified 
Low Back Pain 724.6 ICD9CM Disorders of sacrum 
Low Back Pain 724.70 ICD9CM Unspecified disorder of coccyx 
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Low Back Pain 724.71 ICD9CM Hypermobility of coccyx 
Low Back Pain 724.79 ICD9CM Other disorders of coccyx 
Low Back Pain 738.5 ICD9CM Other acquired deformity of back or spine 
Low Back Pain 739.3 ICD9CM Nonallopathic lesions, lumbar region 
Low Back Pain 739.4 ICD9CM Nonallopathic lesions, sacral region 
Low Back Pain 846.0 ICD9CM Sprain of lumbosacral (joint) (ligament) 
Low Back Pain 846.1 ICD9CM Sprain of sacroiliac ligament 
Low Back Pain 846.2 ICD9CM Sprain of sacrospinatus (ligament) 
Low Back Pain 846.3 ICD9CM Sprain of sacrotuberous (ligament) 
Low Back Pain 846.8 ICD9CM Sprain of other specified sites of sacroiliac region 
Low Back Pain 846.9 ICD9CM Sprain of unspecified site of sacroiliac region 
Low Back Pain 847.2 ICD9CM Sprain of lumbar 
Malignant Neoplasms 140.0 ICD9CM Malignant neoplasm of upper lip, vermilion border 
Malignant Neoplasms 140.1 ICD9CM Malignant neoplasm of lower lip, vermilion border 
Malignant Neoplasms 140.3 ICD9CM Malignant neoplasm of upper lip, inner aspect 
Malignant Neoplasms 140.4 ICD9CM Malignant neoplasm of lower lip, inner aspect 
Malignant Neoplasms 140.5 ICD9CM Malignant neoplasm of lip, unspecified, inner aspect 
Malignant Neoplasms 140.6 ICD9CM Malignant neoplasm of commissure of lip 
Malignant Neoplasms 140.8 ICD9CM Malignant neoplasm of other sites of lip 
Malignant Neoplasms 140.9 ICD9CM Malignant neoplasm of lip, unspecified, vermilion border 
Malignant Neoplasms 141.0 ICD9CM Malignant neoplasm of base of tongue 
Malignant Neoplasms 141.1 ICD9CM Malignant neoplasm of dorsal surface of tongue 
Malignant Neoplasms 141.2 ICD9CM Malignant neoplasm of tip and lateral border of tongue 
Malignant Neoplasms 141.3 ICD9CM Malignant neoplasm of ventral surface of tongue 
Malignant Neoplasms 141.4 ICD9CM Malignant neoplasm of anterior two-thirds of tongue, part unspecified 
Malignant Neoplasms 141.5 ICD9CM Malignant neoplasm of junctional zone of tongue 
Malignant Neoplasms 141.6 ICD9CM Malignant neoplasm of lingual tonsil 
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Malignant Neoplasms 141.8 ICD9CM Malignant neoplasm of other sites of tongue 
Malignant Neoplasms 141.9 ICD9CM Malignant neoplasm of tongue, unspecified 
Malignant Neoplasms 142.0 ICD9CM Malignant neoplasm of parotid gland 
Malignant Neoplasms 142.1 ICD9CM Malignant neoplasm of submandibular gland 
Malignant Neoplasms 142.2 ICD9CM Malignant neoplasm of sublingual gland 
Malignant Neoplasms 142.8 ICD9CM Malignant neoplasm of other major salivary glands 
Malignant Neoplasms 142.9 ICD9CM Malignant neoplasm of salivary gland, unspecified 
Malignant Neoplasms 143.0 ICD9CM Malignant neoplasm of upper gum 
Malignant Neoplasms 143.1 ICD9CM Malignant neoplasm of lower gum 
Malignant Neoplasms 143.8 ICD9CM Malignant neoplasm of other sites of gum 
Malignant Neoplasms 143.9 ICD9CM Malignant neoplasm of gum, unspecified 
Malignant Neoplasms 144.0 ICD9CM Malignant neoplasm of anterior portion of floor of mouth 
Malignant Neoplasms 144.1 ICD9CM Malignant neoplasm of lateral portion of floor of mouth 
Malignant Neoplasms 144.8 ICD9CM Malignant neoplasm of other sites of floor of mouth 
Malignant Neoplasms 144.9 ICD9CM Malignant neoplasm of floor of mouth, part unspecified 
Malignant Neoplasms 145.0 ICD9CM Malignant neoplasm of cheek mucosa 
Malignant Neoplasms 145.1 ICD9CM Malignant neoplasm of vestibule of mouth 
Malignant Neoplasms 145.2 ICD9CM Malignant neoplasm of hard palate 
Malignant Neoplasms 145.3 ICD9CM Malignant neoplasm of soft palate 
Malignant Neoplasms 145.4 ICD9CM Malignant neoplasm of uvula 
Malignant Neoplasms 145.5 ICD9CM Malignant neoplasm of palate, unspecified 
Malignant Neoplasms 145.6 ICD9CM Malignant neoplasm of retromolar area 
Malignant Neoplasms 145.8 ICD9CM Malignant neoplasm of other specified parts of mouth 
Malignant Neoplasms 145.9 ICD9CM Malignant neoplasm of mouth, unspecified 
Malignant Neoplasms 146.0 ICD9CM Malignant neoplasm of tonsil 
Malignant Neoplasms 146.1 ICD9CM Malignant neoplasm of tonsillar fossa 
Malignant Neoplasms 146.2 ICD9CM Malignant neoplasm of tonsillar pillars (anterior) (posterior) 
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Malignant Neoplasms 146.3 ICD9CM Malignant neoplasm of vallecula epiglottica 
Malignant Neoplasms 146.4 ICD9CM Malignant neoplasm of anterior aspect of epiglottis 
Malignant Neoplasms 146.5 ICD9CM Malignant neoplasm of junctional region of oropharynx 
Malignant Neoplasms 146.6 ICD9CM Malignant neoplasm of lateral wall of oropharynx 
Malignant Neoplasms 146.7 ICD9CM Malignant neoplasm of posterior wall of oropharynx 
Malignant Neoplasms 146.8 ICD9CM Malignant neoplasm of other specified sites of oropharynx 
Malignant Neoplasms 146.9 ICD9CM Malignant neoplasm of oropharynx, unspecified site 
Malignant Neoplasms 147.0 ICD9CM Malignant neoplasm of superior wall of nasopharynx 
Malignant Neoplasms 147.1 ICD9CM Malignant neoplasm of posterior wall of nasopharynx 
Malignant Neoplasms 147.2 ICD9CM Malignant neoplasm of lateral wall of nasopharynx 
Malignant Neoplasms 147.3 ICD9CM Malignant neoplasm of anterior wall of nasopharynx 
Malignant Neoplasms 147.8 ICD9CM Malignant neoplasm of other specified sites of nasopharynx 
Malignant Neoplasms 147.9 ICD9CM Malignant neoplasm of nasopharynx, unspecified site 
Malignant Neoplasms 148.0 ICD9CM Malignant neoplasm of postcricoid region of hypopharynx 
Malignant Neoplasms 148.1 ICD9CM Malignant neoplasm of pyriform sinus 
Malignant Neoplasms 148.2 ICD9CM Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect 
Malignant Neoplasms 148.3 ICD9CM Malignant neoplasm of posterior hypopharyngeal wall 
Malignant Neoplasms 148.8 ICD9CM Malignant neoplasm of other specified sites of hypopharynx 
Malignant Neoplasms 148.9 ICD9CM Malignant neoplasm of hypopharynx, unspecified site 
Malignant Neoplasms 149.0 ICD9CM Malignant neoplasm of pharynx, unspecified 
Malignant Neoplasms 149.1 ICD9CM Malignant neoplasm of waldeyer's ring 
Malignant Neoplasms 149.8 ICD9CM Malignant neoplasm of other sites within the lip and oral cavity 
Malignant Neoplasms 149.9 ICD9CM Malignant neoplasm of ill-defined sites within the lip and oral cavity 
Malignant Neoplasms 150.0 ICD9CM Malignant neoplasm of cervical esophagus 
Malignant Neoplasms 150.1 ICD9CM Malignant neoplasm of thoracic esophagus 
Malignant Neoplasms 150.2 ICD9CM Malignant neoplasm of abdominal esophagus 
Malignant Neoplasms 150.3 ICD9CM Malignant neoplasm of upper third of esophagus 
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Malignant Neoplasms 150.4 ICD9CM Malignant neoplasm of middle third of esophagus 
Malignant Neoplasms 150.5 ICD9CM Malignant neoplasm of lower third of esophagus 
Malignant Neoplasms 150.8 ICD9CM Malignant neoplasm of other specified part of esophagus 
Malignant Neoplasms 150.9 ICD9CM Malignant neoplasm of esophagus, unspecified site 
Malignant Neoplasms 151.0 ICD9CM Malignant neoplasm of cardia 
Malignant Neoplasms 151.1 ICD9CM Malignant neoplasm of pylorus 
Malignant Neoplasms 151.2 ICD9CM Malignant neoplasm of pyloric antrum 
Malignant Neoplasms 151.3 ICD9CM Malignant neoplasm of fundus of stomach 
Malignant Neoplasms 151.4 ICD9CM Malignant neoplasm of body of stomach 
Malignant Neoplasms 151.5 ICD9CM Malignant neoplasm of lesser curvature of stomach, unspecified 
Malignant Neoplasms 151.6 ICD9CM Malignant neoplasm of greater curvature of stomach, unspecified 
Malignant Neoplasms 151.8 ICD9CM Malignant neoplasm of other specified sites of stomach 
Malignant Neoplasms 151.9 ICD9CM Malignant neoplasm of stomach, unspecified site 
Malignant Neoplasms 152.0 ICD9CM Malignant neoplasm of duodenum 
Malignant Neoplasms 152.1 ICD9CM Malignant neoplasm of jejunum 
Malignant Neoplasms 152.2 ICD9CM Malignant neoplasm of ileum 
Malignant Neoplasms 152.3 ICD9CM Malignant neoplasm of Meckel's diverticulum 
Malignant Neoplasms 152.8 ICD9CM Malignant neoplasm of other specified sites of small intestine 
Malignant Neoplasms 152.9 ICD9CM Malignant neoplasm of small intestine, unspecified site 
Malignant Neoplasms 153.0 ICD9CM Malignant neoplasm of hepatic flexure 
Malignant Neoplasms 153.1 ICD9CM Malignant neoplasm of transverse colon 
Malignant Neoplasms 153.2 ICD9CM Malignant neoplasm of descending colon 
Malignant Neoplasms 153.3 ICD9CM Malignant neoplasm of sigmoid colon 
Malignant Neoplasms 153.4 ICD9CM Malignant neoplasm of cecum 
Malignant Neoplasms 153.5 ICD9CM Malignant neoplasm of appendix vermiformis 
Malignant Neoplasms 153.6 ICD9CM Malignant neoplasm of ascending colon 
Malignant Neoplasms 153.7 ICD9CM Malignant neoplasm of splenic flexure 
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Malignant Neoplasms 153.8 ICD9CM Malignant neoplasm of other specified sites of large intestine 
Malignant Neoplasms 153.9 ICD9CM Malignant neoplasm of colon, unspecified site 
Malignant Neoplasms 154.0 ICD9CM Malignant neoplasm of rectosigmoid junction 
Malignant Neoplasms 154.1 ICD9CM Malignant neoplasm of rectum 
Malignant Neoplasms 154.2 ICD9CM Malignant neoplasm of anal canal 
Malignant Neoplasms 154.3 ICD9CM Malignant neoplasm of anus, unspecified site 
Malignant Neoplasms 154.8 ICD9CM Malignant neoplasm of other sites of rectum, rectosigmoid junction, and anus 
Malignant Neoplasms 155.0 ICD9CM Malignant neoplasm of liver, primary 
Malignant Neoplasms 155.1 ICD9CM Malignant neoplasm of intrahepatic bile ducts 
Malignant Neoplasms 155.2 ICD9CM Malignant neoplasm of liver, not specified as primary or secondary 
Malignant Neoplasms 156.0 ICD9CM Malignant neoplasm of gallbladder 
Malignant Neoplasms 156.1 ICD9CM Malignant neoplasm of extrahepatic bile ducts 
Malignant Neoplasms 156.2 ICD9CM Malignant neoplasm of ampulla of vater 
Malignant Neoplasms 156.8 
ICD9CM 
Malignant neoplasm of other specified sites of gallbladder and extrahepatic bile 
ducts 
Malignant Neoplasms 156.9 ICD9CM Malignant neoplasm of biliary tract, part unspecified site 
Malignant Neoplasms 157.0 ICD9CM Malignant neoplasm of head of pancreas 
Malignant Neoplasms 157.1 ICD9CM Malignant neoplasm of body of pancreas 
Malignant Neoplasms 157.2 ICD9CM Malignant neoplasm of tail of pancreas 
Malignant Neoplasms 157.3 ICD9CM Malignant neoplasm of pancreatic duct 
Malignant Neoplasms 157.4 ICD9CM Malignant neoplasm of islets of langerhans 
Malignant Neoplasms 157.8 ICD9CM Malignant neoplasm of other specified sites of pancreas 
Malignant Neoplasms 157.9 ICD9CM Malignant neoplasm of pancreas, part unspecified 
Malignant Neoplasms 158.0 ICD9CM Malignant neoplasm of retroperitoneum 
Malignant Neoplasms 158.8 ICD9CM Malignant neoplasm of specified parts of peritoneum 
Malignant Neoplasms 158.9 ICD9CM Malignant neoplasm of peritoneum, unspecified 
Malignant Neoplasms 159.0 ICD9CM Malignant neoplasm of intestinal tract, part unspecified 
Malignant Neoplasms 159.1 ICD9CM Malignant neoplasm of spleen, not elsewhere classified 
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Malignant Neoplasms 159.8 
ICD9CM 
Malignant neoplasm of other sites of digestive system and intra-abdominal 
organs 
Malignant Neoplasms 159.9 
ICD9CM 
Malignant neoplasm of ill-defined sites within the digestive organs and 
peritoneum 
Malignant Neoplasms 160.0 ICD9CM Malignant neoplasm of nasal cavities 
Malignant Neoplasms 160.1 ICD9CM Malignant neoplasm of auditory tube, middle ear, and mastoid air cells 
Malignant Neoplasms 160.2 ICD9CM Malignant neoplasm of maxillary sinus 
Malignant Neoplasms 160.3 ICD9CM Malignant neoplasm of ethmoidal sinus 
Malignant Neoplasms 160.4 ICD9CM Malignant neoplasm of frontal sinus 
Malignant Neoplasms 160.5 ICD9CM Malignant neoplasm of sphenoidal sinus 
Malignant Neoplasms 160.8 ICD9CM Malignant neoplasm of other accessory sinuses 
Malignant Neoplasms 160.9 ICD9CM Malignant neoplasm of accessory sinus, unspecified 
Malignant Neoplasms 161.0 ICD9CM Malignant neoplasm of glottis 
Malignant Neoplasms 161.1 ICD9CM Malignant neoplasm of supraglottis 
Malignant Neoplasms 161.2 ICD9CM Malignant neoplasm of subglottis 
Malignant Neoplasms 161.3 ICD9CM Malignant neoplasm of laryngeal cartilages 
Malignant Neoplasms 161.8 ICD9CM Malignant neoplasm of other specified sites of larynx 
Malignant Neoplasms 161.9 ICD9CM Malignant neoplasm of larynx, unspecified 
Malignant Neoplasms 162.0 ICD9CM Malignant neoplasm of trachea 
Malignant Neoplasms 162.2 ICD9CM Malignant neoplasm of main bronchus 
Malignant Neoplasms 162.3 ICD9CM Malignant neoplasm of upper lobe, bronchus or lung 
Malignant Neoplasms 162.4 ICD9CM Malignant neoplasm of middle lobe, bronchus or lung 
Malignant Neoplasms 162.5 ICD9CM Malignant neoplasm of lower lobe, bronchus or lung 
Malignant Neoplasms 162.8 ICD9CM Malignant neoplasm of other parts of bronchus or lung 
Malignant Neoplasms 162.9 ICD9CM Malignant neoplasm of bronchus and lung, unspecified 
Malignant Neoplasms 163.0 ICD9CM Malignant neoplasm of parietal pleura 
Malignant Neoplasms 163.1 ICD9CM Malignant neoplasm of visceral pleura 
Malignant Neoplasms 163.8 ICD9CM Malignant neoplasm of other specified sites of pleura 
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Malignant Neoplasms 163.9 ICD9CM Malignant neoplasm of pleura, unspecified 
Malignant Neoplasms 164.0 ICD9CM Malignant neoplasm of thymus 
Malignant Neoplasms 164.1 ICD9CM Malignant neoplasm of heart 
Malignant Neoplasms 164.2 ICD9CM Malignant neoplasm of anterior mediastinum 
Malignant Neoplasms 164.3 ICD9CM Malignant neoplasm of posterior mediastinum 
Malignant Neoplasms 164.8 ICD9CM Malignant neoplasm of other parts of mediastinum 
Malignant Neoplasms 164.9 ICD9CM Malignant neoplasm of mediastinum, part unspecified 
Malignant Neoplasms 165.0 ICD9CM Malignant neoplasm of upper respiratory tract, part unspecified 
Malignant Neoplasms 165.8 
ICD9CM 
Malignant neoplasm of other sites within the respiratory system and intrathoracic 
organs 
Malignant Neoplasms 165.9 ICD9CM Malignant neoplasm of ill-defined sites within the respiratory system 
Malignant Neoplasms 170.0 ICD9CM Malignant neoplasm of bones of skull and face, except mandible 
Malignant Neoplasms 170.1 ICD9CM Malignant neoplasm of mandible 
Malignant Neoplasms 170.2 ICD9CM Malignant neoplasm of vertebral column, excluding sacrum and coccyx 
Malignant Neoplasms 170.3 ICD9CM Malignant neoplasm of ribs, sternum, and clavicle 
Malignant Neoplasms 170.4 ICD9CM Malignant neoplasm of scapula and long bones of upper limb 
Malignant Neoplasms 170.5 ICD9CM Malignant neoplasm of short bones of upper limb 
Malignant Neoplasms 170.6 ICD9CM Malignant neoplasm of pelvic bones, sacrum, and coccyx 
Malignant Neoplasms 170.7 ICD9CM Malignant neoplasm of long bones of lower limb 
Malignant Neoplasms 170.8 ICD9CM Malignant neoplasm of short bones of lower limb 
Malignant Neoplasms 170.9 ICD9CM Malignant neoplasm of bone and articular cartilage, site unspecified 
Malignant Neoplasms 171.0 ICD9CM Malignant neoplasm of connective and other soft tissue of head, face, and neck 
Malignant Neoplasms 171.2 
ICD9CM 
Malignant neoplasm of connective and other soft tissue of upper limb, including 
shoulder 
Malignant Neoplasms 171.3 
ICD9CM 
Malignant neoplasm of connective and other soft tissue of lower limb, including 
hip 
Malignant Neoplasms 171.4 ICD9CM Malignant neoplasm of connective and other soft tissue of thorax 
Malignant Neoplasms 171.5 ICD9CM Malignant neoplasm of connective and other soft tissue of abdomen 
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Malignant Neoplasms 171.6 ICD9CM Malignant neoplasm of connective and other soft tissue of pelvis 
Malignant Neoplasms 171.7 ICD9CM Malignant neoplasm of connective and other soft tissue of trunk, unspecified 
Malignant Neoplasms 171.8 ICD9CM Malignant neoplasm of other specified sites of connective and other soft tissue 
Malignant Neoplasms 171.9 ICD9CM Malignant neoplasm of connective and other soft tissue, site unspecified 
Malignant Neoplasms 172.0 ICD9CM Malignant melanoma of skin of lip 
Malignant Neoplasms 172.1 ICD9CM Malignant melanoma of skin of eyelid, including canthus 
Malignant Neoplasms 172.2 ICD9CM Malignant melanoma of skin of ear and external auditory canal 
Malignant Neoplasms 172.3 ICD9CM Malignant melanoma of skin of other and unspecified parts of face 
Malignant Neoplasms 172.4 ICD9CM Malignant melanoma of skin of scalp and neck 
Malignant Neoplasms 172.5 ICD9CM Malignant melanoma of skin of trunk, except scrotum 
Malignant Neoplasms 172.6 ICD9CM Malignant melanoma of skin of upper limb, including shoulder 
Malignant Neoplasms 172.7 ICD9CM Malignant melanoma of skin of lower limb, including hip 
Malignant Neoplasms 172.8 ICD9CM Malignant melanoma of other specified sites of skin 
Malignant Neoplasms 172.9 ICD9CM Melanoma of skin, site unspecified 
Malignant Neoplasms 173.00 ICD9CM Unspecified malignant neoplasm of skin of lip 
Malignant Neoplasms 173.01 ICD9CM Basal cell carcinoma of skin of lip 
Malignant Neoplasms 173.02 ICD9CM Squamous cell carcinoma of skin of lip 
Malignant Neoplasms 173.09 ICD9CM Other specified malignant neoplasm of skin of lip 
Malignant Neoplasms 173.10 ICD9CM Unspecified malignant neoplasm of eyelid, including canthus 
Malignant Neoplasms 173.11 ICD9CM Basal cell carcinoma of eyelid, including canthus 
Malignant Neoplasms 173.12 ICD9CM Squamous cell carcinoma of eyelid, including canthus 
Malignant Neoplasms 173.19 ICD9CM Other specified malignant neoplasm of eyelid, including canthus 
Malignant Neoplasms 173.20 ICD9CM Unspecified malignant neoplasm of skin of ear and external auditory canal 
Malignant Neoplasms 173.21 ICD9CM Basal cell carcinoma of skin of ear and external auditory canal 
Malignant Neoplasms 173.22 ICD9CM Squamous cell carcinoma of skin of ear and external auditory canal 
Malignant Neoplasms 173.29 ICD9CM Other specified malignant neoplasm of skin of ear and external auditory canal 
Malignant Neoplasms 173.30 ICD9CM Unspecified malignant neoplasm of skin of other and unspecified parts of face 
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Malignant Neoplasms 173.31 ICD9CM Basal cell carcinoma of skin of other and unspecified parts of face 
Malignant Neoplasms 173.32 ICD9CM Squamous cell carcinoma of skin of other and unspecified parts of face 
Malignant Neoplasms 173.39 ICD9CM Other specified malignant neoplasm of skin of other and unspecified parts of face 
Malignant Neoplasms 173.40 ICD9CM Unspecified malignant neoplasm of scalp and skin of neck 
Malignant Neoplasms 173.41 ICD9CM Basal cell carcinoma of scalp and skin of neck 
Malignant Neoplasms 173.42 ICD9CM Squamous cell carcinoma of scalp and skin of neck 
Malignant Neoplasms 173.49 ICD9CM Other specified malignant neoplasm of scalp and skin of neck 
Malignant Neoplasms 173.50 ICD9CM Unspecified malignant neoplasm of skin of trunk, except scrotum 
Malignant Neoplasms 173.51 ICD9CM Basal cell carcinoma of skin of trunk, except scrotum 
Malignant Neoplasms 173.52 ICD9CM Squamous cell carcinoma of skin of trunk, except scrotum 
Malignant Neoplasms 173.59 ICD9CM Other specified malignant neoplasm of skin of trunk, except scrotum 
Malignant Neoplasms 173.60 ICD9CM Unspecified malignant neoplasm of skin of upper limb, including shoulder 
Malignant Neoplasms 173.61 ICD9CM Basal cell carcinoma of skin of upper limb, including shoulder 
Malignant Neoplasms 173.62 ICD9CM Squamous cell carcinoma of skin of upper limb, including shoulder 
Malignant Neoplasms 173.69 ICD9CM Other specified malignant neoplasm of skin of upper limb, including shoulder 
Malignant Neoplasms 173.70 ICD9CM Unspecified malignant neoplasm of skin of lower limb, including hip 
Malignant Neoplasms 173.71 ICD9CM Basal cell carcinoma of skin of lower limb, including hip 
Malignant Neoplasms 173.72 ICD9CM Squamous cell carcinoma of skin of lower limb, including hip 
Malignant Neoplasms 173.79 ICD9CM Other specified malignant neoplasm of skin of lower limb, including hip 
Malignant Neoplasms 173.80 ICD9CM Unspecified malignant neoplasm of other specified sites of skin 
Malignant Neoplasms 173.81 ICD9CM Basal cell carcinoma of other specified sites of skin 
Malignant Neoplasms 173.82 ICD9CM Squamous cell carcinoma of other specified sites of skin 
Malignant Neoplasms 173.89 ICD9CM Other specified malignant neoplasm of other specified sites of skin 
Malignant Neoplasms 173.90 ICD9CM Unspecified malignant neoplasm of skin, site unspecified 
Malignant Neoplasms 173.91 ICD9CM Basal cell carcinoma of skin, site unspecified 
Malignant Neoplasms 173.92 ICD9CM Squamous cell carcinoma of skin, site unspecified 
Malignant Neoplasms 173.99 ICD9CM Other specified malignant neoplasm of skin, site unspecified 
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Malignant Neoplasms 174.0 ICD9CM Malignant neoplasm of nipple and areola of female breast 
Malignant Neoplasms 174.1 ICD9CM Malignant neoplasm of central portion of female breast 
Malignant Neoplasms 174.2 ICD9CM Malignant neoplasm of upper-inner quadrant of female breast 
Malignant Neoplasms 174.3 ICD9CM Malignant neoplasm of lower-inner quadrant of female breast 
Malignant Neoplasms 174.4 ICD9CM Malignant neoplasm of upper-outer quadrant of female breast 
Malignant Neoplasms 174.5 ICD9CM Malignant neoplasm of lower-outer quadrant of female breast 
Malignant Neoplasms 174.6 ICD9CM Malignant neoplasm of axillary tail of female breast 
Malignant Neoplasms 174.8 ICD9CM Malignant neoplasm of other specified sites of female breast 
Malignant Neoplasms 174.9 ICD9CM Malignant neoplasm of breast (female), unspecified 
Malignant Neoplasms 175.0 ICD9CM Malignant neoplasm of nipple and areola of male breast 
Malignant Neoplasms 175.9 ICD9CM Malignant neoplasm of other and unspecified sites of male breast 
Malignant Neoplasms 176.0 ICD9CM Kaposi's sarcoma, skin 
Malignant Neoplasms 176.1 ICD9CM Kaposi's sarcoma, soft tissue 
Malignant Neoplasms 176.2 ICD9CM Kaposi's sarcoma, palate 
Malignant Neoplasms 176.3 ICD9CM Kaposi's sarcoma, gastrointestinal sites 
Malignant Neoplasms 176.4 ICD9CM Kaposi's sarcoma, lung 
Malignant Neoplasms 176.5 ICD9CM Kaposi's sarcoma, lymph nodes 
Malignant Neoplasms 176.8 ICD9CM Kaposi's sarcoma, other specified sites 
Malignant Neoplasms 176.9 ICD9CM Kaposi's sarcoma, unspecified site 
Malignant Neoplasms 179 ICD9CM Malignant neoplasm of uterus, part unspecified 
Malignant Neoplasms 180.0 ICD9CM Malignant neoplasm of endocervix 
Malignant Neoplasms 180.1 ICD9CM Malignant neoplasm of exocervix 
Malignant Neoplasms 180.8 ICD9CM Malignant neoplasm of other specified sites of cervix 
Malignant Neoplasms 180.9 ICD9CM Malignant neoplasm of cervix uteri, unspecified site 
Malignant Neoplasms 181 ICD9CM Malignant neoplasm of placenta 
Malignant Neoplasms 182.0 ICD9CM Malignant neoplasm of corpus uteri, except isthmus 
Malignant Neoplasms 182.1 ICD9CM Malignant neoplasm of isthmus 
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Malignant Neoplasms 182.8 ICD9CM Malignant neoplasm of other specified sites of body of uterus 
Malignant Neoplasms 183.0 ICD9CM Malignant neoplasm of ovary 
Malignant Neoplasms 183.2 ICD9CM Malignant neoplasm of fallopian tube 
Malignant Neoplasms 183.3 ICD9CM Malignant neoplasm of broad ligament of uterus 
Malignant Neoplasms 183.4 ICD9CM Malignant neoplasm of parametrium 
Malignant Neoplasms 183.5 ICD9CM Malignant neoplasm of round ligament of uterus 
Malignant Neoplasms 183.8 ICD9CM Malignant neoplasm of other specified sites of uterine adnexa 
Malignant Neoplasms 183.9 ICD9CM Malignant neoplasm of uterine adnexa, unspecified site 
Malignant Neoplasms 184.0 ICD9CM Malignant neoplasm of vagina 
Malignant Neoplasms 184.1 ICD9CM Malignant neoplasm of labia majora 
Malignant Neoplasms 184.2 ICD9CM Malignant neoplasm of labia minora 
Malignant Neoplasms 184.3 ICD9CM Malignant neoplasm of clitoris 
Malignant Neoplasms 184.4 ICD9CM Malignant neoplasm of vulva, unspecified site 
Malignant Neoplasms 184.8 ICD9CM Malignant neoplasm of other specified sites of female genital organs 
Malignant Neoplasms 184.9 ICD9CM Malignant neoplasm of female genital organ, site unspecified 
Malignant Neoplasms 185 ICD9CM Malignant neoplasm of prostate 
Malignant Neoplasms 186.0 ICD9CM Malignant neoplasm of undescended testis 
Malignant Neoplasms 186.9 ICD9CM Malignant neoplasm of other and unspecified testis 
Malignant Neoplasms 187.1 ICD9CM Malignant neoplasm of prepuce 
Malignant Neoplasms 187.2 ICD9CM Malignant neoplasm of glans penis 
Malignant Neoplasms 187.3 ICD9CM Malignant neoplasm of body of penis 
Malignant Neoplasms 187.4 ICD9CM Malignant neoplasm of penis, part unspecified 
Malignant Neoplasms 187.5 ICD9CM Malignant neoplasm of epididymis 
Malignant Neoplasms 187.6 ICD9CM Malignant neoplasm of spermatic cord 
Malignant Neoplasms 187.7 ICD9CM Malignant neoplasm of scrotum 
Malignant Neoplasms 187.8 ICD9CM Malignant neoplasm of other specified sites of male genital organs 
Malignant Neoplasms 187.9 ICD9CM Malignant neoplasm of male genital organ, site unspecified 
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Malignant Neoplasms 188.0 ICD9CM Malignant neoplasm of trigone of urinary bladder 
Malignant Neoplasms 188.1 ICD9CM Malignant neoplasm of dome of urinary bladder 
Malignant Neoplasms 188.2 ICD9CM Malignant neoplasm of lateral wall of urinary bladder 
Malignant Neoplasms 188.3 ICD9CM Malignant neoplasm of anterior wall of urinary bladder 
Malignant Neoplasms 188.4 ICD9CM Malignant neoplasm of posterior wall of urinary bladder 
Malignant Neoplasms 188.5 ICD9CM Malignant neoplasm of bladder neck 
Malignant Neoplasms 188.6 ICD9CM Malignant neoplasm of ureteric orifice 
Malignant Neoplasms 188.7 ICD9CM Malignant neoplasm of urachus 
Malignant Neoplasms 188.8 ICD9CM Malignant neoplasm of other specified sites of bladder 
Malignant Neoplasms 188.9 ICD9CM Malignant neoplasm of bladder, part unspecified 
Malignant Neoplasms 189.0 ICD9CM Malignant neoplasm of kidney, except pelvis 
Malignant Neoplasms 189.1 ICD9CM Malignant neoplasm of renal pelvis 
Malignant Neoplasms 189.2 ICD9CM Malignant neoplasm of ureter 
Malignant Neoplasms 189.3 ICD9CM Malignant neoplasm of urethra 
Malignant Neoplasms 189.4 ICD9CM Malignant neoplasm of paraurethral glands 
Malignant Neoplasms 189.8 ICD9CM Malignant neoplasm of other specified sites of urinary organs 
Malignant Neoplasms 189.9 ICD9CM Malignant neoplasm of urinary organ, site unspecified 
Malignant Neoplasms 190.0 ICD9CM Malignant neoplasm of eyeball, except conjunctiva, cornea, retina, and choroid 
Malignant Neoplasms 190.1 ICD9CM Malignant neoplasm of orbit 
Malignant Neoplasms 190.2 ICD9CM Malignant neoplasm of lacrimal gland 
Malignant Neoplasms 190.3 ICD9CM Malignant neoplasm of conjunctiva 
Malignant Neoplasms 190.4 ICD9CM Malignant neoplasm of cornea 
Malignant Neoplasms 190.5 ICD9CM Malignant neoplasm of retina 
Malignant Neoplasms 190.6 ICD9CM Malignant neoplasm of choroid 
Malignant Neoplasms 190.7 ICD9CM Malignant neoplasm of lacrimal duct 
Malignant Neoplasms 190.8 ICD9CM Malignant neoplasm of other specified sites of eye 
Malignant Neoplasms 190.9 ICD9CM Malignant neoplasm of eye, part unspecified 
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Malignant Neoplasms 191.0 ICD9CM Malignant neoplasm of cerebrum, except lobes and ventricles 
Malignant Neoplasms 191.1 ICD9CM Malignant neoplasm of frontal lobe 
Malignant Neoplasms 191.2 ICD9CM Malignant neoplasm of temporal lobe 
Malignant Neoplasms 191.3 ICD9CM Malignant neoplasm of parietal lobe 
Malignant Neoplasms 191.4 ICD9CM Malignant neoplasm of occipital lobe 
Malignant Neoplasms 191.5 ICD9CM Malignant neoplasm of ventricles 
Malignant Neoplasms 191.6 ICD9CM Malignant neoplasm of cerebellum nos 
Malignant Neoplasms 191.7 ICD9CM Malignant neoplasm of brain stem 
Malignant Neoplasms 191.8 ICD9CM Malignant neoplasm of other parts of brain 
Malignant Neoplasms 191.9 ICD9CM Malignant neoplasm of brain, unspecified 
Malignant Neoplasms 192.0 ICD9CM Malignant neoplasm of cranial nerves 
Malignant Neoplasms 192.1 ICD9CM Malignant neoplasm of cerebral meninges 
Malignant Neoplasms 192.2 ICD9CM Malignant neoplasm of spinal cord 
Malignant Neoplasms 192.3 ICD9CM Malignant neoplasm of spinal meninges 
Malignant Neoplasms 192.8 ICD9CM Malignant neoplasm of other specified sites of nervous system 
Malignant Neoplasms 192.9 ICD9CM Malignant neoplasm of nervous system, part unspecified 
Malignant Neoplasms 193 ICD9CM Malignant neoplasm of thyroid gland 
Malignant Neoplasms 194.0 ICD9CM Malignant neoplasm of adrenal gland 
Malignant Neoplasms 194.1 ICD9CM Malignant neoplasm of parathyroid gland 
Malignant Neoplasms 194.3 ICD9CM Malignant neoplasm of pituitary gland and craniopharyngeal duct 
Malignant Neoplasms 194.4 ICD9CM Malignant neoplasm of pineal gland 
Malignant Neoplasms 194.5 ICD9CM Malignant neoplasm of carotid body 
Malignant Neoplasms 194.6 ICD9CM Malignant neoplasm of aortic body and other paraganglia 
Malignant Neoplasms 194.8 ICD9CM Malignant neoplasm of other endocrine glands and related structures 
Malignant Neoplasms 194.9 ICD9CM Malignant neoplasm of endocrine gland, site unspecified 
Malignant Neoplasms 195.0 ICD9CM Malignant neoplasm of head, face, and neck 
Malignant Neoplasms 195.1 ICD9CM Malignant neoplasm of thorax 
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Malignant Neoplasms 195.2 ICD9CM Malignant neoplasm of abdomen 
Malignant Neoplasms 195.3 ICD9CM Malignant neoplasm of pelvis 
Malignant Neoplasms 195.4 ICD9CM Malignant neoplasm of upper limb 
Malignant Neoplasms 195.5 ICD9CM Malignant neoplasm of lower limb 
Malignant Neoplasms 195.8 ICD9CM Malignant neoplasm of other specified sites 
Malignant Neoplasms 196.0 
ICD9CM 
Secondary and unspecified malignant neoplasm of lymph nodes of head, face, 
and neck 
Malignant Neoplasms 196.1 ICD9CM Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes 
Malignant Neoplasms 196.2 ICD9CM Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes 
Malignant Neoplasms 196.3 
ICD9CM 
Secondary and unspecified malignant neoplasm of lymph nodes of axilla and 
upper limb 
Malignant Neoplasms 196.5 
ICD9CM 
Secondary and unspecified malignant neoplasm of lymph nodes of inguinal 
region and lower limb 
Malignant Neoplasms 196.6 ICD9CM Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes 
Malignant Neoplasms 196.8 ICD9CM Secondary and unspecified malignant neoplasm of lymph nodes of multiple sites 
Malignant Neoplasms 196.9 ICD9CM Secondary and unspecified malignant neoplasm of lymph nodes, site unspecified 
Malignant Neoplasms 197.0 ICD9CM Secondary malignant neoplasm of lung 
Malignant Neoplasms 197.1 ICD9CM Secondary malignant neoplasm of mediastinum 
Malignant Neoplasms 197.2 ICD9CM Secondary malignant neoplasm of pleura 
Malignant Neoplasms 197.3 ICD9CM Secondary malignant neoplasm of other respiratory organs 
Malignant Neoplasms 197.4 ICD9CM Secondary malignant neoplasm of small intestine including duodenum 
Malignant Neoplasms 197.5 ICD9CM Secondary malignant neoplasm of large intestine and rectum 
Malignant Neoplasms 197.6 ICD9CM Secondary malignant neoplasm of retroperitoneum and peritoneum 
Malignant Neoplasms 197.7 ICD9CM Malignant neoplasm of liver, secondary 
Malignant Neoplasms 197.8 ICD9CM Secondary malignant neoplasm of other digestive organs and spleen 
Malignant Neoplasms 198.0 ICD9CM Secondary malignant neoplasm of kidney 
Malignant Neoplasms 198.1 ICD9CM Secondary malignant neoplasm of other urinary organs 
Malignant Neoplasms 198.2 ICD9CM Secondary malignant neoplasm of skin 
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Malignant Neoplasms 198.3 ICD9CM Secondary malignant neoplasm of brain and spinal cord 
Malignant Neoplasms 198.4 ICD9CM Secondary malignant neoplasm of other parts of nervous system 
Malignant Neoplasms 198.5 ICD9CM Secondary malignant neoplasm of bone and bone marrow 
Malignant Neoplasms 198.6 ICD9CM Secondary malignant neoplasm of ovary 
Malignant Neoplasms 198.7 ICD9CM Secondary malignant neoplasm of adrenal gland 
Malignant Neoplasms 198.81 ICD9CM Secondary malignant neoplasm of breast 
Malignant Neoplasms 198.82 ICD9CM Secondary malignant neoplasm of genital organs 
Malignant Neoplasms 198.89 ICD9CM Secondary malignant neoplasm of other specified sites 
Malignant Neoplasms 199.0 ICD9CM Disseminated malignant neoplasm without specification of site 
Malignant Neoplasms 199.1 ICD9CM Other malignant neoplasm without specification of site 
Malignant Neoplasms 199.2 ICD9CM Malignant neoplasm associated with transplant organ 
Malignant Neoplasms 200.00 ICD9CM Reticulosarcoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 200.01 ICD9CM Reticulosarcoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.02 ICD9CM Reticulosarcoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.03 ICD9CM Reticulosarcoma, intra-abdominal lymph nodes 
Malignant Neoplasms 200.04 ICD9CM Reticulosarcoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 200.05 ICD9CM Reticulosarcoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 200.06 ICD9CM Reticulosarcoma, intrapelvic lymph nodes 
Malignant Neoplasms 200.07 ICD9CM Reticulosarcoma, spleen 
Malignant Neoplasms 200.08 ICD9CM Reticulosarcoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.10 ICD9CM Lymphosarcoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 200.11 ICD9CM Lymphosarcoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.12 ICD9CM Lymphosarcoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.13 ICD9CM Lymphosarcoma, intra-abdominal lymph nodes 
Malignant Neoplasms 200.14 ICD9CM Lymphosarcoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 200.15 ICD9CM Lymphosarcoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 200.16 ICD9CM Lymphosarcoma, intrapelvic lymph nodes 
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Malignant Neoplasms 200.17 ICD9CM Lymphosarcoma, spleen 
Malignant Neoplasms 200.18 ICD9CM Lymphosarcoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.20 ICD9CM Burkitt's tumor or lymphoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 200.21 ICD9CM Burkitt's tumor or lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.22 ICD9CM Burkitt's tumor or lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.23 ICD9CM Burkitt's tumor or lymphoma, intra-abdominal lymph nodes 
Malignant Neoplasms 200.24 ICD9CM Burkitt's tumor or lymphoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 200.25 ICD9CM Burkitt's tumor or lymphoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 200.26 ICD9CM Burkitt's tumor or lymphoma, intrapelvic lymph nodes 
Malignant Neoplasms 200.27 ICD9CM Burkitt's tumor or lymphoma, spleen 
Malignant Neoplasms 200.28 ICD9CM Burkitt's tumor or lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.30 ICD9CM Marginal zone lymphoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 200.31 ICD9CM Marginal zone lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.32 ICD9CM Marginal zone lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.33 ICD9CM Marginal zone lymphoma, intraabdominal lymph nodes 
Malignant Neoplasms 200.34 ICD9CM Marginal zone lymphoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 200.35 ICD9CM Marginal zone lymphoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 200.36 ICD9CM Marginal zone lymphoma, intrapelvic lymph nodes 
Malignant Neoplasms 200.37 ICD9CM Marginal zone lymphoma, spleen 
Malignant Neoplasms 200.38 ICD9CM Marginal zone lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.40 ICD9CM Mantle cell lymphoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 200.41 ICD9CM Mantle cell lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.42 ICD9CM Mantle cell lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.43 ICD9CM Mantle cell lymphoma, intra-abdominal lymph nodes 
Malignant Neoplasms 200.44 ICD9CM Mantle cell lymphoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 200.45 ICD9CM Mantle cell lymphoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 200.46 ICD9CM Mantle cell lymphoma, intrapelvic lymph nodes 
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Malignant Neoplasms 200.47 ICD9CM Mantle cell lymphoma, spleen 
Malignant Neoplasms 200.48 ICD9CM Mantle cell lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.50 
ICD9CM 
Primary central nervous system lymphoma, unspecified site, extranodal and solid 
organ sites 
Malignant Neoplasms 200.51 ICD9CM Primary central nervous system lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.52 ICD9CM Primary central nervous system lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.53 ICD9CM Primary central nervous system lymphoma, intra-abdominal lymph nodes 
Malignant Neoplasms 200.54 ICD9CM Primary central nervous system lymphoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 200.55 
ICD9CM 
Primary central nervous system lymphoma, lymph nodes of inguinal region and 
lower limb 
Malignant Neoplasms 200.56 ICD9CM Primary central nervous system lymphoma, intrapelvic lymph nodes 
Malignant Neoplasms 200.57 ICD9CM Primary central nervous system lymphoma, spleen 
Malignant Neoplasms 200.58 ICD9CM Primary central nervous system lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.60 ICD9CM Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 200.61 ICD9CM Anaplastic large cell lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.62 ICD9CM Anaplastic large cell lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.63 ICD9CM Anaplastic large cell lymphoma, intra-abdominal lymph nodes 
Malignant Neoplasms 200.64 ICD9CM Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 200.65 ICD9CM Anaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 200.66 ICD9CM Anaplastic large cell lymphoma, intrapelvic lymph nodes 
Malignant Neoplasms 200.67 ICD9CM Anaplastic large cell lymphoma, spleen 
Malignant Neoplasms 200.68 ICD9CM Anaplastic large cell lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.70 ICD9CM Large cell lymphoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 200.71 ICD9CM Large cell lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 200.72 ICD9CM Large cell lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 200.73 ICD9CM Large cell lymphoma, intra-abdominal lymph nodes 
Malignant Neoplasms 200.74 ICD9CM Large cell lymphoma, lymph nodes of axilla and upper limb 
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Malignant Neoplasms 200.75 ICD9CM Large cell lymphoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 200.76 ICD9CM Large cell lymphoma, intrapelvic lymph nodes 
Malignant Neoplasms 200.77 ICD9CM Large cell lymphoma, spleen 
Malignant Neoplasms 200.78 ICD9CM Large cell lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 200.80 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma, unspecified site, 
extranodal and solid organ sites 
Malignant Neoplasms 200.81 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of 
head, face, and neck 
Malignant Neoplasms 200.82 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma,intrathoracic 
lymph nodes 
Malignant Neoplasms 200.83 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma, intra-abdominal 
lymph nodes 
Malignant Neoplasms 200.84 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of 
axilla and upper limb 
Malignant Neoplasms 200.85 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of 
inguinal region and lower limb 
Malignant Neoplasms 200.86 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma, intrapelvic lymph 
nodes 
Malignant Neoplasms 200.87 ICD9CM Other named variants of lymphosarcoma and reticulosarcoma, spleen 
Malignant Neoplasms 200.88 
ICD9CM 
Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of 
multiple sites 
Malignant Neoplasms 201.00 ICD9CM Hodgkin's paragranuloma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 201.01 ICD9CM Hodgkin's paragranuloma, lymph nodes of head, face, and neck 
Malignant Neoplasms 201.02 ICD9CM Hodgkin's paragranuloma, intrathoracic lymph nodes 
Malignant Neoplasms 201.03 ICD9CM Hodgkin's paragranuloma, intra-abdominal lymph nodes 
Malignant Neoplasms 201.04 ICD9CM Hodgkin's paragranuloma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 201.05 ICD9CM Hodgkin's paragranuloma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 201.06 ICD9CM Hodgkin's paragranuloma, intrapelvic lymph nodes 
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Malignant Neoplasms 201.07 ICD9CM Hodgkin's paragranuloma, spleen 
Malignant Neoplasms 201.08 ICD9CM Hodgkin's paragranuloma, lymph nodes of multiple sites 
Malignant Neoplasms 201.10 ICD9CM Hodgkin's granuloma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 201.11 ICD9CM Hodgkin's granuloma, lymph nodes of head, face, and neck 
Malignant Neoplasms 201.12 ICD9CM Hodgkin's granuloma, intrathoracic lymph nodes 
Malignant Neoplasms 201.13 ICD9CM Hodgkin's granuloma, intra-abdominal lymph nodes 
Malignant Neoplasms 201.14 ICD9CM Hodgkin's granuloma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 201.15 ICD9CM Hodgkin's granuloma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 201.16 ICD9CM Hodgkin's granuloma, intrapelvic lymph nodes 
Malignant Neoplasms 201.17 ICD9CM Hodgkin's granuloma, spleen 
Malignant Neoplasms 201.18 ICD9CM Hodgkin's granuloma, lymph nodes of multiple sites 
Malignant Neoplasms 201.20 ICD9CM Hodgkin's sarcoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 201.21 ICD9CM Hodgkin's sarcoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 201.22 ICD9CM Hodgkin's sarcoma, intrathoracic lymph nodes 
Malignant Neoplasms 201.23 ICD9CM Hodgkin's sarcoma, intra-abdominal lymph nodes 
Malignant Neoplasms 201.24 ICD9CM Hodgkin's sarcoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 201.25 ICD9CM Hodgkin's sarcoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 201.26 ICD9CM Hodgkin's sarcoma, intrapelvic lymph nodes 
Malignant Neoplasms 201.27 ICD9CM Hodgkin's sarcoma, spleen 
Malignant Neoplasms 201.28 ICD9CM Hodgkin's sarcoma, lymph nodes of multiple sites 
Malignant Neoplasms 201.40 
ICD9CM 
Hodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, 
extranodal and solid organ sites 
Malignant Neoplasms 201.41 
ICD9CM 
Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of head, 
face, and neck 
Malignant Neoplasms 201.42 
ICD9CM 
Hodgkin's disease, lymphocytic-histiocytic predominance, intrathoracic lymph 
nodes 
Malignant Neoplasms 201.43 
ICD9CM 




Malignant Neoplasms 201.44 
ICD9CM 
Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of axilla 
and upper limb 
Malignant Neoplasms 201.45 
ICD9CM 
Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of 
inguinal region and lower limb 
Malignant Neoplasms 201.46 
ICD9CM 
Hodgkin's disease, lymphocytic-histiocytic predominance, intrapelvic lymph 
nodes 
Malignant Neoplasms 201.47 ICD9CM Hodgkin's disease, lymphocytic-histiocytic predominance, spleen 
Malignant Neoplasms 201.48 
ICD9CM 
Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of 
multiple sites 
Malignant Neoplasms 201.50 
ICD9CM 
Hodgkin's disease, nodular sclerosis, unspecified site, extranodal and solid organ 
sites 
Malignant Neoplasms 201.51 ICD9CM Hodgkin's disease, nodular sclerosis, lymph nodes of head, face, and neck 
Malignant Neoplasms 201.52 ICD9CM Hodgkin's disease, nodular sclerosis, intrathoracic lymph nodes 
Malignant Neoplasms 201.53 ICD9CM Hodgkin's disease, nodular sclerosis, intra-abdominal lymph nodes 
Malignant Neoplasms 201.54 ICD9CM Hodgkin's disease, nodular sclerosis, lymph nodes of axilla and upper limb 
Malignant Neoplasms 201.55 
ICD9CM 
Hodgkin's disease, nodular sclerosis, lymph nodes of inguinal region and lower 
limb 
Malignant Neoplasms 201.56 ICD9CM Hodgkin's disease, nodular sclerosis, intrapelvic lymph nodes 
Malignant Neoplasms 201.57 ICD9CM Hodgkin's disease, nodular sclerosis, spleen 
Malignant Neoplasms 201.58 ICD9CM Hodgkin's disease, nodular sclerosis, lymph nodes of multiple sites 
Malignant Neoplasms 201.60 
ICD9CM 
Hodgkin's disease, mixed cellularity, unspecified site, extranodal and solid organ 
sites 
Malignant Neoplasms 201.61 ICD9CM Hodgkin's disease, mixed cellularity, lymph nodes of head, face, and neck 
Malignant Neoplasms 201.62 ICD9CM Hodgkin's disease, mixed cellularity, intrathoracic lymph nodes 
Malignant Neoplasms 201.63 ICD9CM Hodgkin's disease, mixed cellularity, intra-abdominal lymph nodes 
Malignant Neoplasms 201.64 ICD9CM Hodgkin's disease, mixed cellularity, lymph nodes of axilla and upper limb 
Malignant Neoplasms 201.65 
ICD9CM 
Hodgkin's disease, mixed cellularity, lymph nodes of inguinal region and lower 
limb 
Malignant Neoplasms 201.66 ICD9CM Hodgkin's disease, mixed cellularity, intrapelvic lymph nodes 
Malignant Neoplasms 201.67 ICD9CM Hodgkin's disease, mixed cellularity, spleen 
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Malignant Neoplasms 201.68 ICD9CM Hodgkin's disease, mixed cellularity, lymph nodes of multiple sites 
Malignant Neoplasms 201.70 
ICD9CM 
Hodgkin's disease, lymphocytic depletion, unspecified site, extranodal and solid 
organ sites 
Malignant Neoplasms 201.71 ICD9CM Hodgkin's disease, lymphocytic depletion, lymph nodes of head, face, and neck 
Malignant Neoplasms 201.72 ICD9CM Hodgkin's disease, lymphocytic depletion, intrathoracic lymph nodes 
Malignant Neoplasms 201.73 ICD9CM Hodgkin's disease, lymphocytic depletion, intra-abdominal lymph nodes 
Malignant Neoplasms 201.74 ICD9CM Hodgkin's disease, lymphocytic depletion, lymph nodes of axilla and upper limb 
Malignant Neoplasms 201.75 
ICD9CM 
Hodgkin's disease, lymphocytic depletion, lymph nodes of inguinal region and 
lower limb 
Malignant Neoplasms 201.76 ICD9CM Hodgkin's disease, lymphocytic depletion, intrapelvic lymph nodes 
Malignant Neoplasms 201.77 ICD9CM Hodgkin's disease, lymphocytic depletion, spleen 
Malignant Neoplasms 201.78 ICD9CM Hodgkin's disease, lymphocytic depletion, lymph nodes of multiple sites 
Malignant Neoplasms 201.90 
ICD9CM 
Hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ 
sites 
Malignant Neoplasms 201.91 ICD9CM Hodgkin's disease, unspecified type, lymph nodes of head, face, and neck 
Malignant Neoplasms 201.92 ICD9CM Hodgkin's disease, unspecified type, intrathoracic lymph nodes 
Malignant Neoplasms 201.93 ICD9CM Hodgkin's disease, unspecified type, intra-abdominal lymph nodes 
Malignant Neoplasms 201.94 ICD9CM Hodgkin's disease, unspecified type, lymph nodes of axilla and upper limb 
Malignant Neoplasms 201.95 
ICD9CM 
Hodgkin's disease, unspecified type, lymph nodes of inguinal region and lower 
limb 
Malignant Neoplasms 201.96 ICD9CM Hodgkin's disease, unspecified type, intrapelvic lymph nodes 
Malignant Neoplasms 201.97 ICD9CM Hodgkin's disease, unspecified type, spleen 
Malignant Neoplasms 201.98 ICD9CM Hodgkin's disease, unspecified type, lymph nodes of multiple sites 
Malignant Neoplasms 202.00 ICD9CM Nodular lymphoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.01 ICD9CM Nodular lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.02 ICD9CM Nodular lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 202.03 ICD9CM Nodular lymphoma, intra-abdominal lymph nodes 
Malignant Neoplasms 202.04 ICD9CM Nodular lymphoma, lymph nodes of axilla and upper limb 
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Malignant Neoplasms 202.05 ICD9CM Nodular lymphoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.06 ICD9CM Nodular lymphoma, intrapelvic lymph nodes 
Malignant Neoplasms 202.07 ICD9CM Nodular lymphoma, spleen 
Malignant Neoplasms 202.08 ICD9CM Nodular lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 202.10 ICD9CM Mycosis fungoides, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.11 ICD9CM Mycosis fungoides, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.12 ICD9CM Mycosis fungoides, intrathoracic lymph nodes 
Malignant Neoplasms 202.13 ICD9CM Mycosis fungoides, intra-abdominal lymph nodes 
Malignant Neoplasms 202.14 ICD9CM Mycosis fungoides, lymph nodes of axilla and upper limb 
Malignant Neoplasms 202.15 ICD9CM Mycosis fungoides, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.16 ICD9CM Mycosis fungoides, intrapelvic lymph nodes 
Malignant Neoplasms 202.17 ICD9CM Mycosis fungoides, spleen 
Malignant Neoplasms 202.18 ICD9CM Mycosis fungoides, lymph nodes of multiple sites 
Malignant Neoplasms 202.20 ICD9CM Sezary's disease, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.21 ICD9CM Sezary's disease, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.22 ICD9CM Sezary's disease, intrathoracic lymph nodes 
Malignant Neoplasms 202.23 ICD9CM Sezary's disease, intra-abdominal lymph nodes 
Malignant Neoplasms 202.24 ICD9CM Sezary's disease, lymph nodes of axilla and upper limb 
Malignant Neoplasms 202.25 ICD9CM Sezary's disease, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.26 ICD9CM Sezary's disease, intrapelvic lymph nodes 
Malignant Neoplasms 202.27 ICD9CM Sezary's disease, spleen 
Malignant Neoplasms 202.28 ICD9CM Sezary's disease, lymph nodes of multiple sites 
Malignant Neoplasms 202.30 ICD9CM Malignant histiocytosis, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.31 ICD9CM Malignant histiocytosis, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.32 ICD9CM Malignant histiocytosis, intrathoracic lymph nodes 
Malignant Neoplasms 202.33 ICD9CM Malignant histiocytosis, intra-abdominal lymph nodes 
Malignant Neoplasms 202.34 ICD9CM Malignant histiocytosis, lymph nodes of axilla and upper limb 
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Malignant Neoplasms 202.35 ICD9CM Malignant histiocytosis, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.36 ICD9CM Malignant histiocytosis, intrapelvic lymph nodes 
Malignant Neoplasms 202.37 ICD9CM Malignant histiocytosis, spleen 
Malignant Neoplasms 202.38 ICD9CM Malignant histiocytosis, lymph nodes of multiple sites 
Malignant Neoplasms 202.40 ICD9CM Leukemic reticuloendotheliosis, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.41 ICD9CM Leukemic reticuloendotheliosis, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.42 ICD9CM Leukemic reticuloendotheliosis, intrathoracic lymph nodes 
Malignant Neoplasms 202.43 ICD9CM Leukemic reticuloendotheliosis, intra-abdominal lymph nodes 
Malignant Neoplasms 202.44 ICD9CM Leukemic reticuloendotheliosis, lymph nodes of axilla and upper arm 
Malignant Neoplasms 202.45 ICD9CM Leukemic reticuloendotheliosis, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.46 ICD9CM Leukemic reticuloendotheliosis, intrapelvic lymph nodes 
Malignant Neoplasms 202.47 ICD9CM Leukemic reticuloendotheliosis, spleen 
Malignant Neoplasms 202.48 ICD9CM Leukemic reticuloendotheliosis, lymph nodes of multiple sites 
Malignant Neoplasms 202.50 ICD9CM Letterer-siwe disease, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.51 ICD9CM Letterer-siwe disease, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.52 ICD9CM Letterer-siwe disease, intrathoracic lymph nodes 
Malignant Neoplasms 202.53 ICD9CM Letterer-siwe disease, intra-abdominal lymph nodes 
Malignant Neoplasms 202.54 ICD9CM Letterer-siwe disease, lymph nodes of axilla and upper limb 
Malignant Neoplasms 202.55 ICD9CM Letterer-siwe disease, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.56 ICD9CM Letterer-siwe disease, intrapelvic lymph nodes 
Malignant Neoplasms 202.57 ICD9CM Letterer-siwe disease, spleen 
Malignant Neoplasms 202.58 ICD9CM Letterer-siwe disease, lymph nodes of multiple sites 
Malignant Neoplasms 202.60 ICD9CM Malignant mast cell tumors, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.61 ICD9CM Malignant mast cell tumors, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.62 ICD9CM Malignant mast cell tumors, intrathoracic lymph nodes 
Malignant Neoplasms 202.63 ICD9CM Malignant mast cell tumors, intra-abdominal lymph nodes 
Malignant Neoplasms 202.64 ICD9CM Malignant mast cell tumors, lymph nodes of axilla and upper limb 
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Malignant Neoplasms 202.65 ICD9CM Malignant mast cell tumors, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.66 ICD9CM Malignant mast cell tumors, intrapelvic lymph nodes 
Malignant Neoplasms 202.67 ICD9CM Malignant mast cell tumors, spleen 
Malignant Neoplasms 202.68 ICD9CM Malignant mast cell tumors, lymph nodes of multiple sites 
Malignant Neoplasms 202.70 ICD9CM Peripheral T cell lymphoma, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.71 ICD9CM Peripheral T cell lymphoma, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.72 ICD9CM Peripheral T cell lymphoma, intrathoracic lymph nodes 
Malignant Neoplasms 202.73 ICD9CM Peripheral T cell lymphoma, intra-abdominal lymph nodes 
Malignant Neoplasms 202.74 ICD9CM Peripheral T cell lymphoma, lymph nodes of axilla and upper limb 
Malignant Neoplasms 202.75 ICD9CM Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.76 ICD9CM Peripheral T cell lymphoma, intrapelvic lymph nodes 
Malignant Neoplasms 202.77 ICD9CM Peripheral T cell lymphoma, spleen 
Malignant Neoplasms 202.78 ICD9CM Peripheral T cell lymphoma, lymph nodes of multiple sites 
Malignant Neoplasms 202.80 ICD9CM Other malignant lymphomas, unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.81 ICD9CM Other malignant lymphomas, lymph nodes of head, face, and neck 
Malignant Neoplasms 202.82 ICD9CM Other malignant lymphomas, intrathoracic lymph nodes 
Malignant Neoplasms 202.83 ICD9CM Other malignant lymphomas, intra-abdominal lymph nodes 
Malignant Neoplasms 202.84 ICD9CM Other malignant lymphomas, lymph nodes of axilla and upper limb 
Malignant Neoplasms 202.85 ICD9CM Other malignant lymphomas, lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.86 ICD9CM Other malignant lymphomas, intrapelvic lymph nodes 
Malignant Neoplasms 202.87 ICD9CM Other malignant lymphomas, spleen 
Malignant Neoplasms 202.88 ICD9CM Other malignant lymphomas, lymph nodes of multiple sites 
Malignant Neoplasms 202.90 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
unspecified site, extranodal and solid organ sites 
Malignant Neoplasms 202.91 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
lymph nodes of head, face, and neck 
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Malignant Neoplasms 202.92 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
intrathoracic lymph nodes 
Malignant Neoplasms 202.93 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
intra-abdominal lymph nodes 
Malignant Neoplasms 202.94 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
lymph nodes of axilla and upper limb 
Malignant Neoplasms 202.95 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
lymph nodes of inguinal region and lower limb 
Malignant Neoplasms 202.96 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
intrapelvic lymph nodes 
Malignant Neoplasms 202.97 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
spleen 
Malignant Neoplasms 202.98 
ICD9CM 
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, 
lymph nodes of multiple sites 
Malignant Neoplasms 203.00 ICD9CM Multiple myeloma, without mention of having achieved remission 
Malignant Neoplasms 203.01 ICD9CM Multiple myeloma, in remission 
Malignant Neoplasms 203.02 ICD9CM Multiple myeloma, in relapse 
Malignant Neoplasms 203.10 ICD9CM Plasma cell leukemia, without mention of having achieved remission 
Malignant Neoplasms 203.11 ICD9CM Plasma cell leukemia, in remission 
Malignant Neoplasms 203.12 ICD9CM Plasma cell leukemia, in relapse 
Malignant Neoplasms 203.80 
ICD9CM 
Other immunoproliferative neoplasms, without mention of having achieved 
remission 
Malignant Neoplasms 203.81 ICD9CM Other immunoproliferative neoplasms, in remission 
Malignant Neoplasms 203.82 ICD9CM Other immunoproliferative neoplasms, in relapse 
Malignant Neoplasms 204.00 ICD9CM Acute lymphoid leukemia, without mention of having achieved remission 
Malignant Neoplasms 204.01 ICD9CM Acute lymphoid leukemia, in remission 
Malignant Neoplasms 204.02 ICD9CM Acute lymphoid leukemia, in relapse 
Malignant Neoplasms 204.10 ICD9CM Chronic lymphoid leukemia, without mention of having achieved remission 
Malignant Neoplasms 204.11 ICD9CM Chronic lymphoid leukemia, in remission 
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Malignant Neoplasms 204.12 ICD9CM Chronic lymphoid leukemia, in relapse 
Malignant Neoplasms 204.20 ICD9CM Subacute lymphoid leukemia, without mention of having achieved remission 
Malignant Neoplasms 204.21 ICD9CM Subacute lymphoid leukemia, in remission 
Malignant Neoplasms 204.22 ICD9CM Subacute lymphoid leukemia, in relapse 
Malignant Neoplasms 204.80 ICD9CM Other lymphoid leukemia, without mention of having achieved remission 
Malignant Neoplasms 204.81 ICD9CM Other lymphoid leukemia, in remission 
Malignant Neoplasms 204.82 ICD9CM Other lymphoid leukemia, in relapse 
Malignant Neoplasms 204.90 ICD9CM Unspecified lymphoid leukemia, without mention of having achieved remission 
Malignant Neoplasms 204.91 ICD9CM Unspecified lymphoid leukemia, in remission 
Malignant Neoplasms 204.92 ICD9CM Unspecified lymphoid leukemia, in relapse 
Malignant Neoplasms 205.00 ICD9CM Acute myeloid leukemia, without mention of having achieved remission 
Malignant Neoplasms 205.01 ICD9CM Acute myeloid leukemia, in remission 
Malignant Neoplasms 205.02 ICD9CM Acute myeloid leukemia, in relapse 
Malignant Neoplasms 205.10 ICD9CM Chronic myeloid leukemia, without mention of having achieved remission 
Malignant Neoplasms 205.11 ICD9CM Chronic myeloid leukemia, in remission 
Malignant Neoplasms 205.12 ICD9CM Chronic myeloid leukemia, in relapse 
Malignant Neoplasms 205.20 ICD9CM Subacute myeloid leukemia, without mention of having achieved remission 
Malignant Neoplasms 205.21 ICD9CM Subacute myeloid leukemia,in remission 
Malignant Neoplasms 205.22 ICD9CM Subacute myeloid leukemia, in relapse 
Malignant Neoplasms 205.30 ICD9CM Myeloid sarcoma, without mention of having achieved remission 
Malignant Neoplasms 205.31 ICD9CM Myeloid sarcoma, in remission 
Malignant Neoplasms 205.32 ICD9CM Myeloid sarcoma, in relapse 
Malignant Neoplasms 205.80 ICD9CM Other myeloid leukemia, without mention of having achieved remission 
Malignant Neoplasms 205.81 ICD9CM Other myeloid leukemia, in remission 
Malignant Neoplasms 205.82 ICD9CM Other myeloid leukemia, in relapse 
Malignant Neoplasms 205.90 ICD9CM Unspecified myeloid leukemia, without mention of having achieved remission 
Malignant Neoplasms 205.91 ICD9CM Unspecified myeloid leukemia, in remission 
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Malignant Neoplasms 205.92 ICD9CM Unspecified myeloid leukemia, in relapse 
Malignant Neoplasms 206.00 ICD9CM Acute monocytic leukemia, without mention of having achieved remission 
Malignant Neoplasms 206.01 ICD9CM Acute monocytic leukemia,in remission 
Malignant Neoplasms 206.02 ICD9CM Acute monocytic leukemia, in relapse 
Malignant Neoplasms 206.10 ICD9CM Chronic monocytic leukemia, without mention of having achieved remission 
Malignant Neoplasms 206.11 ICD9CM Chronic monocytic leukemia, in remission 
Malignant Neoplasms 206.12 ICD9CM Chronic monocytic leukemia, in relapse 
Malignant Neoplasms 206.20 ICD9CM Subacute monocytic leukemia, without mention of having achieved remission 
Malignant Neoplasms 206.21 ICD9CM Subacute monocytic leukemia, in remission 
Malignant Neoplasms 206.22 ICD9CM Subacute monocytic leukemia, in relapse 
Malignant Neoplasms 206.80 ICD9CM Other monocytic leukemia, without mention of having achieved remission 
Malignant Neoplasms 206.81 ICD9CM Other monocytic leukemia, in remission 
Malignant Neoplasms 206.82 ICD9CM Other monocytic leukemia, in relapse 
Malignant Neoplasms 206.90 ICD9CM Unspecified monocytic leukemia, without mention of having achieved remission 
Malignant Neoplasms 206.91 ICD9CM Unspecified monocytic leukemia, in remission 
Malignant Neoplasms 206.92 ICD9CM Unspecified monocytic leukemia, in relapse 
Malignant Neoplasms 207.00 
ICD9CM 
Acute erythremia and erythroleukemia, without mention of having achieved 
remission 
Malignant Neoplasms 207.01 ICD9CM Acute erythremia and erythroleukemia, in remission 
Malignant Neoplasms 207.02 ICD9CM Acute erythremia and erythroleukemia, in relapse 
Malignant Neoplasms 207.10 ICD9CM Chronic erythremia, without mention of having achieved remission 
Malignant Neoplasms 207.11 ICD9CM Chronic erythremia, in remission 
Malignant Neoplasms 207.12 ICD9CM Chronic erythremia, in relapse 
Malignant Neoplasms 207.20 ICD9CM Megakaryocytic leukemia, without mention of having achieved remission 
Malignant Neoplasms 207.21 ICD9CM Megakaryocytic leukemia, in remission 
Malignant Neoplasms 207.22 ICD9CM Megakaryocytic leukemia, in relapse 
Malignant Neoplasms 207.80 ICD9CM Other specified leukemia, without mention of having achieved remission 
Malignant Neoplasms 207.81 ICD9CM Other specified leukemia, in remission 
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Malignant Neoplasms 207.82 ICD9CM Other specified leukemia, in relapse 
Malignant Neoplasms 208.00 
ICD9CM 
Acute leukemia of unspecified cell type, without mention of having achieved 
remission 
Malignant Neoplasms 208.01 ICD9CM Acute leukemia of unspecified cell type, in remission 
Malignant Neoplasms 208.02 ICD9CM Acute leukemia of unspecified cell type, in relapse 
Malignant Neoplasms 208.10 
ICD9CM 
Chronic leukemia of unspecified cell type, without mention of having achieved 
remission 
Malignant Neoplasms 208.11 ICD9CM Chronic leukemia of unspecified cell type, in remission 
Malignant Neoplasms 208.12 ICD9CM Chronic leukemia of unspecified cell type, in relapse 
Malignant Neoplasms 208.20 
ICD9CM 
Subacute leukemia of unspecified cell type, without mention of having achieved 
remission 
Malignant Neoplasms 208.21 ICD9CM Subacute leukemia of unspecified cell type, in remission 
Malignant Neoplasms 208.22 ICD9CM Subacute leukemia of unspecified cell type, in relapse 
Malignant Neoplasms 208.80 
ICD9CM 
Other leukemia of unspecified cell type, without mention of having achieved 
remission 
Malignant Neoplasms 208.81 ICD9CM Other leukemia of unspecified cell type, in remission 
Malignant Neoplasms 208.82 ICD9CM Other leukemia of unspecified cell type, in relapse 
Malignant Neoplasms 208.90 ICD9CM Unspecified leukemia, without mention of having achieved remission 
Malignant Neoplasms 208.91 ICD9CM Unspecified leukemia, in remission 
Malignant Neoplasms 208.92 ICD9CM Unspecified leukemia, in relapse 
Malignant Neoplasms 209.00 ICD9CM Malignant carcinoid tumor of the small intestine, unspecified portion 
Malignant Neoplasms 209.01 ICD9CM Malignant carcinoid tumor of the duodenum 
Malignant Neoplasms 209.02 ICD9CM Malignant carcinoid tumor of the jejunum 
Malignant Neoplasms 209.03 ICD9CM Malignant carcinoid tumor of the ileum 
Malignant Neoplasms 209.10 ICD9CM Malignant carcinoid tumor of the large intestine, unspecified portion 
Malignant Neoplasms 209.11 ICD9CM Malignant carcinoid tumor of the appendix 
Malignant Neoplasms 209.12 ICD9CM Malignant carcinoid tumor of the cecum 
Malignant Neoplasms 209.13 ICD9CM Malignant carcinoid tumor of the ascending colon 
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Malignant Neoplasms 209.14 ICD9CM Malignant carcinoid tumor of the transverse colon 
Malignant Neoplasms 209.15 ICD9CM Malignant carcinoid tumor of the descending colon 
Malignant Neoplasms 209.16 ICD9CM Malignant carcinoid tumor of the sigmoid colon 
Malignant Neoplasms 209.17 ICD9CM Malignant carcinoid tumor of the rectum 
Malignant Neoplasms 209.20 ICD9CM Malignant carcinoid tumor of unknown primary site 
Malignant Neoplasms 209.21 ICD9CM Malignant carcinoid tumor of the bronchus and lung 
Malignant Neoplasms 209.22 ICD9CM Malignant carcinoid tumor of the thymus 
Malignant Neoplasms 209.23 ICD9CM Malignant carcinoid tumor of the stomach 
Malignant Neoplasms 209.24 ICD9CM Malignant carcinoid tumor of the kidney 
Malignant Neoplasms 209.25 ICD9CM Malignant carcinoid tumor of foregut, not otherwise specified 
Malignant Neoplasms 209.26 ICD9CM Malignant carcinoid tumor of midgut, not otherwise specified 
Malignant Neoplasms 209.27 ICD9CM Malignant carcinoid tumor of hindgut, not otherwise specified 
Malignant Neoplasms 209.29 ICD9CM Malignant carcinoid tumor of other sites 
Malignant Neoplasms 209.30 ICD9CM Malignant poorly differentiated neuroendocrine carcinoma, any site 
Malignant Neoplasms 209.31 ICD9CM Merkel cell carcinoma of the face 
Malignant Neoplasms 209.32 ICD9CM Merkel cell carcinoma of the scalp and neck 
Malignant Neoplasms 209.33 ICD9CM Merkel cell carcinoma of the upper limb 
Malignant Neoplasms 209.34 ICD9CM Merkel cell carcinoma of the lower limb 
Malignant Neoplasms 209.35 ICD9CM Merkel cell carcinoma of the trunk 
Malignant Neoplasms 209.36 ICD9CM Merkel cell carcinoma of other sites 
Malignant Neoplasms 209.40 ICD9CM Benign carcinoid tumor of the small intestine, unspecified portion 
Malignant Neoplasms 209.41 ICD9CM Benign carcinoid tumor of the duodenum 
Malignant Neoplasms 209.42 ICD9CM Benign carcinoid tumor of the jejunum 
Malignant Neoplasms 209.43 ICD9CM Benign carcinoid tumor of the ileum 
Malignant Neoplasms 209.50 ICD9CM Benign carcinoid tumor of the large intestine, unspecified portion 
Malignant Neoplasms 209.51 ICD9CM Benign carcinoid tumor of the appendix 
Malignant Neoplasms 209.52 ICD9CM Benign carcinoid tumor of the cecum 
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Malignant Neoplasms 209.53 ICD9CM Benign carcinoid tumor of the ascending colon 
Malignant Neoplasms 209.54 ICD9CM Benign carcinoid tumor of the transverse colon 
Malignant Neoplasms 209.55 ICD9CM Benign carcinoid tumor of the descending colon 
Malignant Neoplasms 209.56 ICD9CM Benign carcinoid tumor of the sigmoid colon 
Malignant Neoplasms 209.57 ICD9CM Benign carcinoid tumor of the rectum 
Malignant Neoplasms 209.60 ICD9CM Benign carcinoid tumor of unknown primary site 
Malignant Neoplasms 209.61 ICD9CM Benign carcinoid tumor of the bronchus and lung 
Malignant Neoplasms 209.62 ICD9CM Benign carcinoid tumor of the thymus 
Malignant Neoplasms 209.63 ICD9CM Benign carcinoid tumor of the stomach 
Malignant Neoplasms 209.64 ICD9CM Benign carcinoid tumor of the kidney 
Malignant Neoplasms 209.65 ICD9CM Benign carcinoid tumor of foregut, not otherwise specified 
Malignant Neoplasms 209.66 ICD9CM Benign carcinoid tumor of midgut, not otherwise specified 
Malignant Neoplasms 209.67 ICD9CM Benign carcinoid tumor of hindgut, not otherwise specified 
Malignant Neoplasms 209.69 ICD9CM Benign carcinoid tumor of other sites 
Malignant Neoplasms 209.70 ICD9CM Secondary neuroendocrine tumor, unspecified site 
Malignant Neoplasms 209.71 ICD9CM Secondary neuroendocrine tumor of distant lymph nodes 
Malignant Neoplasms 209.72 ICD9CM Secondary neuroendocrine tumor of liver 
Malignant Neoplasms 209.73 ICD9CM Secondary neuroendocrine tumor of bone 
Malignant Neoplasms 209.74 ICD9CM Secondary neuroendocrine tumor of peritoneum 
Malignant Neoplasms 209.75 ICD9CM Secondary Merkel cell carcinoma 
Malignant Neoplasms 209.79 ICD9CM Secondary neuroendocrine tumor of other sites 
Other Neoplasms 230.0 ICD9CM Carcinoma in situ of lip, oral cavity, and pharynx 
Other Neoplasms 230.1 ICD9CM Carcinoma in situ of esophagus 
Other Neoplasms 230.2 ICD9CM Carcinoma in situ of stomach 
Other Neoplasms 230.3 ICD9CM Carcinoma in situ of colon 
Other Neoplasms 230.4 ICD9CM Carcinoma in situ of rectum 
Other Neoplasms 230.5 ICD9CM Carcinoma in situ of anal canal 
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Other Neoplasms 230.6 ICD9CM Carcinoma in situ of anus, unspecified 
Other Neoplasms 230.7 ICD9CM Carcinoma in situ of other and unspecified parts of intestine 
Other Neoplasms 230.8 ICD9CM Carcinoma in situ of liver and biliary system 
Other Neoplasms 230.9 ICD9CM Carcinoma in situ of other and unspecified digestive organs 
Other Neoplasms 231.0 ICD9CM Carcinoma in situ of larynx 
Other Neoplasms 231.1 ICD9CM Carcinoma in situ of trachea 
Other Neoplasms 231.2 ICD9CM Carcinoma in situ of bronchus and lung 
Other Neoplasms 231.8 ICD9CM Carcinoma in situ of other specified parts of respiratory system 
Other Neoplasms 231.9 ICD9CM Carcinoma in situ of respiratory system, part unspecified 
Other Neoplasms 232.0 ICD9CM Carcinoma in situ of skin of lip 
Other Neoplasms 232.1 ICD9CM Carcinoma in situ of eyelid, including canthus 
Other Neoplasms 232.2 ICD9CM Carcinoma in situ of skin of ear and external auditory canal 
Other Neoplasms 232.3 ICD9CM Carcinoma in situ of skin of other and unspecified parts of face 
Other Neoplasms 232.4 ICD9CM Carcinoma in situ of scalp and skin of neck 
Other Neoplasms 232.5 ICD9CM Carcinoma in situ of skin of trunk, except scrotum 
Other Neoplasms 232.6 ICD9CM Carcinoma in situ of skin of upper limb, including shoulder 
Other Neoplasms 232.7 ICD9CM Carcinoma in situ of skin of lower limb, including hip 
Other Neoplasms 232.8 ICD9CM Carcinoma in situ of other specified sites of skin 
Other Neoplasms 232.9 ICD9CM Carcinoma in situ of skin, site unspecified 
Other Neoplasms 233.0 ICD9CM Carcinoma in situ of breast 
Other Neoplasms 233.1 ICD9CM Carcinoma in situ of cervix uteri 
Other Neoplasms 233.2 ICD9CM Carcinoma in situ of other and unspecified parts of uterus 
Other Neoplasms 233.30 ICD9CM Carcinoma in situ, unspecified female genital organ 
Other Neoplasms 233.31 ICD9CM Carcinoma in situ, vagina 
Other Neoplasms 233.32 ICD9CM Carcinoma in situ, vulva 
Other Neoplasms 233.39 ICD9CM Carcinoma in situ, other female genital organ 
Other Neoplasms 233.4 ICD9CM Carcinoma in situ of prostate 
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Other Neoplasms 233.5 ICD9CM Carcinoma in situ of penis 
Other Neoplasms 233.6 ICD9CM Carcinoma in situ of other and unspecified male genital organs 
Other Neoplasms 233.7 ICD9CM Carcinoma in situ of bladder 
Other Neoplasms 233.9 ICD9CM Carcinoma in situ of other and unspecified urinary organs 
Other Neoplasms 234.0 ICD9CM Carcinoma in situ of eye 
Other Neoplasms 234.8 ICD9CM Carcinoma in situ of other specified sites 
Other Neoplasms 234.9 ICD9CM Carcinoma in situ, site unspecified 
Other Neoplasms 235.0 ICD9CM Neoplasm of uncertain behavior of major salivary glands 
Other Neoplasms 235.1 ICD9CM Neoplasm of uncertain behavior of lip, oral cavity, and pharynx 
Other Neoplasms 235.2 ICD9CM Neoplasm of uncertain behavior of stomach, intestines, and rectum 
Other Neoplasms 235.3 ICD9CM Neoplasm of uncertain behavior of liver and biliary passages 
Other Neoplasms 235.4 ICD9CM Neoplasm of uncertain behavior of retroperitoneum and peritoneum 
Other Neoplasms 235.5 ICD9CM Neoplasm of uncertain behavior of other and unspecified digestive organs 
Other Neoplasms 235.6 ICD9CM Neoplasm of uncertain behavior of larynx 
Other Neoplasms 235.7 ICD9CM Neoplasm of uncertain behavior of trachea, bronchus, and lung 
Other Neoplasms 235.8 ICD9CM Neoplasm of uncertain behavior of pleura, thymus, and mediastinum 
Other Neoplasms 235.9 ICD9CM Neoplasm of uncertain behavior of other and unspecified respiratory organs 
Other Neoplasms 236.0 ICD9CM Neoplasm of uncertain behavior of uterus 
Other Neoplasms 236.1 ICD9CM Neoplasm of uncertain behavior of placenta 
Other Neoplasms 236.2 ICD9CM Neoplasm of uncertain behavior of ovary 
Other Neoplasms 236.3 ICD9CM Neoplasm of uncertain behavior of other and unspecified female genital organs 
Other Neoplasms 236.4 ICD9CM Neoplasm of uncertain behavior of testis 
Other Neoplasms 236.5 ICD9CM Neoplasm of uncertain behavior of prostate 
Other Neoplasms 236.6 ICD9CM Neoplasm of uncertain behavior of other and unspecified male genital organs 
Other Neoplasms 236.7 ICD9CM Neoplasm of uncertain behavior of bladder 
Other Neoplasms 236.90 ICD9CM Neoplasm of uncertain behavior of urinary organ, unspecified 
Other Neoplasms 236.91 ICD9CM Neoplasm of uncertain behavior of kidney and ureter 
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Other Neoplasms 236.99 ICD9CM Neoplasm of uncertain behavior of other and unspecified urinary organs 
Other Neoplasms 237.0 ICD9CM Neoplasm of uncertain behavior of pituitary gland and craniopharyngeal duct 
Other Neoplasms 237.1 ICD9CM Neoplasm of uncertain behavior of pineal gland 
Other Neoplasms 237.2 ICD9CM Neoplasm of uncertain behavior of adrenal gland 
Other Neoplasms 237.3 ICD9CM Neoplasm of uncertain behavior of paraganglia 
Other Neoplasms 237.4 ICD9CM Neoplasm of uncertain behavior of other and unspecified endocrine glands 
Other Neoplasms 237.5 ICD9CM Neoplasm of uncertain behavior of brain and spinal cord 
Other Neoplasms 237.6 ICD9CM Neoplasm of uncertain behavior of meninges 
Other Neoplasms 237.70 ICD9CM Neurofibromatosis, unspecified 
Other Neoplasms 237.71 ICD9CM Neurofibromatosis, type 1 [von recklinghausen's disease] 
Other Neoplasms 237.72 ICD9CM Neurofibromatosis, type 2 [acoustic neurofibromatosis] 
Other Neoplasms 237.73 ICD9CM Schwannomatosis 
Other Neoplasms 237.79 ICD9CM Other neurofibromatosis 
Other Neoplasms 237.9 ICD9CM Neoplasm of uncertain behavior of other and unspecified parts of nervous system 
Other Neoplasms 238.0 ICD9CM Neoplasm of uncertain behavior of bone and articular cartilage 
Other Neoplasms 238.1 ICD9CM Neoplasm of uncertain behavior of connective and other soft tissue 
Other Neoplasms 238.2 ICD9CM Neoplasm of uncertain behavior of skin 
Other Neoplasms 238.3 ICD9CM Neoplasm of uncertain behavior of breast 
Other Neoplasms 238.4 ICD9CM Polycythemia vera 
Other Neoplasms 238.5 ICD9CM Neoplasm of uncertain behavior of histiocytic and mast cells 
Other Neoplasms 238.6 ICD9CM Neoplasm of uncertain behavior of plasma cells 
Other Neoplasms 238.71 ICD9CM Essential thrombocythemia 
Other Neoplasms 238.72 ICD9CM Low grade myelodysplastic syndrome lesions 
Other Neoplasms 238.73 ICD9CM High grade myelodysplastic syndrome lesions 
Other Neoplasms 238.74 ICD9CM Myelodysplastic syndrome with 5q deletion 
Other Neoplasms 238.75 ICD9CM Myelodysplastic syndrome, unspecified 
Other Neoplasms 238.76 ICD9CM Myelofibrosis with myeloid metaplasia 
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Other Neoplasms 238.77 ICD9CM Post-transplant lymphoproliferative disorder (PTLD) 
Other Neoplasms 238.79 ICD9CM Other lymphatic and hematopoietic tissues 
Other Neoplasms 238.8 ICD9CM Neoplasm of uncertain behavior of other specified sites 
Other Neoplasms 238.9 ICD9CM Neoplasm of uncertain behavior, site unspecified 
Other Neoplasms 239.0 ICD9CM Neoplasm of unspecified nature of digestive system 
Other Neoplasms 239.1 ICD9CM Neoplasm of unspecified nature of respiratory system 
Other Neoplasms 239.2 ICD9CM Neoplasm of unspecified nature of bone, soft tissue, and skin 
Other Neoplasms 239.3 ICD9CM Neoplasm of unspecified nature of breast 
Other Neoplasms 239.4 ICD9CM Neoplasm of unspecified nature of bladder 
Other Neoplasms 239.5 ICD9CM Neoplasm of unspecified nature of other genitourinary organs 
Other Neoplasms 239.6 ICD9CM Neoplasm of unspecified nature of brain 
Other Neoplasms 239.7 
ICD9CM 
Neoplasm of unspecified nature of endocrine glands and other parts of nervous 
system 
Other Neoplasms 239.81 ICD9CM Neoplasms of unspecified nature, retina and choroid 
Other Neoplasms 239.89 ICD9CM Neoplasms of unspecified nature, other specified sites 
Other Neoplasms 239.9 ICD9CM Neoplasm of unspecified nature, site unspecified 
History of Malignant Neoplasm V10.00 ICD9CM Personal history of malignant neoplasm of gastrointestinal tract, unspecified 
History of Malignant Neoplasm V10.01 ICD9CM Personal history of malignant neoplasm of tongue 
History of Malignant Neoplasm V10.02 
ICD9CM 
Personal history of malignant neoplasm of other and unspecified oral cavity and 
pharynx 
History of Malignant Neoplasm V10.03 ICD9CM Personal history of malignant neoplasm of esophagus 
History of Malignant Neoplasm V10.04 ICD9CM Personal history of malignant neoplasm of stomach 
History of Malignant Neoplasm V10.05 ICD9CM Personal history of malignant neoplasm of large intestine 
History of Malignant Neoplasm V10.06 
ICD9CM 
Personal history of malignant neoplasm of rectum, rectosigmoid junction, and 
anus 
History of Malignant Neoplasm V10.07 ICD9CM Personal history of malignant neoplasm of liver 
History of Malignant Neoplasm V10.09 ICD9CM Personal history of malignant neoplasm of other gastrointestinal tract 
History of Malignant Neoplasm V10.11 ICD9CM Personal history of malignant neoplasm of bronchus and lung 
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History of Malignant Neoplasm V10.12 ICD9CM Personal history of malignant neoplasm of trachea 
History of Malignant Neoplasm V10.20 ICD9CM Personal history of malignant neoplasm of respiratory organ, unspecified 
History of Malignant Neoplasm V10.21 ICD9CM Personal history of malignant neoplasm of larynx 
History of Malignant Neoplasm V10.22 
ICD9CM 
Personal history of malignant neoplasm of nasal cavities, middle ear, and 
accessory sinuses 
History of Malignant Neoplasm V10.29 
ICD9CM 
Personal history of malignant neoplasm of other respiratory and intrathoracic 
organs 
History of Malignant Neoplasm V10.3 ICD9CM Personal history of malignant neoplasm of breast 
History of Malignant Neoplasm V10.40 ICD9CM Personal history of malignant neoplasm of female genital organ, unspecified 
History of Malignant Neoplasm V10.41 ICD9CM Personal history of malignant neoplasm of cervix uteri 
History of Malignant Neoplasm V10.42 ICD9CM Personal history of malignant neoplasm of other parts of uterus 
History of Malignant Neoplasm V10.43 ICD9CM Personal history of malignant neoplasm of ovary 
History of Malignant Neoplasm V10.44 ICD9CM Personal history of malignant neoplasm of other female genital organs 
History of Malignant Neoplasm V10.45 ICD9CM Personal history of malignant neoplasm of male genital organ, unspecified 
History of Malignant Neoplasm V10.46 ICD9CM Personal history of malignant neoplasm of prostate 
History of Malignant Neoplasm V10.47 ICD9CM Personal history of malignant neoplasm of testis 
History of Malignant Neoplasm V10.48 ICD9CM Personal history of malignant neoplasm of epididymis 
History of Malignant Neoplasm V10.49 ICD9CM Personal history of malignant neoplasm of other male genital organs 
History of Malignant Neoplasm V10.50 ICD9CM Personal history of malignant neoplasm of urinary organ, unspecified 
History of Malignant Neoplasm V10.51 ICD9CM Personal history of malignant neoplasm of bladder 
History of Malignant Neoplasm V10.52 ICD9CM Personal history of malignant neoplasm of kidney 
History of Malignant Neoplasm V10.53 ICD9CM Personal history of malignant neoplasm of renal pelvis 
History of Malignant Neoplasm V10.59 ICD9CM Personal history of malignant neoplasm of other urinary organs 
History of Malignant Neoplasm V10.60 ICD9CM Personal history of leukemia, unspecified 
History of Malignant Neoplasm V10.61 ICD9CM Personal history of lymphoid leukemia 
History of Malignant Neoplasm V10.62 ICD9CM Personal history of myeloid leukemia 
History of Malignant Neoplasm V10.63 ICD9CM Personal history of monocytic leukemia 
History of Malignant Neoplasm V10.69 ICD9CM Personal history of other leukemia 
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History of Malignant Neoplasm V10.71 ICD9CM Personal history of lymphosarcoma and reticulosarcoma 
History of Malignant Neoplasm V10.72 ICD9CM Personal history of hodgkin's disease 
History of Malignant Neoplasm V10.79 ICD9CM Personal history of other lymphatic and hematopoietic neoplasms 
History of Malignant Neoplasm V10.81 ICD9CM Personal history of malignant neoplasm of bone 
History of Malignant Neoplasm V10.82 ICD9CM Personal history of malignant melanoma of skin 
History of Malignant Neoplasm V10.83 ICD9CM Personal history of other malignant neoplasm of skin 
History of Malignant Neoplasm V10.84 ICD9CM Personal history of malignant neoplasm of eye 
History of Malignant Neoplasm V10.85 ICD9CM Personal history of malignant neoplasm of brain 
History of Malignant Neoplasm V10.86 ICD9CM Personal history of malignant neoplasm of other parts of nervous system 
History of Malignant Neoplasm V10.87 ICD9CM Personal history of malignant neoplasm of thyroid 
History of Malignant Neoplasm V10.88 
ICD9CM 
Personal history of malignant neoplasm of other endocrine glands and related 
structures 
History of Malignant Neoplasm V10.89 ICD9CM Personal history of malignant neoplasm of other sites 
History of Malignant Neoplasm V10.90 ICD9CM Personal history of unspecified malignant neoplasm 
History of Malignant Neoplasm V10.91 ICD9CM Personal history of malignant neuroendocrine tumor 
IV Drug Abuse 304.00 ICD9CM Opioid type dependence, unspecified 
IV Drug Abuse 304.01 ICD9CM Opioid type dependence, continuous 
IV Drug Abuse 304.02 ICD9CM Opioid type dependence, episodic 
IV Drug Abuse 304.03 ICD9CM Opioid type dependence, in remission 
IV Drug Abuse 304.10 ICD9CM Sedative, hypnotic or anxiolytic dependence, unspecified 
IV Drug Abuse 304.11 ICD9CM Sedative, hypnotic or anxiolytic dependence, continuous 
IV Drug Abuse 304.12 ICD9CM Sedative, hypnotic or anxiolytic dependence, episodic 
IV Drug Abuse 304.13 ICD9CM Sedative, hypnotic or anxiolytic dependence, in remission 
IV Drug Abuse 304.20 ICD9CM Cocaine dependence, unspecified 
IV Drug Abuse 304.21 ICD9CM Cocaine dependence, continuous 
IV Drug Abuse 304.22 ICD9CM Cocaine dependence, episodic 
IV Drug Abuse 304.23 ICD9CM Cocaine dependence, in remission 
180 
 
IV Drug Abuse 304.40 ICD9CM Amphetamine and other psychostimulant dependence, unspecified 
IV Drug Abuse 304.41 ICD9CM Amphetamine and other psychostimulant dependence, continuous 
IV Drug Abuse 304.42 ICD9CM Amphetamine and other psychostimulant dependence, episodic 
IV Drug Abuse 304.43 ICD9CM Amphetamine and other psychostimulant dependence, in remission 
IV Drug Abuse 305.40 ICD9CM Sedative, hypnotic or anxiolytic abuse, unspecified 
IV Drug Abuse 305.41 ICD9CM Sedative, hypnotic or anxiolytic abuse, continuous 
IV Drug Abuse 305.42 ICD9CM Sedative, hypnotic or anxiolytic abuse, episodic 
IV Drug Abuse 305.43 ICD9CM Sedative, hypnotic or anxiolytic abuse, in remission 
IV Drug Abuse 305.50 ICD9CM Opioid abuse, unspecified 
IV Drug Abuse 305.51 ICD9CM Opioid abuse, continuous 
IV Drug Abuse 305.52 ICD9CM Opioid abuse, episodic 
IV Drug Abuse 305.53 ICD9CM Opioid abuse, in remission 
IV Drug Abuse 305.60 ICD9CM Cocaine abuse, unspecified 
IV Drug Abuse 305.61 ICD9CM Cocaine abuse, continuous 
IV Drug Abuse 305.62 ICD9CM Cocaine abuse, episodic 
IV Drug Abuse 305.63 ICD9CM Cocaine abuse, in remission 
IV Drug Abuse 305.70 ICD9CM Amphetamine or related acting sympathomimetic abuse, unspecified 
IV Drug Abuse 305.71 ICD9CM Amphetamine or related acting sympathomimetic abuse, continuous 
IV Drug Abuse 305.72 ICD9CM Amphetamine or related acting sympathomimetic abuse, episodic 
IV Drug Abuse 305.73 ICD9CM Amphetamine or related acting sympathomimetic abuse, in remission 
Trauma 800.00 
ICD9CM 
Closed fracture of vault of skull without mention of intracranial injury, unspecified 
state of consciousness 
Trauma 800.01 
ICD9CM 




Closed fracture of vault of skull without mention of intracranial injury, with brief 
[less than one hour] loss of consciousness 
Trauma 800.03 
ICD9CM 
Closed fracture of vault of skull without mention of intracranial injury, with 





Closed fracture of vault of skull without mention of intracranial injury, with 




Closed fracture of vault of skull without mention of intracranial injury, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 800.06 
ICD9CM 
Closed fracture of vault of skull without mention of intracranial injury, with loss of 
consciousness of unspecified duration 
Trauma 800.09 
ICD9CM 




Closed fracture of vault of skull with cerebral laceration and contusion, 
unspecified state of consciousness 
Trauma 800.11 
ICD9CM 
Closed fracture of vault of skull with cerebral laceration and contusion, with no 
loss of consciousness 
Trauma 800.12 
ICD9CM 
Closed fracture of vault of skull with cerebral laceration and contusion, with brief 
[less than one hour] loss of consciousness 
Trauma 800.13 
ICD9CM 
Closed fracture of vault of skull with cerebral laceration and contusion, with 
moderate [1-24 hours] loss of consciousness 
Trauma 800.14 
ICD9CM 
Closed fracture of vault of skull with cerebral laceration and contusion, with 




Closed fracture of vault of skull with cerebral laceration and contusion, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 800.16 
ICD9CM 
Closed fracture of vault of skull with cerebral laceration and contusion, with loss 
of consciousness of unspecified duration 
Trauma 800.19 
ICD9CM 






Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, unspecified state of consciousness 
Trauma 800.21 
ICD9CM 
Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with no loss of consciousness 
Trauma 800.22 
ICD9CM 
Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 800.23 
ICD9CM 
Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 800.24 
ICD9CM 
Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 800.25 
ICD9CM 
Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 800.26 
ICD9CM 
Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 800.29 
ICD9CM 
Closed fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with concussion, unspecified 
Trauma 800.30 
ICD9CM 
Closed fracture of vault of skull with other and unspecified intracranial 
hemorrhage, unspecified state of consciousness 
Trauma 800.31 
ICD9CM 
Closed fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with no loss of consciousness 
Trauma 800.32 
ICD9CM 
Closed fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 800.33 
ICD9CM 
Closed fracture of vault of skull with other and unspecified intracranial 





Closed fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 800.35 
ICD9CM 
Closed fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 800.36 
ICD9CM 
Closed fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 800.39 
ICD9CM 
Closed fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with concussion, unspecified 
Trauma 800.40 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 
nature, unspecified state of consciousness 
Trauma 800.41 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 
nature, with no loss of consciousness 
Trauma 800.42 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 
nature, with brief [less than one hour] loss of consciousness 
Trauma 800.43 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 
nature, with moderate [1-24 hours] loss of consciousness 
Trauma 800.44 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours] loss of consciousness and return to 
pre-existing conscious level 
Trauma 800.45 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 800.46 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 
nature, with loss of consciousness of unspecified duration 
Trauma 800.49 
ICD9CM 
Closed fracture of vault of skull with intracranial injury of other and unspecified 





Open fracture of vault of skull without mention of intracranial injury, unspecified 
state of consciousness 
Trauma 800.51 
ICD9CM 




Open fracture of vault of skull without mention of intracranial injury, with brief 
[less than one hour] loss of consciousness 
Trauma 800.53 
ICD9CM 
Open fracture of vault of skull without mention of intracranial injury, with 
moderate [1-24 hours] loss of consciousness 
Trauma 800.54 
ICD9CM 
Open fracture of vault of skull without mention of intracranial injury, with 




Open fracture of vault of skull without mention of intracranial injury, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 800.56 
ICD9CM 
Open fracture of vault of skull without mention of intracranial injury, with loss of 
consciousness of unspecified duration 
Trauma 800.59 
ICD9CM 




Open fracture of vault of skull with cerebral laceration and contusion, unspecified 
state of consciousness 
Trauma 800.61 
ICD9CM 




Open fracture of vault of skull with cerebral laceration and contusion, with brief 
[less than one hour] loss of consciousness 
Trauma 800.63 
ICD9CM 
Open fracture of vault of skull with cerebral laceration and contusion, with 
moderate [1-24 hours] loss of consciousness 
Trauma 800.64 
ICD9CM 
Open fracture of vault of skull with cerebral laceration and contusion, with 






Open fracture of vault of skull with cerebral laceration and contusion, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 800.66 
ICD9CM 
Open fracture of vault of skull with cerebral laceration and contusion, with loss of 
consciousness of unspecified duration 
Trauma 800.69 
ICD9CM 




Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, unspecified state of consciousness 
Trauma 800.71 
ICD9CM 
Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with no loss of consciousness 
Trauma 800.72 
ICD9CM 
Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 800.73 
ICD9CM 
Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 800.74 
ICD9CM 
Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 800.75 
ICD9CM 
Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 800.76 
ICD9CM 
Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 800.79 
ICD9CM 
Open fracture of vault of skull with subarachnoid, subdural, and extradural 
hemorrhage, with concussion, unspecified 
Trauma 800.80 
ICD9CM 
Open fracture of vault of skull with other and unspecified intracranial 





Open fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with no loss of consciousness 
Trauma 800.82 
ICD9CM 
Open fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 800.83 
ICD9CM 
Open fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 800.84 
ICD9CM 
Open fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 800.85 
ICD9CM 
Open fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 800.86 
ICD9CM 
Open fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 800.89 
ICD9CM 
Open fracture of vault of skull with other and unspecified intracranial 
hemorrhage, with concussion, unspecified 
Trauma 800.90 
ICD9CM 
Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, unspecified state of consciousness 
Trauma 800.91 
ICD9CM 
Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, with no loss of consciousness 
Trauma 800.92 
ICD9CM 
Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, with brief [less than one hour] loss of consciousness 
Trauma 800.93 
ICD9CM 
Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, with moderate [1-24 hours] loss of consciousness 
Trauma 800.94 
ICD9CM 
Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours] loss of consciousness and return to 





Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 800.96 
ICD9CM 
Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, with loss of consciousness of unspecified duration 
Trauma 800.99 
ICD9CM 
Open fracture of vault of skull with intracranial injury of other and unspecified 
nature, with concussion, unspecified 
Trauma 801.00 
ICD9CM 
Closed fracture of base of skull without mention of intra cranial injury, unspecified 
state of consciousness 
Trauma 801.01 
ICD9CM 
Closed fracture of base of skull without mention of intra cranial injury, with no 
loss of consciousness 
Trauma 801.02 
ICD9CM 
Closed fracture of base of skull without mention of intra cranial injury, with brief 
[less than one hour] loss of consciousness 
Trauma 801.03 
ICD9CM 
Closed fracture of base of skull without mention of intra cranial injury, with 
moderate [1-24 hours] loss of consciousness 
Trauma 801.04 
ICD9CM 
Closed fracture of base of skull without mention of intra cranial injury, with 




Closed fracture of base of skull without mention of intra cranial injury, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 801.06 
ICD9CM 
Closed fracture of base of skull without mention of intra cranial injury, with loss of 
consciousness of unspecified duration 
Trauma 801.09 
ICD9CM 




Closed fracture of base of skull with cerebral laceration and contusion, 
unspecified state of consciousness 
Trauma 801.11 
ICD9CM 
Closed fracture of base of skull with cerebral laceration and contusion, with no 





Closed fracture of base of skull with cerebral laceration and contusion, with brief 
[less than one hour] loss of consciousness 
Trauma 801.13 
ICD9CM 
Closed fracture of base of skull with cerebral laceration and contusion, with 
moderate [1-24 hours] loss of consciousness 
Trauma 801.14 
ICD9CM 
Closed fracture of base of skull with cerebral laceration and contusion, with 




Closed fracture of base of skull with cerebral laceration and contusion, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 801.16 
ICD9CM 
Closed fracture of base of skull with cerebral laceration and contusion, with loss 
of consciousness of unspecified duration 
Trauma 801.19 
ICD9CM 




Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, unspecified state of consciousness 
Trauma 801.21 
ICD9CM 
Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with no loss of consciousness 
Trauma 801.22 
ICD9CM 
Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 801.23 
ICD9CM 
Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 801.24 
ICD9CM 
Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 801.25 
ICD9CM 
Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 





Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 801.29 
ICD9CM 
Closed fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with concussion, unspecified 
Trauma 801.30 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, unspecified state of consciousness 
Trauma 801.31 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, with no loss of consciousness 
Trauma 801.32 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 801.33 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 801.34 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 801.35 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 801.36 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 801.39 
ICD9CM 
Closed fracture of base of skull with other and unspecified intracranial 
hemorrhage, with concussion, unspecified 
Trauma 801.40 
ICD9CM 
Closed fracture of base of skull with intracranial injury of other and unspecified 
nature, unspecified state of consciousness 
Trauma 801.41 
ICD9CM 
Closed fracture of base of skull with intracranial injury of other and unspecified 
nature, with no loss of consciousness 
Trauma 801.42 
ICD9CM 
Closed fracture of base of skull with intracranial injury of other and unspecified 





Closed fracture of base of skull with intracranial injury of other and unspecified 
nature, with moderate [1-24 hours] loss of consciousness 
Trauma 801.44 
ICD9CM 
Closed fracture of base of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours) loss of consciousness and return to 
pre-existing conscious level 
Trauma 801.45 
ICD9CM 
Closed fracture of base of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 801.46 
ICD9CM 
Closed fracture of base of skull with intracranial injury of other and unspecified 
nature, with loss of consciousness of unspecified duration 
Trauma 801.49 
ICD9CM 
Closed fracture of base of skull with intracranial injury of other and unspecified 
nature, with concussion, unspecified 
Trauma 801.50 
ICD9CM 
Open fracture of base of skull without mention of intracranial injury, unspecified 
state of consciousness 
Trauma 801.51 
ICD9CM 




Open fracture of base of skull without mention of intracranial injury, with brief 
[less than one hour] loss of consciousness 
Trauma 801.53 
ICD9CM 
Open fracture of base of skull without mention of intracranial injury, with 
moderate [1-24 hours] loss of consciousness 
Trauma 801.54 
ICD9CM 
Open fracture of base of skull without mention of intracranial injury, with 




Open fracture of base of skull without mention of intracranial injury, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 801.56 
ICD9CM 
Open fracture of base of skull without mention of intracranial injury, with loss of 









Open fracture of base of skull with cerebral laceration and contusion, unspecified 
state of consciousness 
Trauma 801.61 
ICD9CM 




Open fracture of base of skull with cerebral laceration and contusion, with brief 
[less than one hour] loss of consciousness 
Trauma 801.63 
ICD9CM 
Open fracture of base of skull with cerebral laceration and contusion, with 
moderate [1-24 hours] loss of consciousness 
Trauma 801.64 
ICD9CM 
Open fracture of base of skull with cerebral laceration and contusion, with 




Open fracture of base of skull with cerebral laceration and contusion, with 
prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 801.66 
ICD9CM 
Open fracture of base of skull with cerebral laceration and contusion, with loss of 
consciousness of unspecified duration 
Trauma 801.69 
ICD9CM 




Open fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, unspecified state of consciousness 
Trauma 801.71 
ICD9CM 
Open fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with no loss of consciousness 
Trauma 801.72 
ICD9CM 
Open fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 801.73 
ICD9CM 
Open fracture of base of skull with subarachnoid, subdural, and extradural 





Open fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 801.75 
ICD9CM 
Open fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 801.76 
ICD9CM 
Open fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 801.79 
ICD9CM 
Open fracture of base of skull with subarachnoid, subdural, and extradural 
hemorrhage, with concussion, unspecified 
Trauma 801.80 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 
hemorrhage, unspecified state of consciousness 
Trauma 801.81 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 
hemorrhage, with no loss of consciousness 
Trauma 801.82 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 801.83 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 801.84 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 801.85 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 801.86 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 801.89 
ICD9CM 
Open fracture of base of skull with other and unspecified intracranial 





Open fracture of base of skull with intracranial injury of other and unspecified 
nature, unspecified state of consciousness 
Trauma 801.91 
ICD9CM 
Open fracture of base of skull with intracranial injury of other and unspecified 
nature, with no loss of consciousness 
Trauma 801.92 
ICD9CM 
Open fracture of base of skull with intracranial injury of other and unspecified 
nature, with brief [less than one hour] loss of consciousness 
Trauma 801.93 
ICD9CM 
Open fracture of base of skull with intracranial injury of other and unspecified 
nature, with moderate [1-24 hours] loss of consciousness 
Trauma 801.94 
ICD9CM 
Open fracture of base of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours] loss of consciousness and return to 
pre-existing conscious level 
Trauma 801.95 
ICD9CM 
Open fracture of base of skull with intracranial injury of other and unspecified 
nature, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 801.96 
ICD9CM 
Open fracture of base of skull with intracranial injury of other and unspecified 
nature, with loss of consciousness of unspecified duration 
Trauma 801.99 
ICD9CM 
Open fracture of base of skull with intracranial injury of other and unspecified 
nature, with concussion, unspecified 
Trauma 802.0 ICD9CM Closed fracture of nasal bones 
Trauma 802.1 ICD9CM Open fracture of nasal bones 
Trauma 802.20 ICD9CM Closed fracture of mandible, unspecified site 
Trauma 802.21 ICD9CM Closed fracture of mandible, condylar process 
Trauma 802.22 ICD9CM Closed fracture of mandible, subcondylar 
Trauma 802.23 ICD9CM Closed fracture of mandible, coronoid process 
Trauma 802.24 ICD9CM Closed fracture of mandible, ramus, unspecified 
Trauma 802.25 ICD9CM Closed fracture of mandible, angle of jaw 
Trauma 802.26 ICD9CM Closed fracture of mandible, symphysis of body 
Trauma 802.27 ICD9CM Closed fracture of mandible, alveolar border of body 
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Trauma 802.28 ICD9CM Closed fracture of mandible, body, other and unspecified 
Trauma 802.29 ICD9CM Closed fracture of mandible, multiple sites 
Trauma 802.30 ICD9CM Open fracture of mandible, unspecified site 
Trauma 802.31 ICD9CM Open fracture of mandible, condylar process 
Trauma 802.32 ICD9CM Open fracture of mandible, subcondylar 
Trauma 802.33 ICD9CM Open fracture of mandible, coronoid process 
Trauma 802.34 ICD9CM Open fracture of mandible, ramus, unspecified 
Trauma 802.35 ICD9CM Open fracture of mandible, angle of jaw 
Trauma 802.36 ICD9CM Open fracture of mandible, symphysis of body 
Trauma 802.37 ICD9CM Open fracture of mandible, alveolar border of body 
Trauma 802.38 ICD9CM Open fracture of mandible, body, other and unspecified 
Trauma 802.39 ICD9CM Open fracture of mandible, multiple sites 
Trauma 802.4 ICD9CM Closed fracture of malar and maxillary bones 
Trauma 802.5 ICD9CM Open fracture of malar and maxillary bones 
Trauma 802.6 ICD9CM Closed fracture of orbital floor (blow-out) 
Trauma 802.7 ICD9CM Open fracture of orbital floor (blow-out) 
Trauma 802.8 ICD9CM Closed fracture of other facial bones 
Trauma 802.9 ICD9CM Open fracture of other facial bones 
Trauma 803.00 
ICD9CM 








Other closed skull fracture without mention of intracranial injury, with brief [less 
than one hour] loss of consciousness 
Trauma 803.03 
ICD9CM 
Other closed skull fracture without mention of intracranial injury, with moderate 
[1-24 hours] loss of consciousness 
Trauma 803.04 
ICD9CM 
Other closed skull fracture without mention of intracranial injury, with prolonged 






Other closed skull fracture without mention of intracranial injury, with prolonged 




Other closed skull fracture without mention of intracranial injury, with loss of 
consciousness of unspecified duration 
Trauma 803.09 
ICD9CM 




Other closed skull fracture with cerebral laceration and contusion, unspecified 
state of consciousness 
Trauma 803.11 
ICD9CM 




Other closed skull fracture with cerebral laceration and contusion, with brief [less 
than one hour] loss of consciousness 
Trauma 803.13 
ICD9CM 
Other closed skull fracture with cerebral laceration and contusion, with moderate 
[1-24 hours] loss of consciousness 
Trauma 803.14 
ICD9CM 
Other closed skull fracture with cerebral laceration and contusion, with prolonged 




Other closed skull fracture with cerebral laceration and contusion, with prolonged 




Other closed skull fracture with cerebral laceration and contusion, with loss of 
consciousness of unspecified duration 
Trauma 803.19 
ICD9CM 




Other closed skull fracture with subarachnoid, subdural, and extradural 





Other closed skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with no loss of consciousness 
Trauma 803.22 
ICD9CM 
Other closed skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 803.23 
ICD9CM 
Other closed skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 803.24 
ICD9CM 
Other closed skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 803.25 
ICD9CM 
Other closed skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 803.26 
ICD9CM 
Other closed skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 803.29 
ICD9CM 
Other closed skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with concussion, unspecified 
Trauma 803.30 
ICD9CM 
Other closed skull fracture with other and unspecified intracranial hemorrhage, 
unspecified state of unconsciousness 
Trauma 803.31 
ICD9CM 
Other closed skull fracture with other and unspecified intracranial hemorrhage, 
with no loss of consciousness 
Trauma 803.32 
ICD9CM 
Other closed skull fracture with other and unspecified intracranial hemorrhage, 
with brief [less than one hour] loss of consciousness 
Trauma 803.33 
ICD9CM 
Other closed skull fracture with other and unspecified intracranial hemorrhage, 
with moderate [1-24 hours] loss of consciousness 
Trauma 803.34 
ICD9CM 
Other closed skull fracture with other and unspecified intracranial hemorrhage, 
with prolonged [more than 24 hours] loss of consciousness and return to pre-





Other closed skull fracture with other and unspecified intracranial hemorrhage, 
with prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 803.36 
ICD9CM 
Other closed skull fracture with other and unspecified intracranial hemorrhage, 
with loss of consciousness of unspecified duration 
Trauma 803.39 
ICD9CM 
Other closed skull fracture with other and unspecified intracranial hemorrhage, 
with concussion, unspecified 
Trauma 803.40 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
unspecified state of consciousness 
Trauma 803.41 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
with no loss of consciousness 
Trauma 803.42 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
with brief [less than one hour] loss of consciousness 
Trauma 803.43 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
with moderate [1-24 hours] loss of consciousness 
Trauma 803.44 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
with prolonged [more than 24 hours] loss of consciousness and return to pre-
existing conscious level 
Trauma 803.45 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
with prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 803.46 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
with loss of consciousness of unspecified duration 
Trauma 803.49 
ICD9CM 
Other closed skull fracture with intracranial injury of other and unspecified nature, 
with concussion, unspecified 
Trauma 803.50 
ICD9CM 










Other open skull fracture without mention of intracranial injury, with brief [less 
than one hour] loss of consciousness 
Trauma 803.53 
ICD9CM 
Other open skull fracture without mention of intracranial injury, with moderate [1-
24 hours] loss of consciousness 
Trauma 803.54 
ICD9CM 
Other open skull fracture without mention of intracranial injury, with prolonged 




Other open skull fracture without mention of intracranial injury, with prolonged 




Other open skull fracture without mention of intracranial injury, with loss of 
consciousness of unspecified duration 
Trauma 803.59 
ICD9CM 




Other open skull fracture with cerebral laceration and contusion, unspecified 
state of consciousness 
Trauma 803.61 
ICD9CM 




Other open skull fracture with cerebral laceration and contusion, with brief [less 
than one hour] loss of consciousness 
Trauma 803.63 
ICD9CM 
Other open skull fracture with cerebral laceration and contusion, with moderate 
[1-24 hours] loss of consciousness 
Trauma 803.64 
ICD9CM 
Other open skull fracture with cerebral laceration and contusion, with prolonged 




Other open skull fracture with cerebral laceration and contusion, with prolonged 






Other open skull fracture with cerebral laceration and contusion, with loss of 
consciousness of unspecified duration 
Trauma 803.69 
ICD9CM 




Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, unspecified state of consciousness 
Trauma 803.71 
ICD9CM 
Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with no loss of consciousness 
Trauma 803.72 
ICD9CM 
Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with brief [less than one hour] loss of consciousness 
Trauma 803.73 
ICD9CM 
Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with moderate [1-24 hours] loss of consciousness 
Trauma 803.74 
ICD9CM 
Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 803.75 
ICD9CM 
Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with prolonged [more than 24 hours] loss of consciousness, without 
return to pre-existing conscious level 
Trauma 803.76 
ICD9CM 
Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with loss of consciousness of unspecified duration 
Trauma 803.79 
ICD9CM 
Other open skull fracture with subarachnoid, subdural, and extradural 
hemorrhage, with concussion, unspecified 
Trauma 803.80 
ICD9CM 
Other open skull fracture with other and unspecified intracranial hemorrhage, 
unspecified state of consciousness 
Trauma 803.81 
ICD9CM 
Other open skull fracture with other and unspecified intracranial hemorrhage, 
with no loss of consciousness 
Trauma 803.82 
ICD9CM 
Other open skull fracture with other and unspecified intracranial hemorrhage, 





Other open skull fracture with other and unspecified intracranial hemorrhage, 
with moderate [1-24 hours] loss of consciousness 
Trauma 803.84 
ICD9CM 
Other open skull fracture with other and unspecified intracranial hemorrhage, 
with prolonged [more than 24 hours] loss of consciousness and return to pre-
existing conscious level 
Trauma 803.85 
ICD9CM 
Other open skull fracture with other and unspecified intracranial hemorrhage, 
with prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 803.86 
ICD9CM 
Other open skull fracture with other and unspecified intracranial hemorrhage, 
with loss of consciousness of unspecified duration 
Trauma 803.89 
ICD9CM 
Other open skull fracture with other and unspecified intracranial hemorrhage, 
with concussion, unspecified 
Trauma 803.90 
ICD9CM 
Other open skull fracture with intracranial injury of other and unspecified nature, 
unspecified state of consciousness 
Trauma 803.91 
ICD9CM 
Other open skull fracture with intracranial injury of other and unspecified nature, 
with no loss of consciousness 
Trauma 803.92 
ICD9CM 
Other open skull fracture with intracranial injury of other and unspecified nature, 
with brief [less than one hour] loss of consciousness 
Trauma 803.93 
ICD9CM 
Other open skull fracture with intracranial injury of other and unspecified nature, 
with moderate [1-24 hours] loss of consciousness 
Trauma 803.94 
ICD9CM 
Other open skull fracture with intracranial injury of other and unspecified nature, 
with prolonged [more than 24 hours] loss of consciousness and return to pre-
existing conscious level 
Trauma 803.95 
ICD9CM 
Other open skull fracture with intracranial injury of other and unspecified nature, 
with prolonged [more than 24 hours] loss of consciousness, without return to pre-
existing conscious level 
Trauma 803.96 
ICD9CM 
Other open skull fracture with intracranial injury of other and unspecified nature, 





Other open skull fracture with intracranial injury of other and unspecified nature, 
with concussion, unspecified 
Trauma 804.00 
ICD9CM 
Closed fractures involving skull or face with other bones, without mention of 
intracranial injury, unspecified state of consciousness 
Trauma 804.01 
ICD9CM 
Closed fractures involving skull or face with other bones, without mention of 
intracranial injury, with no loss of consciousness 
Trauma 804.02 
ICD9CM 
Closed fractures involving skull or face with other bones, without mention of 
intracranial injury, with brief [less than one hour] loss of consciousness 
Trauma 804.03 
ICD9CM 
Closed fractures involving skull or face with other bones, without mention of 
intracranial injury, with moderate [1-24 hours] loss of consciousness 
Trauma 804.04 
ICD9CM 
Closed fractures involving skull or face with other bones, without mention or 
intracranial injury, with prolonged [more than 24 hours] loss of consciousness 
and return to pre-existing conscious level 
Trauma 804.05 
ICD9CM 
Closed fractures involving skull of face with other bones, without mention of 
intracranial injury, with prolonged [more than 24 hours] loss of consciousness, 
without return to pre-existing conscious level 
Trauma 804.06 
ICD9CM 
Closed fractures involving skull of face with other bones, without mention of 
intracranial injury, with loss of consciousness of unspecified duration 
Trauma 804.09 
ICD9CM 
Closed fractures involving skull of face with other bones, without mention of 
intracranial injury, with concussion, unspecified 
Trauma 804.10 
ICD9CM 
Closed fractures involving skull or face with other bones, with cerebral laceration 
and contusion, unspecified state of consciousness 
Trauma 804.11 
ICD9CM 
Closed fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with no loss of consciousness 
Trauma 804.12 
ICD9CM 
Closed fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with brief [less than one hour] loss of consciousness 
Trauma 804.13 
ICD9CM 
Closed fractures involving skull or face with other bones, with cerebral laceration 





Closed fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 804.15 
ICD9CM 
Closed fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with prolonged [more than 24 hours] loss of consciousness, 
without return to pre-existing conscious level 
Trauma 804.16 
ICD9CM 
Closed fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with loss of consciousness of unspecified duration 
Trauma 804.19 
ICD9CM 
Closed fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with concussion, unspecified 
Trauma 804.20 
ICD9CM 
Closed fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, unspecified state of consciousness 
Trauma 804.21 
ICD9CM 
Closed fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with no loss of consciousness 
Trauma 804.22 
ICD9CM 
Closed fractures involving skull or face with other bones with subarachnoid, 




Closed fractures involving skull or face with other bones with subarachnoid, 




Closed fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss 
of consciousness and return to pre-existing conscious level 
Trauma 804.25 
ICD9CM 
Closed fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss 
of consciousness, without return to pre-existing conscious level 
Trauma 804.26 
ICD9CM 
Closed fractures involving skull or face with other bones with subarachnoid, 






Closed fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with concussion, unspecified 
Trauma 804.30 
ICD9CM 
Closed fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, unspecified state of consciousness 
Trauma 804.31 
ICD9CM 
Closed fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with no loss of consciousness 
Trauma 804.32 
ICD9CM 
Closed fractures involving skull or face with other bones, with other and 




Closed fractures involving skull or face with other bones, with other and 




Closed fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with prolonged [more than 24 hours] loss of 
consciousness and return to pre- existing conscious level 
Trauma 804.35 
ICD9CM 
Closed fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with prolonged [more than 24 hours] loss of 
consciousness, without return to pre-existing conscious level 
Trauma 804.36 
ICD9CM 
Closed fractures involving skull or face with other bones, with other and 




Closed fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with concussion, unspecified 
Trauma 804.40 
ICD9CM 
Closed fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, unspecified state of consciousness 
Trauma 804.41 
ICD9CM 
Closed fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with no loss of consciousness 
Trauma 804.42 
ICD9CM 
Closed fractures involving skull or face with other bones, with intracranial injury of 






Closed fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with moderate [1-24 hours] loss of consciousness 
Trauma 804.44 
ICD9CM 
Closed fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with prolonged [more than 24 hours] loss of 
consciousness and return to pre-existing conscious level 
Trauma 804.45 
ICD9CM 
Closed fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with prolonged [more than 24 hours] loss of 
consciousness, without return to pre-existing conscious level 
Trauma 804.46 
ICD9CM 
Closed fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with loss of consciousness of unspecified duration 
Trauma 804.49 
ICD9CM 
Closed fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with concussion, unspecified 
Trauma 804.50 
ICD9CM 
Open fractures involving skull or face with other bones, without mention of 
intracranial injury, unspecified state of consciousness 
Trauma 804.51 
ICD9CM 
Open fractures involving skull or face with other bones, without mention of 
intracranial injury, with no loss of consciousness 
Trauma 804.52 
ICD9CM 
Open fractures involving skull or face with other bones, without mention of 
intracranial injury, with brief [less than one hour] loss of consciousness 
Trauma 804.53 
ICD9CM 
Open fractures involving skull or face with other bones, without mention of 
intracranial injury, with moderate [1-24 hours] loss of consciousness 
Trauma 804.54 
ICD9CM 
Open fractures involving skull or face with other bones, without mention of 
intracranial injury, with prolonged [more than 24 hours] loss of consciousness 
and return to pre-existing conscious level 
Trauma 804.55 
ICD9CM 
Open fractures involving skull or face with other bones, without mention of 
intracranial injury, with prolonged [more than 24 hours] loss of consciousness, 
without return to pre-existing conscious level 
Trauma 804.56 
ICD9CM 
Open fractures involving skull or face with other bones, without mention of 





Open fractures involving skull or face with other bones, without mention of 
intracranial injury, with concussion, unspecified 
Trauma 804.60 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, unspecified state of consciousness 
Trauma 804.61 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with no loss of consciousness 
Trauma 804.62 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with brief [less than one hour] loss of consciousness 
Trauma 804.63 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with moderate [1-24 hours] loss of consciousness 
Trauma 804.64 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with prolonged [more than 24 hours] loss of consciousness and 
return to pre-existing conscious level 
Trauma 804.65 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with prolonged [more than 24 hours] loss of consciousness, 
without return to pre-existing conscious level 
Trauma 804.66 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with loss of consciousness of unspecified duration 
Trauma 804.69 
ICD9CM 
Open fractures involving skull or face with other bones, with cerebral laceration 
and contusion, with concussion, unspecified 
Trauma 804.70 
ICD9CM 
Open fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, unspecified state of consciousness 
Trauma 804.71 
ICD9CM 
Open fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with no loss of consciousness 
Trauma 804.72 
ICD9CM 
Open fractures involving skull or face with other bones with subarachnoid, 




Open fractures involving skull or face with other bones with subarachnoid, 






Open fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss 
of consciousness and return to pre-existing conscious level 
Trauma 804.75 
ICD9CM 
Open fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with prolonged [more than 24 hours] loss 
of consciousness, without return to pre-existing conscious level 
Trauma 804.76 
ICD9CM 
Open fractures involving skull or face with other bones with subarachnoid, 




Open fractures involving skull or face with other bones with subarachnoid, 
subdural, and extradural hemorrhage, with concussion, unspecified 
Trauma 804.80 
ICD9CM 
Open fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, unspecified state of consciousness 
Trauma 804.81 
ICD9CM 
Open fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with no loss of consciousness 
Trauma 804.82 
ICD9CM 
Open fractures involving skull or face with other bones, with other and 




Open fractures involving skull or face with other bones, with other and 




Open fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with prolonged [more than 24 hours] loss of 
consciousness and return to pre-existing conscious level 
Trauma 804.85 
ICD9CM 
Open fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with prolonged [more than 24 hours] loss 





Open fractures involving skull or face with other bones, with other and 




Open fractures involving skull or face with other bones, with other and 
unspecified intracranial hemorrhage, with concussion, unspecified 
Trauma 804.90 
ICD9CM 
Open fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, unspecified state of consciousness 
Trauma 804.91 
ICD9CM 
Open fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with no loss of consciousness 
Trauma 804.92 
ICD9CM 
Open fractures involving skull or face with other bones, with intracranial injury of 




Open fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with moderate [1-24 hours] loss of consciousness 
Trauma 804.94 
ICD9CM 
Open fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with prolonged [more than 24 hours] loss of 
consciousness and return to pre-existing conscious level 
Trauma 804.95 
ICD9CM 
Open fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with prolonged [more than 24 hours] loss of 
consciousness without return to pre-existing conscious level 
Trauma 804.96 
ICD9CM 
Open fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with loss of consciousness of unspecified duration 
Trauma 804.99 
ICD9CM 
Open fractures involving skull or face with other bones, with intracranial injury of 
other and unspecified nature, with concussion, unspecified 
Trauma 805.00 ICD9CM Closed fracture of cervical vertebra, unspecified level 
Trauma 805.01 ICD9CM Closed fracture of first cervical vertebra 
Trauma 805.02 ICD9CM Closed fracture of second cervical vertebra 
Trauma 805.03 ICD9CM Closed fracture of third cervical vertebra 
Trauma 805.04 ICD9CM Closed fracture of fourth cervical vertebra 
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Trauma 805.05 ICD9CM Closed fracture of fifth cervical vertebra 
Trauma 805.06 ICD9CM Closed fracture of sixth cervical vertebra 
Trauma 805.07 ICD9CM Closed fracture of seventh cervical vertebra 
Trauma 805.08 ICD9CM Closed fracture of multiple cervical vertebrae 
Trauma 805.10 ICD9CM Open fracture of cervical vertebra, unspecified level 
Trauma 805.11 ICD9CM Open fracture of first cervical vertebra 
Trauma 805.12 ICD9CM Open fracture of second cervical vertebra 
Trauma 805.13 ICD9CM Open fracture of third cervical vertebra 
Trauma 805.14 ICD9CM Open fracture of fourth cervical vertebra 
Trauma 805.15 ICD9CM Open fracture of fifth cervical vertebra 
Trauma 805.16 ICD9CM Open fracture of sixth cervical vertebra 
Trauma 805.17 ICD9CM Open fracture of seventh cervical vertebra 
Trauma 805.18 ICD9CM Open fracture of multiple cervical vertebrae 
Trauma 805.2 ICD9CM Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury 
Trauma 805.3 ICD9CM Open fracture of dorsal [thoracic] vertebra without mention of spinal cord injury 
Trauma 805.4 ICD9CM Closed fracture of lumbar vertebra without mention of spinal cord injury 
Trauma 805.5 ICD9CM Open fracture of lumbar vertebra without mention of spinal cord injury 
Trauma 805.6 ICD9CM Closed fracture of sacrum and coccyx without mention of spinal cord injury 
Trauma 805.7 ICD9CM Open fracture of sacrum and coccyx without mention of spinal cord injury 
Trauma 805.8 
ICD9CM 




Open fracture of unspecified vertebral column without mention of spinal cord 
injury 
Trauma 806.00 ICD9CM Closed fracture of C1-C4 level with unspecified spinal cord injury 
Trauma 806.01 ICD9CM Closed fracture of C1-C4 level with complete lesion of cord 
Trauma 806.02 ICD9CM Closed fracture of C1-C4 level with anterior cord syndrome 
Trauma 806.03 ICD9CM Closed fracture of C1-C4 level with central cord syndrome 
Trauma 806.04 ICD9CM Closed fracture of C1-C4 level with other specified spinal cord injury 
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Trauma 806.05 ICD9CM Closed fracture of C5-C7 level with unspecified spinal cord injury 
Trauma 806.06 ICD9CM Closed fracture of C5-C7 level with complete lesion of cord 
Trauma 806.07 ICD9CM Closed fracture of C5-C7 level with anterior cord syndrome 
Trauma 806.08 ICD9CM Closed fracture of C5-C7 level with central cord syndrome 
Trauma 806.09 ICD9CM Closed fracture of C5-C7 level with other specified spinal cord injury 
Trauma 806.10 ICD9CM Open fracture of C1-C4 level with unspecified spinal cord injury 
Trauma 806.11 ICD9CM Open fracture of C1-C4 level with complete lesion of cord 
Trauma 806.12 ICD9CM Open fracture of C1-C4 level with anterior cord syndrome 
Trauma 806.13 ICD9CM Open fracture of C1-C4 level with central cord syndrome 
Trauma 806.14 ICD9CM Open fracture of C1-C4 level with other specified spinal cord injury 
Trauma 806.15 ICD9CM Open fracture of C5-C7 level with unspecified spinal cord injury 
Trauma 806.16 ICD9CM Open fracture of C5-C7 level with complete lesion of cord 
Trauma 806.17 ICD9CM Open fracture of C5-C7 level with anterior cord syndrome 
Trauma 806.18 ICD9CM Open fracture of C5-C7 level with central cord syndrome 
Trauma 806.19 ICD9CM Open fracture of C5-C7 level with other specified spinal cord injury 
Trauma 806.20 ICD9CM Closed fracture of T1-T6 level with unspecified spinal cord injury 
Trauma 806.21 ICD9CM Closed fracture of T1-T6 level with complete lesion of cord 
Trauma 806.22 ICD9CM Closed fracture of T1-T6 level with anterior cord syndrome 
Trauma 806.23 ICD9CM Closed fracture of T1-T6 level with central cord syndrome 
Trauma 806.24 ICD9CM Closed fracture of T1-T6 level with other specified spinal cord injury 
Trauma 806.25 ICD9CM Closed fracture of T7-T12 level with unspecified spinal cord injury 
Trauma 806.26 ICD9CM Closed fracture of T7-T12 level with complete lesion of cord 
Trauma 806.27 ICD9CM Closed fracture of T7-T12 level with anterior cord syndrome 
Trauma 806.28 ICD9CM Closed fracture of T7-T12 level with central cord syndrome 
Trauma 806.29 ICD9CM Closed fracture of T7-T12 level with other specified spinal cord injury 
Trauma 806.30 ICD9CM Open fracture of T1-T6 level with unspecified spinal cord injury 
Trauma 806.31 ICD9CM Open fracture of T1-T6 level with complete lesion of cord 
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Trauma 806.32 ICD9CM Open fracture of T1-T6 level with anterior cord syndrome 
Trauma 806.33 ICD9CM Open fracture of T1-T6 level with central cord syndrome 
Trauma 806.34 ICD9CM Open fracture of T1-T6 level with other specified spinal cord injury 
Trauma 806.35 ICD9CM Open fracture of T7-T12 level with unspecified spinal cord injury 
Trauma 806.36 ICD9CM Open fracture of T7-T12 level with complete lesion of cord 
Trauma 806.37 ICD9CM Open fracture of T7-T12 level with anterior cord syndrome 
Trauma 806.38 ICD9CM Open fracture of T7-T12 level with central cord syndrome 
Trauma 806.39 ICD9CM Open fracture of T7-T12 level with other specified spinal cord injury 
Trauma 806.4 ICD9CM Closed fracture of lumbar spine with spinal cord injury 
Trauma 806.5 ICD9CM Open fracture of lumbar spine with spinal cord injury 
Trauma 806.60 ICD9CM Closed fracture of sacrum and coccyx with unspecified spinal cord injury 
Trauma 806.61 ICD9CM Closed fracture of sacrum and coccyx with complete cauda equina lesion 
Trauma 806.62 ICD9CM Closed fracture of sacrum and coccyx with other cauda equina injury 
Trauma 806.69 ICD9CM Closed fracture of sacrum and coccyx with other spinal cord injury 
Trauma 806.70 ICD9CM Open fracture of sacrum and coccyx with unspecified spinal cord injury 
Trauma 806.71 ICD9CM Open fracture of sacrum and coccyx with complete cauda equina lesion 
Trauma 806.72 ICD9CM Open fracture of sacrum and coccyx with other cauda equina injury 
Trauma 806.79 ICD9CM Open fracture of sacrum and coccyx with other spinal cord injury 
Trauma 806.8 ICD9CM Closed fracture of unspecified vertebral column with spinal cord injury 
Trauma 806.9 ICD9CM Open fracture of unspecified vertebral column with spinal cord injury 
Trauma 807.00 ICD9CM Closed fracture of rib(s), unspecified 
Trauma 807.01 ICD9CM Closed fracture of one rib 
Trauma 807.02 ICD9CM Closed fracture of two ribs 
Trauma 807.03 ICD9CM Closed fracture of three ribs 
Trauma 807.04 ICD9CM Closed fracture of four ribs 
Trauma 807.05 ICD9CM Closed fracture of five ribs 
Trauma 807.06 ICD9CM Closed fracture of six ribs 
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Trauma 807.07 ICD9CM Closed fracture of seven ribs 
Trauma 807.08 ICD9CM Closed fracture of eight or more ribs 
Trauma 807.09 ICD9CM Closed fracture of multiple ribs, unspecified 
Trauma 807.10 ICD9CM Open fracture of rib(s), unspecified 
Trauma 807.11 ICD9CM Open fracture of one rib 
Trauma 807.12 ICD9CM Open fracture of two ribs 
Trauma 807.13 ICD9CM Open fracture of three ribs 
Trauma 807.14 ICD9CM Open fracture of four ribs 
Trauma 807.15 ICD9CM Open fracture of five ribs 
Trauma 807.16 ICD9CM Open fracture of six ribs 
Trauma 807.17 ICD9CM Open fracture of seven ribs 
Trauma 807.18 ICD9CM Open fracture of eight or more ribs 
Trauma 807.19 ICD9CM Open fracture of multiple ribs, unspecified 
Trauma 807.2 ICD9CM Closed fracture of sternum 
Trauma 807.3 ICD9CM Open fracture of sternum 
Trauma 807.4 ICD9CM Flail chest 
Trauma 807.5 ICD9CM Closed fracture of larynx and trachea 
Trauma 807.6 ICD9CM Open fracture of larynx and trachea 
Trauma 808.0 ICD9CM Closed fracture of acetabulum 
Trauma 808.1 ICD9CM Open fracture of acetabulum 
Trauma 808.2 ICD9CM Closed fracture of pubis 
Trauma 808.3 ICD9CM Open fracture of pubis 
Trauma 808.41 ICD9CM Closed fracture of ilium 
Trauma 808.42 ICD9CM Closed fracture of ischium 
Trauma 808.43 ICD9CM Multiple closed pelvic fractures with disruption of pelvic circle 
Trauma 808.44 ICD9CM Multiple closed pelvic fractures without disruption of pelvic circle 
Trauma 808.49 ICD9CM Closed fracture of other specified part of pelvis 
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Trauma 808.51 ICD9CM Open fracture of ilium 
Trauma 808.52 ICD9CM Open fracture of ischium 
Trauma 808.53 ICD9CM Multiple open pelvic fractures with disruption of pelvic circle 
Trauma 808.54 ICD9CM Multiple open pelvic fractures without disruption of pelvic circle 
Trauma 808.59 ICD9CM Open fracture of other specified part of pelvis 
Trauma 808.8 ICD9CM Closed unspecified fracture of pelvis 
Trauma 808.9 ICD9CM Open unspecified fracture of pelvis 
Trauma 809.0 ICD9CM Fracture of bones of trunk, closed 
Trauma 809.1 ICD9CM Fracture of bones of trunk, open 
Trauma 810.00 ICD9CM Closed fracture of clavicle, unspecified part 
Trauma 810.01 ICD9CM Closed fracture of sternal end of clavicle 
Trauma 810.02 ICD9CM Closed fracture of shaft of clavicle 
Trauma 810.03 ICD9CM Closed fracture of acromial end of clavicle 
Trauma 810.10 ICD9CM Open fracture of clavicle, unspecified part 
Trauma 810.11 ICD9CM Open fracture of sternal end of clavicle 
Trauma 810.12 ICD9CM Open fracture of shaft of clavicle 
Trauma 810.13 ICD9CM Open fracture of acromial end of clavicle 
Trauma 811.00 ICD9CM Closed fracture of scapula, unspecified part 
Trauma 811.01 ICD9CM Closed fracture of acromial process of scapula 
Trauma 811.02 ICD9CM Closed fracture of coracoid process of scapula 
Trauma 811.03 ICD9CM Closed fracture of glenoid cavity and neck of scapula 
Trauma 811.09 ICD9CM Closed fracture of scapula, other 
Trauma 811.10 ICD9CM Open fracture of scapula, unspecified part 
Trauma 811.11 ICD9CM Open fracture of acromial process of scapula 
Trauma 811.12 ICD9CM Open fracture of coracoid process 
Trauma 811.13 ICD9CM Open fracture of glenoid cavity and neck of scapula 
Trauma 811.19 ICD9CM Open fracture of scapula, other 
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Trauma 812.00 ICD9CM Closed fracture of unspecified part of upper end of humerus 
Trauma 812.01 ICD9CM Closed fracture of surgical neck of humerus 
Trauma 812.02 ICD9CM Closed fracture of anatomical neck of humerus 
Trauma 812.03 ICD9CM Closed fracture of greater tuberosity of humerus 
Trauma 812.09 ICD9CM Other closed fracture of upper end of humerus 
Trauma 812.10 ICD9CM Open fracture of unspecified part of upper end of humerus 
Trauma 812.11 ICD9CM Open fracture of surgical neck of humerus 
Trauma 812.12 ICD9CM Open fracture of anatomical neck of humerus 
Trauma 812.13 ICD9CM Open fracture of greater tuberosity of humerus 
Trauma 812.19 ICD9CM Other open fracture of upper end of humerus 
Trauma 812.20 ICD9CM Closed fracture of unspecified part of humerus 
Trauma 812.21 ICD9CM Closed fracture of shaft of humerus 
Trauma 812.30 ICD9CM Open fracture of unspecified part of humerus 
Trauma 812.31 ICD9CM Open fracture of shaft of humerus 
Trauma 812.40 ICD9CM Closed fracture of unspecified part of lower end of humerus 
Trauma 812.41 ICD9CM Closed supracondylar fracture of humerus 
Trauma 812.42 ICD9CM Closed fracture of lateral condyle of humerus 
Trauma 812.43 ICD9CM Closed fracture of medial condyle of humerus 
Trauma 812.44 ICD9CM Closed fracture of unspecified condyle(s) of humerus 
Trauma 812.49 ICD9CM Other closed fracture of lower end of humerus 
Trauma 812.50 ICD9CM Open fracture of unspecified part of lower end of humerus 
Trauma 812.51 ICD9CM Open supracondylar fracture of humerus 
Trauma 812.52 ICD9CM Open fracture of lateral condyle of humerus 
Trauma 812.53 ICD9CM Open fracture of medial condyle of humerus 
Trauma 812.54 ICD9CM Open fracture of unspecified condyle(s) of humerus 
Trauma 812.59 ICD9CM Other open fracture of lower end of humerus 
Trauma 813.00 ICD9CM Closed fracture of upper end of forearm, unspecified 
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Trauma 813.01 ICD9CM Closed fracture of olecranon process of ulna 
Trauma 813.02 ICD9CM Closed fracture of coronoid process of ulna 
Trauma 813.03 ICD9CM Closed Monteggia's fracture 
Trauma 813.04 ICD9CM Other and unspecified closed fractures of proximal end of ulna (alone) 
Trauma 813.05 ICD9CM Closed fracture of head of radius 
Trauma 813.06 ICD9CM Closed fracture of neck of radius 
Trauma 813.07 ICD9CM Other and unspecified closed fractures of proximal end of radius (alone) 
Trauma 813.08 ICD9CM Closed fracture of radius with ulna, upper end [any part] 
Trauma 813.10 ICD9CM Open fracture of upper end of forearm, unspecified 
Trauma 813.11 ICD9CM Open fracture of olecranon process of ulna 
Trauma 813.12 ICD9CM Open fracture of coronoid process of ulna 
Trauma 813.13 ICD9CM Open Monteggia's fracture 
Trauma 813.14 ICD9CM Other and unspecified open fractures of proximal end of ulna (alone) 
Trauma 813.15 ICD9CM Open fracture of head of radius 
Trauma 813.16 ICD9CM Open fracture of neck of radius 
Trauma 813.17 ICD9CM Other and unspecified open fractures of proximal end of radius (alone) 
Trauma 813.18 ICD9CM Open fracture of radius with ulna, upper end (any part) 
Trauma 813.20 ICD9CM Closed fracture of shaft of radius or ulna, unspecified 
Trauma 813.21 ICD9CM Closed fracture of shaft of radius (alone) 
Trauma 813.22 ICD9CM Closed fracture of shaft of ulna (alone) 
Trauma 813.23 ICD9CM Closed fracture of shaft of radius with ulna 
Trauma 813.30 ICD9CM Open fracture of shaft of radius or ulna, unspecified 
Trauma 813.31 ICD9CM Open fracture of shaft of radius (alone) 
Trauma 813.32 ICD9CM Open fracture of shaft of ulna (alone) 
Trauma 813.33 ICD9CM Open fracture of shaft of radius with ulna 
Trauma 813.40 ICD9CM Closed fracture of lower end of forearm, unspecified 
Trauma 813.41 ICD9CM Closed Colles' fracture 
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Trauma 813.42 ICD9CM Other closed fractures of distal end of radius (alone) 
Trauma 813.43 ICD9CM Closed fracture of distal end of ulna (alone) 
Trauma 813.44 ICD9CM Closed fracture of lower end of radius with ulna 
Trauma 813.45 ICD9CM Torus fracture of radius (alone) 
Trauma 813.46 ICD9CM Torus fracture of ulna (alone) 
Trauma 813.47 ICD9CM Torus fracture of radius and ulna 
Trauma 813.50 ICD9CM Open fracture of lower end of forearm, unspecified 
Trauma 813.51 ICD9CM Open Colles' fracture 
Trauma 813.52 ICD9CM Other open fractures of distal end of radius (alone) 
Trauma 813.53 ICD9CM Open fracture of distal end of ulna (alone) 
Trauma 813.54 ICD9CM Open fracture of lower end of radius with ulna 
Trauma 813.80 ICD9CM Closed fracture of unspecified part of forearm 
Trauma 813.81 ICD9CM Closed fracture of unspecified part of radius (alone) 
Trauma 813.82 ICD9CM Closed fracture of unspecified part of ulna (alone) 
Trauma 813.83 ICD9CM Closed fracture of unspecified part of radius with ulna 
Trauma 813.90 ICD9CM Open fracture of unspecified part of forearm 
Trauma 813.91 ICD9CM Open fracture of unspecified part of radius (alone) 
Trauma 813.92 ICD9CM Open fracture of unspecified part of ulna (alone) 
Trauma 813.93 ICD9CM Open fracture of unspecified part of radius with ulna 
Trauma 814.00 ICD9CM Closed fracture of carpal bone, unspecified 
Trauma 814.01 ICD9CM Closed fracture of navicular [scaphoid] bone of wrist 
Trauma 814.02 ICD9CM Closed fracture of lunate [semilunar] bone of wrist 
Trauma 814.03 ICD9CM Closed fracture of triquetral [cuneiform] bone of wrist 
Trauma 814.04 ICD9CM Closed fracture of pisiform bone of wrist 
Trauma 814.05 ICD9CM Closed fracture of trapezium bone [larger multangular] of wrist 
Trauma 814.06 ICD9CM Closed fracture of trapezoid bone [smaller multangular] of wrist 
Trauma 814.07 ICD9CM Closed fracture of capitate bone [os magnum] of wrist 
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Trauma 814.08 ICD9CM Closed fracture of hamate [unciform] bone of wrist 
Trauma 814.09 ICD9CM Closed fracture of other bone of wrist 
Trauma 814.10 ICD9CM Open fracture of carpal bone, unspecified 
Trauma 814.11 ICD9CM Open fracture of navicular [scaphoid] bone of wrist 
Trauma 814.12 ICD9CM Open fracture of lunate [semilunar] bone of wrist 
Trauma 814.13 ICD9CM Open fracture of triquetral [cuneiform] bone of wrist 
Trauma 814.14 ICD9CM Open fracture of pisiform bone of wrist 
Trauma 814.15 ICD9CM Open fracture of trapezium bone [larger multangular] of wrist 
Trauma 814.16 ICD9CM Open fracture of trapezoid bone [smaller multangular] of wrist 
Trauma 814.17 ICD9CM Open fracture of capitate bone [os magnum] of wrist 
Trauma 814.18 ICD9CM Open fracture of hamate [unciform] bone of wrist 
Trauma 814.19 ICD9CM Open fracture of other bone of wrist 
Trauma 815.00 ICD9CM Closed fracture of metacarpal bone(s), site unspecified 
Trauma 815.01 ICD9CM Closed fracture of base of thumb [first] metacarpal 
Trauma 815.02 ICD9CM Closed fracture of base of other metacarpal bone(s) 
Trauma 815.03 ICD9CM Closed fracture of shaft of metacarpal bone(s) 
Trauma 815.04 ICD9CM Closed fracture of neck of metacarpal bone(s) 
Trauma 815.09 ICD9CM Closed fracture of multiple sites of metacarpus 
Trauma 815.10 ICD9CM Open fracture of metacarpal bone(s), site unspecified 
Trauma 815.11 ICD9CM Open fracture of base of thumb [first] metacarpal 
Trauma 815.12 ICD9CM Open fracture of base of other metacarpal bone(s) 
Trauma 815.13 ICD9CM Open fracture of shaft of metacarpal bone(s) 
Trauma 815.14 ICD9CM Open fracture of neck of metacarpal bone(s) 
Trauma 815.19 ICD9CM Open fracture of multiple sites of metacarpus 
Trauma 816.00 ICD9CM Closed fracture of phalanx or phalanges of hand, unspecified 
Trauma 816.01 ICD9CM Closed fracture of middle or proximal phalanx or phalanges of hand 
Trauma 816.02 ICD9CM Closed fracture of distal phalanx or phalanges of hand 
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Trauma 816.03 ICD9CM Closed fracture of multiple sites of phalanx or phalanges of hand 
Trauma 816.10 ICD9CM Open fracture of phalanx or phalanges of hand, unspecified 
Trauma 816.11 ICD9CM Open fracture of middle or proximal phalanx or phalanges of hand 
Trauma 816.12 ICD9CM Open fracture of distal phalanx or phalanges of hand 
Trauma 816.13 ICD9CM Open fracture of multiple sites of phalanx or phalanges of hand 
Trauma 817.0 ICD9CM Multiple closed fractures of hand bones 
Trauma 817.1 ICD9CM Multiple open fractures of hand bones 
Trauma 818.0 ICD9CM Ill-defined closed fractures of upper limb 
Trauma 818.1 ICD9CM Ill-defined open fractures of upper limb 
Trauma 819.0 
ICD9CM 




Multiple open fractures involving both upper limbs, and upper limb with rib(s) and 
sternum 
Trauma 820.00 ICD9CM Closed fracture of intracapsular section of neck of femur, unspecified 
Trauma 820.01 ICD9CM Closed fracture of epiphysis (separation) (upper) of neck of femur 
Trauma 820.02 ICD9CM Closed fracture of midcervical section of neck of femur 
Trauma 820.03 ICD9CM Closed fracture of base of neck of femur 
Trauma 820.09 ICD9CM Other closed transcervical fracture of neck of femur 
Trauma 820.10 ICD9CM Open fracture of intracapsular section of neck of femur, unspecified 
Trauma 820.11 ICD9CM Open fracture of epiphysis (separation) (upper) of neck of femur 
Trauma 820.12 ICD9CM Open fracture of midcervical section of neck of femur 
Trauma 820.13 ICD9CM Open fracture of base of neck of femur 
Trauma 820.19 ICD9CM Other open transcervical fracture of neck of femur 
Trauma 820.20 ICD9CM Closed fracture of trochanteric section of neck of femur 
Trauma 820.21 ICD9CM Closed fracture of intertrochanteric section of neck of femur 
Trauma 820.22 ICD9CM Closed fracture of subtrochanteric section of neck of femur 
Trauma 820.30 ICD9CM Open fracture of trochanteric section of neck of femur, unspecified 
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Trauma 820.31 ICD9CM Open fracture of intertrochanteric section of neck of femur 
Trauma 820.32 ICD9CM Open fracture of subtrochanteric section of neck of femur 
Trauma 820.8 ICD9CM Closed fracture of unspecified part of neck of femur 
Trauma 820.9 ICD9CM Open fracture of unspecified part of neck of femur 
Trauma 821.00 ICD9CM Closed fracture of unspecified part of femur 
Trauma 821.01 ICD9CM Closed fracture of shaft of femur 
Trauma 821.10 ICD9CM Open fracture of unspecified part of femur 
Trauma 821.11 ICD9CM Open fracture of shaft of femur 
Trauma 821.20 ICD9CM Closed fracture of lower end of femur, unspecified part 
Trauma 821.21 ICD9CM Closed fracture of condyle, femoral 
Trauma 821.22 ICD9CM Closed fracture of epiphysis, lower (separation) of femur 
Trauma 821.23 ICD9CM Closed supracondylar fracture of femur 
Trauma 821.29 ICD9CM Other closed fracture of lower end of femur 
Trauma 821.30 ICD9CM Open fracture of lower end of femur, unspecified part 
Trauma 821.31 ICD9CM Open fracture of condyle, femoral 
Trauma 821.32 ICD9CM Open fracture of epiphysis. Lower (separation) of femur 
Trauma 821.33 ICD9CM Open supracondylar fracture of femur 
Trauma 821.39 ICD9CM Other open fracture of lower end of femur 
Trauma 822.0 ICD9CM Closed fracture of patella 
Trauma 822.1 ICD9CM Open fracture of patella 
Trauma 823.00 ICD9CM Closed fracture of upper end of tibia alone 
Trauma 823.01 ICD9CM Closed fracture of upper end of fibula alone 
Trauma 823.02 ICD9CM Closed fracture of upper end of fibula with tibia 
Trauma 823.10 ICD9CM Open fracture of upper end of tibia alone 
Trauma 823.11 ICD9CM Open fracture of upper end of fibula alone 
Trauma 823.12 ICD9CM Open fracture of upper end of fibula with tibia 
Trauma 823.20 ICD9CM Closed fracture of shaft of tibia alone 
219 
 
Trauma 823.21 ICD9CM Closed fracture of shaft of fibula alone 
Trauma 823.22 ICD9CM Closed fracture of shaft of fibula with tibia 
Trauma 823.30 ICD9CM Open fracture of shaft of tibia alone 
Trauma 823.31 ICD9CM Open fracture of shaft of fibula alone 
Trauma 823.32 ICD9CM Open fracture of shaft of fibula with tibia 
Trauma 823.40 ICD9CM Torus fracture, tibia alone 
Trauma 823.41 ICD9CM Torus fracture, fibula alone 
Trauma 823.42 ICD9CM Torus fracture, fibula with tibia 
Trauma 823.80 ICD9CM Closed fracture of unspecified part of tibia alone 
Trauma 823.81 ICD9CM Closed fracture of unspecified part of fibula alone 
Trauma 823.82 ICD9CM Closed fracture of unspecified part of fibula with tibia 
Trauma 823.90 ICD9CM Open fracture of unspecified part of tibia alone 
Trauma 823.91 ICD9CM Open fracture of unspecified part of fibula alone 
Trauma 823.92 ICD9CM Open fracture of unspecified part of fibula with tibia 
Trauma 824.0 ICD9CM Fracture of medial malleolus, closed 
Trauma 824.1 ICD9CM Fracture of medial malleolus, open 
Trauma 824.2 ICD9CM Fracture of lateral malleolus, closed 
Trauma 824.3 ICD9CM Fracture of lateral malleolus, open 
Trauma 824.4 ICD9CM Bimalleolar fracture, closed 
Trauma 824.5 ICD9CM Bimalleolar fracture, open 
Trauma 824.6 ICD9CM Trimalleolar fracture, closed 
Trauma 824.7 ICD9CM Trimalleolar fracture, open 
Trauma 824.8 ICD9CM Unspecified fracture of ankle, closed 
Trauma 824.9 ICD9CM Unspecified fracture of ankle, open 
Trauma 825.0 ICD9CM Fracture of calcaneus, closed 
Trauma 825.1 ICD9CM Fracture of calcaneus, open 
Trauma 825.20 ICD9CM Closed fracture of unspecified bone(s) of foot [except toes] 
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Trauma 825.21 ICD9CM Closed fracture of astragalus 
Trauma 825.22 ICD9CM Closed fracture of navicular [scaphoid], foot 
Trauma 825.23 ICD9CM Closed fracture of cuboid 
Trauma 825.24 ICD9CM Closed fracture of cuneiform, foot 
Trauma 825.25 ICD9CM Closed fracture of metatarsal bone(s) 
Trauma 825.29 ICD9CM Other closed fracture of tarsal and metatarsal bones 
Trauma 825.30 ICD9CM Open fracture of unspecified bone(s) of foot [except toes] 
Trauma 825.31 ICD9CM Open fracture of astragalus 
Trauma 825.32 ICD9CM Open fracture of navicular [scaphoid], foot 
Trauma 825.33 ICD9CM Open fracture of cuboid 
Trauma 825.34 ICD9CM Open fracture of cuneiform, foot 
Trauma 825.35 ICD9CM Open fracture of metatarsal bone(s) 
Trauma 825.39 ICD9CM Other open fracture of tarsal and metatarsal bones 
Trauma 826.0 ICD9CM Closed fracture of one or more phalanges of foot 
Trauma 826.1 ICD9CM Open fracture of one or more phalanges of foot 
Trauma 827.0 ICD9CM Other, multiple and ill-defined fractures of lower limb, closed 
Trauma 827.1 ICD9CM Other, multiple and ill-defined fractures of lower limb, open 
Trauma 828.0 
ICD9CM 
Closed multiple fractures involving both lower limbs, lower with upper limb, and 
lower limb(s) with rib(s) and sternum 
Trauma 828.1 
ICD9CM 
Open multiple fractures involving both lower limbs, lower with upper limb, and 
lower limb(s) with rib(s) and sternum 
Trauma 829.0 ICD9CM Fracture of unspecified bone, closed 
Trauma 829.1 ICD9CM Fracture of unspecified bone, open 
Trauma 830.0 ICD9CM Closed dislocation of jaw 
Trauma 830.1 ICD9CM Open dislocation of jaw 
Trauma 831.00 ICD9CM Closed dislocation of shoulder, unspecified 
Trauma 831.01 ICD9CM Closed anterior dislocation of humerus 
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Trauma 831.02 ICD9CM Closed posterior dislocation of humerus 
Trauma 831.03 ICD9CM Closed inferior dislocation of humerus 
Trauma 831.04 ICD9CM Closed dislocation of acromioclavicular (joint) 
Trauma 831.09 ICD9CM Closed dislocation of shoulder, other 
Trauma 831.10 ICD9CM Open dislocation of shoulder, unspecified 
Trauma 831.11 ICD9CM Open anterior dislocation of humerus 
Trauma 831.12 ICD9CM Open posterior dislocation of humerus 
Trauma 831.13 ICD9CM Open inferior dislocation of humerus 
Trauma 831.14 ICD9CM Open dislocation of acromioclavicular (joint) 
Trauma 831.19 ICD9CM Open dislocation of shoulder, other 
Trauma 832.00 ICD9CM Closed dislocation of elbow, unspecified 
Trauma 832.01 ICD9CM Closed anterior dislocation of elbow 
Trauma 832.02 ICD9CM Closed posterior dislocation of elbow 
Trauma 832.03 ICD9CM Closed medial dislocation of elbow 
Trauma 832.04 ICD9CM Closed lateral dislocation of elbow 
Trauma 832.09 ICD9CM Closed dislocation of elbow, other 
Trauma 832.10 ICD9CM Open dislocation of elbow, unspecified 
Trauma 832.11 ICD9CM Open anterior dislocation of elbow 
Trauma 832.12 ICD9CM Open posterior dislocation of elbow 
Trauma 832.13 ICD9CM Open medial dislocation of elbow 
Trauma 832.14 ICD9CM Open lateral dislocation of elbow 
Trauma 832.19 ICD9CM Open dislocation of elbow, other 
Trauma 832.2 ICD9CM Nursemaid's elbow 
Trauma 833.00 ICD9CM Closed dislocation of wrist, unspecified part 
Trauma 833.01 ICD9CM Closed dislocation of radioulnar (joint), distal 
Trauma 833.02 ICD9CM Closed dislocation of radiocarpal (joint) 
Trauma 833.03 ICD9CM Closed dislocation of midcarpal (joint) 
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Trauma 833.04 ICD9CM Closed dislocation of carpometacarpal (joint) 
Trauma 833.05 ICD9CM Closed dislocation of metacarpal (bone), proximal end 
Trauma 833.09 ICD9CM Closed dislocation of wrist, other 
Trauma 833.10 ICD9CM Open dislocation of wrist, unspecified part 
Trauma 833.11 ICD9CM Open dislocation of radioulnar (joint), distal 
Trauma 833.12 ICD9CM Open dislocation of radiocarpal (joint) 
Trauma 833.13 ICD9CM Open dislocation of midcarpal (joint) 
Trauma 833.14 ICD9CM Open dislocation of carpometacarpal (joint) 
Trauma 833.15 ICD9CM Open dislocation of metacarpal (bone), proximal end 
Trauma 833.19 ICD9CM Open dislocation of wrist, other 
Trauma 834.00 ICD9CM Closed dislocation of finger, unspecified part 
Trauma 834.01 ICD9CM Closed dislocation of metacarpophalangeal (joint) 
Trauma 834.02 ICD9CM Closed dislocation of interphalangeal (joint), hand 
Trauma 834.10 ICD9CM Open dislocation of finger, unspecified part 
Trauma 834.11 ICD9CM Open dislocation of metacarpophalangeal (joint) 
Trauma 834.12 ICD9CM Open dislocation interphalangeal (joint), hand 
Trauma 835.00 ICD9CM Closed dislocation of hip, unspecified site 
Trauma 835.01 ICD9CM Closed posterior dislocation of hip 
Trauma 835.02 ICD9CM Closed obturator dislocation of hip 
Trauma 835.03 ICD9CM Other closed anterior dislocation of hip 
Trauma 835.10 ICD9CM Open dislocation of hip, unspecified site 
Trauma 835.11 ICD9CM Open posterior dislocation of hip 
Trauma 835.12 ICD9CM Open obturator dislocation of hip 
Trauma 835.13 ICD9CM Other open anterior dislocation of hip 
Trauma 836.0 ICD9CM Tear of medial cartilage or meniscus of knee, current 
Trauma 836.1 ICD9CM Tear of lateral cartilage or meniscus of knee, current 
Trauma 836.2 ICD9CM Other tear of cartilage or meniscus of knee, current 
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Trauma 836.3 ICD9CM Dislocation of patella, closed 
Trauma 836.4 ICD9CM Dislocation of patella, open 
Trauma 836.50 ICD9CM Dislocation of knee, unspecified, closed 
Trauma 836.51 ICD9CM Anterior dislocation of tibia, proximal end, closed 
Trauma 836.52 ICD9CM Posterior dislocation of tibia, proximal end, closed 
Trauma 836.53 ICD9CM Medial dislocation of tibia, proximal end, closed 
Trauma 836.54 ICD9CM Lateral dislocation of tibia, proximal end, closed 
Trauma 836.59 ICD9CM Other dislocation of knee, closed 
Trauma 836.60 ICD9CM Dislocation of knee, unspecified, open 
Trauma 836.61 ICD9CM Anterior dislocation of tibia, proximal end, open 
Trauma 836.62 ICD9CM Posterior dislocation of tibia, proximal end, open 
Trauma 836.63 ICD9CM Medial dislocation of tibia, proximal end, open 
Trauma 836.64 ICD9CM Lateral dislocation of tibia, proximal end, open 
Trauma 836.69 ICD9CM Other dislocation of knee, open 
Trauma 837.0 ICD9CM Closed dislocation of ankle 
Trauma 837.1 ICD9CM Open dislocation of ankle 
Trauma 838.00 ICD9CM Closed dislocation of foot, unspecified 
Trauma 838.01 ICD9CM Closed dislocation of tarsal (bone), joint unspecified 
Trauma 838.02 ICD9CM Closed dislocation of midtarsal (joint) 
Trauma 838.03 ICD9CM Closed dislocation of tarsometatarsal (joint) 
Trauma 838.04 ICD9CM Closed dislocation of metatarsal (bone), joint unspecified 
Trauma 838.05 ICD9CM Closed dislocation of metatarsophalangeal (joint) 
Trauma 838.06 ICD9CM Closed dislocation of interphalangeal (joint), foot 
Trauma 838.09 ICD9CM Closed dislocation of foot, other 
Trauma 838.10 ICD9CM Open dislocation of foot, unspecified 
Trauma 838.11 ICD9CM Open dislocation of tarsal (bone), joint unspecified 
Trauma 838.12 ICD9CM Open dislocation of midtarsal (joint) 
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Trauma 838.13 ICD9CM Open dislocation of tarsometatarsal (joint) 
Trauma 838.14 ICD9CM Open dislocation of metatarsal (bone), joint unspecified 
Trauma 838.15 ICD9CM Open dislocation of metatarsophalangeal (joint) 
Trauma 838.16 ICD9CM Open dislocation of interphalangeal (joint), foot 
Trauma 838.19 ICD9CM Open dislocation of foot, other 
Trauma 839.00 ICD9CM Closed dislocation, cervical vertebra, unspecified 
Trauma 839.01 ICD9CM Closed dislocation, first cervical vertebra 
Trauma 839.02 ICD9CM Closed dislocation, second cervical vertebra 
Trauma 839.03 ICD9CM Closed dislocation, third cervical vertebra 
Trauma 839.04 ICD9CM Closed dislocation, fourth cervical vertebra 
Trauma 839.05 ICD9CM Closed dislocation, fifth cervical vertebra 
Trauma 839.06 ICD9CM Closed dislocation, sixth cervical vertebra 
Trauma 839.07 ICD9CM Closed dislocation, seventh cervical vertebra 
Trauma 839.08 ICD9CM Closed dislocation, multiple cervical vertebrae 
Trauma 839.10 ICD9CM Open dislocation, cervical vertebra, unspecified 
Trauma 839.11 ICD9CM Open dislocation, first cervical vertebra 
Trauma 839.12 ICD9CM Open dislocation, second cervical vertebra 
Trauma 839.13 ICD9CM Open dislocation, third cervical vertebra 
Trauma 839.14 ICD9CM Open dislocation, fourth cervical vertebra 
Trauma 839.15 ICD9CM Open dislocation, fifth cervical vertebra 
Trauma 839.16 ICD9CM Open dislocation, sixth cervical vertebra 
Trauma 839.17 ICD9CM Open dislocation, seventh cervical vertebra 
Trauma 839.18 ICD9CM Open dislocation, multiple cervical vertebrae 
Trauma 839.20 ICD9CM Closed dislocation, lumbar vertebra 
Trauma 839.21 ICD9CM Closed dislocation, thoracic vertebra 
Trauma 839.30 ICD9CM Open dislocation, lumbar vertebra 
Trauma 839.31 ICD9CM Open dislocation, thoracic vertebra 
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Trauma 839.40 ICD9CM Closed dislocation, vertebra, unspecified site 
Trauma 839.41 ICD9CM Closed dislocation, coccyx 
Trauma 839.42 ICD9CM Closed dislocation, sacrum 
Trauma 839.49 ICD9CM Closed dislocation, vertebra, other 
Trauma 839.50 ICD9CM Open dislocation, vertebra, unspecified site 
Trauma 839.51 ICD9CM Open dislocation, coccyx 
Trauma 839.52 ICD9CM Open dislocation, sacrum 
Trauma 839.59 ICD9CM Open dislocation, vertebra,other 
Trauma 839.61 ICD9CM Closed dislocation, sternum 
Trauma 839.69 ICD9CM Closed dislocation, other location 
Trauma 839.71 ICD9CM Open dislocation, sternum 
Trauma 839.79 ICD9CM Open dislocation, other location 
Trauma 839.8 ICD9CM Closed dislocation, multiple and ill-defined sites 
Trauma 839.9 ICD9CM Open dislocation, multiple and ill-defined sites 
Trauma 850.0 ICD9CM Concussion with no loss of consciousness 
Trauma 850.11 ICD9CM Concussion, with loss of consciousness of 30 minutes or less 
Trauma 850.12 ICD9CM Concussion, with loss of consciousness from 31 to 59 minutes 
Trauma 850.2 ICD9CM Concussion with moderate loss of consciousness 
Trauma 850.3 
ICD9CM 




Concussion with prolonged loss of consciousness, without return to pre-existing 
conscious level 
Trauma 850.5 ICD9CM Concussion with loss of consciousness of unspecified duration 
Trauma 850.9 ICD9CM Concussion, unspecified 
Trauma 851.00 
ICD9CM 
Cortex (cerebral) contusion without mention of open intracranial wound, 
unspecified state of consciousness 
Trauma 851.01 
ICD9CM 
Cortex (cerebral) contusion without mention of open intracranial wound, with no 





Cortex (cerebral) contusion without mention of open intracranial wound, with brief 
[less than one hour] loss of consciousness 
Trauma 851.03 
ICD9CM 
Cortex (cerebral) contusion without mention of open intracranial wound, with 
moderate [1-24 hours] loss of consciousness 
Trauma 851.04 
ICD9CM 
Cortex (cerebral) contusion without mention of open intracranial wound, with 




Cortex (cerebral) contusion without mention of open intracranial wound, with 
prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 851.06 
ICD9CM 
Cortex (cerebral) contusion without mention of open intracranial wound, with loss 
of consciousness of unspecified duration 
Trauma 851.09 
ICD9CM 












Cortex (cerebral) contusion with open intracranial wound, with brief [less than 
one hour] loss of consciousness 
Trauma 851.13 
ICD9CM 
Cortex (cerebral) contusion with open intracranial wound, with moderate [1-24 
hours] loss of consciousness 
Trauma 851.14 
ICD9CM 
Cortex (cerebral) contusion with open intracranial wound, with prolonged [more 
than 24 hours] loss of consciousness and return to pre-existing conscious level 
Trauma 851.15 
ICD9CM 
Cortex (cerebral) contusion with open intracranial wound, with prolonged [more 




Cortex (cerebral) contusion with open intracranial wound, with loss of 









Cortex (cerebral) laceration without mention of open intracranial wound, 
unspecified state of consciousness 
Trauma 851.21 
ICD9CM 
Cortex (cerebral) laceration without mention of open intracranial wound, with no 
loss of consciousness 
Trauma 851.22 
ICD9CM 
Cortex (cerebral) laceration without mention of open intracranial wound, with brief 
[less than one hour] loss of consciousness 
Trauma 851.23 
ICD9CM 
Cortex (cerebral) laceration without mention of open intracranial wound, with 
moderate [1-24 hours] loss of consciousness 
Trauma 851.24 
ICD9CM 
Cortex (cerebral) laceration without mention of open intracranial wound, with 




Cortex (cerebral) laceration without mention of open intracranial wound, with 
prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 851.26 
ICD9CM 
Cortex (cerebral) laceration without mention of open intracranial wound, with loss 
of consciousness of unspecified duration 
Trauma 851.29 
ICD9CM 












Cortex (cerebral) laceration with open intracranial wound, with brief [less than 
one hour] loss of consciousness 
Trauma 851.33 
ICD9CM 
Cortex (cerebral) laceration with open intracranial wound, with moderate [1-24 





Cortex (cerebral) laceration with open intracranial wound, with prolonged [more 
than 24 hours] loss of consciousness and return to pre-existing conscious level 
Trauma 851.35 
ICD9CM 
Cortex (cerebral) laceration with open intracranial wound, with prolonged [more 




Cortex (cerebral) laceration with open intracranial wound, with loss of 
consciousness of unspecified duration 
Trauma 851.39 
ICD9CM 




Cerebellar or brain stem contusion without mention of open intracranial wound, 
unspecified state of consciousness 
Trauma 851.41 
ICD9CM 
Cerebellar or brain stem contusion without mention of open intracranial wound, 
with no loss of consciousness 
Trauma 851.42 
ICD9CM 
Cerebellar or brain stem contusion without mention of open intracranial wound, 
with brief [less than one hour] loss of consciousness 
Trauma 851.43 
ICD9CM 
Cerebellar or brain stem contusion without mention of open intracranial wound, 
with moderate [1-24 hours] loss of consciousness 
Trauma 851.44 
ICD9CM 
Cerebellar or brain stem contusion without mention of open intracranial wound, 
with prolonged [more than 24 hours] loss consciousness and return to pre-
existing conscious level 
Trauma 851.45 
ICD9CM 
Cerebellar or brain stem contusion without mention of open intracranial wound, 
with prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 851.46 
ICD9CM 
Cerebellar or brain stem contusion without mention of open intracranial wound, 
with loss of consciousness of unspecified duration 
Trauma 851.49 
ICD9CM 
Cerebellar or brain stem contusion without mention of open intracranial wound, 
with concussion, unspecified 
Trauma 851.50 
ICD9CM 
Cerebellar or brain stem contusion with open intracranial wound, unspecified 









Cerebellar or brain stem contusion with open intracranial wound, with brief [less 
than one hour] loss of consciousness 
Trauma 851.53 
ICD9CM 
Cerebellar or brain stem contusion with open intracranial wound, with moderate 
[1-24 hours] loss of consciousness 
Trauma 851.54 
ICD9CM 
Cerebellar or brain stem contusion with open intracranial wound, with prolonged 




Cerebellar or brain stem contusion with open intracranial wound, with prolonged 




Cerebellar or brain stem contusion with open intracranial wound, with loss of 
consciousness of unspecified duration 
Trauma 851.59 
ICD9CM 




Cerebellar or brain stem laceration without mention of open intracranial wound, 
unspecified state of consciousness 
Trauma 851.61 
ICD9CM 
Cerebellar or brain stem laceration without mention of open intracranial wound, 
with no loss of consciousness 
Trauma 851.62 
ICD9CM 
Cerebellar or brain stem laceration without mention of open intracranial wound, 
with brief [less than 1 hour] loss of consciousness 
Trauma 851.63 
ICD9CM 
Cerebellar or brain stem laceration without mention of open intracranial wound, 
with moderate [1-24 hours] loss of consciousness 
Trauma 851.64 
ICD9CM 
Cerebellar or brain stem laceration without mention of open intracranial wound, 
with prolonged [more than 24 hours] loss of consciousness and return to pre-





Cerebellar or brain stem laceration without mention of open intracranial wound, 
with prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 851.66 
ICD9CM 
Cerebellar or brain stem laceration without mention of open intracranial wound, 
with loss of consciousness of unspecified duration 
Trauma 851.69 
ICD9CM 
Cerebellar or brain stem laceration without mention of open intracranial wound, 
with concussion, unspecified 
Trauma 851.70 
ICD9CM 
Cerebellar or brain stem laceration with open intracranial wound, unspecified 
state of consciousness 
Trauma 851.71 
ICD9CM 




Cerebellar or brain stem laceration with open intracranial wound, with brief [less 
than one hour] loss of consciousness 
Trauma 851.73 
ICD9CM 
Cerebellar or brain stem laceration with open intracranial wound, with moderate 
[1-24 hours] loss of consciousness 
Trauma 851.74 
ICD9CM 
Cerebellar or brain stem laceration with open intracranial wound, with prolonged 




Cerebellar or brain stem laceration with open intracranial wound, with prolonged 




Cerebellar or brain stem laceration with open intracranial wound, with loss of 
consciousness of unspecified duration 
Trauma 851.79 
ICD9CM 




Other and unspecified cerebral laceration and contusion, without mention of open 
intracranial wound, unspecified state of consciousness 
Trauma 851.81 
ICD9CM 
Other and unspecified cerebral laceration and contusion, without mention of open 





Other and unspecified cerebral laceration and contusion, without mention of open 
intracranial wound, with brief [less than one hour] loss of consciousness 
Trauma 851.83 
ICD9CM 
Other and unspecified cerebral laceration and contusion, without mention of open 
intracranial wound, with moderate [1-24 hours] loss of consciousness 
Trauma 851.84 
ICD9CM 
Other and unspecified cerebral laceration and contusion, without mention of open 
intracranial wound, with prolonged [more than 24 hours] loss of consciousness 
and return to pre- existing conscious level 
Trauma 851.85 
ICD9CM 
Other and unspecified cerebral laceration and contusion, without mention of open 
intracranial wound, with prolonged [more than 24 hours] loss of consciousness 
without return to pre-existing conscious level 
Trauma 851.86 
ICD9CM 
Other and unspecified cerebral laceration and contusion, without mention of open 
intracranial wound, with loss of consciousness of unspecified duration 
Trauma 851.89 
ICD9CM 
Other and unspecified cerebral laceration and contusion, without mention of open 
intracranial wound, with concussion, unspecified 
Trauma 851.90 
ICD9CM 
Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, unspecified state of consciousness 
Trauma 851.91 
ICD9CM 
Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, with no loss of consciousness 
Trauma 851.92 
ICD9CM 
Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, with brief [less than one hour] loss of consciousness 
Trauma 851.93 
ICD9CM 
Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, with moderate [1-24 hours] loss of consciousness 
Trauma 851.94 
ICD9CM 
Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness and return to 
pre-existing conscious level 
Trauma 851.95 
ICD9CM 
Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness without return 





Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, with loss of consciousness of unspecified duration 
Trauma 851.99 
ICD9CM 
Other and unspecified cerebral laceration and contusion, with open intracranial 
wound, with concussion, unspecified 
Trauma 852.00 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, unspecified state of consciousness 
Trauma 852.01 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, with no loss of consciousness 
Trauma 852.02 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, with brief [less than one hour] loss of consciousness 
Trauma 852.03 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, with moderate [1-24 hours] loss of consciousness 
Trauma 852.04 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness and return to 
pre-existing conscious level 
Trauma 852.05 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness without return 
to pre-existing conscious level 
Trauma 852.06 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, with loss of consciousness of unspecified duration 
Trauma 852.09 
ICD9CM 
Subarachnoid hemorrhage following injury without mention of open intracranial 
wound, with concussion, unspecified 
Trauma 852.10 
ICD9CM 
Subarachnoid hemorrhage following injury with open intracranial wound, 
unspecified state of consciousness 
Trauma 852.11 
ICD9CM 
Subarachnoid hemorrhage following injury with open intracranial wound, with no 
loss of consciousness 
Trauma 852.12 
ICD9CM 
Subarachnoid hemorrhage following injury with open intracranial wound, with 





Subarachnoid hemorrhage following injury with open intracranial wound, with 
moderate [1-24 hours] loss of consciousness 
Trauma 852.14 
ICD9CM 
Subarachnoid hemorrhage following injury with open intracranial wound, with 




Subarachnoid hemorrhage following injury with open intracranial wound, with 
prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 852.16 
ICD9CM 
Subarachnoid hemorrhage following injury with open intracranial wound, with 
loss of consciousness of unspecified duration 
Trauma 852.19 
ICD9CM 




Subdural hemorrhage following injury without mention of open intracranial 
wound, unspecified state of consciousness 
Trauma 852.21 
ICD9CM 
Subdural hemorrhage following injury without mention of open intracranial 
wound, with no loss of consciousness 
Trauma 852.22 
ICD9CM 
Subdural hemorrhage following injury without mention of open intracranial 
wound, with brief [less than one hour] loss of consciousness 
Trauma 852.23 
ICD9CM 
Subdural hemorrhage following injury without mention of open intracranial 
wound, with moderate [1-24 hours] loss of consciousness 
Trauma 852.24 
ICD9CM 
Subdural hemorrhage following injury without mention of open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness and return to 
pre-existing conscious level 
Trauma 852.25 
ICD9CM 
Subdural hemorrhage following injury without mention of open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness without return 
to pre-existing conscious level 
Trauma 852.26 
ICD9CM 
Subdural hemorrhage following injury without mention of open intracranial 





Subdural hemorrhage following injury without mention of open intracranial 
wound, with concussion, unspecified 
Trauma 852.30 
ICD9CM 
Subdural hemorrhage following injury with open intracranial wound, unspecified 
state of consciousness 
Trauma 852.31 
ICD9CM 




Subdural hemorrhage following injury with open intracranial wound, with brief 
[less than one hour] loss of consciousness 
Trauma 852.33 
ICD9CM 
Subdural hemorrhage following injury with open intracranial wound, with 
moderate [1-24 hours] loss of consciousness 
Trauma 852.34 
ICD9CM 
Subdural hemorrhage following injury with open intracranial wound, with 




Subdural hemorrhage following injury with open intracranial wound, with 
prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 852.36 
ICD9CM 
Subdural hemorrhage following injury with open intracranial wound, with loss of 
consciousness of unspecified duration 
Trauma 852.39 
ICD9CM 




Extradural hemorrhage following injury without mention of open intracranial 
wound, unspecified state of consciousness 
Trauma 852.41 
ICD9CM 
Extradural hemorrhage following injury without mention of open intracranial 
wound, with no loss of consciousness 
Trauma 852.42 
ICD9CM 
Extradural hemorrhage following injury without mention of open intracranial 
wound, with brief [less than 1 hour] loss of consciousness 
Trauma 852.43 
ICD9CM 
Extradural hemorrhage following injury without mention of open intracranial 





Extradural hemorrhage following injury without mention of open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness and return to 
pre-existing conscious level 
Trauma 852.45 
ICD9CM 
Extradural hemorrhage following injury without mention of open intracranial 
wound, with prolonged [more than 24 hours] loss of consciousness without return 
to pre-existing conscious level 
Trauma 852.46 
ICD9CM 
Extradural hemorrhage following injury without mention of open intracranial 
wound, with loss of consciousness of unspecified duration 
Trauma 852.49 
ICD9CM 
Extradural hemorrhage following injury without mention of open intracranial 
wound, with concussion, unspecified 
Trauma 852.50 
ICD9CM 
Extradural hemorrhage following injury with open intracranial wound, unspecified 
state of consciousness 
Trauma 852.51 
ICD9CM 




Extradural hemorrhage following injury with open intracranial wound, with brief 
[less than one hour] loss of consciousness 
Trauma 852.53 
ICD9CM 
Extradural hemorrhage following injury with open intracranial wound, with 
moderate [1-24 hours] loss of consciousness 
Trauma 852.54 
ICD9CM 
Extradural hemorrhage following injury with open intracranial wound, with 




Extradural hemorrhage following injury with open intracranial wound, with 
prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 852.56 
ICD9CM 
Extradural hemorrhage following injury with open intracranial wound, with loss of 
consciousness of unspecified duration 
Trauma 852.59 
ICD9CM 






Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, unspecified state of consciousness 
Trauma 853.01 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, with no loss of consciousness 
Trauma 853.02 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, with brief [less than one hour] loss of consciousness 
Trauma 853.03 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, with moderate [1-24 hours] loss of consciousness 
Trauma 853.04 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, with prolonged [more than 24 hours] loss of 
consciousness and return to pre- existing conscious level 
Trauma 853.05 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, with prolonged [more than 24 hours] loss of 
consciousness without return to pre-existing conscious level 
Trauma 853.06 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, with loss of consciousness of unspecified duration 
Trauma 853.09 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury without mention of 
open intracranial wound, with concussion, unspecified 
Trauma 853.10 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury with open 
intracranial wound, unspecified state of consciousness 
Trauma 853.11 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury with open 
intracranial wound, with no loss of consciousness 
Trauma 853.12 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury with open 
intracranial wound, with brief [less than one hour] loss of consciousness 
Trauma 853.13 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury with open 





Other and unspecified intracranial hemorrhage following injury with open 
intracranial wound, with prolonged [more than 24 hours] loss of consciousness 
and return to pre-existing conscious level 
Trauma 853.15 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury with open 
intracranial wound, with prolonged [more than 24 hours] loss of consciousness 
without return to pre-existing conscious level 
Trauma 853.16 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury with open 
intracranial wound, with loss of consciousness of unspecified duration 
Trauma 853.19 
ICD9CM 
Other and unspecified intracranial hemorrhage following injury with open 
intracranial wound, with concussion, unspecified 
Trauma 854.00 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 
intracranial wound, unspecified state of consciousness 
Trauma 854.01 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 
intracranial wound, with no loss of consciousness 
Trauma 854.02 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 
intracranial wound, with brief [less than one hour] loss of consciousness 
Trauma 854.03 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 
intracranial wound, with moderate [1-24 hours] loss of consciousness 
Trauma 854.04 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 
intracranial wound, with prolonged [more than 24 hours] loss of consciousness 
and return to pre-existing conscious level 
Trauma 854.05 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 
intracranial wound, with prolonged [more than 24 hours] loss of consciousness 
without return to pre-existing conscious level 
Trauma 854.06 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 
intracranial wound, with loss of consciousness of unspecified duration 
Trauma 854.09 
ICD9CM 
Intracranial injury of other and unspecified nature without mention of open 





Intracranial injury of other and unspecified nature with open intracranial wound, 
unspecified state of consciousness 
Trauma 854.11 
ICD9CM 
Intracranial injury of other and unspecified nature with open intracranial wound, 
with no loss of consciousness 
Trauma 854.12 
ICD9CM 
Intracranial injury of other and unspecified nature with open intracranial wound, 
with brief [less than one hour] loss of consciousness 
Trauma 854.13 
ICD9CM 
Intracranial injury of other and unspecified nature with open intracranial wound, 
with moderate [1-24 hours] loss of consciousness 
Trauma 854.14 
ICD9CM 
Intracranial injury of other and unspecified nature with open intracranial wound, 
with prolonged [more than 24 hours] loss of consciousness and return to pre-
existing conscious level 
Trauma 854.15 
ICD9CM 
Intracranial injury of other and unspecified nature with open intracranial wound, 
with prolonged [more than 24 hours] loss of consciousness without return to pre-
existing conscious level 
Trauma 854.16 
ICD9CM 
Intracranial injury of other and unspecified nature with open intracranial wound, 
with loss of consciousness of unspecified duration 
Trauma 854.19 
ICD9CM 
Intracranial injury of other and unspecified nature with open intracranial wound, 
with concussion, unspecified 
Trauma 860.0 ICD9CM Traumatic pneumothorax without mention of open wound into thorax 
Trauma 860.1 ICD9CM Traumatic pneumothorax with open wound into thorax 
Trauma 860.2 ICD9CM Traumatic hemothorax without mention of open wound into thorax 
Trauma 860.3 ICD9CM Traumatic hemothorax with open wound into thorax 
Trauma 860.4 ICD9CM Traumatic pneumohemothorax without mention of open wound into thorax 
Trauma 860.5 ICD9CM Traumatic pneumohemothorax with open wound into thorax 
Trauma 861.00 ICD9CM Unspecified injury of heart without mention of open wound into thorax 
Trauma 861.01 ICD9CM Contusion of heart without mention of open wound into thorax 
Trauma 861.02 
ICD9CM 
Laceration of heart without penetration of heart chambers or without mention of 





Laceration of heart with penetration of heart chambers without mention of open 
wound into thorax 
Trauma 861.10 ICD9CM Unspecified injury of heart with open wound into thorax 
Trauma 861.11 ICD9CM Contusion of heart with open wound into thorax 
Trauma 861.12 
ICD9CM 




Laceration of heart with penetration of heart chambers with open wound into 
thorax 
Trauma 861.20 ICD9CM Unspecified injury of lung without mention of open wound into thorax 
Trauma 861.21 ICD9CM Contusion of lung without mention of open wound into thorax 
Trauma 861.22 ICD9CM Laceration of lung without mention of open wound into thorax 
Trauma 861.30 ICD9CM Unspecified injury of lung with open wound into thorax 
Trauma 861.31 ICD9CM Contusion of lung with open wound into thorax 
Trauma 861.32 ICD9CM Laceration of lung with open wound into thorax 
Trauma 862.0 ICD9CM Injury to diaphragm, without mention of open wound into cavity 
Trauma 862.1 ICD9CM Injury to diaphragm, with open wound into cavity 
Trauma 862.21 ICD9CM Injury to bronchus without mention of open wound into cavity 
Trauma 862.22 ICD9CM Injury to esophagus without mention of open wound into cavity 
Trauma 862.29 
ICD9CM 
Injury to other specified intrathoracic organs without mention of open wound into 
cavity 
Trauma 862.31 ICD9CM Injury to bronchus with open wound into cavity 
Trauma 862.32 ICD9CM Injury to esophagus with open wound into cavity 
Trauma 862.39 ICD9CM Injury to other specified intrathoracic organs with open wound into cavity 
Trauma 862.8 
ICD9CM 
Injury to multiple and unspecified intrathoracic organs, without mention of open 
wound into cavity 
Trauma 862.9 
ICD9CM 
Injury to multiple and unspecified intrathoracic organs, with open wound into 
cavity 
Trauma 863.0 ICD9CM Injury to stomach, without mention of open wound into cavity 
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Trauma 863.1 ICD9CM Injury to stomach, with open wound into cavity 
Trauma 863.20 ICD9CM Injury to small intestine, unspecified site, without open wound into cavity 
Trauma 863.21 ICD9CM Injury to duodenum, without open wound into cavity 
Trauma 863.29 ICD9CM Other injury to small intestine, without mention of open wound into cavity 
Trauma 863.30 ICD9CM Injury to small intestine, unspecified site, with open wound into cavity 
Trauma 863.31 ICD9CM Injury to duodenum, with open wound into cavity 
Trauma 863.39 ICD9CM Other injury to small intestine, with open wound into cavity 
Trauma 863.40 ICD9CM Injury to colon, unspecified site, without mention of open wound into cavity 
Trauma 863.41 ICD9CM Injury to ascending [right] colon, without mention of open wound into cavity 
Trauma 863.42 ICD9CM Injury to transverse colon, without mention of open wound into cavity 
Trauma 863.43 ICD9CM Injury to descending [left] colon, without mention of open wound into cavity 
Trauma 863.44 ICD9CM Injury to sigmoid colon, without mention of open wound into cavity 
Trauma 863.45 ICD9CM Injury to rectum, without mention of open wound into cavity 
Trauma 863.46 
ICD9CM 
Injury to multiple sites in colon and rectum, without mention of open wound into 
cavity 
Trauma 863.49 ICD9CM Other injury to colon or rectum, without mention of open wound into cavity 
Trauma 863.50 ICD9CM Injury to colon, unspecified site, with open wound into cavity 
Trauma 863.51 ICD9CM Injury to ascending [right] colon, with open wound into cavity 
Trauma 863.52 ICD9CM Injury to transverse colon, with open wound into cavity 
Trauma 863.53 ICD9CM Injury to descending [left] colon, with open wound into cavity 
Trauma 863.54 ICD9CM Injury to sigmoid colon, with open wound into cavity 
Trauma 863.55 ICD9CM Injury to rectum, with open wound into cavity 
Trauma 863.56 ICD9CM Injury to multiple sites in colon and rectum, with open wound into cavity 
Trauma 863.59 ICD9CM Other injury to colon or rectum, with open wound into cavity 
Trauma 863.80 
ICD9CM 
Injury to gastrointestinal tract, unspecified site, without mention of open wound 
into cavity 
Trauma 863.81 ICD9CM Injury to pancreas, head, without mention of open wound into cavity 
Trauma 863.82 ICD9CM Injury to pancreas, body, without mention of open wound into cavity 
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Trauma 863.83 ICD9CM Injury to pancreas, tail, without mention of open wound into cavity 
Trauma 863.84 
ICD9CM 
Injury to pancreas, multiple and unspecified sites, without mention of open wound 
into cavity 
Trauma 863.85 ICD9CM Injury to appendix, without mention of open wound into cavity 
Trauma 863.89 ICD9CM Injury to other gastrointestinal sites, without mention of open wound into cavity 
Trauma 863.90 ICD9CM Injury to gastrointestinal tract, unspecified site, with open wound into cavity 
Trauma 863.91 ICD9CM Injury to pancreas, head, with open wound into cavity 
Trauma 863.92 ICD9CM Injury to pancreas, body, with open wound into cavity 
Trauma 863.93 ICD9CM Injury to pancreas, tail, with open wound into cavity 
Trauma 863.94 ICD9CM Injury to pancreas, multiple and unspecified sites, with open wound into cavity 
Trauma 863.95 ICD9CM Injury to appendix, with open wound into cavity 
Trauma 863.99 ICD9CM Injury to other gastrointestinal sites, with open wound into cavity 
Trauma 864.00 ICD9CM Injury to liver without mention of open wound into cavity, unspecified injury 
Trauma 864.01 
ICD9CM 
Injury to liver without mention of open wound into cavity, hematoma and 
contusion 
Trauma 864.02 ICD9CM Injury to liver without mention of open wound into cavity, laceration, minor 
Trauma 864.03 ICD9CM Injury to liver without mention of open wound into cavity, laceration, moderate 
Trauma 864.04 ICD9CM Injury to liver without mention of open wound into cavity, laceration, major 
Trauma 864.05 ICD9CM Injury to liver without mention of open wound into cavity laceration, unspecified 
Trauma 864.09 ICD9CM Other injury to liver without mention of open wound into cavity 
Trauma 864.10 ICD9CM Injury to liver with open wound into cavity, unspecified injury 
Trauma 864.11 ICD9CM Injury to liver with open wound into cavity, hematoma and contusion 
Trauma 864.12 ICD9CM Injury to liver with open wound into cavity, laceration, minor 
Trauma 864.13 ICD9CM Injury to liver with open wound into cavity, laceration, moderate 
Trauma 864.14 ICD9CM Injury to liver with open wound into cavity, laceration, major 
Trauma 864.15 ICD9CM Injury to liver with open wound into cavity laceration, unspecified 
Trauma 864.19 ICD9CM Other injury to liver with open wound into cavity 





Injury to spleen without mention of open wound into cavity, hematoma without 
rupture of capsule 
Trauma 865.02 
ICD9CM 
Injury to spleen without mention of open wound into cavity, capsular tears, 
without major disruption of parenchyma 
Trauma 865.03 
ICD9CM 




Injury to spleen without mention of open wound into cavity, massive parenchymal 
disruption 
Trauma 865.09 ICD9CM Other injury into spleen without mention of open wound into cavity 
Trauma 865.10 ICD9CM Injury to spleen with open wound into cavity, unspecified injury 
Trauma 865.11 
ICD9CM 




Injury to spleen with open wound into cavity, capsular tears, without major 
disruption of parenchyma 
Trauma 865.13 
ICD9CM 
Injury to spleen with open wound into cavity, laceration extending into 
parenchyma 
Trauma 865.14 ICD9CM Injury to spleen with open wound into cavity, massive parenchyma disruption 
Trauma 865.19 ICD9CM Other injury to spleen with open wound into cavity 
Trauma 866.00 ICD9CM Injury to kidney without mention of open wound into cavity, unspecified injury 
Trauma 866.01 
ICD9CM 
Injury to kidney without mention of open wound into cavity, hematoma without 
rupture of capsule 
Trauma 866.02 ICD9CM Injury to kidney without mention of open wound into cavity, laceration 
Trauma 866.03 
ICD9CM 
Injury to kidney without mention of open wound into cavity, complete disruption of 
kidney parenchyma 
Trauma 866.10 ICD9CM Injury to kidney with open wound into cavity, unspecified injury 
Trauma 866.11 
ICD9CM 
Injury to kidney with open wound into cavity, hematoma without rupture of 
capsule 





Injury to kidney with open wound into cavity, complete disruption of kidney 
parenchyma 
Trauma 867.0 ICD9CM Injury to bladder and urethra, without mention of open wound into cavity 
Trauma 867.1 ICD9CM Injury to bladder and urethra, with open wound into cavity 
Trauma 867.2 ICD9CM Injury to ureter, without mention of open wound into cavity 
Trauma 867.3 ICD9CM Injury to ureter, with open wound into cavity 
Trauma 867.4 ICD9CM Injury to uterus, without mention of open wound into cavity 
Trauma 867.5 ICD9CM Injury to uterus, with open wound into cavity 
Trauma 867.6 ICD9CM Injury to other specified pelvic organs, without mention of open wound into cavity 
Trauma 867.7 ICD9CM Injury to other specified pelvic organs, with open wound into cavity 
Trauma 867.8 ICD9CM Injury to unspecified pelvic organ, without mention of open wound into cavity 
Trauma 867.9 ICD9CM Injury to unspecified pelvic organ, with open wound into cavity 
Trauma 868.00 
ICD9CM 
Injury to other intra-abdominal organs without mention of open wound into cavity, 
unspecified intra-abdominal organ 
Trauma 868.01 
ICD9CM 




Injury to other intra-abdominal organs without mention of open wound into cavity, 
bile duct and gallbladder 
Trauma 868.03 
ICD9CM 








Injury to other and multiple intra-abdominal organs without mention of open 
wound into cavity 
Trauma 868.10 
ICD9CM 
Injury to other intra-abdominal organs with open wound into cavity, unspecified 
intra-abdominal organ 





Injury to other intra-abdominal organs with open wound into cavity, bile duct and 
gallbladder 
Trauma 868.13 ICD9CM Injury to other intra-abdominal organs with open wound into cavity, peritoneum 
Trauma 868.14 
ICD9CM 
Injury to other intra-abdominal organs with open wound into cavity, 
retroperitoneum 
Trauma 868.19 ICD9CM Injury to other and multiple intra-abdominal organs, with open wound into cavity 
Trauma 869.0 
ICD9CM 
Internal injury to unspecified or ill-defined organs without mention of open wound 
into cavity 
Trauma 869.1 ICD9CM Internal injury to unspecified or ill-defined organs with open wound into cavity 
Trauma 905.0 ICD9CM Late effect of fracture of skull and face bones 
Trauma 905.1 ICD9CM Late effect of fracture of spine and trunk without mention of spinal cord lesion 
Trauma 905.2 ICD9CM Late effect of fracture of upper extremities 
Trauma 905.3 ICD9CM Late effect of fracture of neck of femur 
Trauma 905.4 ICD9CM Late effect of fracture of lower extremities 
Trauma 905.5 ICD9CM Late effect of fracture of multiple and unspecified bones 
Trauma 905.6 ICD9CM Late effect of dislocation 
Trauma 905.7 ICD9CM Late effect of sprain and strain without mention of tendon injury 
Trauma 905.8 ICD9CM Late effect of tendon injury 
Trauma 905.9 ICD9CM Late effect of traumatic amputation 
Trauma 906.0 ICD9CM Late effect of open wound of head, neck, and trunk 
Trauma 906.1 ICD9CM Late effect of open wound of extremities without mention of tendon injury 
Trauma 906.2 ICD9CM Late effect of superficial injury 
Trauma 906.3 ICD9CM Late effect of contusion 
Trauma 906.4 ICD9CM Late effect of crushing 
Trauma 906.5 ICD9CM Late effect of burn of eye, face, head, and neck 
Trauma 906.6 ICD9CM Late effect of burn of wrist and hand 
Trauma 906.7 ICD9CM Late effect of burn of other extremities 
Trauma 906.8 ICD9CM Late effect of burns of other specified sites 
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Trauma 906.9 ICD9CM Late effect of burn of unspecified site 
Trauma 907.0 ICD9CM Late effect of intracranial injury without mention of skull fracture 
Trauma 907.1 ICD9CM Late effect of injury to cranial nerve 
Trauma 907.2 ICD9CM Late effect of spinal cord injury 
Trauma 907.3 ICD9CM Late effect of injury to nerve root(s), spinal plexus(es), and other nerves of trunk 
Trauma 907.4 ICD9CM Late effect of injury to peripheral nerve of shoulder girdle and upper limb 
Trauma 907.5 ICD9CM Late effect of injury to peripheral nerve of pelvic girdle and lower limb 
Trauma 907.9 ICD9CM Late effect of injury to other and unspecified nerve 
Trauma 908.0 ICD9CM Late effect of internal injury to chest 
Trauma 908.1 ICD9CM Late effect of internal injury to intra-abdominal organs 
Trauma 908.2 ICD9CM Late effect of internal injury to other internal organs 
Trauma 908.3 ICD9CM Late effect of injury to blood vessel of head, neck, and extremities 
Trauma 908.4 ICD9CM Late effect of injury to blood vessel of thorax, abdomen, and pelvis 
Trauma 908.5 ICD9CM Late effect of foreign body in orifice 
Trauma 908.6 ICD9CM Late effect of certain complications of trauma 
Trauma 908.9 ICD9CM Late effect of unspecified injury 
Trauma 909.0 ICD9CM Late effect of poisoning due to drug, medicinal or biological substance 
Trauma 909.1 ICD9CM Late effect of toxic effects of nonmedical substances 
Trauma 909.2 ICD9CM Late effect of radiation 
Trauma 909.3 ICD9CM Late effect of complications of surgical and medical care 
Trauma 909.4 ICD9CM Late effect of certain other external causes 
Trauma 909.5 ICD9CM Late effect of adverse effect of drug, medicinal or biological substance 
Trauma 909.9 ICD9CM Late effect of other and unspecified external causes 
Trauma 926.11 ICD9CM Crushing injury of back 
Trauma 926.12 ICD9CM Crushing injury of buttock 
Trauma 929.0 ICD9CM Crushing injury of multiple sites, not elsewhere classified 
Trauma 929.9 ICD9CM Crushing injury of unspecified site 
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Trauma 952.00 ICD9CM C1-C4 level with unspecified spinal cord injury 
Trauma 952.01 ICD9CM C1-C4 level with complete lesion of spinal cord 
Trauma 952.02 ICD9CM C1-C4 level with anterior cord syndrome 
Trauma 952.03 ICD9CM C1-C4 level with central cord syndrome 
Trauma 952.04 ICD9CM C1-C4 level with other specified spinal cord injury 
Trauma 952.05 ICD9CM C5-C7 level with unspecified spinal cord injury 
Trauma 952.06 ICD9CM C5-C7 level with complete lesion of spinal cord 
Trauma 952.07 ICD9CM C5-C7 level with anterior cord syndrome 
Trauma 952.08 ICD9CM C5-C7 level with central cord syndrome 
Trauma 952.09 ICD9CM C5-C7 level with other specified spinal cord injury 
Trauma 952.10 ICD9CM T1-T6 level with unspecified spinal cord injury 
Trauma 952.11 ICD9CM T1-T6 level with complete lesion of spinal cord 
Trauma 952.12 ICD9CM T1-T6 level with anterior cord syndrome 
Trauma 952.13 ICD9CM T1-T6 level with central cord syndrome 
Trauma 952.14 ICD9CM T1-T6 level with other specified spinal cord injury 
Trauma 952.15 ICD9CM T7-T12 level with unspecified spinal cord injury 
Trauma 952.16 ICD9CM T7-T12 level with complete lesion of spinal cord 
Trauma 952.17 ICD9CM T7-T12 level with anterior cord syndrome 
Trauma 952.18 ICD9CM T7-T12 level with central cord syndrome 
Trauma 952.19 ICD9CM T7-T12 level with other specified spinal cord injury 
Trauma 952.2 ICD9CM Lumbar spinal cord injury without evidence of spinal bone injury 
Trauma 952.3 ICD9CM Sacral spinal cord injury without evidence of spinal bone injury 
Trauma 952.4 ICD9CM Cauda equina spinal cord injury without evidence of spinal bone injury 
Trauma 952.8 ICD9CM Multiple sites of spinal cord injury without evidence of spinal bone injury 
Trauma 952.9 ICD9CM Unspecified site of spinal cord injury without evidence of spinal bone injury 
Trauma 958.0 ICD9CM Air embolism 
Trauma 958.1 ICD9CM Fat embolism 
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Trauma 958.2 ICD9CM Secondary and recurrent hemorrhage 
Trauma 958.3 ICD9CM Posttraumatic wound infection not elsewhere classified 
Trauma 958.4 ICD9CM Traumatic shock 
Trauma 958.5 ICD9CM Traumatic anuria 
Trauma 958.6 ICD9CM Volkmann's ischemic contracture 
Trauma 958.7 ICD9CM Traumatic subcutaneous emphysema 
Trauma 958.8 ICD9CM Other early complications of trauma 
Trauma 958.90 ICD9CM Compartment syndrome, unspecified 
Trauma 958.91 ICD9CM Traumatic compartment syndrome of upper extremity 
Trauma 958.92 ICD9CM Traumatic compartment syndrome of lower extremity 
Trauma 958.93 ICD9CM Traumatic compartment syndrome of abdomen 
Trauma 958.99 ICD9CM Traumatic compartment syndrome of other sites 
Trauma 959.01 ICD9CM Head injury, unspecified 
Trauma 959.09 ICD9CM Injury of face and neck 
Trauma 959.11 ICD9CM Other injury of chest wall 
Trauma 959.12 ICD9CM Other injury of abdomen 
Trauma 959.13 ICD9CM Fracture of corpus cavernosum penis 
Trauma 959.14 ICD9CM Other injury of external genitals 
Trauma 959.19 ICD9CM Other injury of other sites of trunk 
Trauma 959.2 ICD9CM Shoulder and upper arm injury 
Trauma 959.3 ICD9CM Elbow, forearm, and wrist injury 
Trauma 959.4 ICD9CM Hand, except finger injury 
Trauma 959.5 ICD9CM Finger injury 
Trauma 959.6 ICD9CM Hip and thigh injury 
Trauma 959.7 ICD9CM Knee, leg, ankle, and foot injury 
Trauma 959.8 ICD9CM Other specified sites, including multiple injury 
Trauma 959.9 ICD9CM Unspecified site injury 
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Neurologic Impairment 344.60 ICD9CM Cauda equina syndrome without mention of neurogenic bladder 
Neurologic Impairment 729.2 ICD9CM Neuralgia, neuritis, and radiculitis, unspecified 
Imaging Study 72010 CPT Radiologic examination, spine, entire, survey study, anteroposterior and lateral 
Imaging Study 72020 CPT Radiologic examination, spine, single view, specify level 
Imaging Study 72052 CPT Radiologic examination, spine, cervical; 6 or more views 
Imaging Study 72100 CPT Radiologic examination, spine, lumbosacral; 2 or 3 views 
Imaging Study 72110 CPT Radiologic examination, spine, lumbosacral; minimum of 4 views 
Imaging Study 
72114 CPT 
Radiologic examination, spine, lumbosacral; complete, including bending views, 
minimum of 6 views 
Imaging Study 72120 CPT Radiologic examination, spine, lumbosacral; bending views only, 2 or 3 views 
Imaging Study 72200 CPT Radiologic examination, sacroiliac joints; less than 3 views 
Imaging Study 72202 CPT Radiologic examination, sacroiliac joints; 3 or more views 
Imaging Study 72220 CPT Radiologic examination, sacrum and coccyx, minimum of 2 views 
Imaging Study 72131 CPT Computed tomography, lumbar spine; without contrast material 
Imaging Study 72132 CPT Computed tomography, lumbar spine; with contrast material 
Imaging Study 
72133 CPT 
Computed tomography, lumbar spine; without contrast material, followed by 
contrast material(s) and further sections 
Imaging Study 
72141 CPT 
Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; 
without contrast material 
Imaging Study 
72142 CPT 
Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; 
with contrast material(s) 
Imaging Study 
72146 CPT 
Magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; 
without contrast material 
Imaging Study 
72147 CPT 
Magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; 
with contrast material(s) 
Imaging Study 
72148 CPT 
Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; 





Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; 
with contrast material(s) 
Imaging Study 
72156 CPT 
Magnetic resonance (eg, proton) imaging, spinal canal and contents, without 
contrast material, followed by contrast material(s) and further sequences; cervical 
Imaging Study 
72158 CPT 
Magnetic resonance (eg, proton) imaging, spinal canal and contents, without 
contrast material, followed by contrast material(s) and further sequences; lumbar 
Intraspinal Abscess 013.50 ICD9CM Tuberculous abscess of spinal cord, confirmation unspecified  
Intraspinal Abscess 
013.51 ICD9CM 
Tuberculous abscess of spinal cord, bacteriological or histological examination 
not done  
Intraspinal Abscess 
013.52 ICD9CM 
Tuberculous abscess of spinal cord, bacteriological or histological examination 
unknown (at present)  
Intraspinal Abscess 
013.53 ICD9CM 




Tuberculous abscess of spinal cord, tubercle bacilli not found (in sputum) by 
microscopy, but found by bacterial culture  
Intraspinal Abscess 
013.55 ICD9CM 
Tuberculous abscess of spinal cord, tubercle bacilli not found by bacteriological 
examination, but tuberculosis confirmed histologically  
Intraspinal Abscess 
013.56 ICD9CM 
Tuberculous abscess of spinal cord, tubercle bacilli not found by bacteriological 
or histological examination, but tuberculosis confirmed by other methods 
[inoculation of animals]  
Intraspinal Abscess 324.1 ICD9CM Intraspinal abscess of spinal cord  
Intraspinal Abscess 324.9 ICD9CM Intraspinal abscess of unspecified site  
HIV 042 ICD9CM Human immunodeficiency virus [HIV] disease 




Table 18 Variables of Interest with Description 
Dependent Variables Description 
Year of 
Data 
Enrollee Demographics   2012 
Age Member's age on 1/1/2012 2012 
Gender Most recent gender value of member 2012 
Female Female 2012 
Male Male 2012 
Neighborhood Effects   2012 
Rurality Member's rurality based upon Rural-Urban Commuting Area Codes 2012 
Urban Urban 2012 
Rural Rural 2012 
Race/Ethnicity   2012 
% White, non-Hispanic Percent of non-Hispanic White population at block level 2012 
% Hispanic Percent of Hispanic population at block level 2012 
% Black Percent of non-Hispanic Black population at block level 2012 
% Asian Percent of non-Hispanic Asian population at block level 2012 
% other Percent of other non-Hispanic population at block level 2012 
Education   2012 
% less than High School Percent of age 25+ population with less than high school education in block group 2012 
% High School but no Bachelor's 
degree 
Percent of age 25+ population with high school education but no bachelor's degree in block 
group 2012 
% Bachelor's degree or greater Percent of age 25+ population with bachelor's degree or graduate degree in block group 2012 
Median Household Income   2012 
Median income $0-$44,999 Percentage of households with median Household Income $0-$44,999 in census tract 2012 
Median income $45,000-$59,999 
Percentage of households with median Household Income $45,000-$59,999 in census 
tract 2012 
Median income $60,000-$74,999 
Percentage of households with median Household Income $60,000-$74,999 in census 
tract 2012 
Median income $75,000 and 
above 
Percentage of households with median Household Income $75,000 and above in census 
tract 2012 
Poverty Rate Percent of households with income below federal poverty limit in census tract 2012 
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Health risk measures   2011, 2012 
Health Status Member's health status based upon utilization level 2012 
Very healthy users No utilization 2012 
Healthy users Healthy users 2012 
Low health risk Low health risk 2012 
Moderate health risk Moderate health risk 2012 
High health risk High health risk 2012 
Very high health risk Very high health risk 2012 
Prior year Health Status Member's health status for the prior year based upon utilization level 2011 
Very healthy users No utilization 2011 
Healthy users Healthy users 2011 
Low health risk Low health risk 2011 
Moderate health risk Moderate health risk 2011 
High health risk High health risk 2011 
Very high health risk Very high health risk 2011 
Insurance Plan Design   2012 
Commercial Member's most recent insurance product is a commercial plan 2012 
High Deductible High deductible plan indicator 2012 
Medicaid/MSHO Member's most recent insurance product is a Medicaid or MSHO plan 2012 
Medicare Member's most recent insurance product is a Medicare plan 2012 
Provider Characteristics   2012 
Age Provider's age on 1/1/2012 2012 
40- years old 40- years old 2012 
40 to 49 years old 40 to 49 years old 2012 
50 to 59 years old 50 to 59 years old 2012 
60+ years old 60+ years old 2012 
Gender Gender of provider 2012 
Female Female 2012 
Male Male 2012 
State State of provider's servicing address 2012 
MN Minnesota 2012 
252 
 
WI Wisconsin 2012 
ND North Dakota 2012 
SD South Dakota 2012 
Rurality Provider's rurality of servicing address based upon Rural-Urban Commuting Area Codes 2012 
Urban Urban 2012 
Rural Rural 2012 
Credentialing Provider's credentialing based upon degree code and credentialing category 2012 
Physician extenders Registered Nurse Practitioner, Physician Assistant, Doctor of Chiropractic 2012 
Physician Doctor of Medicine, Doctors of Osteopathic Medicine, Ob-gynecologist 2012 
Specialty Provider's specialty category based upon specialty code and practice area  2012 
PCP Primary care provider 2012 
OB/GYN Ob-gynecologist 2012 
Orthopedist Orthopedist 2012 
Chiropractor Chiropractor 2012 




Table 19 Primary and Secondary RUCA Codes, 2010 
RUCA Code Description Category 
1   Metropolitan area core: primary flow within an urbanized area (UA)   
1.0 No additional code Urban 
1.1 Secondary flow 30% to 50% to a larger UA Urban 
2 Metropolitan area high commuting: primary flow 30% or more to a UA   
2.0 No additional code Urban 
2.1 Secondary flow 30% to 50% to a larger UA Urban 
3 Metropolitan area low commuting: primary flow 10% to 30% to a UA   
3.0 No additional code Urban 
4 Metropolitan area core: primary flow within an Urban Cluster of 10,000 to 49,999 (large UC)   
4.0 No additional code Rural 
4.1 Secondary flow 30% to 50% to a UA Urban 
5 Metropolitan high commuting: primary flow 30% or more to a large UC   
5.0 No additional code Rural 
5.1 Secondary flow 30% to 50% to a UA Urban 
6 Metropolitan low commuting: primary flow 10% to 30% to a large UC   
6.0 No additional code Rural 
7 Small town core: primary flow within an Urban Cluster of 2,500 to 9,999 (small UC)   
7.0 No additional code Rural 
7.1 Secondary flow 30% to 50% to a UA Urban 
7.2 Secondary flow 30% to 50% to a large UC Rural 
8 Small town high commuting: primary flow 30% or more to a small UC   
8.0 No additional code Rural 
8.1 Secondary flow 30% to 50% to a UA Urban 
8.2 Secondary flow 30% to 50% to a large UC Rural 
9 Small town low commuting: primary flow 10% to 30% to a small UC   
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9.0 No additional code Rural 
10 Rural areas: primary flow to a tract outside a UA or UC   
10.0 No additional code Rural 
10.1 Secondary flow 30% to 50% to a UA Urban 
10.2 Secondary flow 30% to 50% to a large UC Rural 
10.3 Secondary flow 30% to 50% to a small UC Rural 





Table 20 Evaluation and Management (E&M) CPT codes 
Value Set Name Code Code System Definition 
Evaluation and Management 99050 CPT Normal office visit - provided out of hours or alternate location 
Evaluation and Management 99053 CPT Normal office visit - provided out of hours or alternate location 
Evaluation and Management 99054 CPT Normal office visit - provided out of hours or alternate location 
Evaluation and Management 99056 CPT Normal office visit - provided out of hours or alternate location 
Evaluation and Management 99058 CPT Normal office visit - provided out of hours or alternate location 
Evaluation and Management 99201 CPT New patient - Office/OP 
Evaluation and Management 99202 CPT New patient - Office/OP 
Evaluation and Management 99203 CPT New patient - Office/OP 
Evaluation and Management 99204 CPT New patient - Office/OP 
Evaluation and Management 99205 CPT New patient - Office/OP 
Evaluation and Management 99211 CPT Established patient - Office/OP 
Evaluation and Management 99212 CPT Established patient - Office/OP 
Evaluation and Management 99213 CPT Established patient - Office/OP 
Evaluation and Management 99214 CPT Established patient - Office/OP 
Evaluation and Management 99215 CPT Established patient - Office/OP 
Evaluation and Management 99241 CPT Consultation Services - Office/OP (Medicare stopped recognizing 2010) 
Evaluation and Management 99342 CPT Consultation Services - Office/OP (Medicare stopped recognizing 2010) 
Evaluation and Management 99243 CPT Consultation Services - Office/OP (Medicare stopped recognizing 2010) 
Evaluation and Management 99244 CPT Consultation Services - Office/OP (Medicare stopped recognizing 2010) 
Evaluation and Management 99245 CPT Consultation Services - Office/OP (Medicare stopped recognizing 2010) 
Evaluation and Management 99324 CPT Domiciliary, rest home, custodial care - new patient 
Evaluation and Management 99325 CPT Domiciliary, rest home, custodial care - new patient 
Evaluation and Management 99326 CPT Domiciliary, rest home, custodial care - new patient 
Evaluation and Management 99327 CPT Domiciliary, rest home, custodial care - new patient 
Evaluation and Management 99328 CPT Domiciliary, rest home, custodial care - new patient 
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Evaluation and Management 99334 CPT Domiciliary, rest home, custodial care - established patient 
Evaluation and Management 99335 CPT Domiciliary, rest home, custodial care - established patient 
Evaluation and Management 99336 CPT Domiciliary, rest home, custodial care - established patient 
Evaluation and Management 99337 CPT Domiciliary, rest home, custodial care - established patient 
Evaluation and Management 99339 CPT Domiciliary, rest home, custodial care - care plan oversight 
Evaluation and Management 99340 CPT Domiciliary, rest home, custodial care - care plan oversight 
Evaluation and Management 99341 CPT Home visit - new patient 
Evaluation and Management 99342 CPT Home visit - new patient 
Evaluation and Management 99343 CPT Home visit - new patient 
Evaluation and Management 99344 CPT Home visit - new patient 
Evaluation and Management 99345 CPT Home visit - new patient 
Evaluation and Management 99347 CPT Home visit - established patient 
Evaluation and Management 99348 CPT Home visit - established patient 
Evaluation and Management 99349 CPT Home visit - established patient 
Evaluation and Management 99350 CPT Home visit - established patient 
Evaluation and Management 99354 CPT Prolonged care - OP 
Evaluation and Management 99355 CPT Prolonged care - OP 
Evaluation and Management 99374 CPT Physician supervision of a patient with HHC 
Evaluation and Management 99375 CPT Physician supervision of a patient with HHC 
Evaluation and Management 99381 CPT Preventive medicine - Initial visit 
Evaluation and Management 99382 CPT Preventive medicine - Initial visit 
Evaluation and Management 99383 CPT Preventive medicine - Initial visit 
Evaluation and Management 99384 CPT Preventive medicine - Initial visit 
Evaluation and Management 99385 CPT Preventive medicine - Initial visit 
Evaluation and Management 99386 CPT Preventive medicine - Initial visit 
Evaluation and Management 99387 CPT Preventive medicine - Initial visit 
Evaluation and Management 99391 CPT Preventive medicine - Periodic visit 
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Evaluation and Management 99392 CPT Preventive medicine - Periodic visit 
Evaluation and Management 99393 CPT Preventive medicine - Periodic visit 
Evaluation and Management 99394 CPT Preventive medicine - Periodic visit 
Evaluation and Management 99395 CPT Preventive medicine - Periodic visit 
Evaluation and Management 99396 CPT Preventive medicine - Periodic visit 
Evaluation and Management 99397 CPT Preventive medicine - Periodic visit 
Evaluation and Management 99441 CPT Telephone Services–Physician 
Evaluation and Management 99442 CPT Telephone Services–Physician 
Evaluation and Management 99443 CPT Telephone Services–Physician 




Table 21 Provider Place of Service (POS) Inclusion Criteria for Attribution 
POS Code POS Name Description 
3 School A facility whose primary purpose is education. 
5 Indian Health Service Free-standing Facility 
A facility or location whose primary purpose is to provide temporary housing to 
homeless individuals (e.g., emergency shelters, individual or family shelters).  
6 Indian Health Service Provider-based Facility 
A facility or location, owned and operated by the Indian Health Service, which 
provides diagnostic, therapeutic (surgical and non-surgical), and rehabilitation 
services rendered by, or under the supervision of, physicians to American 
Indians and Alaska Natives admitted as inpatients or outpatients 
11 Office 
Location, other than a hospital, skilled nursing facility (SNF), military treatment 
facility, community health center, State or local public health clinic, or 
intermediate care facility (ICF), where the health professional routinely 
provides health examinations, diagnosis, and treatment of illness or injury on 
an ambulatory basis.  
12 Home 
Location, other than a hospital or other facility, where the patient receives care 
in a private residence. 
13 Assisted Living Facility 
Congregate residential facility with self-contained living units providing 
assessment of each resident's needs and on-site support 24 hours a day, 7 
days a week, with the capacity to deliver or arrange for services including 
some health care and other services 
14 Group Home 
A residence, with shared living areas, where clients receive supervision and 
other services such as social and/or behavioral services, custodial service, 
and minimal services (e.g., medication administration).   
15 Mobile Unit 
A facility/unit that moves from place-to-place equipped to provide preventive, 
screening, diagnostic, and/or treatment services. 
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26 Military Treatment Facility 
A medical facility operated by one or more of the Uniformed Services. Military 
Treatment Facility (MTF) also refers to certain former U.S. Public Health 
Service (USPHS) facilities now designated as Uniformed Service Treatment 
Facilities (USTF). 
49 Independent Clinic 
A location, not part of a hospital and not described by any other Place of 
Service code, that is organized and operated to provide preventive, 
diagnostic, therapeutic, rehabilitative, or palliative services to outpatients only. 
50 Federally Qualified Health Center 
A facility located in a medically underserved area that provides Medicare 
beneficiaries preventive primary medical care under the general direction of a 
physician. 
71 Public Health Clinic 
A facility maintained by either State or local health departments that provides 
ambulatory primary medical care under the general direction of a physician. 
72 Rural Health Clinic 
 A certified facility that is located in a rural medically underserved area that 






Table 22 Provider Credentialing Inclusion Criteria for Attribution 
Health Care Services Credentialing Credentialing Description Credentialing Category 
Cervical Cancer Screening MD Doctor of Medicine Physician 
Cervical Cancer Screening DO Doctors of Osteopathic Medicine Physician 
Cervical Cancer Screening RNP Registered Nurse Practitioner Physician extender 
Cervical Cancer Screening PA Physician Assistant Physician extender 
Cervical Cancer Screening OBGYN Ob-gynecologist Physician 
Prostate Cancer Screening MD Doctor of Medicine Physician 
Prostate Cancer Screening DO Doctors of Osteopathic Medicine Physician 
Prostate Cancer Screening RNP Registered Nurse Practitioner Physician extender 
Prostate Cancer Screening PA Physician Assistant Physician extender 
Colorectal Cancer Screening MD Doctor of Medicine Physician 
Colorectal Cancer Screening DO Doctors of Osteopathic Medicine Physician 
Colorectal Cancer Screening RNP Registered Nurse Practitioner Physician extender 
Colorectal Cancer Screening PA Physician Assistant Physician extender 
Colorectal Cancer Screening OBGYN Ob-gynecologist Physician 
Low Back Pain Imaging MD Doctor of Medicine Physician 
Low Back Pain Imaging DO Doctors of Osteopathic Medicine Physician 
Low Back Pain Imaging RNP Registered Nurse Practitioner Physician extender 
Low Back Pain Imaging PA Physician Assistant Physician extender 
Low Back Pain Imaging OBGYN Ob-gynecologist Physician 





Table 23 Provider Specialty Inclusion Criteria for Attribution 
Health Care Services Specialty Code Specialty Description Specialty Category 
Cervical Cancer Screening 0001 Family practice Primary care provider 
Cervical Cancer Screening 0004 Internist Primary care provider 
Cervical Cancer Screening 0073 Family practice specialist Primary care provider 
Cervical Cancer Screening 0076 Internal medicine specialist Primary care provider 
Cervical Cancer Screening 0007 Ob-gynecologist Ob-gynecologist 
Cervical Cancer Screening 0074 Ob-gyn specialist Ob-gynecologist 
Cervical Cancer Screening 0012 Pediatrician Primary care provider 
Cervical Cancer Screening 0075 Pediatric specialist Primary care provider 
Prostate Cancer Screening 0001 Family practice Primary care provider 
Prostate Cancer Screening 0004 Internist Primary care provider 
Prostate Cancer Screening 0073 Family practice specialist Primary care provider 
Prostate Cancer Screening 0076 Internal medicine specialist Primary care provider 
Colorectal Cancer Screening 0001 Family practice Primary care provider 
Colorectal Cancer Screening 0004 Internist Primary care provider 
Colorectal Cancer Screening 0073 Family practice specialist Primary care provider 
Colorectal Cancer Screening 0076 Internal medicine specialist Primary care provider 
Colorectal Cancer Screening 0007 Ob-gynecologist Ob-gynecologist 
Colorectal Cancer Screening 0074 Ob-gyn specialist Ob-gynecologist 
Low Back Pain Imaging 0001 Family practice Primary care provider 
Low Back Pain Imaging 0004 Internist Primary care provider 
Low Back Pain Imaging 0007 Ob-gynecologist Other specialist 
Low Back Pain Imaging 0012 Pediatrician Primary care provider 
Low Back Pain Imaging 0005 Neurologist Other specialist 
Low Back Pain Imaging 0006 Neurosurgeon Other specialist 
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Low Back Pain Imaging 0009 Orthopedist Orthopedist 
Low Back Pain Imaging 0011 Pathologist Other specialist 
Low Back Pain Imaging 0014 Colon & Rectal Surgeon Other specialist 
Low Back Pain Imaging 0016 Radiologist Other specialist 
Low Back Pain Imaging 0017 General Surgeon        Other specialist 
Low Back Pain Imaging 0019 Urologist Other specialist 
Low Back Pain Imaging 0020 Anesthesiologist Other specialist 
Low Back Pain Imaging 0023 Rehabilitation Medicine         Other specialist 
Low Back Pain Imaging 0025 Cardiologist Other specialist 
Low Back Pain Imaging 0031 Nephrologist Other specialist 
Low Back Pain Imaging 0032 Rheumatologist Other specialist 
Low Back Pain Imaging 0033 Endocrinologist Other specialist 
Low Back Pain Imaging 0037 Vascular Surgeon       Other specialist 
Low Back Pain Imaging 0039 Emergency Medicine Other specialist 
Low Back Pain Imaging 0044 Chiropractic care Chiropractor 
Low Back Pain Imaging 0049 Special provider agreements Other specialist 
Low Back Pain Imaging 0057 Convenience Care        Other specialist 
Low Back Pain Imaging 0066 After hours clinic/Urgicenter Other specialist 
Low Back Pain Imaging 0083 Registered nurse - special services Other specialist 




Table 24 Sample Characteristics - Cervical cancer screening for young women 
Cervical Cancer Screening N Frequency Mean 
Dependent Variables       
Cervical cancer screening 54,146 2,587 4.8% 
HPV 54,146 1,254 2.3% 
Pap smear 28,761 1,493 5.2% 
Enrollee Demographics       
Age 54,146   20.2 
13-20 years old 54,146 28,761 53.1% 
21-29 years old 54,146 25,385 46.9% 
Health Status       
Healthy users 53,968 12,768 23.7% 
Low health risk 53,968 12,137 22.5% 
Moderate health risk 53,968 22,132 41.0% 
High health risk 53,968 6,931 12.8% 
Prior year Health Status       
Healthy users 46,610 13,881 29.8% 
Low health risk 46,610 11,071 23.8% 
Moderate health risk 46,610 16,597 35.6% 
High health risk 46,610 5,061 10.9% 
Frailty  53,968 1,417 2.6% 
Prior year Frailty  46,610 984 2.1% 
Prior year months enrolled 46,610   10.5 
Neighborhood Effects (49475/54145)       
Education       
% less than High School 49,475   8.2% 
% High School but no Bachelor's degree 49,475   59.2% 
% Bachelor's degree or greater 49,475   32.6% 
Race/Ethnicity       
% White, non-Hispanic 49,475   83.7% 
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% Hispanic 49,475   4.3% 
% Black 49,475   5.2% 
% Asian 49,475   3.8% 
% other 49,475   3.0% 
% speaking English only 49,475   89.6% 
% households with income below the fed'l poverty limit 49,475   10.4% 
% Foreign Born 49,475   7.0% 
Median Household Income ($) 49,475   67,546 
Median income $0-$44,999 49,475 10,767 21.8% 
Median income $45,000-$59,999 49,475 11,242 22.7% 
Median income $60,000-$74,999 49,475 10,262 20.7% 
Median income $75,000 and above 49,475 17,204 34.8% 
RUCA       
Urban 49,475 39,138 79.1% 
Rural 49,475 10,337 20.9% 
Product Type       
Commercial 54,146 45,528 84.1% 
High Deductible 24,353 16,211 66.6% 
Medicaid/Medicare 54,146 8,618 15.9% 
Self-insured 54,146 20,093 37.1% 
Provider Dependent Variables       
Cervical cancer screening 32,515 1,831 5.6% 
HPV 32,515 892 2.7% 
Pap smear 16,917 1,047 6.2% 
Provider Demographics       
Age 32,247   45.1 
Age (imputed) 32,515   45.1 
Gender       
Female 32,483 23,568 72.6% 
Male 32,483 8,915 27.4% 
Gender (imputed)       
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Female 32,515 23,569 72.5% 
Male 32,515 8,946 27.5% 
State       
MN 32,515 28,767 88.5% 
WI 32,515 1,547 4.8% 
ND 32,515 1,833 5.6% 
SD 32,515 368 1.1% 
RUCA       
Urban 22,837 18,579 81.4% 
Rural 22,837 4,258 18.6% 
RUCA (imputed)       
Urban 32,515 25,993 79.9% 
Rural 32,515 6,522 20.1% 
Credential       
Physician 32,515 22,802 70.1% 
Physician extenders 32,515 9,713 29.9% 
Specialty       
PCP 32,515 27,132 83.4% 
OB/GYN 32,515 5,383 16.6% 
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Table 25 Sample Characteristics - Prostate cancer screening for men 75 years and older 
Prostate Cancer Screening N Frequency Mean 
Dependent Variables       
Prostate Cancer Screening 18,168 2,522 13.9% 
Enrollee Demographics       
Age 18,168   80.2 
Health Status       
Healthy users 18,167 1,036 5.7% 
Low health risk 18,167 517 2.8% 
Moderate health risk 18,167 7,124 39.2% 
High health risk 18,167 9,490 52.2% 
Prior year Health Status       
Healthy users 16,476 984 6.0% 
Low health risk 16,476 568 3.4% 
Moderate health risk 16,476 6,997 42.5% 
High health risk 16,476 7,927 48.1% 
Frailty  18,167 3,402 18.7% 
Prior year Frailty  16,476 2,257 13.7% 
Prior year months enrolled 16,476   11.6 
Neighborhood Effects       
Education       
% less than High School 17,059   8.9% 
% High School but no Bachelor's degree 17,059   62.7% 
% Bachelor's degree or greater 17,059   28.5% 
Race/Ethnicity       
% White, non-Hispanic 17,059   90.9% 
% Hispanic 17,059   2.5% 
% Black 17,059   2.3% 
% Asian 17,059   2.1% 
% other 17,059   2.3% 
% speaking English only 17,059   92.1% 
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% households with income below the fed'l poverty limit 17,059   10.5% 
% Foreign Born 17,059   5.0% 
Median Household Income ($) 17,059   59,127 
Median income $0-$44,999 17,059 4,935 28.9% 
Median income $45,000-$59,999 17,059 5,195 30.5% 
Median income $60,000-$74,999 17,059 3,463 20.3% 
Median income $75,000 and above 17,059 3,466 20.3% 
RUCA       
Urban 17,059 9,933 58.2% 
Rural 17,059 7,126 41.8% 
Product Type       
Commercial 18,168 865 4.8% 
High Deductible 128 77 60.2% 
Medicaid/MSHO 18,168 1,444 7.9% 
Medicare 18,168 15,859 87.3% 
Self-insured 18,168 755 4.2% 
Provider Dependent Variables       
Prostate Cancer Screening 11,618 2,185 18.8% 
Provider Demographics       
Age 11,612   51.0 
Age (imputed) 11,618   51.0 
Gender       
Female 11,618 2,312 19.9% 
Male 11,618 9,306 80.1% 
Gender (imputed)       
Female 11,618 2,312 19.9% 
Male 11,618 9,306 80.1% 
State       
MN 11,618 9,514 81.9% 
WI 11,618 598 5.1% 
ND 11,618 743 6.4% 
SD 11,618 763 6.6% 
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RUCA       
Urban 10,753 7,200 67.0% 
Rural 10,753 3,553 33.0% 
RUCA (imputed)       
Urban 11,618 7,767 66.9% 
Rural 11,618 3,851 33.1% 
Credential       
Physician 11,618 10,216 87.9% 
Physician extenders 11,618 1,402 12.1% 
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Table 26 Sample Characteristics - Colorectal cancer screening for adults older than 75 years 
Colorectal Cancer Screening N Frequency Mean 
Dependent Variables       
Colorectal Cancer Screening 40,944 1,237 3.0% 
Colonoscopy 40,944 593 1.4% 
Enrollee Demographics       
Age 40,944   82.1 
Gender       
Female 40,944 24,947 39.1% 
Male 40,944 15,997 0.0% 
Health Status       
Healthy users 40,943 1,889 4.6% 
Low health risk 40,943 987 2.4% 
Moderate health risk 40,943 16,775 41.0% 
High health risk 40,943 21,292 52.0% 
Prior year Health Status       
Healthy users 37,516 1,872 5.0% 
Low health risk 37,516 1,202 3.2% 
Moderate health risk 37,516 16,803 44.8% 
High health risk 37,516 17,639 47.0% 
Frailty  40,943 9,354 22.8% 
Prior year Frailty  37,516 6,086 16.2% 
Prior year months enrolled 37,516   11.6 
Neighborhood Effects       
Education       
% less than High School 38,248   8.9% 
% High School but no Bachelor's degree 38,248   62.0% 
% Bachelor's degree or greater 38,248   29.1% 
Race/Ethnicity 38,248     
% White, non-Hispanic 38,248   90.3% 
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% Hispanic 38,248   2.6% 
% Black 38,248   2.6% 
% Asian 38,248   2.2% 
% other 38,248   2.4% 
% speaking English only 38,248   91.7% 
% households with income below the fed'l poverty limit 38,248   10.9% 
% Foreign Born 38,248   5.3% 
Median Household Income ($) 38,248   57,783 
Median income $0-$44,999 38,248 12,379 32.4% 
Median income $45,000-$59,999 38,248 11,159 29.2% 
Median income $60,000-$74,999 38,248 7,402 19.4% 
Median income $75,000 and above 38,248 7,308 19.1% 
RUCA       
Urban 38,248 23,215 60.7% 
Rural 38,248 15,033 39.3% 
Product Type       
Commercial 40,944 1,772 4.3% 
High Deductible 190 120 63.2% 
Medicaid/MSHO 40,944 5,379 13.1% 
Medicare 40,944 33,793 82.5% 
Self-insured 40,944 1,611 3.9% 
Provider Dependent Variables       
Colorectal Cancer Screening 26,612 997 3.7% 
Colonoscopy 26,612 438 1.6% 
Provider Demographics       
Age 26,602   50.2 
Age (imputed) 26,612   50.2 
Gender       
Female 26,612 17,239 64.8% 
Male 26,612 9,373 35.2% 
Gender (imputed)       
Female 26,612 17,239 64.8% 
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Male 26,612 9,373 35.2% 
State       
MN 26,612 22,221 83.5% 
WI 26,612 1,284 4.8% 
ND 26,612 1,462 5.5% 
SD 26,612 1,645 6.2% 
RUCA       
Urban 24,715 17,052 69.0% 
Rural 24,715 7,663 31.0% 
RUCA (imputed)       
Urban 26,612 18,318 68.8% 
Rural 26,612 8,294 31.2% 
Credential       
Physician 26,612 23,131 86.9% 




Table 27 Sample Characteristics - Imaging studies for non-specific low back pain 
Low Back Pain Imaging N Frequency Mean 
Dependent Variables       
Low back pain imaging 9,088 1,615 17.8% 
X-ray 9,088 1,609 17.7% 
CT 9,088 92 1.0% 
MRI 9,088 961 10.6% 
Enrollee Demographics       
Age 9,088   36.8 
18-29 years old 9,088   26.7% 
30-39 years old 11,492   33.7% 
40-50 years old 11,492   39.6% 
Gender       
Female 9,088 5,229 57.5% 
Male 9,088 3,859 42.5% 
Health Status       
Healthy users 9,085 121 1.3% 
Low health risk 9,085 1,019 11.2% 
Moderate health risk 9,085 5,896 64.9% 
High health risk 9,085 2,049 22.6% 
Prior year Health Status       
Healthy users 7,616 1,667 21.9% 
Low health risk 7,616 1,234 16.2% 
Moderate health risk 7,616 3,717 48.8% 
High health risk 7,616 998 13.1% 
Frailty  9,085 454 5.0% 
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Prior year Frailty  7,616 213 2.8% 
Prior year months enrolled 7,616   10.5 
Neighborhood Effects       
Education       
% less than High School 8,287   8.1% 
% High School but no Bachelor's degree 8,287   60.7% 
% Bachelor's degree or greater 8,287   31.2% 
Race/Ethnicity       
% White, non-Hispanic 8,287   86.0% 
% Hispanic 8,287   3.9% 
% Black 8,287   4.1% 
% Asian 8,287   3.1% 
% other 8,287   2.8% 
% speaking English only 8,287   90.7% 
% households with income below the fed'l poverty limit 8,287   9.7% 
% Foreign Born 8,287   6.1% 
Median Household Income ($) 8,287   66285 
Median income $0-$44,999 8,287 1,740 21.0% 
Median income $45,000-$59,999 8,287 2,003 24.2% 
Median income $60,000-$74,999 8,287 1,851 22.3% 
Median income $75,000 and above 8,287 2,693 32.5% 
RUCA       
Urban 8,287 6,184 74.6% 
Rural 8,287 2,103 25.4% 
Product Type       
Commercial 9,088 8,159 89.8% 
High Deductible 4,733 3,148 66.5% 
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Medicaid/Medicare 9,088 929 10.2% 
Self-insured 9,088 3,446 37.9% 
        
Provider Dependent Variables       
Low back pain imaging 8,287 1,458 17.6% 
X-ray 8,287 1,443 17.4% 
CT 8,287 82 1.0% 
MRI 8,287 889 10.7% 
Provider Demographics       
Age 7,985   45.5 
Age (imputed) 8,287   45.5 
Gender       
Female 8,178 2,417 29.6% 
Male 8,178 5,761 70.4% 
Gender (imputed)       
Female 8,287 2,417 29.2% 
Male 8,287 5,870 70.8% 
State       
MN 8,287 7,080 85.4% 
WI 8,287 389 4.7% 
ND 8,287 596 7.2% 
SD 8,287 222 2.7% 
RUCA       
Urban 6,320 4,455 70.5% 
Rural 6,320 1,865 29.5% 
RUCA (imputed)       
Urban 8,287 6,014 72.6% 
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Rural 8,287 2,273 27.4% 
Credential       
Physician 8,287 7,422 89.6% 
Physician extenders 8,287 865 10.4% 
Specialty       
PCP 8,287 2,948 35.6% 
Orthopedist 8,287 197 2.4% 
Chiropractor 8,287 4,049 48.9% 
other 8,287 1,093 13.2% 





























              Age 3.39 *** 3.93 *** 4.07 *** 4.03 *** 4.12 *** 4.06 *** 4.06 *** 
Neighborhood Effects 
              Rural 0.63 * 
    
1.10 * 
      % White, non-Hispanic 0.01 * 0.03 ** 0.02 
 
0.01 *** 0.03 ** 0.03 ** 0.03 ** 
% High School Degree -0.05 
 
-0.12 * -0.07 
 
-0.12 ** -0.11 ** -0.13 ** -0.13 ** 
% Bachelor's degree or 
greater -0.07 ** -0.13 ** -0.09 ** -0.13 *** -0.13 *** -0.14 *** -0.14 *** 
% households with income 
















Plan Type (Ref=Medicaid) 













 Prior Year Health Status 
              Healthy users 3.81 *** 0.57 








 Low health risk 3.98 *** 1.10 








 Moderate health risk 5.84 *** 1.56 * 
  
1.35 ** 1.31 * 1.12 
 
1.12 
 High health risk 10.01 *** 3.22 *** 
  
3.29 *** 3.28 *** 3.13 *** 3.13 *** 
Very high health risk 6.25 *** 3.06 








 Provider Characteristics 
              Age (Ref=40- years old) 




0.89 ** 0.87 * 0.87 * 0.92 * 0.92 ** 




0.83 * 0.72 
 
0.89 * 0.84 
 
0.84 * 















1.99 *** 1.50 *** 1.35 *** 1.57 *** 1.39 *** 1.39 *** 
Rural 
  
1.73 ** 1.10 * 
  
1.24 ** 1.50 ** 1.50 *** 
Credentialing 
(Ref=Physician extenders) 













 Specialty (Ref=PCP) 
              OB/GYN 
  
3.24 *** 2.52 *** 3.06 *** 
  














 Number of groups     3,750   6,551   6,148   6,148   6,148   6,148   
*** p<0.01, ** p<0.05, * p<0.1 





































              Age 0.37 *** 0.42 *** 0.47 *** 0.44 *** 0.46 *** 0.43 *** 0.43 *** 
Neighborhood Effects 
              Rural -0.22 
     
-0.04 




















































 Plan Type 













 Prior Year Health Status 






















 Moderate health risk 2.90 *** 
  
1.13 *** 1.10 *** 1.08 *** 1.14 *** 1.14 *** 






















 Provider Characteristics 
              Age 







































































              OB/GYN 
  
1.58 *** 1.60 *** 1.44 *** 
  














 Number of groups     9,284   5,117   8,773   8,773   8,773   8,773   
*** p<0.01, ** p<0.05, * p<0.1 
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            Age -1.36 *** -1.66 *** -1.70 *** -1.65 *** -1.67 *** -1.67 *** 
Neighborhood Effects 
            Rural -2.31 *** 
    
-0.05 












































 Plan Type 
            Commercial  -0.02 
 
-0.04 ** 0.04 
 
-0.05 *** -0.06 *** -0.06 *** 
Medicare 0.08 *** 0.07 *** 0.07 *** 0.07 *** 0.07 *** 0.07 *** 
Prior Year Health Status 
            Healthy users 
    
8.01 ** 9.03 ** 8.26 * 8.26 ** 
Low health risk 
  
9.40 * 13.10 *** 12.99 *** 11.31 *** 11.31 *** 
Moderate health risk 
  
10.43 ** 10.35 *** 9.92 *** 8.87 *** 8.87 *** 
High health risk 
  
11.47 ** 9.13 *** 8.62 *** 7.54 *** 7.54 *** 




5.72 ** 5.45 ** 3.84 
 
3.84 
 Provider Characteristics 
            Age 











 50 to 59 years old 
  
2.62 ** 2.67 * 2.74 ** 3.25 ** 3.25 *** 
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60+ years old 
  






















            Physician 
  












 Number of groups     3,564   3,011   3,408   3,408   3,408   
*** p<0.01, ** p<0.05, * p<0.1 


















































 Neighborhood Effects 
              Rural 0.46 * 
    
0.88 ** 











 % High School Degree -0.07 *** -0.13 *** -0.08 ** -0.12 *** -0.12 *** -0.13 *** -0.13 *** 
% Bachelor's degree or 
greater -0.04 
 
-0.09 *** -0.06 * -0.09 *** -0.09 *** -0.09 *** -0.09 *** 
% households with income 













 Plan Type 
              Commercial  0.14 ** -0.22 ** -0.43 ** -0.59 ** -0.60 ** -0.72 ** -0.72 ** 
Medicare 1.54 *** 1.16 *** 0.92 *** 1.05 *** 1.04 *** 0.96 ** 0.96 *** 
Prior Year Health Status 
              Healthy users 










 Low health risk 










 Moderate health risk 










 High health risk 










 Very high health risk 










 Provider Characteristics 
              Age 
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 60+ years old 
  
1.02 ** 0.74 
 
0.90 * 0.91 * 1.14 * 1.14 * 
Female 
  





1.28 *** 1.32 *** 
  
1.13 *** 1.17 *** 1.17 *** 
Credentialing 
              Physician 
  
1.03 *** 0.89 ** 0.89 ** 0.88 ** 0.81 ** 0.81 ** 
Specialty 
























 Number of groups     5,832   4,959   5,635   5,635   5,635   5,635   
*** p<0.01, ** p<0.05, * p<0.1 

































































 Neighborhood Effects 
              Rural -0.02 
     
0.23 







































 % households with income below FPL 0.00 *** 0.00 *** 0.00 ** 0.00 *** 0.00 *** 0.00 *** 0.00 *** 
Plan Type 


























 Prior Year Health Status 
              Healthy users 










 Low health risk 










 Moderate health risk 










 High health risk 
    
5.81 ** 4.76 ** 5.24 ** 4.60 ** 4.60 ** 
Very high health risk 










 Provider Characteristics 
              Age 








































-2.83 *** -2.82 ** -2.60 ** -0.30 
 

























              Orthopedist 
  
34.64 *** 33.03 *** 35.28 *** 
  
35.98 *** 35.98 *** 
Chiropractor 
  
-15.14 *** -14.39 *** -14.23 *** 
  



























 Number of groups     4,619   2,871   4,080   4,080   4,080   4,080   
*** p<0.01, ** p<0.05, * p<0.1 
              
